{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## CORD-19-Research-Data-Set-Atlas\n",
    "\n",
    "This workbook covers the process of querying data from a db hosted on Atlas.\n",
    "\n",
    "For this code to run, you'll need to create a MongoDB on Atlas named \"covid-19\" with a collection named \"noncomm-subset\". \n",
    "\n",
    "### Download data\n",
    "\n",
    "You can download the data from:\n",
    "\n",
    "https://pages.semanticscholar.org/coronavirus-research\n",
    "\n",
    "I'm using the non-commercial use subset (76mb download). To keep the example size manageable, I moved the first 70 records into the data directory of this repository. \n",
    "\n",
    "### Install Mongo\n",
    "\n",
    "https://docs.mongodb.com/manual/installation/\n",
    "\n",
    "### Mongo Client\n",
    "\n",
    "You may want to get familiar with the MongoDB client and CRUD operations before working with python. \n",
    "\n",
    "### Build an Atlas MongoDB from the CORD-19 Subset\n",
    "\n",
    "Build a database name \"covid-19\", and a collection named \"noncomm-subset\".\n",
    "\n",
    "Add records through (substitute in your username, password, and \n",
    "\n",
    "mongoimport --uri \"mongodb+srv://your_username:your_password@your_atlas_uri/covid-19\" --collection noncomm-subset --drop --file filename.json\n",
    "\n",
    "for example, to upload one file, mine would be (still redacting password and username)\n",
    "\n",
    "mongoimport --uri \"mongodb+srv://username:password@python-mongodb-workshop.unmjr.gcp.mongodb.net/covid-19\" --collection noncomm-subset --drop --file 1b58422e266ab9339c919119923229d080f27360.json \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "from pymongo import MongoClient"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "client = MongoClient()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "MDB_URL = \"mongodb+srv://python_workshop_user:python_workshop_pwd@python-mongodb-workshop-unmjr.gcp.mongodb.net/test\"\n",
    "client = MongoClient(MDB_URL)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['covid-19',\n",
       " 'sample_airbnb',\n",
       " 'sample_analytics',\n",
       " 'sample_geospatial',\n",
       " 'sample_mflix',\n",
       " 'sample_restaurants',\n",
       " 'sample_supplies',\n",
       " 'sample_training',\n",
       " 'sample_weatherdata',\n",
       " 'admin',\n",
       " 'local']"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "client.list_database_names()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "db = client.get_database(\"covid-19\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['noncomm-subset']"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "db.list_collection_names()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "pmc_content = db['noncomm-subset']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5f4ecb5cb752ba3f43f46c36'), 'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'cite_spans': [], 'ref_spans': [], 'section': 'Editorial'}, {'text': \"The Middle East Respiratory Syndrome (MERS) crisis in Korea is coming to an end, but that's not the end of the story. The World Health Organization (WHO) has warned that the MERS crisis was a 'wakeup call. ' Like Severe Acute Respiratory Syndrome (SARS) in 2003 and swine flu in 2009, epidemic outbreaks will continue to happen anywhere. Korea was simply unlucky. In retrospect, it is regrettable to say that we could have done much better. Scholars and colleagues in the medical informatics field should take a moment and think hard about how we can work to fight against another epidemic invasion in the future.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'The Ebola epidemic of 2013 is the largest such outbreak on record, influencing many nations in Africa as well as other countries [1] . The WHO expert panel has pointed out the inadequate emergency care response and has recommended more effective mechanisms for research and development. Others have strongly recommended WHO to innovate because recent Ebola outbreaks have been radically different from previous events, and they have tended to be simultaneous and parallel: \"Highly mobile populations, the spread of Ebola into densely populated cities ... made this epidemic of many outbreaks difficult to control [2] . \"', 'cite_spans': [{'start': 129, 'end': 132, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 613, 'end': 616, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': \"Other criticisms also include outdated therapeutic protocols, irrelevant information, untimely communication, delays in decision-making due to uncoordinated leadership, unreasonable social behavior, and so on. The recom- tems. The NEDSS can be called a medical informatics leader, which provides a standardized information infrastructure with HL7, LOINC, and SNOMED-CT. Highly useful information is well organized and ready to be used in the US-CDC [6] , so we don't have to reinvent the wheel. All we need is to find a conduit for connection. For example, the task of disease surveillance for MERS is relatively small compared to NEDSS. Using the cell phone data network, we can instantly establish a real-time patient tracking system to monitor 3-tuple data (time, location, temperature) in the country. Cell phone rental can help track down suspicious foreign visitors from arrival to departure. With the support of ISO standards, global healthcare networking is not a hard nut to crack.\", 'cite_spans': [{'start': 449, 'end': 452, 'text': '[6]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'When the MERS epidemic outbreak was on the headline news, many attempts were made to compare MERS with tuberculosis. That is, the mortality rate of MERS is far below that of tuberculosis, so it was argued that there was no need to worry about it. The point was clear, but the timing was not right. Have you ever got a thorn stuck under your fingernail? Saying that \"It\\'s OK you\\'re not bleeding\" or \"You won\\'t die from it\" would not comfort anybody at all. I would venture to say that it is surely mistaken to compare the pain at present with a probable outcome yet to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': 'When hospital visitors became MERS patients, a typical example of nosocomial infection was demonstrated. It was a surprise attack, and the whole country was shaken and panicked. The WHO experts reminded us that hospital shopping greatly contributed to the rapid spread of MERS in Korea. We have to understand why patients pursue hospital shopping. The death of professionalism may be an unexpected result of the fashionable social network services (SNS). Patients use SNSs to data-mine their own diagnosis and prescription and then seek medical advice to compare with their own ideas about their personal health. However, such patients suggesting their own diagnoses and treatments can be described as \"Jack of all trades, master of none\". Medical informatics leadership was nowhere to be found. When the MERS epidemic turned fatal, SNS was the only rescue. MERS was unknown to the general public, and the cure was uncertain, so chaos was bound to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In Korea medical informatics is on trial. We are standing in front of a river that runs medicine. IT has been trying to cross the river but has never been successful, especially in medical expert systems. The other side of the river is not the land of promise. Because the river of medicine eventu-ally runs into the ocean of the human race, why don't we go with the river instead? There is no doubt that doctors and nurses were the final frontiers in the MERS battle. Despite all the wonderful scientific accomplishments, the MERS crisis reminds us that clinical expertise is the most important value as clearly as ever. Technology can help medicine, not the other way around; that is the way medical informatics should go in between.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"Taoism states that dynamic balance can be obtained from two opposite powers competing with each other, unifying as a complete energy. Similarly, medical informatics should be able to balance between analog medicine and digital technology to create a new value. Medicine is composed of oldfashioned values, such as rapport, which is fading out slowly. Digital technology should help clinicians restore the humanistic flavor of medicine by eliminating managerial overload in healthcare settings. Technology can start from there. Neither Cyclops (the single-eyed monster in Homer's Odyssey) nor Argus (the 100-eyed giant in Greek mythology) is ideal to find the right path. Two-eyed medical informaticians must walk through the path on the mountain ridge, carefully looking at both sides of IT and medicine for balance.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In 1347, the first biological warfare took place in the siege of Caffa (now Feodosia in Ukraine) on the Black Sea coast. The Mongol army with bubonic plague catapulted corpse of those who had died from the Black Death over the city walls. Fleeing from central trading ports along the coast, infected inhabitants and rats may have carried the disease throughout Europe [7] (The plague might have killed more than 25 million people). A few regions survived. They simply closed their ports of entry and isolated patients in remote places. The same principle still applies. When in doubt, isolate an infection until it's clear. Time goes by, technology advances, but the basic principle never changes. Medicine should stay analog with a little hint of digital. That's all it takes to fight against any epidemic or pandemic attack in the future.\", 'cite_spans': [{'start': 368, 'end': 371, 'text': '[7]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Report of the Ebola Interim Assessment Panel', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"What we've learned about fighting Ebola\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Dhillon', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Srikrishna', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Harvard Business Review; c2015', 'authors': [{'first': '(', 'middle': [], 'last': 'Boston', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ma)', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The next epidemic: lessons from Ebola', 'authors': [{'first': 'B', 'middle': [], 'last': 'Gates', 'suffix': ''}], 'year': 2015, 'venue': 'N Engl J Med', 'volume': '372', 'issn': '15', 'pages': '1381--1385', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'US Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Centers for Disease Control and Prevention; c2015', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Digital disease detection: harnessing the Web for public health surveillance', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Brownstein', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Freifeld', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Madoff', 'suffix': ''}], 'year': 2009, 'venue': 'N Engl J Med', 'volume': '360', 'issn': '21', 'pages': '2153--2160', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'History of biological warfare and bioterrorism', 'authors': [{'first': 'V', 'middle': [], 'last': 'Barras', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Greub', 'suffix': ''}], 'year': 2014, 'venue': 'Clin Microbiol Infect', 'volume': '20', 'issn': '6', 'pages': '497--502', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': 'Hune Cho http://dx.doi.org/10.4258/hir.2015.21.3.141', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5f4ecb5ec3eee16b992c2bae'), 'paper_id': '00e5a723d44eb9f2698c38b518eff85c00f9753b', 'metadata': {'title': '', 'authors': [{'first': 'Vijay', 'middle': [], 'last': 'Harypursat', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chongqing Public Health Medical Center', 'location': {'postCode': '400036', 'settlement': 'Chongqing', 'country': 'China'}}, 'email': ''}, {'first': 'Yao-Kai', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chongqing Public Health Medical Center', 'location': {'postCode': '400036', 'settlement': 'Chongqing', 'country': 'China'}}, 'email': 'yaokaichen@hotmail.com'}, {'first': '', 'middle': [], 'last': 'Yao-Kai', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chongqing Public Health Medical Center', 'location': {'addrLine': '109 Baoyu Road, Shapingba District', 'postCode': '400036', 'settlement': 'Chongqing', 'country': 'China'}}, 'email': ''}, {'first': '', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Chongqing Public Health Medical Center', 'location': {'addrLine': '109 Baoyu Road, Shapingba District', 'postCode': '400036', 'settlement': 'Chongqing', 'country': 'China'}}, 'email': ''}]}, 'abstract': [], 'body_text': [{'text': 'Coronaviruses have in the past been known to be the etiologic agents of mild upper respiratory infections in humans, similar to the ubiquitous and relatively benign \"common cold\"-type upper respiratory illnesses induced by the human rhinoviruses in adults and children. Subsequent to the severe acute respiratory syndrome (SARS) outbreak in China 2003, and the Middle East respiratory syndrome (MERS) outbreak in the Middle East in 2012, global concerns regarding the pathogenicity and epidemic/ pandemic potential of novel human coronaviruses began to emerge, with some experts predicting that novel coronaviruses could likely again cross the species barrier and present humans with future pandemic-potential infections [1] . These concerns have proven prescient with the emergence, late in 2019, of the 2019 coronavirus disease or novel coronavirus pneumonia (NCP) outbreak, caused by SARS-CoV-2 (previously known as 2019-nCoV), in Wuhan, China.', 'cite_spans': [{'start': 721, 'end': 724, 'text': '[1]', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': ''}, {'text': 'A significantly large variety of coronavirus species cause a diverse range of diseases in domesticated and wild mammals and birds, and these animals may also be carriers of and reservoirs for coronaviruses [2] . Six coronavirus species had, prior to the 08 th January 2020, been known to cause disease in humans. Four species are endemic in human populations, and cause mild common cold symptoms in immunocompetent humans. The two remaining species, SARS-CoV and MERS-CoV, are zoonotic in origin, and their infection of humans may have fatal outcomes. SARS-CoV-2 is the seventh coronavirus species that is now known to infect humans, is also zoonotic in origin, and is the causative organism for the current viral pneumonia epidemic in China.', 'cite_spans': [{'start': 206, 'end': 209, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': ''}, {'text': 'Both SARS-CoV and MERS-CoV are believed to have originated from bats, with common masked civets and dromedary camels respectively being intermediary hosts [ 3] .', 'cite_spans': [{'start': 155, 'end': 159, 'text': '[ 3]', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': ''}, {'text': 'SARS-like coronaviruses have been isolated from Chinese horseshoe bats, and may attach to and utilize the angiotensin converting enzyme 2 (ACE2) receptor in human lower respiratory tract cells to gain entry into these cells, thus facilitating transmission to, and initiating infection in, humans [4] . The genomic sequence of SARS-CoV-2 is strikingly similar to that of SARS-like coronaviruses found in bats, and phylogenetic data from recent genomic studies on bat-associated coronaviruses and SARS-CoV-2 suggest that bats are the natural reservoir for coronaviruses in general, and SARS-CoV-2 in particular [5] . It has been postulated that the reservoir for SARS-CoV-2 is the Chinese horseshoe bat, which is known to host SARS-like coronaviruses. It is now hypothesized that one of the reservoir coronavirus species in bats crossed the species barrier to an intermediate mammal host (presumed to be a masked civet) sold at the wet market at the epicenter of the current epidemic, with subsequent mutation and transmission to humans, initiating the present epidemic of COVID-19.', 'cite_spans': [{'start': 296, 'end': 299, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 609, 'end': 612, 'text': '[5]', 'ref_id': 'BIBREF4'}], 'ref_spans': [], 'section': ''}, {'text': 'It has been noted that the two previously known human coronaviruses causing epidemic disease and spread, SARS-CoV and MERS-CoV, had a relatively low rate of spread from an individual infected patient (an index referred to as its basic reproductive number-R。). The R。of SARS was estimated to be around 3, meaning that on average, each infected patient is presumed to spread the virus to 3 other individuals [6] . It is currently estimated that the R。for SARS-CoV-2 is between 2.2 and 2.7 [6, 7] . However, approximately 10% of individuals infected with SARS-CoV and MERS-CoV were associated with a phenomenon referred to as \"super spreading\", associated with an R。>10 [8] . Wide transmission and spread of SARS-CoV and MERS-CoV occurred to a large extent by means of super-spreading events [8] . Human super spreaders for SARS-CoV-2 have not been identified thus far in limited epidemiological studies conducted in the past six weeks of the outbreak [6] . However, clinicians and researchers should be acutely aware of the likelihood for the potential existence of such transmitters of SARS-CoV-2 infection in the general population, and of the means to identify and isolate such individuals expeditiously in order to prevent a reduction of the current epidemic doubling time of approximately 7 days, and to limit viral transmission and spread [7] . A compelling mathematical modeling study done by researchers at Hong persons, and that if there was no reduction in viral transmissibility, the epidemic in Wuhan would peak at around April 2020 [7] . Ominously, a further mathematical model, proposed by Tang et al, [9] suggests that the basic reproductive number for SARS-CoV-2 might be as high as 6.47. outbreak to the global economy will, without doubt, be scrupulously studied after the present outbreak ends, and the global economic costs will be immense, and the human cost, agonizing. Each preventable zoonotic outbreak costs the country of origin and the world vast amounts of money and resources, and an inestimable cost in human lives, and if emerging zoonotic outbreaks can be prevented by severely limiting human exposure to wild animals and their trade, then effective measures to ensure that this occurs should be implemented by regulatory government authorities globally as soon as it is practicable.', 'cite_spans': [{'start': 406, 'end': 409, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 487, 'end': 490, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 491, 'end': 493, 'text': '7]', 'ref_id': 'BIBREF6'}, {'start': 667, 'end': 670, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 789, 'end': 792, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 949, 'end': 952, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 1343, 'end': 1346, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 1543, 'end': 1546, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 1614, 'end': 1617, 'text': '[9]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': ''}, {'text': 'It is clearly apparent that the work done thus far in the quest to contain the current SARS-CoV-2 outbreak is massive, focused and resolute. It is also abundantly evident that a large quantum of work remains to be done in order for the current public health effort to be successful in containing the present outbreak. Managing this requires international cooperation using traditional and proven public health strategies that ultimately succeeded inthe SARS epidemic. It is, however, inevitable that new zoonotic infections will emerge in the future. It is therefore an urgent priority for local and international health and wildlife regulatory authorities to structure and implement robust control mechanisms that effectively reduce human exposure to wild game meat and their products. In contrast to Africa, the consumption of wild game meat in Asia is not generally motivated by poverty, hunger or starvation. The common motivations for the human consumption of wild game meat in Asia are for their purported medicinal value, and the supposed health-enhancing effects of certain varieties of wild game meat, or their products. Specific rare and exotic Asian and other international wild game and their products, are also consumed and offered to guests and influential persons in an effort project status, prestige and wealth, depending on the rarity of the animal involved.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'There is also the existence of wildlife trafficking between Asia and other regions of the world, which has created an international supply and demand chain, with savvy wildlife entrepreneurs marketing wild game meat and products as \"traditional specialties\", in their effort to boost sales. The existence of local and international wildlife trade for meat and animal products needs urgent and decisive change. It is fervently hoped that the steadfast efforts by China, in partnership with the international community, will reap positive results with respect to SARS-CoV-2 control in the future weeks and months. Additionally, urgent international attention to and curtailment of the hitherto unregulated and commonplace trade in wild game, meat and products is essential if a repeat of the human and economic loss, and public fear and social disruption wreaked by the current SARS-CoV-2 outbreak is to be avoided in the future. ', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'None', 'cite_spans': [], 'ref_spans': [], 'section': 'Conflict of Interest'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential', 'authors': [{'first': 'E', 'middle': [], 'last': 'Kindler', 'suffix': ''}, {'first': 'H', 'middle': ['R'], 'last': 'Jonsdottir', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Muth', 'suffix': ''}, {'first': 'O', 'middle': ['J'], 'last': 'Hamming', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Hartmann', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Rodriguez', 'suffix': ''}], 'year': 2013, 'venue': '', 'volume': '4', 'issn': '', 'pages': '611--00612', 'other_ids': {'DOI': ['10.1128/mBio.00611-12']}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'The battle against SARS and MERS coronaviruses: Reservoirs and Animal Models', 'authors': [{'first': 'S', 'middle': ['R'], 'last': 'Gong', 'suffix': ''}, {'first': 'L', 'middle': ['L'], 'last': 'Bao', 'suffix': ''}], 'year': 2018, 'venue': 'Animal Model Exp Med', 'volume': '1', 'issn': '', 'pages': '125--133', 'other_ids': {'DOI': ['10.1002/ame2.12017']}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Clinical features of patients infected with 2019 novel coronavirus in Wuhan', 'authors': [{'first': 'C', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ren', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Hu', 'suffix': ''}], 'year': 2020, 'venue': 'China. Lancet', 'volume': '', 'issn': '20', 'pages': '30183--30188', 'other_ids': {'DOI': ['10.1016/S0140-6736(20)30183-5']}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor', 'authors': [{'first': 'X', 'middle': ['Y'], 'last': 'Ge', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Li', 'suffix': ''}, {'first': 'X', 'middle': ['L'], 'last': 'Yang', 'suffix': ''}, {'first': 'A', 'middle': ['A'], 'last': 'Chmura', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Zhu', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Epstein', 'suffix': ''}], 'year': 2013, 'venue': 'Nature', 'volume': '503', 'issn': '', 'pages': '535--538', 'other_ids': {'DOI': ['10.1038/nature12711']}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding', 'authors': [{'first': 'R', 'middle': [], 'last': 'Lu', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Zhao', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Niu', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wu', 'suffix': ''}], 'year': 2020, 'venue': 'The Lancet', 'volume': '', 'issn': '20', 'pages': '30251--30259', 'other_ids': {'DOI': ['10.1016/S0140-6736(20']}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia', 'authors': [{'first': 'Q', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Guan', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Wu', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Zhou', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Tong', 'suffix': ''}], 'year': 2020, 'venue': 'N Engl J Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1056/NEJMoa2001316']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study', 'authors': [{'first': 'J', 'middle': ['T'], 'last': 'Wu', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Lk', 'suffix': ''}, {'first': 'G', 'middle': ['M'], 'last': 'Leung', 'suffix': ''}], 'year': 2020, 'venue': 'The Lancet', 'volume': '', 'issn': '20', 'pages': '30260--30269', 'other_ids': {'DOI': ['10.1016/S0140-6736(20']}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'the role of super-spreaders in infectious disease', 'authors': [{'first': 'G', 'middle': [], 'last': 'Wong', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Zhou', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Bi', 'suffix': ''}, {'first': 'G', 'middle': ['F'], 'last': 'Gao', 'suffix': ''}, {'first': 'Sars', 'middle': [], 'last': 'Mers', 'suffix': ''}, {'first': 'Ebola', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2015, 'venue': 'Cell host & microbe', 'volume': '18', 'issn': '', 'pages': '398--401', 'other_ids': {'DOI': ['10.1016/j.chom.2015.09.013']}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions', 'authors': [{'first': 'B', 'middle': [], 'last': 'Tang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'Q', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'N', 'middle': ['L'], 'last': 'Bragazzi', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Tang', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Xiao', 'suffix': ''}], 'year': None, 'venue': 'Journal of Clinical Medicine', 'volume': '2020', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.3390/jcm9020462']}}, 'BIBREF9': {'ref_id': 'b9', 'title': \"Economic Impact of the 2015 MERS Outbreak on the Republic of Korea's Tourism-Related Industries. Health security\", 'authors': [{'first': 'H', 'middle': [], 'last': 'Joo', 'suffix': ''}, {'first': 'B', 'middle': ['A'], 'last': 'Maskery', 'suffix': ''}, {'first': 'A', 'middle': ['D'], 'last': 'Berro', 'suffix': ''}, {'first': 'L', 'middle': ['D'], 'last': 'Rotz', 'suffix': ''}, {'first': 'Y-K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'Brown', 'suffix': ''}], 'year': 2019, 'venue': '', 'volume': '17', 'issn': '', 'pages': '100--108', 'other_ids': {'DOI': ['10.1089/hs.2018.0115']}}}, 'ref_entries': {'FIGREF0': {'text': 'University indicates, despite limitations to their study, that these figures may not be a fair representation of the actual scale of the SARS-CoV-2 outbreak in China. Their figures estimated that the total number of infected individuals in greater Wuhan alone on the 25th January 2020 was 75,815 (95% confidence interval [CI] 37,304-130,330)', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'The putative zoonotic origin of SARS-CoV-2, and the zoonotic origins of the SARS and MERS epidemics, brings into sharp focus the existence of unregulated wet markets in China, trading in live wild game, game meat and game products. Zoonotic origins for emerging viral infections are not new, with AIDS, Ebola, influenza viruses, SARS, MERS, and a multitude of other viral illnesses all crossing the species barrier and causing devastating illness in humans, at enormous economic and human cost[10] . The presence and availability of markets that trade in wild animals for human consumption, and for purchase as pets, greatly increases the potential for viral infections originatingfrom these reservoir animals to jump to human populations. The complete ban on market trading and sale of wild game meat in China on 26 th January 2020 will help prevent zoonotic transmission of SARS-CoV-2 in the current epidemic and, to a certain degree, help prevent emergence of new zoonotic infections. Further social and cultural changes regarding wild game trading and consumption is required in China and worldwide, to prevent scenarios where regular emergence of zoonotic infections becomes commonplace, with their inevitably attendant economic and human costs. It is estimated that the SARS epidemic cost the global economy approximately $US 54 billion in 2003 alone. The 2015 MERS outbreak in the Republic of Korea resulted in a $US 2.6 billion loss for the South Korean tourism industry alone. The 2014 outbreak of Ebola in Guinea, Liberia and Sierra Leone costed their already lean economies approximately $US 300 million. The human and economic costs of the SARS-CoV-2', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'This work was supported by grants from the National Science and Technology Major Project of China during the 13th Five-year Plan Period (No.2018ZX10302104) and the Chongqing Special Research Project for Prevention and Control of Novel Coronavirus Pneumonia (the grant number is unavailable currently).', 'latex': None, 'type': 'figure'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5f4ecb5f0e8ef23a9d9c7eae'), 'paper_id': '01aa247284f0baf43293d8ea335b70781365a985', 'metadata': {'title': 'Comparative Evaluation of Three Homogenization Methods for Isolating Middle East Respiratory Syndrome Coronavirus Nucleic Acids From Sputum Samples for Real-Time Reverse Transcription PCR', 'authors': [{'first': 'Heungsup', 'middle': [], 'last': 'Sung', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Dongeun', 'middle': [], 'last': 'Yong', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Chang-Seok', 'middle': [], 'last': 'Ki', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Jae-Seok', 'middle': [], 'last': 'Kim', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Moon-Woo', 'middle': [], 'last': 'Seong', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Hyukmin', 'middle': [], 'last': 'Lee', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Mi-Na', 'middle': [], 'last': 'Kim', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [{'text': 'Background: Real-time reverse transcription PCR (rRT-PCR) of sputum samples is commonly used to diagnose Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Owing to the difficulty of extracting RNA from sputum containing mucus, sputum homogenization is desirable prior to nucleic acid isolation. We determined optimal homogenization methods for isolating viral nucleic acids from sputum.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'We evaluated the following three sputum-homogenization methods: proteinase K and DNase I (PK-DNase) treatment, phosphate-buffered saline (PBS) treatment, and Nacetyl-L-cysteine and sodium citrate (NALC) treatment. Sputum samples were spiked with inactivated MERS-CoV culture isolates. RNA was extracted from pretreated, spiked samples using the easyMAG system (bioMérieux, France). Extracted RNAs were then subjected to rRT-PCR for MERS-CoV diagnosis (DiaPlex Q MERS-coronavirus, SolGent, Korea).', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'Results: While analyzing 15 spiked sputum samples prepared in technical duplicate, false-negative results were obtained with five (16.7%) and four samples (13.3%), respectively, by using the PBS and NALC methods. The range of threshold cycle (Ct) values observed when detecting upE in sputum samples was 31.1-35.4 with the PK-DNase method, 34.7-39.0 with the PBS method, and 33.9-38.6 with the NALC method. Compared with the control, which were prepared by adding a one-tenth volume of 1:1,000 diluted viral culture to PBS solution, the ranges of Ct values obtained by the PBS and NALC methods differed significantly from the mean control Ct of 33.2 (both P < 0.0001).', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'The PK-DNase method is suitable for homogenizing sputum samples prior to RNA extraction. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'irrespective of the length of time between symptom onset and sample collection [2] . Real-time reverse transcription PCR (rRT-PCR) with sputum samples is commonly used to diagnose MERS-CoV infection.', 'cite_spans': [{'start': 79, 'end': 82, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'If a negative result is obtained for patients with a high index of suspicion for MERS-CoV infection, additional samples should be collected and tested [3] . A series of negative results does not rule out the possibility of MERS-CoV infection [1, 3] . Possible explanations for false-negative MERS-CoV test results include low viral load very early or late in the illness, inadequate sputum samples due to poor sample collection from patients with dry cough or no cough, inappropriate sample handling or shipping, and technical issues, such as viral genome mutation or PCR inhibition [3] . Sufficient nucleic acid extraction and the removal of substances that inhibit amplification are critical factors influencing the detection of MERS-CoV by rRT-PCR [4] . However, rRT-PCR of sputum samples yields conflicting results owing to the difficulty of extracting RNA from sputum containing mucus. Many reports have indicated that lower respiratory samples such as bronchoalveolar lavage (BAL) fluid and sputum contain the highest viral loads [3, [5] [6] [7] . However, one report indicated that no significant difference occurred in viral load cycle threshold (Ct) values between sputa and nasopharyngeal aspirates (NPAs) [8] . For this reason, sputum sample homogenization is desirable prior to isolating nucleic acids for MERS-CoV rRT-PCR. In this study, we compared three different sputum homogenization methods and identified an optimal homogenization method prior to the nucleic acid isolation from sputum samples.', 'cite_spans': [{'start': 151, 'end': 154, 'text': '[3]', 'ref_id': None}, {'start': 242, 'end': 245, 'text': '[1,', 'ref_id': 'BIBREF0'}, {'start': 246, 'end': 248, 'text': '3]', 'ref_id': None}, {'start': 583, 'end': 586, 'text': '[3]', 'ref_id': None}, {'start': 751, 'end': 754, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 1036, 'end': 1039, 'text': '[3,', 'ref_id': None}, {'start': 1040, 'end': 1043, 'text': '[5]', 'ref_id': None}, {'start': 1044, 'end': 1047, 'text': '[6]', 'ref_id': 'BIBREF6'}, {'start': 1048, 'end': 1051, 'text': '[7]', 'ref_id': 'BIBREF7'}, {'start': 1216, 'end': 1219, 'text': '[8]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': \"Forty-eight consecutive sputum samples sent to the laboratory for MERS-CoV rRT-PCR testing were evaluated in terms of the number of white blood cells, squamous epithelial cells, and ciliated columnar epithelial cells. The sputum samples were graded by using Murray and Washington's grading system [9] .\", 'cite_spans': [{'start': 297, 'end': 300, 'text': '[9]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Sputum quality'}, {'text': 'An inactivated viral culture of MERS-CoV was provided by the Division of Respiratory Viruses (Center for Infectious Diseases, Korean National Institute of Health, Korean Center for Disease Control). The Korean National Institute of Health did not disclose the exact titer of the cultured MERS-CoV. Since other viral respiratory pathogens and bacterial pathogens should be considered during diagnosis [2] , we evaluated whether the three homogenization methods have an adverse impact on the detection of other respiratory viruses. For this reason, we evaluated three homogenization methods using NPA samples that were found to contain various respiratory viruses using the Anyplex II RV16 Detection kit (Seegene, Seoul, Korea). Next, we evaluated the three homogenization methods using sputum samples spiked with a 1:10 or 1:1,000 dilution of viral culture mixed with an identical volume of sputum. Finally, we evaluated each homogenization method using virus-spiked sputum samples prepared by adding one volume of 1:100 diluted inactivated viral culture to nine volumes of clinical sample (i.e., sputum or BAL).', 'cite_spans': [{'start': 400, 'end': 403, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'Preparation of virus-spiked sputum samples'}, {'text': \"Sputum samples were pretreated by using one of three methods. The first method involved proteinase K and DNase I treatment (PK-DNase), as recommended by the NucliSENS easy-MAG protocol (bioMérieux SA, Marcy-l'Etoile, France). One hundred microliters of proteinase K (1 mg proteinase K/1 mL proteinase K buffer; Promega, Madison, WI, USA) was added to 100 µL of sample and incubated for 15 min at 55°C. The samples were mixed by vortexing every 5 min. Subsequently, a 20-µL of DNase I solution (1 U/µL) was added for every 100 µL of sample, followed by incubation at 37°C for 30 min. In the second method, sputum samples were mixed with an equal volume of phosphate-buffered saline (PBS). In the third method, the sputum samples were mixed with an equal volume of N-acetyl-L-cysteine (NALC) in sodium citrate solution (prepared by dissolving 0.5g NALC in each 100 mL of 1.47% sodium citrate solution). Following the second and third methods, the samples were mixed by vortexing for 1 min.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Sputum-homogenization methods'}, {'text': \"RNA was extracted as described previously [10] by using the NucliSENS easyMAG system (bioMérieux SA, Marcy-l'Etoile, France). RNA from each pretreated sample (500 µL) was eluted in a 50-μL volume. Extracted RNA was tested by rRT-PCR using Anyplex II RV16 Detection kit (Seegene) for the preliminary test, or by rRT-PCR using DiaPlexQ MERS Virus Detection kit (Sol-Gent, Daejeon, Korea) with Bio-Rad CFX96 instrument (Bio-Rad, Hercules, CA, USA). The sequences of the primers and probes used with the DiaPlexQ kit covered the same general regions of the upE and ORF1a transcripts.\", 'cite_spans': [{'start': 42, 'end': 46, 'text': '[10]', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'RNA extraction and MERS-CoV rRT-PCR testing'}, {'text': 'Quantitative results were expressed as mean ± SD, and groups were compared by using the one-sample t-test. P values < 0.05 were considered statistically significant. MedCalc software version 16.2 (MedCalc Software bvba, Ostend, Belgium) was used for statistical analysis.', 'cite_spans': [], 'ref_spans': [], 'section': 'Statistical analysis'}, {'text': \"According to Murray and Washington's grading system [9] , among the 48 sputum samples tested, 18 (37.5%) belonged to group 1, 6 (12.5%) belonged to group 3, 2 (4.2%) belonged to group 4, 5 (10.4%) belonged to group 5, and 17 (35.4%) belonged to group 6. Thirty-two samples (66.7%), including 20 from groups 1-3, harbored a detectable quantity of ciliated columnar epithelial cells. Seventeen samples (35.4%) harbored identifiable proteinaceous mucous threads (viewed via light microscopy).\", 'cite_spans': [{'start': 52, 'end': 55, 'text': '[9]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'RESULTS'}, {'text': 'The efficacies of the three homogenization methods tested with NPA samples are summarized in Table 1 . For DNA respiratory viruses (such as adenovirus and human bocavirus), PK-DNase treatment caused a slight increase in Ct values compared with PBS or NALC treatment. When we additionally tested six adenovirus-positive NPAs and five bocavirus-positive NPAs, the Ct values obtained following PBS preparation were 1.50-6.18 (median 5.42) and 1.60-7.61 (median 3.4) lower, respectively, than those obtained following PK-DNase preparation. Among the 10 samples derived from RNA respiratory viruses, the minimum Ct values resulted from PK-DNase treatment of three samples, PBS treatment of five samples, and NALC treatment of two samples.', 'cite_spans': [], 'ref_spans': [{'start': 93, 'end': 100, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'RESULTS'}, {'text': 'Using identical volumes of sputum and inactivated viral culture diluted 1:10 or 1:1,000, the effects of each homogenization method on the MERS-CoV rRT-PCR results were evaluated (Table 2). Using a 1:10 dilution of inactivated viral culture, all samples treated with PK-DNase exhibited lower Ct values than those subjected to PBS or NALC treatment. The differences in Ct values between samples treated with PK-DNase or PBS were 5.4-7.8 for upE and 4.4-6.8 for ORF1a, while those for samples treated with PK-DNase or NALC were 4.7-5.8 for upE and 4.4-5.6 for ORF1a. Using the same volume of a 1:1,000 dilution of inactivated viral culture, one purulent sputum sample showed a false-negative result after PBS treatment. The Ct values of the other two sputum samples were similar following PK-DNase, PBS, and NALC treatments.', 'cite_spans': [], 'ref_spans': [], 'section': 'RESULTS'}, {'text': 'Using a one-tenth volume of a 1:1,000 dilution of inactivated viral culture (to simulate conditions comparable to those of real clinical samples), the effects of each method on the MERS-CoV rRT-PCR results were evaluated (Table 3) . Among the three sputum samples, false-negative results were detected in two samples following PBS treatment and in three samples after NALC treatment (Table 3) . Although the Ct values after PK-DNase treatment tended to be lower than those following PBS or To assess statistical significance, we tested 15 additional spiked samples, which were prepared by adding a one-tenth volume of 1:1,000 diluted viral culture (Table 4 ). Among the 15 spiked sputum samples prepared in duplicate (30 total samples), false-negative results were detected in five samples (16.7%) using the PBS method and in four samples (13.3%) using the NALC method. The ranges of Ct values for upE from sputum samples were 31.1-35.4 using the PK-DNase method, 34.7-39.0 using the PBS method, and 33.9-38.6 using the NALC method. Compared with the control, which were prepared by adding a one-tenth volume of 1:1,000 diluted viral culture to PBS solution, the ranges of Ct values following the PBS and NALC methods significantly differed from the mean Ct value (33.2) of the control (both P < 0.0001).', 'cite_spans': [], 'ref_spans': [{'start': 221, 'end': 230, 'text': '(Table 3)', 'ref_id': 'TABREF2'}, {'start': 383, 'end': 392, 'text': '(Table 3)', 'ref_id': 'TABREF2'}, {'start': 648, 'end': 656, 'text': '(Table 4', 'ref_id': 'TABREF3'}], 'section': 'RESULTS'}, {'text': 'For the extraction of MERS-CoV RNA from sputum sample, homogenization of sputum by PK-DNase I treatment was superior to treatment with PBS or NALC and sodium citrate. Proteinase K is a serine protease that exhibits broad cleavage specificity [11] . The enzyme cleaves peptide bonds adjacent to carboxylic group of aliphatic and aromatic amino acids and is useful for the general digestion of proteins in biological samples. More-over, proteinase K degrades any RNases present in samples, preventing RNA degradation. Viral nucleic acids are protected from DNase I degradation by the viral protein capsids, although some enveloped viruses may be lost [12] . The genomes of DNA viruses such as adenovirus and bocavirus can be affected by proteinase K and DNase I, possibly owing to the digestion of viral capsid proteins by proteinase K and subsequent degradation of genomic DNA by DNase I.', 'cite_spans': [{'start': 242, 'end': 246, 'text': '[11]', 'ref_id': 'BIBREF12'}, {'start': 649, 'end': 653, 'text': '[12]', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Confirmation of probable or suspected MERS-CoV infection based on clinical and epidemiological criteria can only be accomplished through laboratory testing. However, other viral respiratory pathogens and bacterial pathogens should be considered during diagnosis [3] . When using lower respiratory samples originally earmarked for MERS-CoV testing, other viral respiratory pathogens should be tested for routine diagnostic processes. Because the ability to detect DNA respiratory viruses can be reduced by DNase I treatment, proteinase K treatment alone is worth considering for the routine detection of respiratory viruses from sputum samples.', 'cite_spans': [{'start': 262, 'end': 265, 'text': '[3]', 'ref_id': None}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"The United States Centers for Disease Control and Prevention recommends that respiratory samples be extracted by using either the NucliSENS easyMAG system or MagNA Pure Compact Nucleic Acid Isolation kit [2] . Sputum samples categorized into groups 4-5 according to Murray and Washington's grading system [9] usually cannot undergo automated extraction owing to high viscosity and, thus, require a pre-homogenization process. Treatment with PBS or NALC and sodium citrate occasionally produces false-negative results with purulent sputum. Adding PBS and mixing via vortexing are necessary to culture respiratory viruses from sputum, and this procedure offers the advantage of involving minimum sample handling. However, thoroughly homogenizing thick or purulent sputum using this method is problematic. Because viral isolation by cell culture is not recommended for the routine confirmation of cases of MERS-CoV [2, 3] , the PBS plus vortexing method for processing sputum samples is not suitable for detecting MERS-CoV by rRT-PCR. Previously, it was reported that NALC and sodium citrate treatment (without NaOH) did not damage mycobacterial mRNA or rRNA in sputum samples [13] . NALC and sodium citrate solutions are readily available in clinical microbiology laboratories. Treatment with NALC and sodium citrate solution resulted in complete homogenization of sputum samples, including purulent sputum. However, this method is not suitable for detecting RNA targets in purulent sputum. Because proteinase K treatment requires heat inactivation of potential pathogens (incubation for 15 min at 55°C), this method offers additional laboratory safety. Only 10% of sputum samples sent for MERS-CoV rRT-PCR testing were clinically relevant in terms of bacterial culture (group 5 according to Murray and Washington's grading system [9] ). Among patients infected with MERS-CoV, a dry cough is more common than a productive cough [16, 17] . Therefore, optimum sample collection is not feasible for patients unable to produce sputum. However, two thirds of sputum samples in our study contained identifiable ciliated columnar epithelial cells. Dipeptidyl peptidase 4, the human receptor for MERS-CoV [16] , is expressed in type I and II alveolar cells, ciliated or non-ciliated bronchial epithelial cells, and bronchial submucosal glands [18, 19] . Although it is difficult to obtain high-quality sputum from patients with no cough or a dry cough, obtaining and testing sputum samples containing ciliated columnar epithelial cells is recommended, if possible.\", 'cite_spans': [{'start': 204, 'end': 207, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 305, 'end': 308, 'text': '[9]', 'ref_id': 'BIBREF9'}, {'start': 912, 'end': 915, 'text': '[2,', 'ref_id': 'BIBREF1'}, {'start': 916, 'end': 918, 'text': '3]', 'ref_id': None}, {'start': 1174, 'end': 1178, 'text': '[13]', 'ref_id': 'BIBREF14'}, {'start': 1829, 'end': 1832, 'text': '[9]', 'ref_id': 'BIBREF9'}, {'start': 1926, 'end': 1930, 'text': '[16,', 'ref_id': 'BIBREF17'}, {'start': 1931, 'end': 1934, 'text': '17]', 'ref_id': 'BIBREF18'}, {'start': 2195, 'end': 2199, 'text': '[16]', 'ref_id': 'BIBREF17'}, {'start': 2333, 'end': 2337, 'text': '[18,', 'ref_id': 'BIBREF19'}, {'start': 2338, 'end': 2341, 'text': '19]', 'ref_id': None}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Our study has several limitations. First, it was performed by using spiked sputum samples; thus, our results may differ from those obtained by using authentic MERS-CoV-positive samples. However, the spiked sputum samples were similar to real sputum samples, as they were produced by adding a one-tenth volume of spiked viral solution to total sputum samples. Second, we tested a relatively small number of sputum samples under each test condition. Therefore, our findings should be confirmed by additional, larger studies.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'In conclusion, the PK-DNase I treatment is suitable for the homogenization of sputum prior to RNA extraction for MERS-CoV rRT-PCR detection. Furthermore, adequate sputum homogenization prior to the isolation of nucleic acids is critical for accurate diagnosis of MERS-CoV infection.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'An appropriate lower respiratory tract sample is essential for diagnosis of Middle East Respiratory Syndrome (MERS)', 'authors': [{'first': 'J', 'middle': ['H'], 'last': 'Lee', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Lee', 'suffix': ''}, {'first': 'H', 'middle': ['B'], 'last': 'Lee', 'suffix': ''}], 'year': 2015, 'venue': 'J Korean Med Sci', 'volume': '30', 'issn': '', 'pages': '1207--1215', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Version 2', 'authors': [], 'year': 2015, 'venue': 'Centers for Disease Control and Prevention', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Comparison of five methods for extraction of Legionella pneumophila from respiratory specimens', 'authors': [{'first': 'D', 'middle': [], 'last': 'Wilson', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Yen-Lieberman', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Reischl', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Warshawsky', 'suffix': ''}, {'first': 'G', 'middle': ['W'], 'last': 'Procop', 'suffix': ''}], 'year': 2004, 'venue': 'J Clin Microbiol', 'volume': '42', 'issn': '', 'pages': '5913--5919', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission', 'authors': [], 'year': 2013, 'venue': 'Lancet', 'volume': '381', 'issn': '', 'pages': '2265--72', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States', 'authors': [{'first': 'M', 'middle': [], 'last': 'Kapoor', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Pringle', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kumar', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Dearth', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Lovchik', 'suffix': ''}], 'year': 2014, 'venue': 'Clin Infect Dis', 'volume': '59', 'issn': '', 'pages': '1511--1519', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection', 'authors': [{'first': 'C', 'middle': [], 'last': 'Drosten', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Seilmaier', 'suffix': ''}, {'first': 'V', 'middle': ['M'], 'last': 'Corman', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Hartmann', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Scheible', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Sack', 'suffix': ''}], 'year': 2013, 'venue': 'Lancet Infect Dis', 'volume': '13', 'issn': '', 'pages': '745--51', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome', 'authors': [{'first': 'Z', 'middle': ['A'], 'last': 'Memish', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Al-Tawfiq', 'suffix': ''}, {'first': 'H', 'middle': ['Q'], 'last': 'Makhdoom', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Assiri', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Alhakeem', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Albarrak', 'suffix': ''}], 'year': 2014, 'venue': 'J Infect Dis', 'volume': '210', 'issn': '', 'pages': '1590--1594', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Microscopic and bacteriologic analysis of expectorated sputum', 'authors': [{'first': 'P', 'middle': ['R'], 'last': 'Murray', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Washington', 'suffix': ''}], 'year': 1975, 'venue': 'Mayo Clin Proc', 'volume': '50', 'issn': '', 'pages': '339--383', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Comparison of Anyplex II RV16 with the xTAG respiratory viral panel and Seeplex RV15 for detecwww', 'authors': [{'first': 'H', 'middle': ['K'], 'last': 'Kim', 'suffix': ''}, {'first': 'S', 'middle': ['H'], 'last': 'Oh', 'suffix': ''}, {'first': 'K', 'middle': ['A'], 'last': 'Yun', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Sung', 'suffix': ''}, {'first': 'M', 'middle': ['N'], 'last': 'Kim', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.3343/alm.2016.36.5.457']}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'tion of respiratory viruses', 'authors': [], 'year': 2013, 'venue': 'J Clin Microbiol', 'volume': '51', 'issn': '', 'pages': '1137--1178', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Enzymes of molecular biology', 'authors': [{'first': 'P', 'middle': ['J'], 'last': 'Sweeney', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Walker', 'suffix': ''}], 'year': 1993, 'venue': 'In: Burrell MM', 'volume': '16', 'issn': '', 'pages': '305--316', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Method for discovering novel DNA viruses in blood using viral particle selection and shotgun sequencing', 'authors': [{'first': 'B', 'middle': [], 'last': 'Breitbart', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Rohwer', 'suffix': ''}], 'year': 2005, 'venue': 'Biotechniques', 'volume': '39', 'issn': '', 'pages': '729--765', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Alkaline decontamination of sputum specimens adversely affects stability of mycobacterial mRNA', 'authors': [{'first': 'L', 'middle': ['E'], 'last': 'Desjardin', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': 'Perkins', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Teixeira', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': 'Cave', 'suffix': ''}, {'first': 'K', 'middle': ['D'], 'last': 'Eisenach', 'suffix': ''}], 'year': 1996, 'venue': 'J Clin Microbiol', 'volume': '34', 'issn': '', 'pages': '2435--2444', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Optimized dialysis and protease inhibition of sputum dithiothreitol supernatants', 'authors': [{'first': 'E', 'middle': ['M'], 'last': 'Erin', 'suffix': ''}, {'first': 'G', 'middle': ['R'], 'last': 'Jenkins', 'suffix': ''}, {'first': 'O', 'middle': ['M'], 'last': 'Kon', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Zacharasiewicz', 'suffix': ''}, {'first': 'G', 'middle': ['C'], 'last': 'Nicholson', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Neighbour', 'suffix': ''}], 'year': 2008, 'venue': 'Am J Respir Crit Care Med', 'volume': '177', 'issn': '', 'pages': '132--173', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Effect of physical and chemical methods of homogenization on inflammatory mediators in sputum of asthma patients', 'authors': [{'first': 'E', 'middle': [], 'last': 'Grebski', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Peterson', 'suffix': ''}, {'first': 'T', 'middle': ['C'], 'last': 'Medici', 'suffix': ''}], 'year': 2001, 'venue': 'Chest', 'volume': '119', 'issn': '', 'pages': '1521--1526', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Middle East respiratory syndrome', 'authors': [{'first': 'A', 'middle': [], 'last': 'Zumla', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Hui', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Perlman', 'suffix': ''}], 'year': 2015, 'venue': 'Lancet', 'volume': '386', 'issn': '', 'pages': '995--1007', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study', 'authors': [{'first': 'A', 'middle': [], 'last': 'Assiri', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Al-Tawfiq', 'suffix': ''}, {'first': 'A', 'middle': ['A'], 'last': 'Al-Rabeeah', 'suffix': ''}, {'first': 'Al-Rabiah', 'middle': [], 'last': 'Fa', 'suffix': ''}, {'first': 'Al-Hajjar', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'Al', 'middle': ['-'], 'last': 'Barrak', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2013, 'venue': 'Lancet Infect Dis', 'volume': '13', 'issn': '', 'pages': '752--61', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC', 'authors': [{'first': 'V', 'middle': ['S'], 'last': 'Raj', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Mou', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Smits', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Dekkers', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Müller', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Dijkman', 'suffix': ''}], 'year': 2013, 'venue': 'Nature', 'volume': '495', 'issn': '', 'pages': '251--255', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases', 'authors': [{'first': '', 'middle': [], 'last': 'Mers-Cov Biology', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Group', 'suffix': ''}], 'year': 2014, 'venue': 'J Clin Virol', 'volume': '61', 'issn': '', 'pages': '275--283', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'Rapid and accurate diagnosis of infection and control measures are critical for preventing the spread of Middle East respiratory syndrome coronavirus (MERS-CoV) [1]. For laboratory diagnosis of MERS-CoV infection, lower respiratory samples are preferred www.annlabmed.org http://dx.doi.org/10.3343/alm.2016.36.5.457', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Cycle threshold (Ct) values following three homogenization methods used before Anyplex II RV16 detection of respiratory viruses in nasopharyngeal aspirates by rRT-PCR', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Cycle threshold (Ct) values observed with three homogenization methods following mixture of identical volumes of a 1:10 or 1:1,000 dilution of inactivated MERS-CoV culture with sputum samples NALC treatment, the values for BAL samples did not differ markedly depending on the homogenization method used.', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'Cycle threshold (Ct) values for triplicate sputum and bronchoalveolar lavage (BAL) samples following processing using three different homogenization methods', 'latex': None, 'type': 'table'}, 'TABREF3': {'text': '', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'No potential conflicts of interest relevant to this article were reported.', 'cite_spans': [], 'ref_spans': [], 'section': \"Authors' Disclosures of Potential Conflicts of Interest\"}]}\n",
      "{'_id': ObjectId('5f4ecb6378e7f0946fa23d7a'), 'paper_id': '01af2562df4acf3113843d039c3b82bb801b1427', 'metadata': {'title': 'Chest Computed Tomography Abnormalities and Their Relationship to the Clinical Manifestation of Respiratory Syncytial Virus Infection in a Genetically Confirmed Outbreak', 'authors': [{'first': 'Daijiro', 'middle': [], 'last': 'Nabeya', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Takeshi', 'middle': [], 'last': 'Kinjo', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Gretchen', 'middle': ['Lynn'], 'last': 'Parrott', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Sawako', 'middle': [], 'last': 'Nakachi', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Tomoko', 'middle': [], 'last': 'Yamashiro', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Nanae', 'middle': [], 'last': 'Ikemiyagi', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Wakako', 'middle': [], 'last': 'Arakaki', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Hiroaki', 'middle': [], 'last': 'Masuzaki', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Jiro', 'middle': [], 'last': 'Fujita', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [{'text': 'Studies reporting chest images of respiratory syncytial virus (RSV)-induced lower respiratory tract infection (LRTI) in an outbreak setting and their relationship to the clinical manifestation are limited. During a genetically confirmed RSV outbreak, eight patients underwent both chest X-ray and computed tomography (CT). Among these, 5 cases had newly appearing abnormalities on CT, although chest X-ray was able to detect abnormalities in only 2 cases (40%). Although bronchial wall thickening was common, other findings and their distribution were variable, even in an outbreak setting. All patients with both a history of anticancer chemotherapy against hematological cancer and lower respiratory symptoms, such as wheezing, sputum, and hypoxemia, had abnormalities on CT, suggesting that these two factors might be important for predicting the existence of LRTI in RSV-infected patients.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'During the 2014 outbreak, RSV infection was diagnosed by reverse transcriptase polymerase chain reaction using respiratory specimens, and genetic proximity was confirmed by a phylogenetical analysis (15). Eight RSV-infected patients', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Respiratory syncytial virus (RSV) is well known as a virus causing lower respiratory tract infection (LRTI) in infants and immunocompromised adults (1) (2) (3) . Bronchopneumonia patterns are common findings of RSV-induced LRTI (RSV-LRTI); however, RSV-LRTI often shows variable findings on chest imaging (4) (5) (6) (7) (8) (9) (10) (11) . Although some factors, such as the virulence of RSV and host immune status, might affect the chest computed tomography (CT) findings of RSV-LRTI (12, 13) , the detailed mechanisms remain unknown.', 'cite_spans': [{'start': 148, 'end': 151, 'text': '(1)', 'ref_id': 'BIBREF0'}, {'start': 152, 'end': 155, 'text': '(2)', 'ref_id': 'BIBREF1'}, {'start': 156, 'end': 159, 'text': '(3)', 'ref_id': 'BIBREF2'}, {'start': 305, 'end': 308, 'text': '(4)', 'ref_id': 'BIBREF3'}, {'start': 309, 'end': 312, 'text': '(5)', 'ref_id': 'BIBREF4'}, {'start': 313, 'end': 316, 'text': '(6)', 'ref_id': 'BIBREF5'}, {'start': 317, 'end': 320, 'text': '(7)', 'ref_id': 'BIBREF6'}, {'start': 321, 'end': 324, 'text': '(8)', 'ref_id': 'BIBREF7'}, {'start': 325, 'end': 328, 'text': '(9)', 'ref_id': 'BIBREF8'}, {'start': 329, 'end': 333, 'text': '(10)', 'ref_id': 'BIBREF9'}, {'start': 334, 'end': 338, 'text': '(11)', 'ref_id': 'BIBREF11'}, {'start': 486, 'end': 490, 'text': '(12,', 'ref_id': 'BIBREF12'}, {'start': 491, 'end': 494, 'text': '13)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'From this perspective, an RSV outbreak due to genetically identical RSV is an ideal setting for investigating the chest images of RSV-LRTI. Thus far, however, there has only been one report showing the chest images of RSV-LRTI in the outbreak setting (11) . In addition, reports inves-tigating the correlation between the clinical manifestations and abnormal findings on chest CT remain rare (14) .', 'cite_spans': [{'start': 251, 'end': 255, 'text': '(11)', 'ref_id': 'BIBREF11'}, {'start': 392, 'end': 396, 'text': '(14)', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'In 2014, a genetically identical RSV outbreak occurred in the hemato-oncology ward of the University of the Ryukyus Hospital (15) , and a subset of RSV-infected patients underwent both chest X-ray and CT during the outbreak. We herein report our analysis of the radiological findings and the clinical manifestations in the outbreak. +37days underwent both chest X-ray and CT during the outbreak.', 'cite_spans': [{'start': 125, 'end': 129, 'text': '(15)', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'The clinical information and chest X-ray findings were retrospectively reviewed from patient medical records within one week of the chest CT scan.', 'cite_spans': [], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'The medical records and radiological images of the collected cases were retrospectively reviewed, with identifying information removed. This study was reviewed and approved by the Clinical Research Ethics Committee of University of the Ryukyus.', 'cite_spans': [], 'ref_spans': [], 'section': 'Ethics'}, {'text': \"The patients' background characteristics, clinical manifestations, laboratory data, and findings from chest imaging are shown in Table. Seven cases (88%) received various immunosuppressive treatment, and none had airway diseases, such as bronchial asthma. Five cases (63%) had newly appearing abnormal findings on chest CT; however, no abnormal findings were detected by chest X-ray in 3 of those 5 patients (60%). Most cases had upper respiratory symptoms, including rhinitis and sore throat. However, lower respiratory symptoms, such as wheeze, sputum, and hypoxemia, were only seen in patients with newly appearing findings on chest CT. Bacterial culture for respiratory specimens was performed in six cases, and bacteria were detected in three cases; however, no patient was diagnosed with bacterial pneumonia or treated with targeted antibiotics against these detected bacteria. In addition, no cases received antiviral therapy against RSV.\", 'cite_spans': [], 'ref_spans': [{'start': 129, 'end': 135, 'text': 'Table.', 'ref_id': None}], 'section': 'Results'}, {'text': 'Chest CT findings for the five patients are shown in Figs. 1-5. The most common finding among these patients was bronchial wall thickenings; seen in 4 of 5 patients (80%). In terms of the findings in the parenchymal lesion, the patterns and distributions were varied and inconsistent. Two cases showed ground-glass opacities (GGOs) along the bronchi; however, the distribution differed, as one was a localized GGO and the other a multilobar GGO. One case showed ground-glass nodules with a tree-in-bud pattern. The remaining case showed diffuse GGOs with centrilobular septal thickening, also known as the \"crazy-paving\" pattern. Three cases underwent two or more CT scans during the course of their disease, and the abnormal findings on chest CT disappeared (Fig. 1, 2, 5 ).', 'cite_spans': [], 'ref_spans': [{'start': 759, 'end': 772, 'text': '(Fig. 1, 2, 5', 'ref_id': 'FIGREF1'}], 'section': 'Results'}, {'text': 'In the present study, all patients who had lower respiratory symptoms, such as wheezing, sputum, and hypoxemia, had abnormal findings on chest CT. Indeed, sputum and hypoxemia are included as criteria for LRTI disease according to the guideline for respiratory virus infection in leukemia patients (16) . In addition, all cases receiving chemotherapy for hematological malignancy also had abnormal findings on chest CT. This is probably associated with bone marrow suppression by cytotoxic anticancer drugs. Of note, lymphocytopenia and neutropenia are considered as risk factors for LRTI in RSV-infected cases (16) . Therefore, it might be advised to perform chest CT in order to examine the existence of LRTI for RSV-infected hematological malignancy patients with both a history of anticancer chemotherapy and lower respiratory symptoms.', 'cite_spans': [{'start': 298, 'end': 302, 'text': '(16)', 'ref_id': 'BIBREF16'}, {'start': 611, 'end': 615, 'text': '(16)', 'ref_id': 'BIBREF16'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': \"In RSV-LRTI, CT is more sensitive for detecting pulmonary findings than chest X-ray (6), as a bronchopneumonia pattern is more common in RSV-LRTI than an alveolar pattern (5, 7, 11) , and chest X-ray rarely detects the findings of a bronchopneumonia pattern. The present study showed that a bronchopneumonia pattern was indeed the most common (case 2 and 3), and chest X-ray missed these abnormal findings in most cases. Therefore, chest CT, rather than X-ray, should be performed to confirm LRTI in RSV-infected patients with lower respiratory symptoms. However, chest Xray is appropriate for evaluating pulmonary overexpansion due to bronchiolitis in infants (17) . Although bronchiolitis caused by RSV is relatively common in infants (18), it is not common in adults (11, 19) . In fact, overexpansion due to bronchiolitis was not observed in any of our eight cases. This study shows no trends for abnormal chest findings, even in the outbreak setting, which is consistent with a pre- +20days vious report by Mayer et al. (11) . Several reasons may explain this. First, although the pathophysiology remains unknown, the host's immunological status might affect CT findings. Immune responses by lymphocytes and neutrophils are correlated with disease severity, which may affect the patterns of abnormal CT findings (13) . Indeed, the patients in our study had different primary diseases and received varying immunosuppressive therapies, as shown in the Table. Second, bacterial co-infection might affect the radiological findings. However, bronchioalveolar lavage fluid was collected from only one patient, and most specimens for bacterial culture were sputum; therefore, the possibility of contamination by oral bacteria could not be excluded. In addition, the bacteria detected in our study were uncommon pathogens for causing pneumonia. Indeed, no patient was treated with antibiotics targeting these detected bacteria. Although the influence of these bacteria on CT findings is unknown, it is possible that these pathogens were colonized, rather than co-infection, so their impact on CT might be limited.\", 'cite_spans': [{'start': 171, 'end': 174, 'text': '(5,', 'ref_id': 'BIBREF4'}, {'start': 175, 'end': 177, 'text': '7,', 'ref_id': 'BIBREF6'}, {'start': 178, 'end': 181, 'text': '11)', 'ref_id': 'BIBREF11'}, {'start': 661, 'end': 665, 'text': '(17)', 'ref_id': 'BIBREF17'}, {'start': 770, 'end': 774, 'text': '(11,', 'ref_id': 'BIBREF11'}, {'start': 775, 'end': 778, 'text': '19)', 'ref_id': 'BIBREF19'}, {'start': 1024, 'end': 1028, 'text': '(11)', 'ref_id': 'BIBREF11'}, {'start': 1316, 'end': 1320, 'text': '(13)', 'ref_id': 'BIBREF13'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Although various findings are seen in patients with RSV-LRTI (9), many reports have shown that nodules and tree-inbud patterns are relatively common (5-8, 10). Kim et al. compared the CT findings among RSV, parainfluenza virus, and influenza virus, demonstrating the frequent observation of bronchial wall thickening while consolidation and GGOs were rarely seen in RSV-LRTI compared to the other two viruses (4). Miller et al. reported that an airway-centric pattern, consisting of tree-in-bud opacities and bronchial wall thickening, was characteristic of RSV-LRTI compared to other respiratory viruses (9) . It has also been reported that nodules and tree-in-bud patterns were seen during the early phase of RSV pneumonia (9, 11) . Thus, although the findings and distributions for chest CT in cases 2, 3, and 4 varied, they were categorized as airway-centric patterns, and differences may exist due to the progression of disease. Case 4, which had tree-in-bud nodular opacities, progressed to respiratory failure after the CT scan, suggesting that these findings had been observed in the early phase of RSV pneumonia. Case 5 was initially diagnosed with idiopathic pulmonary alveolar hemorrhaging due to the hemoptysis and crazy-paving pattern on chest CT. The crazy-paving pattern is uncommon for RSV-LRTI; however, a previous case report showed that RSV infection can present as a crazypaving pattern in patients receiving hematopoietic stem cell transplantation (20) .', 'cite_spans': [{'start': 605, 'end': 608, 'text': '(9)', 'ref_id': 'BIBREF8'}, {'start': 725, 'end': 728, 'text': '(9,', 'ref_id': 'BIBREF8'}, {'start': 729, 'end': 732, 'text': '11)', 'ref_id': 'BIBREF11'}, {'start': 1469, 'end': 1473, 'text': '(20)', 'ref_id': 'BIBREF20'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Chest CT showed variable findings for RSV infection, even during an outbreak setting. In most cases, chest X-ray failed to detect abnormalities. In RSV-infected hematological malignancy patients receiving anticancer chemotherapy, lower respiratory symptoms may predict the existence of CT abnormalities due to RSV-LRTI.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusions'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes', 'authors': [{'first': 'P', 'middle': [], 'last': 'Pilie', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Werbel', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Riddell', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Shu', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Schaubel', 'suffix': ''}, {'first': 'K', 'middle': ['S'], 'last': 'Gregg', 'suffix': ''}], 'year': 2015, 'venue': 'Transpl Infect Dis', 'volume': '17', 'issn': '', 'pages': '551--557', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease', 'authors': [{'first': 'Y', 'middle': ['J'], 'last': 'Kim', 'suffix': ''}, {'first': 'K', 'middle': ['A'], 'last': 'Guthrie', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Waghmare', 'suffix': ''}], 'year': 2014, 'venue': 'J Infect Dis', 'volume': '209', 'issn': '', 'pages': '1195--1204', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit', 'authors': [{'first': 'N', 'middle': [], 'last': 'Lehners', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Schnitzler', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Geis', 'suffix': ''}], 'year': 2013, 'venue': 'Bone Marrow Transplant', 'volume': '48', 'issn': '', 'pages': '1548--1553', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'CT findings in viral lower respiratory tract infections caused by parainfluenza virus, influenza virus and respiratory syncytial virus', 'authors': [{'first': 'M', 'middle': ['C'], 'last': 'Kim', 'suffix': ''}, {'first': 'M', 'middle': ['Y'], 'last': 'Kim', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Lee', 'suffix': ''}], 'year': 2016, 'venue': 'Medicine (Baltimore)', 'volume': '95', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'CT manifestations of respiratory syncytial virus infection in lung transplant recipients', 'authors': [{'first': 'J', 'middle': ['P'], 'last': 'Ko', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Shepard', 'suffix': ''}, {'first': 'M', 'middle': ['W'], 'last': 'Sproule', 'suffix': ''}], 'year': 2000, 'venue': 'J Comput Assist Tomogr', 'volume': '24', 'issn': '', 'pages': '235--241', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Clinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience', 'authors': [{'first': 'E', 'middle': ['J'], 'last': 'Ariza-Heredia', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Fishman', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Cleary', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Smith', 'suffix': ''}, {'first': 'R', 'middle': ['R'], 'last': 'Razonable', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Abbo', 'suffix': ''}], 'year': 2012, 'venue': 'Transpl Infect Dis', 'volume': '14', 'issn': '', 'pages': '64--71', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'High-resolution CT findings of respiratory syncytial virus pneumonia after bone marrow transplantation', 'authors': [{'first': 'E', 'middle': ['L'], 'last': 'Gasparetto', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Escuissato', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Marchiori', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ono', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Frare E Silva', 'suffix': ''}, {'first': 'N', 'middle': ['L'], 'last': 'Müller', 'suffix': ''}], 'year': 2004, 'venue': 'AJR Am J Roentgenol', 'volume': '182', 'issn': '', 'pages': '1133--1137', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Pulmonary infections after bone marrow transplantation: high-resolution CT findings in 111 patients', 'authors': [{'first': 'D', 'middle': ['L'], 'last': 'Escuissato', 'suffix': ''}, {'first': 'E', 'middle': ['L'], 'last': 'Gasparetto', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Marchiori', 'suffix': ''}], 'year': 2005, 'venue': 'AJR Am J Roentgenol', 'volume': '185', 'issn': '', 'pages': '608--615', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'CT of viral lower respiratory tract infections in adults: comparison among viral organisms and between viral and bacterial infections', 'authors': [{'first': 'W', 'middle': ['T'], 'last': 'Miller', 'suffix': ''}, {'first': 'T', 'middle': ['J'], 'last': 'Mickus', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Barbosa', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Mullin', 'suffix': ''}, {'first': 'V', 'middle': ['M'], 'last': 'Van Deerlin', 'suffix': ''}, {'first': 'K', 'middle': ['T'], 'last': 'Shiley', 'suffix': ''}], 'year': 2011, 'venue': 'AJR Am J Roentgenol', 'volume': '197', 'issn': '', 'pages': '1088--1095', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Human metapneumovirus (HMPV) associated pulmonary infections in immunocompromised adults--initial CT findings, disease course and comparison to respiratory-syncytial-virus (RSV) induced pulmonary infections', 'authors': [{'first': 'R', 'middle': [], 'last': 'Syha', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Beck', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Hetzel', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'CTmorphological characterization of respiratory syncytial virus (RSV) pneumonia in immune-compromised adults', 'authors': [{'first': 'J', 'middle': ['L'], 'last': 'Mayer', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Lehners', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Egerer', 'suffix': ''}, {'first': 'H', 'middle': ['U'], 'last': 'Kauczor', 'suffix': ''}, {'first': 'C', 'middle': ['P'], 'last': 'Heußel', 'suffix': ''}], 'year': 2014, 'venue': 'Rofo', 'volume': '186', 'issn': '', 'pages': '686--692', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'How respiratory syncytial virus genotypes influence the clinical course in infants hospitalized for bronchiolitis', 'authors': [{'first': 'F', 'middle': [], 'last': 'Midulla', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Nenna', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Scagnolari', 'suffix': ''}], 'year': 2019, 'venue': 'J Infect Dis', 'volume': '219', 'issn': '', 'pages': '526--534', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'The human immune response to respiratory syncytial virus infection', 'authors': [{'first': 'C', 'middle': ['D'], 'last': 'Russell', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Unger', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Walton', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Schwarze', 'suffix': ''}], 'year': 2017, 'venue': 'Clin Microbiol Rev', 'volume': '30', 'issn': '', 'pages': '481--502', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Chest CT features of community-acquired respiratory viral infections in adult inpatients with lower respiratory tract infections', 'authors': [{'first': 'K', 'middle': ['T'], 'last': 'Shiley', 'suffix': ''}, {'first': 'V', 'middle': ['M'], 'last': 'Van Deerlin', 'suffix': ''}, {'first': 'W', 'middle': ['T'], 'last': 'Miller', 'suffix': ''}], 'year': 2010, 'venue': 'J Thorac Imaging', 'volume': '25', 'issn': '', 'pages': '68--75', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit', 'authors': [{'first': 'D', 'middle': [], 'last': 'Nabeya', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Kinjo', 'suffix': ''}, {'first': 'G', 'middle': ['L'], 'last': 'Parrott', 'suffix': ''}], 'year': 2017, 'venue': 'J Med Virol', 'volume': '89', 'issn': '', 'pages': '1364--1372', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus', 'authors': [{'first': 'H', 'middle': ['H'], 'last': 'Hirsch', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Martino', 'suffix': ''}, {'first': 'K', 'middle': ['N'], 'last': 'Ward', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Boeckh', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Einsele', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Ljungman', 'suffix': ''}], 'year': 2013, 'venue': 'Fourth European Conference on Infections in Leukaemia', 'volume': '56', 'issn': '', 'pages': '258--266', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'The chest radiograph in acute bronchiolitis', 'authors': [{'first': 'K', 'middle': ['P'], 'last': 'Dawson', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Long', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kennedy', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Mogridge', 'suffix': ''}], 'year': 1990, 'venue': 'J Paediatr Child Health', 'volume': '26', 'issn': '', 'pages': '209--211', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis', 'authors': [{'first': 'J', 'middle': ['M'], 'last': 'Mansbach', 'suffix': ''}, {'first': 'P', 'middle': ['A'], 'last': 'Piedra', 'suffix': ''}, {'first': 'S', 'middle': ['J'], 'last': 'Teach', 'suffix': ''}], 'year': 2012, 'venue': 'Arch Pediatr Adolesc Med', 'volume': '166', 'issn': '', 'pages': '700--706', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Respiratory syncytial virus infection in adults', 'authors': [{'first': 'A', 'middle': ['R'], 'last': 'Falsey', 'suffix': ''}], 'year': 2007, 'venue': 'Semin Respir Crit Care Med', 'volume': '28', 'issn': '', 'pages': '171--181', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Crazy-paving\" patterns on high-resolution CT scans in patients with pulmonary complications after hematopoietic stem cell transplantation', 'authors': [{'first': 'E', 'middle': [], 'last': 'Marchiori', 'suffix': ''}, {'first': 'D', 'middle': ['L'], 'last': 'Escuissato', 'suffix': ''}, {'first': 'T', 'middle': ['D'], 'last': 'Gasparetto', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Considera', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Franquet', 'suffix': ''}], 'year': 2009, 'venue': 'Korean J Radiol', 'volume': '10', 'issn': '', 'pages': '21--24', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'grade fever:>=37.3 to 37.9°C, High grade fever:>=38.0°C, Lymphocytopenia:lymphocyte<100/μL, Neutropenia:neutrophil<500/μL. ATLL: adult T-cell leukemia/lymphoma, BWT: bronchial wall thickening, GGN: ground-glass nodule, GGO: ground-glass opacity, GVHD: graft versus host disease, HSCT: hematopoietic stem cell transplant, LRTI: lower respiratory tract infection, NT: not tested', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'Chest CT findings in case 1. The first CT examination (left) was performed 10 days after the supposed onset date. Bronchial wall thickening in the lower right lobe was observed. Thirty-seven days later, these findings had disappeared (right).', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'Chest CT findings in case 2. The first CT examination (upper left) was performed seven days after the supposed onset date. Multi-lobar ground-glass opacities along bronchi are shown. Bronchial wall thickening was observed in the upper right lobe. These lesions became patchy infiltrate and then gradually disappeared. Chest CT findings in case 3. The CT examination was performed four days after the supposed onset date. Multi-lobar ground-glass opacities along bronchi were detected.', 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'Chest CT findings in case 4. The CT examination was performed nine days after the supposed onset date. Localized ground-glass nodules were mainly seen in the centrilobular area (dotted line circle). Bronchial wall thickening was also seen.', 'latex': None, 'type': 'figure'}, 'FIGREF4': {'text': 'Chest CT findings in case 5. The first CT (left) was performed one day after the supposed onset date. A diffuse crazy-paving pattern, centrilobular septal thickening, and ground-glass opacities were seen. Twenty day later, these findings had become sparse (right).', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Table. Details of Collected Cases.', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'The authors state that they have no Conflict of Interest (COI).', 'cite_spans': [], 'ref_spans': [], 'section': 'acknowledgement'}]}\n",
      "{'_id': ObjectId('5f4ecb658e119c369748ef2f'), 'paper_id': '01b3d789dbd69fff374842fbe2d7f4150fb3d8f5', 'metadata': {'title': 'Functional analysis of the SRV-1 RNA frameshifting pseudoknot', 'authors': [{'first': 'René', 'middle': ['C L'], 'last': 'Olsthoorn', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Leiden University', 'location': {'settlement': 'Leiden'}}, 'email': ''}, {'first': 'Richard', 'middle': [], 'last': 'Reumerman', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Leiden University', 'location': {'settlement': 'Leiden'}}, 'email': ''}, {'first': 'Cornelis', 'middle': ['W'], 'last': 'Hilbers', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Radboud University Nijmegen', 'location': {'settlement': 'Nijmegen', 'country': 'The Netherlands'}}, 'email': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Cornelis', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': '', 'middle': [], 'last': 'Pleij', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Leiden University', 'location': {'settlement': 'Leiden'}}, 'email': ''}, {'first': 'Hans', 'middle': ['A'], 'last': 'Heus', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Radboud University Nijmegen', 'location': {'settlement': 'Nijmegen', 'country': 'The Netherlands'}}, 'email': ''}]}, 'abstract': [{'text': 'Simian retrovirus type-1 uses programmed ribosomal frameshifting to control expression of the Gag-Pol polyprotein from overlapping gag and pol open-reading frames. The frameshifting signal consists of a heptanucleotide slippery sequence and a downstream-located 12-base pair pseudoknot. The solution structure of this pseudoknot, previously solved by NMR [Michiels,P.J., Versleijen,A.A., Verlaan,P.W., Pleij,C.W., Hilbers,C.W. and Heus,H.A. (2001) Solution structure of the pseudoknot of SRV-1 RNA, involved in ribosomal frameshifting. J. Mol. Biol., 310, 1109-1123] has a classical H-type fold and forms an extended triple helix by interactions between loop 2 and the minor groove of stem 1 involving base-base and base-sugar contacts. A mutational analysis was performed to test the functional importance of the triple helix for À1 frameshifting in vitro. Changing bases in L2 or base pairs in S1 involved in a base triple resulted in a 2-to 5-fold decrease in frameshifting efficiency. Alterations in the length of L2 had adverse effects on frameshifting. The in vitro effects were well reproduced in vivo, although the effect of enlarging L2 was more dramatic in vivo. The putative role of refolding kinetics of frameshifter pseudoknots is discussed. Overall, the data emphasize the role of the triple helix in À1 frameshifting.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Ribosomal frameshifting is a translational recoding mechanism that allows the synthesis of multiple proteins from a single mRNA. During this process a certain proportion of the ribosomes is forced to move one or two nucleotides backwards (-1 or À2 frameshift) or forwards (+1 or +2 frameshift) whereafter they continue translation in the new reading frame. As a result the stop codon of the first open-reading frame is bypassed and a fusion protein is synthesized [reviewed in (1, 2) ] Frameshifting is frequently used by RNA viruses, in particular by those with a single genome, and is thought to lead to precise ratios of viral proteins, which is crucial for successful infection (3, 4) . Frameshifting is occasionally used by the eukaryotic cell, e.g., to regulate expression of antizyme (5) or by the prokaryotic cell to regulate production of release factor RF2 (6) and synthesis of the gamma subunit of DNA polymerase (7) .', 'cite_spans': [{'start': 477, 'end': 480, 'text': '(1,', 'ref_id': 'BIBREF0'}, {'start': 481, 'end': 483, 'text': '2)', 'ref_id': 'BIBREF1'}, {'start': 682, 'end': 685, 'text': '(3,', 'ref_id': 'BIBREF2'}, {'start': 686, 'end': 688, 'text': '4)', 'ref_id': 'BIBREF3'}, {'start': 791, 'end': 794, 'text': '(5)', 'ref_id': 'BIBREF4'}, {'start': 867, 'end': 870, 'text': '(6)', 'ref_id': 'BIBREF5'}, {'start': 924, 'end': 927, 'text': '(7)', 'ref_id': 'BIBREF6'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': \"The signal that makes a ribosome shift comprises two elements: a slippery sequence, where the ribosome switches the reading frame, and an adjacent stimulatory signal, usually a specific RNA structure. For À1 frameshifting, the slippery sequence usually consists of a heptanucleotide motif X XXY YYZ, where X can be any three identical nucleotides, Y can be three A's or U's, and Z is not G (8) . The slippery sequence has been shown to be shifty on its own in vitro, up to 2%, but is strongly stimulated, up to 40-fold, by the presence of a hairpin, a pseudoknot, a three-way junction (9) or an antisense oligonucleotide (10, 11) , located 5 to 8 nt downstream of the slippery sequence.\", 'cite_spans': [{'start': 390, 'end': 393, 'text': '(8)', 'ref_id': 'BIBREF7'}, {'start': 585, 'end': 588, 'text': '(9)', 'ref_id': 'BIBREF8'}, {'start': 621, 'end': 625, 'text': '(10,', 'ref_id': 'BIBREF9'}, {'start': 626, 'end': 629, 'text': '11)', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': 'Despite recent progress (12) (13) (14) , the exact mechanism by which a downstream RNA structure stimulates À1 frameshifting remains unclear. The current view is that the downstream RNA element forms a physical barrier that causes a fraction of ribosomes to stall in their translocation step and puts tension on the mRNA-tRNA interaction (15) . This tension is relieved by realignment of A-site and P-site tRNAs in the 5 0 -direction, whereafter the ribosome resumes translation in the À1 reading frame. Several data also point to a role for the E-site tRNA in stimulating frameshifting (16, 17) .', 'cite_spans': [{'start': 24, 'end': 28, 'text': '(12)', 'ref_id': 'BIBREF11'}, {'start': 29, 'end': 33, 'text': '(13)', 'ref_id': 'BIBREF12'}, {'start': 34, 'end': 38, 'text': '(14)', 'ref_id': 'BIBREF13'}, {'start': 338, 'end': 342, 'text': '(15)', 'ref_id': 'BIBREF14'}, {'start': 587, 'end': 591, 'text': '(16,', 'ref_id': 'BIBREF15'}, {'start': 592, 'end': 595, 'text': '17)', 'ref_id': 'BIBREF16'}], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': \"In general, a pseudoknot is more efficient in stimulating frameshifting than a hairpin of the same sequence (18, R.C.L. Olsthoorn unpublished data). This difference is likely related to a higher thermodynamic stability of the pseudoknot. Indeed, from thermodynamic analyses it appears that pseudoknots are more stable than their hairpin counterparts (19) (20) (21) . Recent studies employing mechanical 'pulling' of frameshifter pseudoknots have shown a correlation between the mechanical strength of a pseudoknot and its frameshifting capacity (13, 14) and influence of major groove and minor groove triplex structures (22) . The higher strength of a pseudoknot can be primarily attributed to the formation of base triples between the lower stem S1 and loop 2 (Figure 1 ), making it more resistant against unwinding by an elongating ribosome (15, 23) . Base triples in the pseudoknots of Beet western yellows virus (BWYV) (24) , Pea enation mosaic virus (PEMV-1) (21) and Sugarcane yellow leaf virus (ScYLV) (25) have been shown to play an essential role in frameshifting.\", 'cite_spans': [{'start': 350, 'end': 354, 'text': '(19)', 'ref_id': 'BIBREF18'}, {'start': 355, 'end': 359, 'text': '(20)', 'ref_id': 'BIBREF19'}, {'start': 360, 'end': 364, 'text': '(21)', 'ref_id': 'BIBREF20'}, {'start': 545, 'end': 549, 'text': '(13,', 'ref_id': 'BIBREF12'}, {'start': 550, 'end': 553, 'text': '14)', 'ref_id': 'BIBREF13'}, {'start': 620, 'end': 624, 'text': '(22)', 'ref_id': 'BIBREF21'}, {'start': 843, 'end': 847, 'text': '(15,', 'ref_id': 'BIBREF14'}, {'start': 848, 'end': 851, 'text': '23)', 'ref_id': 'BIBREF22'}, {'start': 923, 'end': 927, 'text': '(24)', 'ref_id': 'BIBREF23'}, {'start': 964, 'end': 968, 'text': '(21)', 'ref_id': 'BIBREF20'}, {'start': 1009, 'end': 1013, 'text': '(25)', 'ref_id': 'BIBREF24'}], 'ref_spans': [{'start': 761, 'end': 770, 'text': '(Figure 1', 'ref_id': None}], 'section': 'INTRODUCTION'}, {'text': 'We previously solved the solution structure of the pseudoknot present in the overlapping region of gag and pol genes of Simian retrovirus type-1 (SRV-1) by NMR (26) . The structure has a classical H-type fold and is further characterized by interactions between the minor groove of stem 1 and loop 2, which forms a triple helix by various tertiary interactions and extensive stacking ( Figure 1A) .', 'cite_spans': [{'start': 160, 'end': 164, 'text': '(26)', 'ref_id': 'BIBREF25'}], 'ref_spans': [{'start': 386, 'end': 396, 'text': 'Figure 1A)', 'ref_id': None}], 'section': 'INTRODUCTION'}, {'text': 'Here we present a detailed mutational analysis of the SRV-1 pseudoknot addressing the role of the triple helix for À1 frameshifting in vitro and in vivo. The data not only emphasize the functional role of the triple helix in À1 frameshifting but also suggest a role for refolding kinetics of frameshifter pseudoknots.', 'cite_spans': [], 'ref_spans': [], 'section': 'INTRODUCTION'}, {'text': \"Mutations in the SRV-1 frameshifting signal were made in plasmid SF2 that is derivative of pSFCASS5 (8), a frameshift reporter construct used in earlier phenotypic studies. SF105-113 [except SF110 (A28G) see SF210] were obtained by a two-step PCR mutagenesis procedure using degenerated primers on plasmid pSF103 that contains the sequence of the 'NMR pseudoknot' (26) . The appropriate mutants were selected by dideoxy sequencing.\", 'cite_spans': [{'start': 364, 'end': 368, 'text': '(26)', 'ref_id': 'BIBREF25'}], 'ref_spans': [], 'section': 'Constructs'}, {'text': \"SF202-206 and SF209-211 were constructed as follows. First a BglII-NcoI fragment from the SF2 vector was replaced by a short DNA fragment obtained by hybridization of oligonucleotides (5 0 -GATCTTAATACGACT CACTATAGGGCTCAGGGAAACTGATCA-CGTGG C-3 0 ) and 5 0 -CATGGCCACGTGATCAGTTTCCCTGA GCCCTATAGTGAGTC-GTATTAA-3 0 ) creating a unique BclI restriction site just downstream of the slippery sequence. The resulting plasmid pSF201 was opened at the BclI and NcoI sites and sets of complementary oligonucleotides corresponding to mutants SF202-206 were inserted. In mutant SF207, which codes only for the À1 reading frame product, the BglII-NcoI fragment was replaced by two short complementary oligonucleotides: SF218/SF219: 5 0 GATCTGGCCACTAGTAC/5 0 CATGG TACTAGTGGCCA). Note that this in-frame product is 21 aa shorter than the frameshifted À1 product. A C B Figure 1 . Structure of the 'NMR' SRV-1 frameshift pseudoknot and the effect of substitutions in L2 on its frameshift-inducing capacity. This pseudoknot differs from the viral pseudoknot by having G2C18-to-CG, C10G32-to-UA, G20-to-C and deletion of GCU between C24 and A25 substitutions (26) . (A) The 3D model of the NMR pseudoknot (PDB 1E95); L2 bases, magenta; S1 and S2 base pairs in cyan, L1 base in red, 3 0 single-stranded sequence AC in yellow. (B) Substitutions in the NMR pseudoknot sequence. Dashed lines illustrate base triples. (C) Rabbit reticulocyte lysate translation products of mRNAs derived from BamHI-digested templates were separated on a 17.5% SDS polyacrylamide gel and detected by fluorography. The migration of the 19 kDa 0-frame product (NFS) and the 22 kDa 'frameshift' product (FS) are indicated. SF103, wild-type; see Table 1 for the explanation of other constructs.\", 'cite_spans': [{'start': 1142, 'end': 1146, 'text': '(26)', 'ref_id': 'BIBREF25'}], 'ref_spans': [{'start': 855, 'end': 863, 'text': 'Figure 1', 'ref_id': None}, {'start': 1702, 'end': 1709, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'Constructs'}, {'text': 'SF213-224 were constructed as follows. First the entire BglII-NcoI fragment of pSF2 was replaced by a synthetic dsDNA fragment (5 0 -GATCTTAATACGACTCAC TATA-GGGCTCATTTAAACTAGTTGAGGGGCCA TATTTCGC-3 0 and 5 0 -CATGGCGAAATATGGCCC CTCAACTAGTTTAAATGAGCCCTATAGTGAGTC GTATTAA-3 0 , sequences forming a SpeI restriction site are underlined). The resulting plasmid pSF208 was opened at the BglII and SpeI sites and oligonucleotides SF226 (5 0 -GATCTTAATACGACTCACT-ATAGGGCTCAGG GAAA-3 0 ) and SF227 (5 0 -CTAGTTTCCCTGAGCCCT ATA-GTGAGTCGTATTAA-3 0 ) were inserted. This yielded pSF212, which was subsequently digested with SpeI and NcoI to insert sets of complementary oligonucleotides corresponding to mutants SF213-224. The sequences of these oligonucleotides are available on request. All mutants were checked by dideoxy sequencing and are listed in Table 1 .', 'cite_spans': [], 'ref_spans': [{'start': 842, 'end': 849, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'Constructs'}, {'text': 'In vitro transcription DNA templates were linearized by BamHI digestion and purified by successive phenol/chloroform extraction and column filtration (Qiagen). SP6 polymerase directed transcription was carried out in a 50-ml reaction containing 1-3 mg linearized DNA, 1 mM NTPs, 40 mM Tris-HCl (pH 7.9), 10 mM NaCl, 10 mM DTT, 6 mM MgCl 2 , 2 mM spermidine, 6 units of Rnase inhibitor (RNAguard, Pharmacia) and 15 units of SP6 polymerase (Promega). After an incubation period of 2 h at 37 C, samples were taken and run on agarose gels to determine the quality and quantity of the transcripts. Appropriate dilutions of the reaction mix in desalted and sterilized water were directly used for in vitro translations. Alternatively, transcripts were purified by phenol/ chloroform extraction and isopropanol precipitation as described earlier (27) .', 'cite_spans': [{'start': 839, 'end': 843, 'text': '(27)', 'ref_id': 'BIBREF26'}], 'ref_spans': [], 'section': 'Constructs'}, {'text': 'Reactions contained 4 ml of RNA solution, 4.5 ml of reticulocyte lysate (Promega), 1 ml of 35 S methionine (ICN, in vitro translation grade), 0.5 ml of 1 mM amino acids (ÀMet) and were incubated for 60 min at 28 C. Samples were boiled for 3 min in the Laemmli buffer and loaded onto 12% SDS polyacrylamide gels. Gels were dried and exposed to phosphoimager screens. Band intensity of 0 frame and À1 frame products was measured using Molecular Imager FX (Biorad) and Quantity One software. Frameshift percentages were calculated as the amount of À1 frame product divided by the sum of 0 and À1 frame products, corrected for the number of methionines, multiplied by 100.', 'cite_spans': [], 'ref_spans': [], 'section': 'In vitro translation'}, {'text': \"Pseudoknot mutants were cloned in KpnI/BamHI digested pDUAL-HIV(0) (4). The GGGAAAC slippery sequence was changed to the more efficient UUUAAAC (28) to obtain a better read-out. In these constructs the stopcodon of the first open-reading frame, Renilla luciferase, is located downstream of the pseudoknot. A non-frameshifting control was constructed by changing the slippery sequence to UUUAAGC, while in the in-frame control a C-residue was added directly downstream of this heptamer. In both constructs the pseudoknot was the NMR-pseudoknot. A list of oligonucleotide sequences is available on request. All constructs were confirmed by DNA sequencing. HeLa cells (24-well plate) were transfected with 250 ng of plasmid using lipofectamine-2000 (Invitrogen). Cells were lysed 20 h after transfection and luciferase activities were measured in a Glomax-multidetector (Promega) according to manufacturer's protocol.\", 'cite_spans': [{'start': 144, 'end': 148, 'text': '(28)', 'ref_id': 'BIBREF27'}], 'ref_spans': [], 'section': 'In vivo assay'}, {'text': 'The NMR structure of the SRV-1 pseudoknot (26) revealed a number of interesting features that may be relevant to the process of frameshifting. These features include stacking of adenosines A21-A26 in loop L2 and flipping out of cytosine 24, base-base and/or base-sugar interactions of A21, A26, U27 and A28 from L2 with the minor groove of stem S1 ( Figure 1A ). To test the importance of these interactions in frameshifting, mutations were introduced in these regions of the pseudoknot and their frameshifting capacity was measured in rabbit reticulocyte lysates and compared to the NMR wild-type pseudoknot ( Table 1) .', 'cite_spans': [], 'ref_spans': [{'start': 350, 'end': 359, 'text': 'Figure 1A', 'ref_id': None}, {'start': 611, 'end': 619, 'text': 'Table 1)', 'ref_id': 'TABREF0'}], 'section': 'RESULTS AND DISCUSSION'}, {'text': \"C20. For NMR purposes the wild-type G-residue at this position was replaced by a C (26) . Back mutation to a G (SF105) resulted in a 1.2-fold increase in frameshifting ( Figure 1C ). An adenosine at this position (SF106) was even more beneficial for frameshifting showing a 1.5-fold increase relative to the control NMR pseudoknot ( Figure 1C , compare lanes 'SF103 0 and '106 0 ). A uracil at this position was not tested since this would lead to a premature stopcodon in the À1 frame. Insertion of UUU (SF114) between C19 and C20 led to a slight decrease in frameshifting: 88% relative to the NMR wild-type (SF103). Even though in the latter mutant two additional base pairs might be formed with the 5 0 single-stranded sequence (AU and GU) these are probably melted when the ribosome is stalled over the slippery sequence.\", 'cite_spans': [{'start': 83, 'end': 87, 'text': '(26)', 'ref_id': 'BIBREF25'}], 'ref_spans': [{'start': 170, 'end': 179, 'text': 'Figure 1C', 'ref_id': None}, {'start': 333, 'end': 342, 'text': 'Figure 1C', 'ref_id': None}], 'section': 'Changes in L2'}, {'text': 'A21. This nucleotide forms a base triple with the C2-G18 base pair. Mutation of A21 to G did not affect frameshifting, but replacement with C or U decreased the relative frameshifting activity to 60 and 63%, respectively (Table 1) . Although a guanine cannot substitute for the triple interaction with the C2-G18 base pair, its stacking properties may compensate for this. The two pyrimidines may be too small to bridge the distance here to form an interaction with C2-G18.', 'cite_spans': [], 'ref_spans': [{'start': 221, 'end': 230, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Changes in L2'}, {'text': 'C24. This nucleotide is extruded from loop 2 by the stacking interaction of the continuous run of adenines and is not involved in any interaction. Thus, from a structural point of view, the presence of C24 in loop L2 seems superfluous or even a nuisance by hindering the stacking of the A21-A26 adenosines. Changing C24 to U (SF111) did not affect frameshifting ( Figure 1C) , suggesting that also a uridine at this position is flipped out. Replacing C24 by G (SF112) or deleting it (SF202) had no significant effect on frameshifting while an adenosine at this position slightly enhanced frameshifting activity (SF113), possibly as a result of extended adenosine stacking. These results show, as expected, that C24 is irrelevant and dispensable for frameshifting.', 'cite_spans': [], 'ref_spans': [{'start': 364, 'end': 374, 'text': 'Figure 1C)', 'ref_id': None}], 'section': 'Changes in L2'}, {'text': 'A26. A26 forms three hydrogen bonds with stem 2. Two hydrogen bonds from the N3 and hydroxyl group of A23 to the C16 2 0 OH together form a single ribose-zipper motif. The third hydrogen bond is between the N1 and amino group of G4. A pyrimidine seems too small to fulfil these interactions and indeed replacing A26 by C or U showed an approximately 3-fold lower frameshifting activity (Table 1, SF217 and SF216 ). G would be capable of forming the ribose zipper motif though a considerable clash between its N1 and the G4 amino group can be expected. The relatively high frameshifting activity, 70% of the A26G pseudoknot, suggests that, at this position in L2, stacking properties assisted by the ribose interaction may be more important than formation of the zipper motif itself.', 'cite_spans': [], 'ref_spans': [{'start': 386, 'end': 395, 'text': '(Table 1,', 'ref_id': 'TABREF0'}, {'start': 396, 'end': 411, 'text': 'SF217 and SF216', 'ref_id': None}], 'section': 'Changes in L2'}, {'text': 'U27. U27 forms only a single hydrogen bond via O2 to the amino group of G15, putting less structural restraints on frameshifting. Still mutation of this residue reduced frameshifting 1.4-to 2.5-fold ( Table 1 ). The 2-fold reduction seen by substituting C for U27 is not easily explained as this pyrimidine has an identically positioned O 2 to hydrogen bond to the amino group of G15.', 'cite_spans': [], 'ref_spans': [{'start': 201, 'end': 208, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'Changes in L2'}, {'text': \"A28. A28 is a key nucleotide in stabilization of the pseudoknot fold by anchoring L2 to the S1/S2 junction through formation of two hydrogen bonds with the 2 0 -hydroxyl group of G14. Replacement by U (SF108) or G (SF210) resulted in almost 2-fold decrease whereas a C (SF109), though having a similarly positioned N1 and amino groups as an adenosine, resulted in $4-fold drop in frameshifting ( Figure 1C) . Apparently, the relatively small pyrimidine ring is too far away to form interactions with the 2 0 OH of G14. In addition, the lower frameshift activity of the C-mutant could also be caused by formation of a base pair with G14, which could change the overall structure around the S1/S2 junction. In summary, the effect of single-nucleotide mutations in L2 show the functional, critical importance of the A26:G4-C16 and A28:C5-G15 triples that were previously identified by NMR spectroscopy (26) . Base triples at these positions, stabilizing the S1/S2 junction have been recognized to be essential for frameshifting in other pseudoknots as well, be it with different hydrogen bond patterns (21, 24, 25, 29) . To provide additional evidence for the importance of the specific interactions between L2 and S1 in frameshifting, we accumulated a number of the adverse mutations into one construct. Therefore, a construct was designed with a pyrimidine-rich L2 sequence CUCUCGUG (SF229, 'L2-mut') that included the A21U, C24U, A26G and A28G mutations. SF229 showed an 8-fold lower activity in frameshifting (Table 1) , which is approximately the sum of the single-nucleotide changes.\", 'cite_spans': [{'start': 899, 'end': 903, 'text': '(26)', 'ref_id': 'BIBREF25'}, {'start': 1099, 'end': 1103, 'text': '(21,', 'ref_id': 'BIBREF20'}, {'start': 1104, 'end': 1107, 'text': '24,', 'ref_id': 'BIBREF23'}, {'start': 1108, 'end': 1111, 'text': '25,', 'ref_id': 'BIBREF24'}, {'start': 1112, 'end': 1115, 'text': '29)', 'ref_id': 'BIBREF28'}], 'ref_spans': [{'start': 396, 'end': 406, 'text': 'Figure 1C)', 'ref_id': None}, {'start': 1510, 'end': 1519, 'text': '(Table 1)', 'ref_id': 'TABREF0'}], 'section': 'Changes in L2'}, {'text': 'G1-C19. A previous sequence comparison showed that most frameshifter pseudoknots start with a 5 0 G-C3 0 base pair (30). Changing this base pair, which is not involved in any loop interaction, to C-G (SF209) affected frameshifting efficiency somewhat (73%). As stacking energies of this base pair are also lower (À2.4 versus À3.3 kcal/mol) this confers to the general notion that helix stability is an important determinant in frameshifting. Changing G1-C19 into an A-U base pair (SF211) or a G-G mismatch (SF107) reduced the efficiency even further to about 40%, again emphasizing the role of S1 stability.', 'cite_spans': [], 'ref_spans': [], 'section': 'Changes in S1'}, {'text': 'G3-C17. This pair is also not involved in any triple interaction, but replacing it with A-U (SF342) resulted in a 60% drop in frameshifting. Again this indicates that the stability of S1 plays an important role in the frameshifting capacity of the pseudoknot. Previously, changing G3-C17 in the wild-type pseudoknot to A-U resulted in an almost 5-fold drop in frameshifting (31) . Since we do not have high-resolution structural information of the wild-type pseudoknot (L2: GAAACAAGCUUA), we cannot exclude that the G3-C17 base pair forms a base triple in this context, which could further attribute to the enhanced effect of mutating this base pair.', 'cite_spans': [{'start': 374, 'end': 378, 'text': '(31)', 'ref_id': 'BIBREF29'}], 'ref_spans': [], 'section': 'Changes in S1'}, {'text': 'G4-C16. This base pair is involved in a base triple with A26, mutation of which had quite some impact on frameshifting (see above). Changing G4-C16 into A-U (SF204) is predicted to result in the loss of one hydrogen bond (G24N2H-A26N1), similar to changing A26 to G (SF218), which was still 71% active in frameshifting. The observed dramatic low activity of the A-U base pair mutant (13%) cannot be solely attributed to the loss of one hydrogen bond and must therefore also be due to compromising the stability of the S1 stem.', 'cite_spans': [], 'ref_spans': [], 'section': 'Changes in S1'}, {'text': 'C5-G15. This pair forms a triple interaction with U27, mutation of which had at most a one-third lower frameshifting activity. Changing the base pair to U-A (SF203) caused an almost 4-fold drop in frameshifting activity, again showing the importance of stem stability.', 'cite_spans': [], 'ref_spans': [], 'section': 'Changes in S1'}, {'text': 'C6-G14. This pair forms a base triple with A28 via the hydroxyl group of G14. This interaction is not expected to change by mutating it to a U-A bp (SF205). The 2.5-fold decrease must therefore be a consequence of reduced stem stability and/or stacking properties with the S2 U-A pair at the junction. This large decrease again illustrates the critical importance of the A28:C6-G15 triple interaction.', 'cite_spans': [], 'ref_spans': [], 'section': 'Changes in S1'}, {'text': 'As with the single-nucleotide substitutions, the effect of the base pair mutations also correlates with the NMR structure, thereby illustrating the functional importance of the S1-L2 interactions. Also the stability of S1 as a primary determinant of frameshifting is clearly confirmed.', 'cite_spans': [], 'ref_spans': [], 'section': 'Changes in S1'}, {'text': 'Using the above knowledge we attempted to create a supershifting pseudoknot (Figure 2 ). To this end we substituted G for C20, removed C24 and restored the G2-C18 and C10-G32 base pairs, as present in the SRV-1 pseudoknot. To our surprise this mutant was 3-fold less active in frameshifting than the parent SF206 pseudoknot. Close inspection of the sequence indicated a possible alternative structure containing two hairpins competing with pseudoknot formation (Figure 2 ). To prevent this alternative structure, we mutated C10-G32 to U-A (SF223) or G-C (SF224). In these constructs the U-A pair is predicted to destabilize the 4-and 7-bp hairpins and the G-C base pair is predicted to completely disrupt the 4-bp hairpin and destabilize the 7-bp hairpin. Frameshift levels of SF224 increased approximately 2-fold compared to SF222, while that of SF223 increased more than 3-fold suggesting that the role of alternative structure formation should not be underestimated.', 'cite_spans': [], 'ref_spans': [{'start': 76, 'end': 85, 'text': '(Figure 2', 'ref_id': None}, {'start': 461, 'end': 470, 'text': '(Figure 2', 'ref_id': None}], 'section': 'Supershifter'}, {'text': \"Although SF224 is a slightly better shifter than SF206 (1.11-fold) with an absolute frameshift frequency of 24% it still cannot be considered a supershifter. Previous experiments with SRV-1 pseudoknot mutants yielded better shifters (31) . One of these, SF67, which differed from . Figure 2 . Putative alternative structure of the 'supershifter' pseudoknots. The boxed G-C base pairs and the circled G are also present in the wild-type SRV-1 pseudoknot. The position of the C24 deletion is indicated by the dot and arrowhead.\", 'cite_spans': [{'start': 233, 'end': 237, 'text': '(31)', 'ref_id': 'BIBREF29'}], 'ref_spans': [{'start': 282, 'end': 290, 'text': 'Figure 2', 'ref_id': None}], 'section': 'Supershifter'}, {'text': 'SF222 by still having C24, was capable of shifting 30% of the translating ribosomes. Thus, it appears that depending on the context deleting C24 is not always beneficial for frameshifting.', 'cite_spans': [], 'ref_spans': [], 'section': 'Supershifter'}, {'text': 'At present it is difficult to interpret these results. One explanation could be that C24 or other L2 nucleotides also play a role in refolding of the pseudoknot after ribosome passage. It can be envisaged that a faster refolding pseudoknot might be a more efficient frameshifter, because in order to cause a frameshift, a stable pseudoknot needs to be regenerated before it encounters the next ribosome.', 'cite_spans': [], 'ref_spans': [], 'section': 'Supershifter'}, {'text': 'If refolding kinetics of the pseudoknot is a determinant in frameshift efficiency the length of L2 is also expected to have an effect on frameshifting. To test this possibility we changed the length of L2 to 3 and 27 nt in mutants SF348 and SF350, respectively. The absolute frameshifting activity of SF348 was only 1.3%, i.e. a 16-fold decrease compared to SF206. SF350 showed 8.4% frameshifting, a 2.5-fold drop. Of course, when introducing such dramatic changes, one should also consider their effects on the pseudoknot structure and stability. In SF348 most of the base triples are presumably lost and a 3-nt loop crossing the minor groove of stem S1 may not be sterically and thermodynamically favorable. In fact, the very large-16-fold-reduction in frameshifting suggests that the pseudoknot is not formed at all (the presence of a pseudoknot structure was not checked by e.g. structure probing).', 'cite_spans': [], 'ref_spans': [], 'section': 'Supershifter'}, {'text': 'With SF350, containing the 27-nt L2, the situation is different. In this mutant some of the triples may still form but the additional unstructured 18 nt are expected to introduce a substantial entropic penalty into the system, which increases DG and therefore reduces frameshifting. In addition, a large loop may lead to a longer refolding time of the pseudoknot once a ribosome has passed through this structure.', 'cite_spans': [], 'ref_spans': [], 'section': 'Supershifter'}, {'text': \"To investigate whether the mutations that affected frameshifting efficiency in vitro would also exert their effect in vivo, we introduced some of the above mutations into a dual luciferase reporter plasmid and assayed their activity in vivo ('Materials and Methods' section). The frameshifting efficiency of the wild-type SRV-1 pseudoknot and GGGAAAC slippery sequence (SF400) was only $8%, against a background of 2% of a non-frameshifting control (data not shown). This is a factor of 3 lower than that reported in vitro (28) . The NMR pseudoknot showed $11% of frameshifting (SF402, data not shown) that increased to $19% in combination with the UUUAAAC slippery sequence (SF404). This 1.7-fold increase is very similar to the previously reported increase from 23 to 40% in vitro for changing the slippery sequence (28) . Mutations were made in the pseudoknot of plasmid SF404. As can be seen in Figure 3 , the substitutions had almost the same effect on frameshifting in vivo as in vitro. The only exception seems to be the effect of enlarging L2, which is consistently more detrimental for frameshifting in vivo than in vitro. This could be due to refolding kinetics of the pseudoknot, what in combination with heavier ribosomal traffic in vivo would result in a lower fraction of properly folded pseudoknots. However, other possibilities, like enhanced RNase susceptibility or alternative folds involving L2, may also account for this effect.\", 'cite_spans': [{'start': 523, 'end': 527, 'text': '(28)', 'ref_id': 'BIBREF27'}, {'start': 818, 'end': 822, 'text': '(28)', 'ref_id': 'BIBREF27'}], 'ref_spans': [{'start': 899, 'end': 907, 'text': 'Figure 3', 'ref_id': None}], 'section': 'In vivo frameshifting'}, {'text': \"The interactions between L2 and S1 in the SRV-1 pseudoknot as previously determined by NMR (26) turn out to be important for frameshifting. Although single alterations of the base triples found in the NMR study had at most a 3-fold deleterious effect on frameshifting, combining several of these changes into one mutant, L2-mut, led to an 8-fold decrease in vitro and a 6-fold decrease in vivo. This is quite remarkable as the mutated sequence should still be able to fold as a pseudoknot, but apparently critical stem-loop interactions are lacking. As found for other frameshifter pseudoknots, the composition and length of L2 can greatly influence frameshifting. Most frameshifter pseudoknots have adenine-rich L2 loops, presumably because of the need for stable triple helix formation, which is best performed by adenosine's N1 and C6-amino groups (2) .\", 'cite_spans': [{'start': 851, 'end': 854, 'text': '(2)', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': \"Deletion of the bulging C24 from the loop L2 did not affect frameshifting significantly in vitro and in vivo. This adds to the notion that this nucleotide can be safely squeezed out to allow stacking of adenosines in L2. It is noteworthy that other frameshifter pseudoknots also have a cytosine flanked by adenines in L2: GAACAAA in Figure 3 . Comparison of in vivo and in vitro frameshifting activities relative to that of the NMR pseudoknot. White bars, in vivo; gray bars, in vitro. The efficiency of the NMR pseudoknot ('wild-type') is set at 100%. Experiments were done at least three times in triplicate.\", 'cite_spans': [], 'ref_spans': [{'start': 333, 'end': 341, 'text': 'Figure 3', 'ref_id': None}], 'section': 'CONCLUSIONS'}, {'text': 'BWYV (29) , UAAAAACAC in ScYLV (25) , ACUCAAA A in MMTV (32) and AAACAA in HIV-1 type O (33) . Interestingly, L2 of the human telomerase pseudoknot, not involved in frameshifting, consists of CAAACAAA. This pseudoknot has recently been shown to function in frameshifting in vitro (22) . Also here the adenosines formed triple interactions with base pairs in stem S1 and were essential for frameshifting (22, 34) . The effect of substituting the second C in L2 has not been investigated; its presence may be required to prevent slippage of the RNA polymerase.', 'cite_spans': [{'start': 5, 'end': 9, 'text': '(29)', 'ref_id': 'BIBREF28'}, {'start': 31, 'end': 35, 'text': '(25)', 'ref_id': 'BIBREF24'}, {'start': 56, 'end': 60, 'text': '(32)', 'ref_id': 'BIBREF30'}, {'start': 88, 'end': 92, 'text': '(33)', 'ref_id': 'BIBREF31'}, {'start': 280, 'end': 284, 'text': '(22)', 'ref_id': 'BIBREF21'}, {'start': 403, 'end': 407, 'text': '(22,', 'ref_id': 'BIBREF21'}, {'start': 408, 'end': 411, 'text': '34)', 'ref_id': 'BIBREF32'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': 'The main role of the triple interactions seems to be in stabilizing the pseudoknot such that high frequencies of frameshifting are possible. Mutations that remove triple interactions in general lead to lower frameshifting. Conversely, it seems that frameshifting pseudoknots with weaker stems need to be stabilized by such triples. For instance in the BWYV and PEMV-1 pseudoknots, S2 is only three base pairs but this is compensated by an additional triple between L1 and S2. The high number of triples in luteovirus pseudoknots may explain why for instance the ScLYV pseudoknot with a relatively high number of A-U base pairs in the bottom of S1 is still capable of inducing $15% of frameshifting (25) . On the other hand, when S1 is increased to 11 base pairs, triple interactions do not seem to contribute anymore as frameshifting becomes independent of the sequence of L2 (C-H. Yu and R.C.L Olsthoorn, unpublished data).', 'cite_spans': [{'start': 698, 'end': 702, 'text': '(25)', 'ref_id': 'BIBREF24'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': 'If we assume that ribosomes first sense the bottom of stem S1 we would expect base triples to be present at the bottom of the stem or in the 5 0 end of L2. This would be in line with the observation that the first three base pairs of a frameshift pseudoknot are usually G-C (30). However, most triples are found near the 3 0 end of L2 close to the junction with S2. Possibly, triples at the junction render the pseudoknot more resistant to forced unwinding by the ribosomal helicase, which would otherwise serve as a pivot.', 'cite_spans': [], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': \"Because the mere presence of a pseudoknot structure with a certain minimal thermodynamic stability might not be the sole primary determinant of frameshifting a number of alternative models have been proposed in which mechanical resistance of the pseudoknot to forced unwinding is the key (12, 15, 23) . In these models a pseudoknot trapped in the mRNA entry tunnel resists mechanical unwinding, which causes the ribosome to pause. Indeed, recent optical tweezers experiments, in which rupture forces of RNAs are measured by pulling 5 0 and 3 0 ends apart, showed a correlation between frameshifting and mechanical strength of the pseudoknot and confirmed a positive effect of base triple interactions on frame shift efficiency (13, 14, 22) . Frameshifting by the trapped pseudoknot is thought to be either passive, by stalling the ribosome for a sufficient amount of time, or active, by building up tension at the mRNA-tRNA interface by a counteracting ribosome, which can be relieved by a À1 frameshift (15) . Observations that ribosomes can stall for seconds to minutes without frameshifting to occur (35) and pausing appears to be necessary, but not sufficient for frameshifting (36, 37) , rather point to an active role. Although it now seems mechanical resistance to RNA unfolding is the key to ribosomal frameshifting, how the ribosome exactly 'chokes' on such a structure is still far from being understood. Remaining questions are for instance if torsional restraint of the pseudoknot resisting ribosomal unwinding is essential (23) , whether the pseudoknot truly plays an active role in for instance overbending the tRNA in the P-site (12) and at which stage of translational elongation frameshifting actually occurs.\", 'cite_spans': [{'start': 288, 'end': 292, 'text': '(12,', 'ref_id': 'BIBREF11'}, {'start': 293, 'end': 296, 'text': '15,', 'ref_id': 'BIBREF14'}, {'start': 297, 'end': 300, 'text': '23)', 'ref_id': 'BIBREF22'}, {'start': 727, 'end': 731, 'text': '(13,', 'ref_id': 'BIBREF12'}, {'start': 732, 'end': 735, 'text': '14,', 'ref_id': 'BIBREF13'}, {'start': 736, 'end': 739, 'text': '22)', 'ref_id': 'BIBREF21'}, {'start': 1004, 'end': 1008, 'text': '(15)', 'ref_id': 'BIBREF14'}, {'start': 1103, 'end': 1107, 'text': '(35)', 'ref_id': 'BIBREF33'}, {'start': 1182, 'end': 1186, 'text': '(36,', 'ref_id': 'BIBREF34'}, {'start': 1187, 'end': 1190, 'text': '37)', 'ref_id': 'BIBREF35'}, {'start': 1536, 'end': 1540, 'text': '(23)', 'ref_id': 'BIBREF22'}, {'start': 1644, 'end': 1648, 'text': '(12)', 'ref_id': 'BIBREF11'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': 'One should also keep in mind the possible formation of alternative structures that can affect the frameshifting efficiency by lowering the fraction of properly folded pseudoknots. This possibility has not been investigated in detail but our own data ( Figure 2 ) suggest that this may be a relevant issue. Especially during heavy ribosomal traffic, as may be the case in vivo, fast and correct refolding of pseudoknots could be an important parameter for frameshifting. Under such circumstances it is conceivable that a hairpin is more preferred as it probably refolds faster than a pseudoknot. A recent study on the HIV-1 frameshift signal has shown that a decrease in the translation initiation frequency can lead to an increase in the frequency of frameshifting (38) . Also a previous study in yeast has shown a correlation between frameshifting and translation initiation frequency (36) . Our data with the enlargement of L2 also hint at a possible role for folding kinetics.', 'cite_spans': [{'start': 765, 'end': 769, 'text': '(38)', 'ref_id': 'BIBREF36'}, {'start': 886, 'end': 890, 'text': '(36)', 'ref_id': 'BIBREF34'}], 'ref_spans': [{'start': 252, 'end': 260, 'text': 'Figure 2', 'ref_id': None}], 'section': 'CONCLUSIONS'}, {'text': 'Although the time scale of folding (milliseconds) may at first seem irrelevant compared to the time scale of translation elongation (seconds) it has recently been reported that the conversion rate between two comparatively stable hairpins ranges from a few seconds to several minutes (39) . Also, slow-folding pseudoknots, 5-350 s, limit the activity of the Hepatitis Delta virus ribozyme (40) . Thus the efficiency of a frameshifter pseudoknot may not be solely dictated by its stability but also by its kinetic properties.', 'cite_spans': [{'start': 284, 'end': 288, 'text': '(39)', 'ref_id': 'BIBREF37'}, {'start': 389, 'end': 393, 'text': '(40)', 'ref_id': 'BIBREF38'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Structure and function of the stimulatory RNAs involved in programmed eukaryotic-1 ribosomal frameshifting', 'authors': [{'first': 'I', 'middle': [], 'last': 'Brierley', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Pennell', 'suffix': ''}], 'year': 2001, 'venue': 'Cold Spring Harb. Symp. Quant. Biol', 'volume': '66', 'issn': '', 'pages': '233--248', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Frameshifting RNA pseudoknots: structure and mechanism', 'authors': [{'first': 'D', 'middle': ['P'], 'last': 'Giedroc', 'suffix': ''}, {'first': 'P', 'middle': ['V'], 'last': 'Cornish', 'suffix': ''}], 'year': 2009, 'venue': 'Virus Res', 'volume': '139', 'issn': '', 'pages': '193--208', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Ribosomal frameshifting efficiency and gag/gag-pol ratio are critical for yeast M1 double-stranded RNA virus propagation', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Wickner', 'suffix': ''}], 'year': 1992, 'venue': 'J. Virol', 'volume': '66', 'issn': '', 'pages': '3669--3676', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1', 'authors': [{'first': 'D', 'middle': [], 'last': 'Dulude', 'suffix': ''}, {'first': 'Y', 'middle': ['A'], 'last': 'Berchiche', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Gendron', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Brakier-Gingras', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Heveker', 'suffix': ''}], 'year': 2006, 'venue': 'Virology', 'volume': '345', 'issn': '', 'pages': '127--136', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Ribosomal frameshifting in decoding antizyme mRNAs from yeast and protists to humans: close to 300 cases reveal remarkable diversity despite underlying conservation', 'authors': [{'first': 'I', 'middle': ['P'], 'last': 'Ivanov', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Atkins', 'suffix': ''}], 'year': 2007, 'venue': 'Nucleic Acids Res', 'volume': '35', 'issn': '', 'pages': '1842--1858', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Expression of peptide chain release factor 2 requires high-efficiency frameshift', 'authors': [{'first': 'W', 'middle': ['J'], 'last': 'Craigen', 'suffix': ''}, {'first': 'C', 'middle': ['T'], 'last': 'Caskey', 'suffix': ''}], 'year': 1986, 'venue': 'Nature', 'volume': '322', 'issn': '', 'pages': '273--275', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Programmed ribosomal frameshifting generates the Escherichia coli DNA polymerase III gamma subunit from within the tau subunit reading frame', 'authors': [{'first': 'A', 'middle': ['L'], 'last': 'Blinkowa', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Walker', 'suffix': ''}], 'year': 1990, 'venue': 'Nucleic Acids Res', 'volume': '18', 'issn': '', 'pages': '1725--1729', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': \"Mutational analysis of the 'slippery-sequence' component of a coronavirus ribosomal frameshifting signal\", 'authors': [{'first': 'I', 'middle': [], 'last': 'Brierley', 'suffix': ''}, {'first': 'A', 'middle': ['J'], 'last': 'Jenner', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Inglis', 'suffix': ''}], 'year': 1992, 'venue': 'J. Mol. Biol', 'volume': '227', 'issn': '', 'pages': '463--479', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Recoding in bacteriophages and bacterial IS elements', 'authors': [{'first': 'P', 'middle': ['V'], 'last': 'Baranov', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Fayet', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Hendrix', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Atkins', 'suffix': ''}], 'year': 2006, 'venue': 'Trends Genet', 'volume': '22', 'issn': '', 'pages': '174--181', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides', 'authors': [{'first': 'M', 'middle': ['T'], 'last': 'Howard', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Gesteland', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Atkins', 'suffix': ''}], 'year': 2004, 'venue': 'RNA', 'volume': '10', 'issn': '', 'pages': '1653--1661', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Novel application of sRNA: stimulation of ribosomal frameshifting', 'authors': [{'first': 'R', 'middle': ['C'], 'last': 'Olsthoorn', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Laurs', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Sohet', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Hilbers', 'suffix': ''}, {'first': 'H', 'middle': ['A'], 'last': 'Heus', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Pleij', 'suffix': ''}], 'year': 2004, 'venue': 'RNA', 'volume': '10', 'issn': '', 'pages': '1702--1703', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting', 'authors': [{'first': 'O', 'middle': [], 'last': 'Namy', 'suffix': ''}, {'first': 'S', 'middle': ['J'], 'last': 'Moran', 'suffix': ''}, {'first': 'D', 'middle': ['I'], 'last': 'Stuart', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Gilbert', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Brierley', 'suffix': ''}], 'year': 2006, 'venue': 'Nature', 'volume': '441', 'issn': '', 'pages': '244--247', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Correlation between mechanical strength of messenger RNA pseudoknots and ribosomal frameshifting', 'authors': [{'first': 'T', 'middle': ['M'], 'last': 'Hansen', 'suffix': ''}, {'first': 'S', 'middle': ['N'], 'last': 'Reihani', 'suffix': ''}, {'first': 'L', 'middle': ['B'], 'last': 'Oddershede', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Sorensen', 'suffix': ''}], 'year': 2007, 'venue': 'Proc. Natl Acad. Sci. USA', 'volume': '104', 'issn': '', 'pages': '5830--5835', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Characterization of the mechanical unfolding of RNA pseudoknots', 'authors': [{'first': 'L', 'middle': [], 'last': 'Green', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Kim', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Bustamante', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Tinoco', 'suffix': ''}], 'year': 2008, 'venue': 'J. Mol. Biol', 'volume': '375', 'issn': '', 'pages': '511--528', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'The 9-A solution: how mRNA pseudoknots promote efficient programmed -1 ribosomal frameshifting', 'authors': [{'first': 'E', 'middle': ['P'], 'last': 'Plant', 'suffix': ''}, {'first': 'K', 'middle': ['L'], 'last': 'Jacobs', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Harger', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Meskauskas', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Jacobs', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Baxter', 'suffix': ''}, {'first': 'A', 'middle': ['N'], 'last': 'Petrov', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2003, 'venue': 'RNA', 'volume': '9', 'issn': '', 'pages': '168--174', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'An extended signal involved in eukaryotic -1 frameshifting operates through modification of the E site tRNA', 'authors': [{'first': 'M', 'middle': [], 'last': 'Bekaert', 'suffix': ''}, {'first': 'J', 'middle': ['P'], 'last': 'Rousset', 'suffix': ''}], 'year': 2005, 'venue': 'Mol. Cell', 'volume': '17', 'issn': '', 'pages': '61--68', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'The three transfer RNAs occupying the A, P and E sites on the ribosome are involved in viral programmed À1 ribosomal frameshift', 'authors': [{'first': 'M', 'middle': [], 'last': 'Leger', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Dulude', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Steinberg', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Brakier-Gingras', 'suffix': ''}], 'year': 2007, 'venue': 'Nucleic Acids Res', 'volume': '35', 'issn': '', 'pages': '5581--5592', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Ribosomal pausing during translation of an RNA pseudoknot', 'authors': [{'first': 'P', 'middle': [], 'last': 'Somogyi', 'suffix': ''}, {'first': 'A', 'middle': ['J'], 'last': 'Jenner', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Brierley', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Inglis', 'suffix': ''}], 'year': 1993, 'venue': 'Mol. Cell. Biol', 'volume': '13', 'issn': '', 'pages': '6931--6940', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Energetics of a strongly pH dependent RNA tertiary structure in a frameshifting pseudoknot', 'authors': [{'first': 'P', 'middle': ['L'], 'last': 'Nixon', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Giedroc', 'suffix': ''}], 'year': 2000, 'venue': 'J. Mol. Biol', 'volume': '296', 'issn': '', 'pages': '659--671', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Structure, stability and function of RNA pseudoknots involved in stimulating ribosomal frameshifting', 'authors': [{'first': 'D', 'middle': ['P'], 'last': 'Giedroc', 'suffix': ''}, {'first': 'C', 'middle': ['A'], 'last': 'Theimer', 'suffix': ''}, {'first': 'P', 'middle': ['L'], 'last': 'Nixon', 'suffix': ''}], 'year': 2000, 'venue': 'J. Mol. Biol', 'volume': '298', 'issn': '', 'pages': '167--185', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Solution structure of a luteoviral P1-P2 frameshifting mRNA pseudoknot', 'authors': [{'first': 'P', 'middle': ['L'], 'last': 'Nixon', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Rangan', 'suffix': ''}, {'first': 'Y', 'middle': ['G'], 'last': 'Kim', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Rich', 'suffix': ''}, {'first': 'D', 'middle': ['W'], 'last': 'Hoffman', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Hennig', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Giedroc', 'suffix': ''}], 'year': 2002, 'venue': 'J. Mol. Biol', 'volume': '322', 'issn': '', 'pages': '621--633', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Triplex structures in an RNA pseudoknot enhance mechanical stability and increase efficiency of À1 ribosomal frameshifting', 'authors': [{'first': 'G', 'middle': [], 'last': 'Chen', 'suffix': ''}, {'first': 'K', 'middle': ['Y'], 'last': 'Chang', 'suffix': ''}, {'first': 'M', 'middle': ['Y'], 'last': 'Chou', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Bustamante', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Tinoco', 'suffix': ''}], 'year': 2009, 'venue': 'Proc. Natl Acad. Sci. USA', 'volume': '106', 'issn': '', 'pages': '12706--12711', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Torsional restraint: a new twist on frameshifting pseudoknots', 'authors': [{'first': 'E', 'middle': ['P'], 'last': 'Plant', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}], 'year': 2005, 'venue': 'Nucleic Acids Res', 'volume': '33', 'issn': '', 'pages': '1825--1833', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Specific mutations in a viral RNA pseudoknot drastically change ribosomal frameshifting efficiency', 'authors': [{'first': 'Y', 'middle': ['G'], 'last': 'Kim', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Su', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Maas', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'O&apos;neill', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Rich', 'suffix': ''}], 'year': 1999, 'venue': 'Proc. Natl Acad. Sci. USA', 'volume': '96', 'issn': '', 'pages': '14234--14239', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'A loop 2 cytidine-stem 1 minor groove interaction as a positive determinant for pseudoknot-stimulated À1 ribosomal frameshifting', 'authors': [{'first': 'P', 'middle': ['V'], 'last': 'Cornish', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Hennig', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Giedroc', 'suffix': ''}], 'year': 2005, 'venue': 'Proc. Natl Acad. Sci. USA', 'volume': '102', 'issn': '', 'pages': '12694--12699', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Solution structure of the pseudoknot of SRV-1 RNA, involved in ribosomal frameshifting', 'authors': [{'first': 'P', 'middle': ['J'], 'last': 'Michiels', 'suffix': ''}, {'first': 'A', 'middle': ['A'], 'last': 'Versleijen', 'suffix': ''}, {'first': 'P', 'middle': ['W'], 'last': 'Verlaan', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Pleij', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Hilbers', 'suffix': ''}, {'first': 'H', 'middle': ['A'], 'last': 'Heus', 'suffix': ''}], 'year': 2001, 'venue': 'J. Mol. Biol', 'volume': '310', 'issn': '', 'pages': '1109--1123', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'A conformational switch at the 3 0 end of a plant virus RNA regulates viral replication', 'authors': [{'first': 'R', 'middle': ['C'], 'last': 'Olsthoorn', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Mertens', 'suffix': ''}, {'first': 'F', 'middle': ['T'], 'last': 'Brederode', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Bol', 'suffix': ''}], 'year': 1999, 'venue': 'EMBO J', 'volume': '18', 'issn': '', 'pages': '4856--4864', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Identification and analysis of the pseudoknot-containing gag-pro ribosomal frameshift signal of simian retrovirus-1', 'authors': [{'first': 'E', 'middle': [], 'last': 'Ten Dam', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Brierley', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Inglis', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Pleij', 'suffix': ''}], 'year': 1994, 'venue': 'Nucleic Acids Res', 'volume': '22', 'issn': '', 'pages': '2304--2310', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Minor groove RNA triplex in the crystal structure of a ribosomal frameshifting viral pseudoknot', 'authors': [{'first': 'L', 'middle': [], 'last': 'Su', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Chen', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Egli', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Berger', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Rich', 'suffix': ''}], 'year': 1995, 'venue': 'Nat. Struct. Biol', 'volume': '6', 'issn': '', 'pages': '285--292', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Analysis of the role of the pseudoknot component in the SRV-1 gag-pro ribosomal frameshift signal: loop lengths and stability of the stem regions', 'authors': [{'first': 'E', 'middle': ['B'], 'last': 'Ten Dam', 'suffix': ''}, {'first': 'P', 'middle': ['W'], 'last': 'Verlaan', 'suffix': ''}, {'first': 'C', 'middle': ['W'], 'last': 'Pleij', 'suffix': ''}], 'year': 1995, 'venue': 'RNA', 'volume': '1', 'issn': '', 'pages': '146--154', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'An RNA pseudoknot and an optimal heptameric shift site are required for highly efficient ribosomal frameshifting on a retroviral messenger RNA', 'authors': [{'first': 'M', 'middle': [], 'last': 'Chamorro', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Parkin', 'suffix': ''}, {'first': 'H', 'middle': ['E'], 'last': 'Varmus', 'suffix': ''}], 'year': 1992, 'venue': 'Proc. Natl Acad. Sci. USA', 'volume': '89', 'issn': '', 'pages': '713--717', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'The frameshift stimulatory signal of human immunodeficiency virus type 1 group O is a pseudoknot', 'authors': [{'first': 'M', 'middle': [], 'last': 'Baril', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Dulude', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Steinberg', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Brakier-Gingras', 'suffix': ''}], 'year': 2003, 'venue': 'J. Mol. Biol', 'volume': '331', 'issn': '', 'pages': '571--583', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'An intermolecular RNA triplex provides insight into structural determinants for the pseudoknot stimulator of À1 ribosomal frameshifting', 'authors': [{'first': 'M', 'middle': ['Y'], 'last': 'Chou', 'suffix': ''}, {'first': 'K', 'middle': ['Y'], 'last': 'Chang', 'suffix': ''}], 'year': 2009, 'venue': 'Nucleic Acids Res', 'volume': '38', 'issn': '', 'pages': '1676--1685', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Following translation by single ribosomes one codon at a time', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Wen', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Lancaster', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hodges', 'suffix': ''}, {'first': 'A', 'middle': ['C'], 'last': 'Zeri', 'suffix': ''}, {'first': 'S', 'middle': ['H'], 'last': 'Yoshimura', 'suffix': ''}, {'first': 'H', 'middle': ['F'], 'last': 'Noller', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Bustamante', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Tinoco', 'suffix': ''}], 'year': 2008, 'venue': 'Nature', 'volume': '452', 'issn': '', 'pages': '598--603', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Kinetics of ribosomal pausing during programmed À1 translational frameshifting', 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Lopinski', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Dinman', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Bruenn', 'suffix': ''}], 'year': 2000, 'venue': 'Mol. Cell. Biol', 'volume': '20', 'issn': '', 'pages': '1095--1103', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Ribosomal pausing at a frameshifter RNA pseudoknot is sensitive to reading phase but shows little correlation with frameshift efficiency', 'authors': [{'first': 'H', 'middle': [], 'last': 'Kontos', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Napthine', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Brierley', 'suffix': ''}], 'year': 2001, 'venue': 'Mol. Cell. Biol', 'volume': '21', 'issn': '', 'pages': '8657--8670', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'The presence of the TAR RNA structure alters the programmed À1 ribosomal frameshift efficiency of the human immunodeficiency virus type 1 (HIV-1) by modifying the rate of translation initiation', 'authors': [{'first': 'K', 'middle': [], 'last': 'Gendron', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Charbonneau', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Dulude', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Heveker', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Ferbeyre', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Brakier-Gingras', 'suffix': ''}], 'year': 2008, 'venue': 'Nucleic Acids Res', 'volume': '36', 'issn': '', 'pages': '30--40', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'A caged uridine for the selective preparation of an RNA fold and determination of its refolding kinetics by real-time NMR', 'authors': [{'first': 'P', 'middle': [], 'last': 'Wenter', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Furtig', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Hainard', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Schwalbe', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Pitsch', 'suffix': ''}], 'year': 2006, 'venue': 'Chembiochem', 'volume': '7', 'issn': '', 'pages': '417--420', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'The folding pathway of the genomic hepatitis delta virus ribozyme is dominated by slow folding of the pseudoknots', 'authors': [{'first': 'D', 'middle': ['M'], 'last': 'Chadalavada', 'suffix': ''}, {'first': 'S', 'middle': ['E'], 'last': 'Senchak', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Bevilacqua', 'suffix': ''}], 'year': 2002, 'venue': 'J. Mol. Biol', 'volume': '317', 'issn': '', 'pages': '559--575', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': \"Summary of all mutants and their relative frameshifting efficiency compared to wild-type ('NMR pseudoknot') All assays were performed at least three times, at non-saturating mRNA concentrations. SD ± 10%. SF200-SF350 series were constructed in a modified version of the SF103 construct ('Materials and Methods' section).\", 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We thank D. Dulude and L. Brakier-Gringras for providing the dual luciferase reporter plasmids.', 'cite_spans': [], 'ref_spans': [], 'section': 'ACKNOWLEDGEMENTS'}, {'text': 'Funding for open access charge: Leiden University and Radboud University.', 'cite_spans': [], 'ref_spans': [], 'section': 'FUNDING'}, {'text': 'Conflict of interest statement. None declared.', 'cite_spans': [], 'ref_spans': [], 'section': 'annex'}]}\n",
      "{'_id': ObjectId('5f4ecb69580eebc2ccae630d'), 'paper_id': '01bc7fe59fc7feb0e3d23c716aa23a694a4362a2', 'metadata': {'title': 'Open Forum Infectious Diseases Open Forum Infectious Diseases ® Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use', 'authors': [{'first': 'Outpatient', 'middle': [], 'last': 'Antibiotic', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Stewardship', 'middle': ['•'], 'last': 'Ofid', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'California Infection Control Consultants', 'location': {'settlement': 'San Ramon', 'region': 'California'}}, 'email': ''}, {'first': 'Patrick', 'middle': [], 'last': 'Joseph', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'California Infection Control Consultants', 'location': {'settlement': 'San Ramon', 'region': 'California'}}, 'email': ''}, {'first': 'Eliot', 'middle': [], 'last': 'Godofsky', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University Hepatitis Center', 'location': {'settlement': 'Bradenton', 'region': 'Florida'}}, 'email': ''}]}, 'abstract': [], 'body_text': [{'text': 'Acute upper respiratory infections (URIs), inclusive of acute pharyngitis, sinusitis, and tracheobronchitis, are the most common reason for antibiotic therapy in primary care and urgent care settings and account for nearly 90% of the 41 million antibiotic prescriptions per year for acute respiratory infections (ARI) in the United States [1] . Unfortunately, viral respiratory infections like influenza often lead to inappropriate prescribing of antibiotics, contributing to the expanding problem of microbial resistance. In addition, routine antibiotic overuse can lead to unnecessary consultations, emergency room (ER) visits, allergic reactions including anaphylaxis, Stevens Johnson syndrome, and Clostridium difficile infection [1] .', 'cite_spans': [{'start': 339, 'end': 342, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 734, 'end': 737, 'text': '[1]', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': ''}, {'text': 'Clinical differentiation between a viral and bacterial URI can be challenging. Diagnostic uncertainty, combined with patient or family pressures, frequently facilitates the misuse of antibiotics [1] . Acute pharyngitis is primarily viral in adults, with only about 10% of patients having a bacterial cause, most commonly a group A beta-hemolytic streptococcus (GABHS) [2] . None of the symptoms, physical findings, or the clinical criteria scores are highly specific for differentiating GABHS from non-GABHS causes [3] . Despite the relatively high frequency of viral pharyngitis in adults, physicians prescribe antibiotics for 78% to 98% of patients with clinical pharyngitis in an effort not to miss bacterial GABHS pharyngitis [4, 5] . Furthermore, even though 90% of acute bronchitis is thought to be of viral etiology in the United States, the rate of antibiotic prescribing was shown to be between 60% and 80% [6] .', 'cite_spans': [{'start': 195, 'end': 198, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 368, 'end': 371, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 515, 'end': 518, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 730, 'end': 733, 'text': '[4,', 'ref_id': 'BIBREF3'}, {'start': 734, 'end': 736, 'text': '5]', 'ref_id': 'BIBREF4'}, {'start': 916, 'end': 919, 'text': '[6]', 'ref_id': 'BIBREF5'}], 'ref_spans': [], 'section': ''}, {'text': 'Rapid antigen testing, cell culture, and newer molecular tests are limited by their cost, availability, and inability to differentiate microbial colonization or carrier states from clinical infection [7] . This may result in unnecessary antibiotic prescriptions, underscoring the importance of accurately defining a clinically significant bacterial infection [3, 8, 9] .', 'cite_spans': [{'start': 200, 'end': 203, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 359, 'end': 362, 'text': '[3,', 'ref_id': 'BIBREF2'}, {'start': 363, 'end': 365, 'text': '8,', 'ref_id': 'BIBREF7'}, {'start': 366, 'end': 368, 'text': '9]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': ''}, {'text': 'Confirmation of a clinically significant active infection requires the identification of an infectious agent via antigen detection, culture growth, or molecular techniques in association with a positive immune response, whereas the lack of a systemic immune response suggests a carrier state or colonization.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Traditionally, paired serology is performed, necessitating 2 patient visits 2-4 weeks apart, and thus is impractical. Antigen testing and molecular tests are more time efficient [10] but may overestimate the prevalence of true infection, leading to the prescription of unnecessary antibiotics [7, 8] .', 'cite_spans': [{'start': 178, 'end': 182, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 293, 'end': 296, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 297, 'end': 299, 'text': '8]', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': ''}, {'text': 'Efficiently defining a clinically significant bacterial infection requiring antibiotic therapy is the rate-limiting step of antibiotic stewardship in the outpatient setting. Biomarkers such as C-reactive protein (CRP) or procalcitonin (PCT) independently may identify clinically significant infections, thereby reducing the risk of missing a clinically significant bacterial infection. However, these biomarkers lack adequate specificity to differentiate a viral from a bacterial infection and ultimately lead to antibiotic overtreatment of viral infections. Myxovirus resistance protein A (MxA), a protein induced by type I interferon, is selectively elevated in patients with viral infections and has the potential to greatly enhance the rapid distinction between viral and bacterial respiratory infections [7, 8] . Combining CRP or PCT with an elevated MxA will help identify patients who most likely have viral infection, allowing physicians to consider reserving antibiotics in this patient population and proceed with a watchful, waiting strategy.', 'cite_spans': [{'start': 809, 'end': 812, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 813, 'end': 815, 'text': '8]', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': ''}, {'text': 'Major databases, including MEDLINE and the Cochrane Library, were searched for prospective human clinical studies, including children and/or adults published between January 1966 and November 2017 that evaluated Myxovirus resistance protein A (MxA) as a biomarker for diagnosing viral infections as well as both C-reactive protein (CRP) and procalcitonin (PCT) as potential biomarkers for identifying and differentiating true bacterial upper respiratory infection (URI) from colonization.', 'cite_spans': [], 'ref_spans': [], 'section': 'METHODS'}, {'text': 'Both viruses and bacteria may colonize the nasopharynx (NP) and oropharynx (OP) without causing infection. Advances in molecular testing and microbial antigen detection with enhanced sensitivity may allow detection of colonization or postinfectious shedding of respiratory pathogens without clinical significance [10] . Respiratory viruses, such as the herpes viruses, including Epstein-Barr (EBV) [11] , herpes simplex virus (HSV) [12] , and cytomegalovirus (CMV) [13] , are associated with chronic intermittent asymptomatic nucleic acid shedding.', 'cite_spans': [{'start': 313, 'end': 317, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 398, 'end': 402, 'text': '[11]', 'ref_id': 'BIBREF10'}, {'start': 432, 'end': 436, 'text': '[12]', 'ref_id': 'BIBREF11'}, {'start': 465, 'end': 469, 'text': '[13]', 'ref_id': None}], 'ref_spans': [], 'section': 'Colonization and the Carrier State'}, {'text': 'Streptococcal carriers are at low risk to spread GABHS to close contacts. They do not require antibiotic treatment and are at minimal risk for development of rheumatic fever [14] . Streptococcal carriage may persist for many months and frequently poses diagnostic challenges when a symptomatic viral URI develops in carriers. The low predictive value of throat swabs relates to the prevalence of carrier rates [15] , and neither the blood agar plate culture nor the rapid antigen tests can accurately differentiate individuals with true GABHS pharyngitis from GABHS carriers [16] . Studies have shown that only 40%-50% of the children with GABHS isolated from the upper respiratory tract who presented with symptoms of tonsillitis or pharyngitis demonstrated a systemic immune response [16] [17] [18] .', 'cite_spans': [{'start': 174, 'end': 178, 'text': '[14]', 'ref_id': 'BIBREF13'}, {'start': 410, 'end': 414, 'text': '[15]', 'ref_id': 'BIBREF14'}, {'start': 575, 'end': 579, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 786, 'end': 790, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 791, 'end': 795, 'text': '[17]', 'ref_id': 'BIBREF16'}, {'start': 796, 'end': 800, 'text': '[18]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'Colonization and the Carrier State'}, {'text': 'When Group A strep is cultured from the OP and associated with an antibody response characteristic of a true infection, CRP will elevate 80%-90% of the time [15, 17] . Conversely, patients with a negative initial CRP test seldom show a rise in antibody titer [19] , and 96% have CRP <10 mg/mL [20] . The high carrier rate of GABHS and false-positive diagnoses may contribute to the apparent \"failure\" rate of approximately 20% with penicillin therapy [21] . Valkenburg et al. have shown that an antistreptococcal antibody titer is more accurate than a throat culture in predicting therapeutic outcome [22] .', 'cite_spans': [{'start': 157, 'end': 161, 'text': '[15,', 'ref_id': 'BIBREF14'}, {'start': 162, 'end': 165, 'text': '17]', 'ref_id': 'BIBREF16'}, {'start': 259, 'end': 263, 'text': '[19]', 'ref_id': 'BIBREF18'}, {'start': 293, 'end': 297, 'text': '[20]', 'ref_id': 'BIBREF19'}, {'start': 451, 'end': 455, 'text': '[21]', 'ref_id': 'BIBREF20'}, {'start': 601, 'end': 605, 'text': '[22]', 'ref_id': 'BIBREF21'}], 'ref_spans': [], 'section': 'Colonization and the Carrier State'}, {'text': 'Differentiation of infection from colonization requires the demonstration of an antibody response. However, proving this immune response is time-consuming and may lead to false-negative results following appropriate antibiotic therapy [23] . A study by Ivaska et al. [3] showed that in 83 patients presenting with pharyngitis, there was no significant difference in the mean initial serum antistreptolysin O (ASO) levels between the GABHS and non-GABHS patients and only 5 patients showed a 2-fold ASO increase in paired serum samples. Of the 5 patients with an antibody response, 3 of them were GABHS positive, 1 of them was GCBHS positive, and 1 was negative for streptococci by throat culture. Conversely, blood MxA levels were found to be elevated in 79% of patients with viral pharyngitis and remained low in 90% of patients with GABHS without virus detection [3] .', 'cite_spans': [{'start': 235, 'end': 239, 'text': '[23]', 'ref_id': 'BIBREF22'}, {'start': 267, 'end': 270, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 865, 'end': 868, 'text': '[3]', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Colonization and the Carrier State'}, {'text': 'MxA expression in peripheral blood is a highly specific marker for viral infection [24] [25] [26] [27] [28] [29] [30] . MxA is an intracellular blood protein that mediates cellular resistance against a wide range of viruses and elevates in the presence of most acute active viral infections including influenza A and B, respiratory syncytial virus, parainfluenzaviruses, Epstein-Barrr, herpes simplex, cytomegalovirus, adenovirus, coronavirus, rhinovirus, and metapneumovirus infections. However, it is not specific to a particular type of virus [7, [25] [26] [27] 30] .', 'cite_spans': [{'start': 83, 'end': 87, 'text': '[24]', 'ref_id': 'BIBREF23'}, {'start': 88, 'end': 92, 'text': '[25]', 'ref_id': 'BIBREF24'}, {'start': 93, 'end': 97, 'text': '[26]', 'ref_id': 'BIBREF25'}, {'start': 98, 'end': 102, 'text': '[27]', 'ref_id': 'BIBREF26'}, {'start': 103, 'end': 107, 'text': '[28]', 'ref_id': 'BIBREF27'}, {'start': 108, 'end': 112, 'text': '[29]', 'ref_id': 'BIBREF28'}, {'start': 113, 'end': 117, 'text': '[30]', 'ref_id': 'BIBREF29'}, {'start': 546, 'end': 549, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 550, 'end': 554, 'text': '[25]', 'ref_id': 'BIBREF24'}, {'start': 555, 'end': 559, 'text': '[26]', 'ref_id': 'BIBREF25'}, {'start': 560, 'end': 564, 'text': '[27]', 'ref_id': 'BIBREF26'}, {'start': 565, 'end': 568, 'text': '30]', 'ref_id': 'BIBREF29'}], 'ref_spans': [], 'section': 'Myxovirus Resistance Protein A'}, {'text': \"Interferons (IFNs) are naturally occurring proteins that are an important part of the host's innate defense mechanisms and are released in response to viral infections [7, 31] . The MxA gene is expressed in blood mononuclear cells or locally in tissues, and expression is upregulated exclusively by type I IFNs [25, 26] . The MxA gene does not respond to other cytokines such as IL-1 or TNF-α. Neither type I IFN nor MxA elevates in healthy patients or those presenting with bacterial infections [7] .\", 'cite_spans': [{'start': 168, 'end': 171, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 172, 'end': 175, 'text': '31]', 'ref_id': 'BIBREF30'}, {'start': 311, 'end': 315, 'text': '[25,', 'ref_id': 'BIBREF24'}, {'start': 316, 'end': 319, 'text': '26]', 'ref_id': 'BIBREF25'}, {'start': 496, 'end': 499, 'text': '[7]', 'ref_id': 'BIBREF6'}], 'ref_spans': [], 'section': 'Myxovirus Resistance Protein A'}, {'text': 'In most cases of acute viral infections, type I IFN and MxA are released into the peripheral blood. Detection of interferons in serum is difficult and unreliable, mainly due to their short half-life [30] . In contrast, MxA has a long half-life of 2.3 days, low baseline level of less than 15 ng/mL, and a fast induction time of 1-2 hours after infection [32] . The low basal levels of MxA protein in tissues, its exclusive expression by type I IFNs, and its relatively long half-life make it an excellent biomarker for systemic IFN-α/β production in viral infections.', 'cite_spans': [{'start': 199, 'end': 203, 'text': '[30]', 'ref_id': 'BIBREF29'}, {'start': 354, 'end': 358, 'text': '[32]', 'ref_id': 'BIBREF31'}], 'ref_spans': [], 'section': 'Myxovirus Resistance Protein A'}, {'text': 'Recent studies show that other viral biomarkers, such as TNF-related apoptosis-inducing ligand (TRAIL) and IP-10, are less effective than MxA at differentiating viral infection. TRAIL and IP-10 show area under the curve (AUC) specifically for viral infection of 0.72 and IP-10 of 0.72 [33] . Other studies further support the superiority of MxA as a biomarker for identifying a viral infection, especially in URI [3, 24] .', 'cite_spans': [{'start': 285, 'end': 289, 'text': '[33]', 'ref_id': 'BIBREF32'}, {'start': 413, 'end': 416, 'text': '[3,', 'ref_id': 'BIBREF2'}, {'start': 417, 'end': 420, 'text': '24]', 'ref_id': 'BIBREF23'}], 'ref_spans': [], 'section': 'Myxovirus Resistance Protein A'}, {'text': 'CRP is a nonspecific, acute-phase protein that increases during an inflammatory process such as a severe infection. The normal CRP serum concentration is less than 1-3 mg/L and can rise above 500 mg/L in the presence of severe inflammation or infection [7] . A high CRP level generally indicates bacterial rather than viral infection and can also be used to assess disease severity. A systematic review of acute rhinosinusitis showed that a CRP of less than 10 mg/L provided evidence against bacterial sinusitis and a CRP greater than 20 mg/L showed evidence supporting bacterial sinusitis [34] . Calvino et al. showed that CRP elevated above 20 mg/L in nearly all cases of GABHS, ensuring that a clinically significant infection would less likely be missed, but could not differentiate viral from bacterial infection [35] . Similarly, Putto et al. found that in examining 62 children with positive bacterial cultures, 89% showed a CRP elevated over 20 mg/L, consistent with a clinically significant bacterial infection [36] .', 'cite_spans': [{'start': 253, 'end': 256, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 590, 'end': 594, 'text': '[34]', 'ref_id': 'BIBREF33'}, {'start': 818, 'end': 822, 'text': '[35]', 'ref_id': 'BIBREF34'}, {'start': 1020, 'end': 1024, 'text': '[36]', 'ref_id': 'BIBREF35'}], 'ref_spans': [], 'section': 'C-Reactive Protein'}, {'text': 'Typically, bacterial infection stimulates/elevates CRP while having no impact on MxA levels [29] . CRP elevates within 4-6 hours of infection, doubles every 8 hours, and peaks at approximately 36-50 hours [37] . Although less common than bacterial infection, viral pathogens such as adenovirus, parainfluenzavirus, influenza, respiratory syncytial virus, Epstein-Barr virus, herpes simplex virus, and varicella zoster virus can raise CRP levels significantly over 20 mg/L [7, 24-27, 30, 38] . Therefore, a test system that utilizes both CRP and MxA simultaneously can potentially differentiate viral infections from bacterial disease as the elevated CRP from a viral infection would also be associated with an elevation in MxA, whereas the MxA levels would be normal in bacterial infection.', 'cite_spans': [{'start': 92, 'end': 96, 'text': '[29]', 'ref_id': 'BIBREF28'}, {'start': 205, 'end': 209, 'text': '[37]', 'ref_id': 'BIBREF36'}, {'start': 472, 'end': 490, 'text': '[7, 24-27, 30, 38]', 'ref_id': None}], 'ref_spans': [], 'section': 'C-Reactive Protein'}, {'text': 'PCT is the peptide precursor of calcitonin, a hormone that is synthesized by the parafollicular C cells of the thyroid and regulates calcium homeostasis. Standard reference values of PCT in adults and children older than 72 hours are usually 0.15 ng/mL or less [39] . In response to inflammation associated with bacterial endotoxin or inflammatory cytokines, PCT elevates within 2-6 hours, peaks at 12-24 hours, and has a half-life of 25-40 hours [37, 40] . Higher procalcitonin levels in patients with bacterial sepsis are associated with a greater likelihood of severe sepsis, septic shock, and decreased survival [40] . Colonization or carrier states without a systemic host response do not significantly raise procalcitonin levels [41] . Procalcitonin levels fall with successful treatment of either severe bacterial infection or noninfectious inflammatory stimuli [40] .', 'cite_spans': [{'start': 261, 'end': 265, 'text': '[39]', 'ref_id': 'BIBREF38'}, {'start': 447, 'end': 451, 'text': '[37,', 'ref_id': 'BIBREF36'}, {'start': 452, 'end': 455, 'text': '40]', 'ref_id': 'BIBREF39'}, {'start': 616, 'end': 620, 'text': '[40]', 'ref_id': 'BIBREF39'}, {'start': 735, 'end': 739, 'text': '[41]', 'ref_id': 'BIBREF40'}, {'start': 869, 'end': 873, 'text': '[40]', 'ref_id': 'BIBREF39'}], 'ref_spans': [], 'section': 'Procalcitonin'}, {'text': 'URIs tend to cause modest elevations in PCT [42, 43] . Using a lower PCT threshold of 0.1 ng/mL in association with polymerase chain reaction-confirmed bacterial cultures of common oral pathogens such as GABHS or atypical pathogens such as Chlamydophila or Mycoplasma, would suggest a true active bacterial infection. Higher PCT cutoffs of 0.15-0.25 ng/mL could be used in association with growth of typical bacterial colonizers or in association with a negative bacterial culture to suggest active bacterial infection in patients without another confirmed source of infection, such as a viral infection [8, 40] . The PCT response to viral infections and noninfectious inflammatory stimuli such as autoimmune disease and chronic inflammatory processes typically do not exceed 0.75 ng/mL [44, 45] . Branch et al. found that 17% of viral infections had a PCT >0.25 ng/mL [46] . At low concentrations (<1.0 ng/mL), PCT is inadequate by itself to differentiate viral from bacterial etiology [8, 47, 48] .', 'cite_spans': [{'start': 44, 'end': 48, 'text': '[42,', 'ref_id': 'BIBREF41'}, {'start': 49, 'end': 52, 'text': '43]', 'ref_id': 'BIBREF42'}, {'start': 604, 'end': 607, 'text': '[8,', 'ref_id': 'BIBREF7'}, {'start': 608, 'end': 611, 'text': '40]', 'ref_id': 'BIBREF39'}, {'start': 787, 'end': 791, 'text': '[44,', 'ref_id': 'BIBREF43'}, {'start': 792, 'end': 795, 'text': '45]', 'ref_id': 'BIBREF44'}, {'start': 869, 'end': 873, 'text': '[46]', 'ref_id': 'BIBREF45'}, {'start': 987, 'end': 990, 'text': '[8,', 'ref_id': 'BIBREF7'}, {'start': 991, 'end': 994, 'text': '47,', 'ref_id': 'BIBREF46'}, {'start': 995, 'end': 998, 'text': '48]', 'ref_id': 'BIBREF47'}], 'ref_spans': [], 'section': 'Procalcitonin'}, {'text': 'Ten prospective human studies, totaling 1683 patients, were identified that evaluated MxA as a viral biomarker in children and/or adults. Both systematic review articles, meta-analyses, and randomized controlled clinical trials that examined CRP and/or PCT as a biomarker for identifying clinically significant bacterial infections and supporting antibiotic stewardship were identified.', 'cite_spans': [], 'ref_spans': [], 'section': 'RESULTS'}, {'text': 'CRP and PCT levels do not correlate consistently with each other, but in primary care patients with URI, each has moderate predictive value for clinical outcome [49] . Both CRP and PCT have been shown to elevate in infectious pharyngitis; however [42, 43] , CRP is more sensitive and PCT is more specific for detection of bacterial tonsillopharyngitis [43] . In most acute respiratory infections, including URI, antibiotic therapy based on either biomarker alone has led to reduced antibiotic prescriptions without increased morbidity [50] [51] [52] [53] [54] .', 'cite_spans': [{'start': 161, 'end': 165, 'text': '[49]', 'ref_id': 'BIBREF48'}, {'start': 247, 'end': 251, 'text': '[42,', 'ref_id': 'BIBREF41'}, {'start': 252, 'end': 255, 'text': '43]', 'ref_id': 'BIBREF42'}, {'start': 352, 'end': 356, 'text': '[43]', 'ref_id': 'BIBREF42'}, {'start': 535, 'end': 539, 'text': '[50]', 'ref_id': 'BIBREF49'}, {'start': 540, 'end': 544, 'text': '[51]', 'ref_id': 'BIBREF50'}, {'start': 545, 'end': 549, 'text': '[52]', 'ref_id': 'BIBREF51'}, {'start': 550, 'end': 554, 'text': '[53]', 'ref_id': 'BIBREF52'}, {'start': 555, 'end': 559, 'text': '[54]', 'ref_id': 'BIBREF53'}], 'ref_spans': [], 'section': 'Clinical Outcomes Using Biomarker Guidance'}, {'text': 'Numerous studies have delineated the utility of CRP in antibiotic stewardship, specifically decreasing antibiotic prescriptions for patients with respiratory tract infections [50] [51] [52] [53] . In Europe, a CRP >20 mg/L is recommended in the Pneumonia Guidelines by the National Institute for Health and Care Excellence (NICE) as a trigger for prescribing antibiotics [50] .', 'cite_spans': [{'start': 175, 'end': 179, 'text': '[50]', 'ref_id': 'BIBREF49'}, {'start': 180, 'end': 184, 'text': '[51]', 'ref_id': 'BIBREF50'}, {'start': 185, 'end': 189, 'text': '[52]', 'ref_id': 'BIBREF51'}, {'start': 190, 'end': 194, 'text': '[53]', 'ref_id': 'BIBREF52'}, {'start': 371, 'end': 375, 'text': '[50]', 'ref_id': 'BIBREF49'}], 'ref_spans': [], 'section': 'Clinical Outcomes Using Biomarker Guidance'}, {'text': 'Using this CRP threshold, there was no statistically significant increase in patient consultations, emergency visits, or adverse outcomes [50] . In a recent systematic review and meta-analysis of 13 studies in primary care including 10 005 patients, CRP testing led to significantly reduced antibiotic prescribing at the index consultation without increasing morbidity [51] .', 'cite_spans': [{'start': 138, 'end': 142, 'text': '[50]', 'ref_id': 'BIBREF49'}, {'start': 369, 'end': 373, 'text': '[51]', 'ref_id': 'BIBREF50'}], 'ref_spans': [], 'section': 'Clinical Outcomes Using Biomarker Guidance'}, {'text': 'The effect of CRP testing on the outcome of patients in general practice was evaluated in a recent randomized clinical trial. A total of 179 patients were included, 101 in the CRP measurement group and 78 in the control group. Results suggested that CRP testing in patients with acute cough may reduce antibiotic prescribing and referral for radiography without compromising outcome [55] . Similar results have been demonstrated in identifying patients with chronic obstructive pulmonary disease (COPD) exacerbations who do not need antibiotic treatment [56] .', 'cite_spans': [{'start': 383, 'end': 387, 'text': '[55]', 'ref_id': 'BIBREF54'}, {'start': 554, 'end': 558, 'text': '[56]', 'ref_id': 'BIBREF55'}], 'ref_spans': [], 'section': 'Clinical Outcomes Using Biomarker Guidance'}, {'text': 'Clinical trials using PCT to guide antibiotic therapy for patients with acute respiratory tract infections have shown that a biomarker-driven algorithm can decrease antibiotic prescribing significantly and without an increase in adverse events or treatment failures [57] [58] [59] [60] [61] [62] . PCT-guided antibiotic stewardship reduced initial antibiotic prescription rates by 40% to 50% in patients with lower respiratory infection (LRI) presenting to the emergency departments [61] , 70% to 80% in ambulatory patients presenting to their general physicians [63] , and reduced total antibiotic exposure in community-acquired pneumonia by 40% to 50% [64] . In a single-center randomized controlled study, a significant reduction in antibiotic use in patients hospitalized with severe acute exacerbations of asthma was shown utilizing an algorithm of PCT measurements. In this study, withholding antibiotic treatment did not cause any apparent harm [65] .', 'cite_spans': [{'start': 266, 'end': 270, 'text': '[57]', 'ref_id': 'BIBREF56'}, {'start': 271, 'end': 275, 'text': '[58]', 'ref_id': 'BIBREF57'}, {'start': 276, 'end': 280, 'text': '[59]', 'ref_id': 'BIBREF58'}, {'start': 281, 'end': 285, 'text': '[60]', 'ref_id': 'BIBREF59'}, {'start': 286, 'end': 290, 'text': '[61]', 'ref_id': 'BIBREF60'}, {'start': 291, 'end': 295, 'text': '[62]', 'ref_id': 'BIBREF61'}, {'start': 483, 'end': 487, 'text': '[61]', 'ref_id': 'BIBREF60'}, {'start': 563, 'end': 567, 'text': '[63]', 'ref_id': 'BIBREF62'}, {'start': 654, 'end': 658, 'text': '[64]', 'ref_id': 'BIBREF63'}, {'start': 952, 'end': 956, 'text': '[65]', 'ref_id': 'BIBREF64'}], 'ref_spans': [], 'section': 'Clinical Outcomes Using Biomarker Guidance'}, {'text': 'Several clinical studies have verified that high MxA protein levels are strongly correlated with a systemic viral infection while elevated CRP levels are more closely associated with bacterial disease [3, 7, 8, [24] [25] [26] . Simultaneously performing CRP and MxA should predictably increase sensitivity and specificity for identifying bacterial disease.', 'cite_spans': [{'start': 201, 'end': 204, 'text': '[3,', 'ref_id': 'BIBREF2'}, {'start': 205, 'end': 207, 'text': '7,', 'ref_id': 'BIBREF6'}, {'start': 208, 'end': 210, 'text': '8,', 'ref_id': 'BIBREF7'}, {'start': 211, 'end': 215, 'text': '[24]', 'ref_id': 'BIBREF23'}, {'start': 216, 'end': 220, 'text': '[25]', 'ref_id': 'BIBREF24'}, {'start': 221, 'end': 225, 'text': '[26]', 'ref_id': 'BIBREF25'}], 'ref_spans': [], 'section': 'The Role for Combining Biomarkers to Guide Outpatient Antibiotic Prescribing'}, {'text': 'Combining MxA detection with a marker specific to bacterial infection, such as CRP, could be of greater predictive value and allow more reliable differentiation between viral and bacterial infections than using a marker of bacterial infection alone [7, 8, 24] . A high MxA with or without an elevated CRP would strongly suggest a viral infectious process and the absence of a bacterial infection [24] . Unlike the common occurrence of incidental identification of multiple pathogens in the OP or NP, true active co-infection that leads to a systemic viral and bacterial immune response is not common in URI [1, 8] . If both viral and bacterial pathogens are identified, an associated PCT ≥0.75 ng/mL or CRP ≥100 mg/L may support a diagnosis of a true co-infection result. Others have suggested that a defined ratio of CRP/MxA would optimize differentiation between a viral and bacterial infection [3] .', 'cite_spans': [{'start': 249, 'end': 252, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 253, 'end': 255, 'text': '8,', 'ref_id': 'BIBREF7'}, {'start': 256, 'end': 259, 'text': '24]', 'ref_id': 'BIBREF23'}, {'start': 396, 'end': 400, 'text': '[24]', 'ref_id': 'BIBREF23'}, {'start': 607, 'end': 610, 'text': '[1,', 'ref_id': 'BIBREF0'}, {'start': 611, 'end': 613, 'text': '8]', 'ref_id': 'BIBREF7'}, {'start': 897, 'end': 900, 'text': '[3]', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'The Role for Combining Biomarkers to Guide Outpatient Antibiotic Prescribing'}, {'text': 'Rapid CRP tests are shown to promote more prudent use of antibiotics in primary care and have led to a 19% reduction in antibiotic prescriptions [66] . A prospective, multicenter, cross-sectional study of adults and children with febrile URIs evaluated the diagnostic accuracy of a 15-minute, single-use disposable immunoassay that includes both CRP and MxA (FebriDx; RPS Diagnostics, Sarasota, FL) [8] . During a multicenter, US-based study that enrolled 370 patients, 205 symptomatic patients with URI and 165 asymptomatic patients from 10 clinical sites, including academic emergency departments and community care centers, demonstrated a 97% negative predictive value (NPV) for bacterial infection. Also, the use of CRP independent of MxA would have led to overtreatment of 38% of viral infections [8] . The pattern of results from test systems with CRP or PCT combined with MxA may assist health care professionals to identify an immune response to a suspected viral and/or bacterial infection and greatly enhance antibiotic stewardship in the outpatient setting [7, 24] . This was recently demonstrated in a FebriDx study of 21 children and adults (mean age = 46 years) that evaluated the use of MxA plus CRP as a guide for outpatient antibiotic management. Therapy was altered in 48%, and unnecessary antibiotic prescriptions were reduced by 80% without any adverse effects [9] .', 'cite_spans': [{'start': 145, 'end': 149, 'text': '[66]', 'ref_id': 'BIBREF65'}, {'start': 399, 'end': 402, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 802, 'end': 805, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 1068, 'end': 1071, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 1072, 'end': 1075, 'text': '24]', 'ref_id': 'BIBREF23'}, {'start': 1381, 'end': 1384, 'text': '[9]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'The Role for Combining Biomarkers to Guide Outpatient Antibiotic Prescribing'}, {'text': 'The value of inpatient antibiotic stewardship is embraced by many professional societies such as the IDSA and the Center for Disease Control and Prevention (CDC). There are presently several recommendations, guidelines, and requirements from some licensing organizations that continue to be updated as diagnostics evolve and outcome measurements improve [67] . The current focus on inpatients fits well with existing hospital surveillance programs and the ability to identify multiply drug-resistant organisms.', 'cite_spans': [{'start': 354, 'end': 358, 'text': '[67]', 'ref_id': 'BIBREF66'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': 'Inpatient stewardship is driven in part by modern microbiology, which is often not available or impractical in the outpatient setting. Outpatient stewardship is also critical, but more difficult to implement. According to the CDC and American College of Physicians, up to 50% of antibiotic courses prescribed in the outpatient setting are inappropriate and completely unnecessary. This equates to more than $3 billion in direct costs. Additionally, billions of indirect costs include: (1) antibiotic-resistant illnesses, (2) antibiotic adverse events, and (3) secondary infections with Clostridium difficile diarrhea [1] .', 'cite_spans': [{'start': 617, 'end': 620, 'text': '[1]', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': \"A major obstacle to effective outpatient antibiotic stewardship and appropriate antibiotic prescribing is the difficulty in accurately defining the microbial cause of respiratory infections, especially distinguishing viral from bacterial etiology. This diagnosis is even more challenging when rapid tests identify bacterial pathogens present in the carrier state. Additionally, attempts to differentiate bacterial from viral infections using only the history and physical findings are inaccurate about one-half of the time [64] . Patients may also have symptoms mimicking an infectious process, which is actually caused by hypersensitivity, especially rhinovirus and coronavirus acting directly as allergens, eliciting an IgE elevated response. This may lead to low-grade fevers and exacerbation of reactive airway disease in predisposed patients with a history of underlying allergies, atopy, asthma, or COPD [68, 69] . Lastly, patient expectations of therapy present another challenge to overcome in the outpatient setting. In 1 study, up to 50% of parents had a previsit expectation of receiving an antibiotic [70] . When patients expect or demand antibiotics, they are more likely to receive them even though patients' satisfaction may not be affected by prescribing of antibiotics [53] .\", 'cite_spans': [{'start': 523, 'end': 527, 'text': '[64]', 'ref_id': 'BIBREF63'}, {'start': 910, 'end': 914, 'text': '[68,', 'ref_id': 'BIBREF67'}, {'start': 915, 'end': 918, 'text': '69]', 'ref_id': 'BIBREF68'}, {'start': 1113, 'end': 1117, 'text': '[70]', 'ref_id': 'BIBREF69'}, {'start': 1286, 'end': 1290, 'text': '[53]', 'ref_id': 'BIBREF52'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': 'One approach to improve appropriate outpatient antibiotic use is to supplement the history and physical examination with point-of-care tests for selected biomarkers. Biomarkers such as CRP, PCT, and MxA respond differently to the host immune response and can help distinguish viral from a bacterial infection, including noninfectious causes of symptoms. At low levels, CRP and PCT are sensitive but not specific to bacterial infection, while at high levels, both CRP and PCT become more specific to bacterial infection. Although PCT and CRP are not specific enough to differentiate a viral from bacterial infection, these biomarkers in combination with MxA substantially improve the differential diagnostic accuracy [7, 9, 24] . The combined interpretation of MxA with either CRP or PCT dramatically improves both sensitivity and specificity for differentiating a viral from bacterial infection [7, 8] .', 'cite_spans': [{'start': 716, 'end': 719, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 720, 'end': 722, 'text': '9,', 'ref_id': 'BIBREF8'}, {'start': 723, 'end': 726, 'text': '24]', 'ref_id': 'BIBREF23'}, {'start': 895, 'end': 898, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 899, 'end': 901, 'text': '8]', 'ref_id': 'BIBREF7'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': \"A rapid point-of-care test that measures both CRP and MxA is available in Europe and Canada, but not currently in the United States. Utilization results of the FebriDx test in outpatient clinical practice are impressively encouraging, including diagnostic accuracy and positive impact on appropriate antibiotic prescribing [9] . The 97% NPV reduces the clinician's fear of missing a serious bacterial infection and supports watchful waiting, while the ability to demonstrate tangible results at the office visit can relieve patient pressures for antibiotic prescriptions [9] . A recent survey estimates that 85% of US primary care clinicians currently use a rapid strep test and 60% use a rapid flu test, oftentimes in the same patient [71] . A rapid point-ofcare test utilizing detection of both MxA and CRP without any required ancillary reader equipment would likely reduce the need for rapid strep and flu testing and provide direct cost savings while reducing indirect costs related to the cost of unnecessary antibiotics themselves, adverse events, and potential resistance.\", 'cite_spans': [{'start': 323, 'end': 326, 'text': '[9]', 'ref_id': 'BIBREF8'}, {'start': 571, 'end': 574, 'text': '[9]', 'ref_id': 'BIBREF8'}, {'start': 736, 'end': 740, 'text': '[71]', 'ref_id': 'BIBREF70'}], 'ref_spans': [], 'section': 'CONCLUSIONS'}, {'text': 'In summary, it is critically important that antibiotic stewardship rapidly move into the outpatient setting. Diagnostic algorithms based solely on history and physical are historically inaccurate for many common outpatient syndromes. Incorporating point-of-care testing with a combination of biomarkers such as CRP and MxA can be extremely useful as an important adjunct to traditional methods. Further studies should be directed toward the delineation of biomarker utility in the outpatient setting.', 'cite_spans': [], 'ref_spans': [], 'section': 'CONCLUSIONS'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Appropriate antibiotic use for acute respiratory tract infection in adults', 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Harris', 'suffix': ''}, {'first': 'L', 'middle': ['A'], 'last': 'Hicks', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Qaseem', 'suffix': ''}], 'year': 2016, 'venue': 'Ann Intern Med', 'volume': '165', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Acute pharyngitis', 'authors': [{'first': 'A', 'middle': ['L'], 'last': 'Bisno', 'suffix': ''}], 'year': 2001, 'venue': 'N Engl J Med', 'volume': '344', 'issn': '', 'pages': '205--216', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Aetiology of febrile pharyngitis in children: potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection', 'authors': [{'first': 'L', 'middle': [], 'last': 'Ivaska', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Niemelä', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Lempainen', 'suffix': ''}], 'year': 2017, 'venue': 'J Infect', 'volume': '74', 'issn': '', 'pages': '385--92', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Diagnosis and management of adults with pharyngitis. A cost-effectiveness analysis', 'authors': [{'first': 'J', 'middle': ['M'], 'last': 'Neuner', 'suffix': ''}, {'first': 'M', 'middle': ['B'], 'last': 'Hamel', 'suffix': ''}, {'first': 'R', 'middle': ['S'], 'last': 'Phillips', 'suffix': ''}], 'year': 2003, 'venue': 'Ann Intern Med', 'volume': '139', 'issn': '', 'pages': '113--135', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Centers for Disease Control and Prevention. Principles of appropriate antibiotic use for acute pharyngitis in adults: background', 'authors': [{'first': 'R', 'middle': ['J'], 'last': 'Cooper', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Hoffman', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Bartlett', 'suffix': ''}], 'year': 2001, 'venue': 'Ann Emerg Med', 'volume': '37', 'issn': '', 'pages': '711--720', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Changing use of antibiotics in community-based outpatient practice', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Steinman', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Gonzales', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Linder', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Landefeld', 'suffix': ''}], 'year': 1991, 'venue': 'Ann Intern Med', 'volume': '138', 'issn': '', 'pages': '525--558', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection', 'authors': [{'first': 'R', 'middle': [], 'last': 'Sambursky', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Shapiro', 'suffix': ''}], 'year': 2015, 'venue': 'Eur Clin Respir J', 'volume': '2', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Diagnostic accuracy of FebriDx: a rapid test to detect immune responses to viral and bacterial upper respiratory infections', 'authors': [{'first': 'W', 'middle': ['H'], 'last': 'Self', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Rosen', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Sharp', 'suffix': ''}], 'year': 2017, 'venue': 'J Clin Med', 'volume': '6', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'FebriDx point-of-care testing to guide antibiotic therapy for acute respiratory tract infection in UK primary care: a retrospective outcome analysis', 'authors': [{'first': 'M', 'middle': [], 'last': 'Davidson', 'suffix': ''}], 'year': 2017, 'venue': 'J Infect Dis Preve Med', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Molecular and clinical diagnosis of group A streptococcal pharyngitis in children', 'authors': [{'first': 'S', 'middle': [], 'last': 'Felsenstein', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Faddoul', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Sposto', 'suffix': ''}], 'year': 2014, 'venue': 'J Clin Microbiol', 'volume': '52', 'issn': '', 'pages': '3884--3893', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Oropharyngeal shedding of Epstein-Barr virus in the absence of circulating B cells', 'authors': [{'first': 'S', 'middle': ['E'], 'last': 'Hoover', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kawada', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Wilson', 'suffix': ''}, {'first': 'J', 'middle': ['I'], 'last': 'Cohen', 'suffix': ''}], 'year': 2008, 'venue': 'J Infect Dis', 'volume': '198', 'issn': '', 'pages': '318--341', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Asymptomatic shedding of herpes simplex virus 1 and 2: implications for prevention of transmission', 'authors': [{'first': 'G', 'middle': ['J'], 'last': 'Mertz', 'suffix': ''}], 'year': 2008, 'venue': 'J Infect Dis', 'volume': '198', 'issn': '', 'pages': '1098--100', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Gerber', 'suffix': ''}, {'first': 'R', 'middle': ['S'], 'last': 'Baltimore', 'suffix': ''}, {'first': 'C', 'middle': ['B'], 'last': 'Eaton', 'suffix': ''}], 'year': 2009, 'venue': 'American Academy of Pediatrics. Circulation', 'volume': '119', 'issn': '', 'pages': '1541--51', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child', 'authors': [{'first': 'E', 'middle': ['L'], 'last': 'Kaplan', 'suffix': ''}, {'first': 'F', 'middle': ['H'], 'last': 'Top', 'suffix': ''}, {'first': 'B', 'middle': ['A'], 'last': 'Dudding', 'suffix': ''}, {'first': 'L', 'middle': ['W'], 'last': 'Wannamaker', 'suffix': ''}], 'year': 1971, 'venue': 'J Infect Dis', 'volume': '123', 'issn': '', 'pages': '490--501', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Gerber', 'suffix': ''}, {'first': 'M', 'middle': ['F'], 'last': 'Randolph', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Chanatry', 'suffix': ''}], 'year': 1986, 'venue': 'J Pediatr', 'volume': '108', 'issn': '', 'pages': '654--662', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'C-reactive protein in streptococcal pharyngitis', 'authors': [{'first': 'E', 'middle': ['L'], 'last': 'Kaplan', 'suffix': ''}, {'first': 'L', 'middle': ['W'], 'last': 'Wannamaker', 'suffix': ''}], 'year': 1977, 'venue': 'Pediatrics', 'volume': '60', 'issn': '', 'pages': '28--32', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Group A beta-hemolytic streptococcal pharyngitis in preschool children aged 3 months to 5 years', 'authors': [{'first': 'M', 'middle': [], 'last': 'Nussinovitch', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Finkelstein', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Amir', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Varsano', 'suffix': ''}], 'year': 1999, 'venue': 'Clin Pediatr (Phila)', 'volume': '38', 'issn': '', 'pages': '357--60', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Antibody titers in acute rheumatic fever', 'authors': [{'first': 'L', 'middle': ['W'], 'last': 'Wannamaker', 'suffix': ''}, {'first': 'E', 'middle': ['M'], 'last': 'Ayoub', 'suffix': ''}], 'year': 1960, 'venue': 'Circulation', 'volume': '21', 'issn': '', 'pages': '598--614', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'The diagnostic value of C-reactive protein', 'authors': [{'first': 'L', 'middle': ['A'], 'last': 'Hanson', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Jodal', 'suffix': ''}, {'first': 'K', 'middle': ['G'], 'last': 'Sabel', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wadsworth', 'suffix': ''}], 'year': 1983, 'venue': 'Pediatr Infect Dis', 'volume': '2', 'issn': '', 'pages': '87--96', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Streptococcal pharyngitis: the case for penicillin therapy', 'authors': [{'first': 'S', 'middle': ['T'], 'last': 'Shulman', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Gerber', 'suffix': ''}, {'first': 'R', 'middle': ['R'], 'last': 'Tanz', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Markowitz', 'suffix': ''}], 'year': 1994, 'venue': 'Pediatr Infect Dis J', 'volume': '13', 'issn': '', 'pages': '1--7', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Streptococcal pharyngitis in the general population. II. The attack rate of rheumatic fever and acute glomerulonephritis in patients', 'authors': [{'first': 'H', 'middle': ['A'], 'last': 'Valkenburg', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Haverkorn', 'suffix': ''}, {'first': 'W', 'middle': ['R'], 'last': 'Goslings', 'suffix': ''}], 'year': 1971, 'venue': 'J Infect Dis', 'volume': '124', 'issn': '', 'pages': '348--58', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'The group A streptococcal carrier state. A reexamination', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Gerber', 'suffix': ''}, {'first': 'M', 'middle': ['F'], 'last': 'Randolph', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Mayo', 'suffix': ''}], 'year': 1988, 'venue': 'Am J Dis Child', 'volume': '142', 'issn': '', 'pages': '562--567', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Diagnosis of viral infections using myxovirus resistance protein A (MxA)', 'authors': [{'first': 'I', 'middle': [], 'last': 'Engelmann', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Dubos', 'suffix': ''}, {'first': 'P', 'middle': ['E'], 'last': 'Lobert', 'suffix': ''}], 'year': 2015, 'venue': 'Pediatrics', 'volume': '135', 'issn': '', 'pages': '985--93', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'New sandwich-type enzyme-linked immunosorbent assay for human MxA protein in a whole blood using monoclonal antibodies against GTP-binding domain for recognition of viral infection', 'authors': [{'first': 'M', 'middle': [], 'last': 'Kawamura', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kusano', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Furuya', 'suffix': ''}], 'year': 2012, 'venue': 'J Clin Lab Anal', 'volume': '26', 'issn': '', 'pages': '174--83', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'MxA-based recognition of viral illness in febrile children by a whole blood assay', 'authors': [{'first': 'M', 'middle': [], 'last': 'Nakabayashi', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Adachi', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Itazawa', 'suffix': ''}], 'year': 2006, 'venue': 'Pediatr Res', 'volume': '60', 'issn': '', 'pages': '770--774', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'MxA protein in infants and children with respiratory tract infection', 'authors': [{'first': 'J', 'middle': [], 'last': 'Forster', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Schweizer', 'suffix': ''}, {'first': 'R', 'middle': ['F'], 'last': 'Schumacher', 'suffix': ''}], 'year': 1996, 'venue': 'Acta Paediatr', 'volume': '85', 'issn': '', 'pages': '163--170', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'MxA protein in capillary blood of children with viral infections', 'authors': [{'first': 'V', 'middle': [], 'last': 'Chieux', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Hober', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Chehadeh', 'suffix': ''}], 'year': 1999, 'venue': 'J Med Virol', 'volume': '59', 'issn': '', 'pages': '547--51', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'The MxA protein levels in whole blood lysates of patients with various viral infections', 'authors': [{'first': 'V', 'middle': [], 'last': 'Chieux', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Hober', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Harvey', 'suffix': ''}], 'year': 1998, 'venue': 'J Virol Methods', 'volume': '70', 'issn': '', 'pages': '183--91', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children', 'authors': [{'first': 'M', 'middle': [], 'last': 'Halminen', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Ilonen', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Julkunen', 'suffix': ''}], 'year': 1997, 'venue': 'Pediatr Res', 'volume': '41', 'issn': '', 'pages': '647--50', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Interferon-induced antiviral actions and their regulation', 'authors': [{'first': 'G', 'middle': ['C'], 'last': 'Sen', 'suffix': ''}, {'first': 'R', 'middle': ['M'], 'last': 'Ransohoff', 'suffix': ''}], 'year': 1993, 'venue': 'Adv Virus Res', 'volume': '42', 'issn': '', 'pages': '57--102', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Control of IFN-inducible MxA gene expression in human cells', 'authors': [{'first': 'T', 'middle': [], 'last': 'Ronni', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Melén', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Malygin', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Julkunen', 'suffix': ''}], 'year': 1993, 'venue': 'J Immunol', 'volume': '150', 'issn': '', 'pages': '1715--1741', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'TRAIL and IP-10 as biomarkers of viral infections in the emergency department', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Van Der Does', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Tjikhoeri', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Ramakers', 'suffix': ''}], 'year': 2016, 'venue': 'J Infect', 'volume': '72', 'issn': '', 'pages': '761--764', 'other_ids': {}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Diagnosis of acute rhinosinusitis in primary care: a systematic review of test accuracy', 'authors': [{'first': 'M', 'middle': ['H'], 'last': 'Ebell', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Mckay', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Guilbault', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Ermias', 'suffix': ''}], 'year': 2016, 'venue': 'Br J Gen Pract', 'volume': '66', 'issn': '', 'pages': '612--644', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Association between C-reactive protein rapid test and group A streptococcus infection in acute pharyngitis', 'authors': [{'first': 'O', 'middle': [], 'last': 'Calviño', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Llor', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Gómez', 'suffix': ''}], 'year': 2014, 'venue': 'J Am Board Fam Med', 'volume': '27', 'issn': '', 'pages': '424--430', 'other_ids': {}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'C reactive protein in the evaluation of febrile illness', 'authors': [{'first': 'A', 'middle': [], 'last': 'Putto', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Ruuskanen', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Meurman', 'suffix': ''}], 'year': 1986, 'venue': 'Arch Dis Child', 'volume': '61', 'issn': '', 'pages': '24--33', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': 'Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis', 'authors': [{'first': 'L', 'middle': [], 'last': 'Simon', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Gauvin', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Amre', 'suffix': ''}], 'year': 2004, 'venue': 'Clin Infect Dis', 'volume': '39', 'issn': '', 'pages': '206--223', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'Serum amyloid A levels in patients with infections due to cytomegalovirus, varicella-zoster virus, and herpes simplex virus', 'authors': [{'first': 'I', 'middle': [], 'last': 'Sarov', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Shainkin-Kestenbaum', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Zimlichman', 'suffix': ''}], 'year': 1982, 'venue': 'J Infect Dis', 'volume': '146', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Procalcitonin increase after endotoxin injection in normal subjects', 'authors': [{'first': 'P', 'middle': [], 'last': 'Dandona', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Nix', 'suffix': ''}, {'first': 'M', 'middle': ['F'], 'last': 'Wilson', 'suffix': ''}], 'year': 1994, 'venue': 'J Clin Endocrinol Metab', 'volume': '79', 'issn': '', 'pages': '1605--1613', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections', 'authors': [{'first': 'P', 'middle': [], 'last': 'Schuetz', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Wirz', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Sager', 'suffix': ''}], 'year': 2017, 'venue': 'Cochrane Database Syst Rev', 'volume': '10', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'Use of plasma procalcitonin levels as an adjunct to clinical microbiology', 'authors': [{'first': 'D', 'middle': ['N'], 'last': 'Gilbert', 'suffix': ''}], 'year': 2010, 'venue': 'J Clin Microbiol', 'volume': '48', 'issn': '', 'pages': '2325--2334', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Are procalcitonin or other infection markers useful in the detection of group A streptococcal acute tonsillitis?', 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Christensen', 'suffix': ''}, {'first': 'M', 'middle': ['K'], 'last': 'Thomsen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Ovesen', 'suffix': ''}, {'first': 'T', 'middle': ['E'], 'last': 'Klug', 'suffix': ''}], 'year': 2014, 'venue': 'Scand J Infect Dis', 'volume': '46', 'issn': '', 'pages': '376--83', 'other_ids': {}}, 'BIBREF42': {'ref_id': 'b42', 'title': 'Diagnostic value of serum procalcitonin and C-reactive protein in Egyptian children with streptococcal tonsillopharyngitis', 'authors': [{'first': 'M', 'middle': [], 'last': 'Elsammak', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Hanna', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Ghazal', 'suffix': ''}], 'year': 2006, 'venue': 'Pediatr Infect Dis J', 'volume': '25', 'issn': '', 'pages': '174--180', 'other_ids': {}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Yu', 'suffix': ''}, {'first': 'X', 'middle': ['X'], 'last': 'Li', 'suffix': ''}, {'first': 'L', 'middle': ['X'], 'last': 'Jiang', 'suffix': ''}], 'year': 2016, 'venue': 'Infect Dis (Lond)', 'volume': '48', 'issn': '', 'pages': '63--72', 'other_ids': {}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Management of patients with respiratory infections in primary care: procalcitonin, C-reactive protein or both?', 'authors': [{'first': 'M', 'middle': [], 'last': 'Meili', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Müller', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Kulkarni', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Schütz', 'suffix': ''}], 'year': 2015, 'venue': 'Expert Rev Respir Med', 'volume': '9', 'issn': '', 'pages': '587--601', 'other_ids': {}}, 'BIBREF45': {'ref_id': 'b45', 'title': 'Serum procalcitonin measurement and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial', 'authors': [{'first': 'A', 'middle': ['R'], 'last': 'Branche', 'suffix': ''}, {'first': 'E', 'middle': ['E'], 'last': 'Walsh', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Vargas', 'suffix': ''}], 'year': 2015, 'venue': 'J Infect Dis', 'volume': '212', 'issn': '', 'pages': '1692--700', 'other_ids': {}}, 'BIBREF46': {'ref_id': 'b46', 'title': 'Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever', 'authors': [{'first': 'C', 'middle': [], 'last': 'Chirouze', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Schuhmacher', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Rabaud', 'suffix': ''}], 'year': 2002, 'venue': 'Clin Infect Dis', 'volume': '35', 'issn': '', 'pages': '156--61', 'other_ids': {}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings', 'authors': [{'first': 'M', 'middle': [], 'last': 'Korppi', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Remes', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Heiskanen-Kosma', 'suffix': ''}], 'year': 2003, 'venue': 'Pediatr Pulmonol', 'volume': '35', 'issn': '', 'pages': '56--61', 'other_ids': {}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Infection biomarkers in primary care patients with acute respiratory tract infections-comparison of Procalcitonin and C-reactive protein', 'authors': [{'first': 'M', 'middle': [], 'last': 'Meili', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kutz', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Briel', 'suffix': ''}], 'year': 2016, 'venue': 'BMC Pulm Med', 'volume': '16', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance', 'authors': [{'first': 'S', 'middle': [], 'last': 'Eccles', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Pincus', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Higgins', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Woodhead', 'suffix': ''}], 'year': 2014, 'venue': 'BMJ', 'volume': '349', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Chen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Wu', 'suffix': ''}], 'year': 2013, 'venue': 'Br J Gen Pract', 'volume': '63', 'issn': '', 'pages': '787--94', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Narrative review of primary care pointof-care testing (POCT) and antibacterial use in respiratory tract infection (RTI)', 'authors': [{'first': 'J', 'middle': [], 'last': 'Cooke', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Butler', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Hopstaken', 'suffix': ''}], 'year': 2015, 'venue': 'BMJ Open Respir Res', 'volume': '2', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial', 'authors': [{'first': 'J', 'middle': ['W'], 'last': 'Cals', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Butler', 'suffix': ''}, {'first': 'R', 'middle': ['M'], 'last': 'Hopstaken', 'suffix': ''}], 'year': 2009, 'venue': 'BMJ', 'volume': '338', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'A decision aid to rule out pneumonia and reduce unnecessary prescriptions of antibiotics in primary care patients with cough and fever', 'authors': [{'first': 'J', 'middle': [], 'last': 'Steurer', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Held', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Spaar', 'suffix': ''}], 'year': 2011, 'venue': 'BMC Med', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF54': {'ref_id': 'b54', 'title': 'Usefulness of C-reactive protein testing in acute cough/ respiratory tract infection: an open cluster-randomized clinical trial with C-reactive protein testing in the intervention group', 'authors': [{'first': 'E', 'middle': [], 'last': 'Andreeva', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Melbye', 'suffix': ''}], 'year': 2014, 'venue': 'BMC Fam Pract', 'volume': '15', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF55': {'ref_id': 'b55', 'title': 'Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease', 'authors': [{'first': 'C', 'middle': [], 'last': 'Llor', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Moragas', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Hernández', 'suffix': ''}], 'year': 2012, 'venue': 'Am J Respir Crit Care Med', 'volume': '186', 'issn': '', 'pages': '716--739', 'other_ids': {}}, 'BIBREF56': {'ref_id': 'b56', 'title': 'Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial', 'authors': [{'first': 'J', 'middle': [], 'last': 'Tang', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Long', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Yan', 'suffix': ''}], 'year': 2013, 'venue': 'BMC Infect Dis', 'volume': '13', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF57': {'ref_id': 'b57', 'title': 'Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial', 'authors': [{'first': 'M', 'middle': [], 'last': 'Christ-Crain', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Jaccard-Stolz', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Bingisser', 'suffix': ''}], 'year': 2004, 'venue': 'Lancet', 'volume': '363', 'issn': '', 'pages': '600--607', 'other_ids': {}}, 'BIBREF58': {'ref_id': 'b58', 'title': 'Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial', 'authors': [{'first': 'M', 'middle': [], 'last': 'Christ-Crain', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Stolz', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Bingisser', 'suffix': ''}], 'year': 2006, 'venue': 'Am J Respir Crit Care Med', 'volume': '174', 'issn': '', 'pages': '84--93', 'other_ids': {}}, 'BIBREF59': {'ref_id': 'b59', 'title': 'C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD', 'authors': [{'first': 'D', 'middle': [], 'last': 'Stolz', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Christ-Crain', 'suffix': ''}, {'first': 'N', 'middle': ['G'], 'last': 'Morgenthaler', 'suffix': ''}], 'year': 2007, 'venue': 'Chest', 'volume': '131', 'issn': '', 'pages': '1058--67', 'other_ids': {}}, 'BIBREF60': {'ref_id': 'b60', 'title': 'Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care', 'authors': [{'first': 'M', 'middle': [], 'last': 'Briel', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Schuetz', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Mueller', 'suffix': ''}], 'year': 2008, 'venue': 'Arch Intern Med', 'volume': '168', 'issn': '', 'pages': '2007--2015', 'other_ids': {}}, 'BIBREF61': {'ref_id': 'b61', 'title': 'Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype', 'authors': [{'first': 'P', 'middle': [], 'last': 'Schuetz', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Christ-Crain', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Müller', 'suffix': ''}], 'year': 2009, 'venue': 'Swiss Med Wkly', 'volume': '139', 'issn': '', 'pages': '318--344', 'other_ids': {}}, 'BIBREF62': {'ref_id': 'b62', 'title': 'Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection', 'authors': [{'first': 'O', 'middle': [], 'last': 'Burkhardt', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Ewig', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Haagen', 'suffix': ''}], 'year': 2010, 'venue': 'Eur Respir J', 'volume': '36', 'issn': '', 'pages': '601--608', 'other_ids': {}}, 'BIBREF63': {'ref_id': 'b63', 'title': 'Aetiology of respiratory tract infections: clinical assessment versus serological tests', 'authors': [{'first': 'D', 'middle': [], 'last': 'Lieberman', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Shvartzman', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Korsonsky', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Lieberman', 'suffix': ''}], 'year': 2001, 'venue': 'Br J Gen Pract', 'volume': '51', 'issn': '', 'pages': '998--1000', 'other_ids': {}}, 'BIBREF64': {'ref_id': 'b64', 'title': 'Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up', 'authors': [{'first': 'W', 'middle': [], 'last': 'Long', 'suffix': ''}, {'first': 'L', 'middle': ['J'], 'last': 'Li', 'suffix': ''}, {'first': 'G', 'middle': ['Z'], 'last': 'Huang', 'suffix': ''}], 'year': 2014, 'venue': 'Crit Care', 'volume': '18', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF65': {'ref_id': 'b65', 'title': 'Access to pointof-care tests reduces the prescription of antibiotics among antibiotic-requesting subjects with respiratory tract infections', 'authors': [{'first': 'C', 'middle': [], 'last': 'Llor', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Bjerrum', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Munck', 'suffix': ''}], 'year': 2014, 'venue': 'HAPPY AUDIT Investigators', 'volume': '59', 'issn': '', 'pages': '1918--1941', 'other_ids': {}}, 'BIBREF66': {'ref_id': 'b66', 'title': 'Better tests, better care: improved diagnostics for infectious diseases', 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Caliendo', 'suffix': ''}, {'first': 'D', 'middle': ['N'], 'last': 'Gilbert', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Ginocchio', 'suffix': ''}], 'year': 2013, 'venue': 'Clin Infect Dis', 'volume': '57', 'issn': '3', 'pages': '139--70', 'other_ids': {}}, 'BIBREF67': {'ref_id': 'b67', 'title': 'Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease', 'authors': [{'first': 'M', 'middle': ['J'], 'last': 'Wiselka', 'suffix': ''}, {'first': 'K', 'middle': ['G'], 'last': 'Nicholson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Kent', 'suffix': ''}], 'year': 1991, 'venue': 'Thorax', 'volume': '46', 'issn': '', 'pages': '706--717', 'other_ids': {}}, 'BIBREF68': {'ref_id': 'b68', 'title': 'Spectrum of clinical illness in hospitalized patients with \"common cold\" virus infections', 'authors': [{'first': 'H', 'middle': ['M'], 'last': 'El-Sahly', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Atmar', 'suffix': ''}, {'first': 'W', 'middle': ['P'], 'last': 'Glezen', 'suffix': ''}, {'first': 'S', 'middle': ['B'], 'last': 'Greenberg', 'suffix': ''}], 'year': 2000, 'venue': 'Clin Infect Dis', 'volume': '31', 'issn': '', 'pages': '96--100', 'other_ids': {}}, 'BIBREF69': {'ref_id': 'b69', 'title': 'Antibiotics and respiratory infections: are patients more satisfied when expectations are met?', 'authors': [{'first': 'R', 'middle': ['M'], 'last': 'Hamm', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Hicks', 'suffix': ''}, {'first': 'D', 'middle': ['A'], 'last': 'Bemben', 'suffix': ''}], 'year': 1996, 'venue': 'J Fam Pract', 'volume': '43', 'issn': '', 'pages': '56--62', 'other_ids': {}}, 'BIBREF70': {'ref_id': 'b70', 'title': 'Current and future use of point-of-care tests in primary care: an international survey in Australia', 'authors': [{'first': 'J', 'middle': [], 'last': 'Howick', 'suffix': ''}, {'first': 'J', 'middle': ['W'], 'last': 'Cals', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Jones', 'suffix': ''}], 'year': 2014, 'venue': 'BMJ Open', 'volume': '4', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {}, 'back_matter': [{'text': 'Author contributions. P.J. wrote the paper. E.G. performed critical review.Financial support. This study was unsponsored, and the authors received no specific funding for this work.Potential conflicts of interest. All authors: no reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}]}\n",
      "{'_id': ObjectId('5f4ecb6be5b9408d4dcfcdd0'), 'paper_id': '0a098b3876e799d9b21608e26e80d05aa9ec6475', 'metadata': {'title': '', 'authors': [{'first': 'J', 'middle': ['B'], 'last': 'Bump', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [], 'body_text': [{'text': \"This paper addresses the need for conceptual and analytic clarity on nutrition governance, an essential underpinning of more effective approaches for undernutrition, the 'single greatest constraint to global development' and obesity, which already accounts for 4% of the world's disease burden and is growing rapidly. The governance of nutrition, which is essential to designing and implementing policies to realise the right to food, is among the most important and most defining duties of society. But research and action on nutrition governance are hampered by the absence of conceptual rigour, even as the continuing very high burden of undernutrition and the rapid rise in obesity highlight the need for such structures. The breadth of nutrition itself suggests that governance is both needed and sure to be complicated. This analysis explores the reasons attention has come to governance in development policy making, and why it has focused on nutrition governance in particular. It then assesses how the concept of nutrition governance has been used, finding that it has become increasingly prominent in scholarship on poor nutritional outcomes, but remains weakly specified and is invoked by different authors to mean different things. Undernutrition analysts have stressed coordination problems and structural issues related to the general functioning of government. Those studying obesity have emphasised international trade policies, regulatory issues and corporate behaviour. This paper argues that the lack of a clear, operational definition of governance is a serious obstacle to conceptualising and solving major problems in nutrition. To address this need, it develops a unified definition of nutrition governance consisting of three principles: accountability, participation and responsiveness. These are justified with reference to the social contract that defines modern nations and identifies citizens as the ultimate source of national power and legitimacy. A unified framework is then employed to explore solutions to nutrition governance problems.\", 'cite_spans': [], 'ref_spans': [], 'section': 'AbsTrACT'}, {'text': 'Nutrition is a requirement of all life and one of the most basic underpinnings of health, and as such is of great interest to all people. The right to food is therefore one of the most fundamental human entitlements and a central responsibility for all states. 1 2 The governance of nutrition, which is essential to designing and implementing policies to realise this right, 3 4 is thus among the most important and most defining duties of society. Better governance, broadly defined, has potential to improve many aspects of nutrition, for instance by coordinating actions between sectors and agencies, promoting accountability of corporate actors, improving the food supply, increasing community ownership in intervention programmes, improving the responsiveness of government to citizen demand and helping to uphold the right to food.', 'cite_spans': [{'start': 261, 'end': 264, 'text': '1 2', 'ref_id': None}, {'start': 375, 'end': 378, 'text': '3 4', 'ref_id': None}], 'ref_spans': [], 'section': 'InTroduCTIon'}, {'text': 'What is already known? ► The governance of nutrition is essential to addressing both undernutrition and obesity, but international and domestic actors have struggled in this area.', 'cite_spans': [], 'ref_spans': [], 'section': 'Key questions'}, {'text': 'What are the new findings?', 'cite_spans': [], 'ref_spans': [], 'section': 'Key questions'}, {'text': '► Governance has risen on donor agendas since the fall of the Berlin Wall in 1989, and has become more important with the proliferation of international actors, increasing cross-border actions and greater globalisation of commerce and disease. ► Increased prominence of nutrition governance reflects greater donor engagement, the multisectoral nature of food, increasing obesity the need for health-related regulation of trade and food crises caused by climate change and food crop diversion. ► Existing governance frameworks do not clarify their principles; this paper develops a unified conceptualisation of nutrition governance from basic philosophy to show the relationships between undernutrition and obesity, clarify the challenges and illuminate opportunities for intervention.', 'cite_spans': [], 'ref_spans': [], 'section': 'Key questions'}, {'text': '► Nutrition governance and the right to food can be advanced by using the three elements of accountability, participation and responsiveness to assess all governance interventions and the performance of international actors.', 'cite_spans': [], 'ref_spans': [], 'section': 'What do the new findings imply?'}, {'text': \"But both research and action on nutrition governance are hampered by the absence of clarity or consensus on the meaning of this concept, even as many problems highlight the need for such structures. Undernutrition alone has been called 'the single greatest constraint facing global development' 5 and obesity accounts for nearly 4% of the entire global disease burden already and is increasing rapidly. 6 Globalisation of the food industry has been linked to rising obesity, diet-related chronic disease and the nutritional transition. 7 The breadth of nutrition itself suggests that governance is both needed and sure to be complicated. The production, distribution, sale and consumption of food engages agriculture, trade, transportation, education, health and other areas of both the public and private sectors.\", 'cite_spans': [{'start': 295, 'end': 296, 'text': '5', 'ref_id': 'BIBREF4'}, {'start': 403, 'end': 404, 'text': '6', 'ref_id': 'BIBREF5'}, {'start': 536, 'end': 537, 'text': '7', 'ref_id': 'BIBREF6'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Nonetheless, despite this need, basic questions about nutrition governance lack ready answers. For instance, what are the most important elements of governance? When planning a governance improvement intervention, where would one begin? For all the things that governance seems to be, what is it not? Is it the same as politics, or something different?', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Conceptual rigour around nutrition governance would help navigate the seemingly impenetrable tangle of issues that now characterise this topic. The range of actors includes everything from individuals to the multinational food industry. The spectrum of influences is just as wide, including everything from personal preferences to national policies and global trade regimes, each of which has different sources of authority and legitimacy. In many scenarios, the lines of accountability are not obvious and even the relevant constituencies can be challenging to identify. Despite the profound influence of governance on nutrition, Sunguya et al have found that only 40% of low-income and middle-income country (LMIC) governments even have policies in this area. And although logic suggests that having a policy would be helpful, their analysis found no association with better nutrition outcomes. 8 In many places, rapid urbanisation is exacerbating weak governance problems, 9 and unregistered informal settlements expose the dysfunction of traditional welfare state approaches when citizens become invisible to the bureaucracy. 10 11 Where citizens do participate in the policy process, they may be ambivalent about issues experts view as urgent, 12 or their opinions may be influenced by food industry marketing or sponsored research. 13 14 How would one analyse or manage these complex issues?', 'cite_spans': [{'start': 897, 'end': 898, 'text': '8', 'ref_id': 'BIBREF7'}, {'start': 976, 'end': 977, 'text': '9', 'ref_id': 'BIBREF8'}, {'start': 1130, 'end': 1135, 'text': '10 11', 'ref_id': None}, {'start': 1249, 'end': 1251, 'text': '12', 'ref_id': 'BIBREF11'}, {'start': 1338, 'end': 1343, 'text': '13 14', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The purpose of this article is to rigorously analyse nutrition governance, which is essential to more effective intervention by national and international actors striving to uphold the right to food. First, I explain the literature review methods used to gather materials for analysis. Second, I examine why governance has become prominent on the health and development agendas. Third, I investigate the meaning of nutrition governance empirically, by assessing how the concept has been used. Fourth, I develop a clear definition of nutrition governance. Fifth, I present a framework for analysing nutrition governance and characterising its major features. In the conclusion, I use the framework to illuminate governance problems and corresponding opportunities for global-level actors.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"This inquiry began with a search of literature to gather information for the analysis and to gain insights into activities related to nutrition governance. To identify publications on nutrition governance, a keyword search for 'nutrition governance' was conducted in the PubMed database. i PubMed was chosen as the starting point because it is the world's largest database of health and medical literature. To capture additional literature from the social sciences, humanities, newspapers and books, the JSTOR database was searched, as well. Searches with Google Scholar and a review of citations in the most directly relevant papers were used to complete the initial sample. ii All results were reviewed and papers were retained if they used the term nutrition governance, or focused on nutrition and included aspects of governance as defined broadly by Lee et al to include accountability, transparency, participation, responsiveness, a consensus orientation, the rule of law, effectiveness and efficiency and equity and inclusiveness. 15 Papers were excluded if they mentioned nutrition governance insubstantially or were irrelevant, for instance, as part of author affiliations, but not in the article itself. [16] [17] [18] [19] A more extensive discussion of methods is available as online supplementary annex 1.\", 'cite_spans': [{'start': 676, 'end': 678, 'text': 'ii', 'ref_id': None}, {'start': 1038, 'end': 1040, 'text': '15', 'ref_id': 'BIBREF14'}, {'start': 1214, 'end': 1218, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 1219, 'end': 1223, 'text': '[17]', 'ref_id': 'BIBREF16'}, {'start': 1224, 'end': 1228, 'text': '[18]', 'ref_id': 'BIBREF17'}, {'start': 1229, 'end': 1233, 'text': '[19]', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'MeTHods'}, {'text': 'The final sample for analysis comprised 177 papers. Table 1 presents the search strategy for each database along with the number of papers obtained:', 'cite_spans': [], 'ref_spans': [{'start': 52, 'end': 59, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'MeTHods'}, {'text': \"The limitations of this exercise include at least the following: these databases are biased towards English-language publications and western journals, and may not accurately capture governance work, even in these areas. Scholarship on governance may not have been indexed consistently or with the same keywords over the period of interest. The journals indexed by PubMed are not constant and the aggregate number has increased over this period. The searches used the keyword 'governance', which is a current term but may not have been the most commonly used term for describing its subject over the past 40 years. These limitations notwithstanding, the review is likely to have generated a reasonable sample of literature for analysing the aspects of nutrition governance of interest in this paper. \", 'cite_spans': [], 'ref_spans': [], 'section': 'MeTHods'}, {'text': 'FIndIngs And dIsCussIon Governance is such an obvious requirement for development that it is not intuitive why attention should have come to this area only in the past two or three decades, and especially in the last 10 years. I decided to investigate the reasons, hypothesising that they would help demonstrate the importance of nutrition governance and reveal the specific problems it is expected to solve.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"governance and the development policy agenda Before the fall of the Berlin Wall in 1989, most aid was conditional on geopolitical alignment rather than on how states treated their own citizens. But after the Cold War, economic and political rights issues were no longer enmeshed in the larger US-Soviet ideological struggle. Freed from this constraint, western donors began to project their own political convictions via democratisation and governance projects. The growth of the rights movement and several international agreements on rights in the early 1990s testifies further to the power of this shift. 20 When the concern for state alignment evaporated, it helped bring attention to the role of governance in translating development aid into poverty reduction. This was an important factor in the introduction and subsequent popularity of the Sector Wide Approaches (SWAps) and other general budget support mechanisms that blossomed in the 1990s. 21 After mixed results from the 1980s' Washington Consensus aid approach, it was also clear that the market alone would not solve all problems; the rise of governance was a partial retreat from that position, 22 as was the embrace of public-private partnerships. 23 Weaknesses in governance at various levels from the national to the global drew attention as constraints to health systems. 24 The proliferation of actors in global health also spurred calls for better governance because of the need for coordination and accountability. 25 Targeted aid and democratisation projects became even more closely linked after the 9/11 attacks brought emphasis in US policymaking to the problems of failed states and poor populations. After 9/11, US assistance was directed to poor people in failed states in hopes of preventing scarcity-induced radicalizsation. The emphasis on safety nets and social protection could be read as a move by donors to enhance democratic participation by the poor. 26 However, these actions also fit neatly in the long legacy of aid programmes targeting health issues primarily because of their impact on trade and markets. 27 In the last 10 years, governance has become a well-established subfield in global health, in part because many problems related to governance have become more obvious. Governance was a natural follow-on focus after the decentralisation policies widely promoted in the 1990s, particularly because many of the formal policies and institutions designed to promote local engagement had not actually democratised decision making. 28 But the growing attention to governance also reflects rapid globalisation. The rising threat of disease and the growth of interstate commerce both increase the need for shared decision making between diverse groups and entities. 29 30 Globalisation has also highlighted the need for governance over both health and trade, which since World War II have been institutionalised distinctly. 31 Large-scale disease outbreaks, such as severe acute respiratory syndrome in 2003 and Ebola in West Africa in 2014 have made visible the importance of functioning governance mechanisms in health. [32] [33] [34] Trade-related non-communicable diseases linked to tobacco, processed foods and other goods have exposed shortcomings in existing structures. 35 International actors have recognised governance in many of their projects and analyses. Beginning in 1996, the World Bank began collecting governance indicators every other year; since 2002, it has collected these data annually from 212 countries and territories. 36 World Bank projects classified as 'Public Sector Governance' have become far more numerous over the years. In the 1980s, there were 304 such projects. In the 1990s, there 20 The multiplication of new NGOs, UN entities, corporations and others engaged in nutrition has continued and represents a growing challenge for coordination. 25 39 Additionally, the complexity of nutrition and its engagement with a great many sectors-agriculture, education, trade, health and others-present many coordination challenges. Second, food and nutrition interventions could be targeted at the community level and could give voice to poor citizens by promoting their participation. Hence, they were seen as natural vehicles to advance donors' general priorities in economic and political rights, and in attempting to prevent scarcity-induced radicalisation in failed states. More broadly, donors attempted to enhance democratic participation by the poor, but questions of how donor-driven governance models were supposed to interact with existing governance structures largely went unaddressed. 26 Third, the advance of globalisation highlighted the need for supranational regulation and strengthened governance at all levels. In 1999, Lang argued that globalisation was undermining traditional governance of food because national authority was not capable to regulating multinational businesses or countering their marketing. 40 The global growth of fast food and advertising largely bypassed health authorities because it was regulated internationally only as a trade issue with little reference to health consequences. 41 Others have advanced similar points on the importance of 'food governance', 42 for food and nutrition, perhaps similar to the Framework Convention on Tobacco Control, and coordinated action by the World Bank, WHO and the UN. 35 43 44 Fourth, real food prices rose quickly in the 2000s, peaking in 2008 and 2011, driven by depreciation in the dollar, diversion of some crops to biofuel use, oil price appreciation, export restrictions, demand surges, droughts and other factors. 45 46 Between 2000 and 2011, food prices increased 183% in real terms. 47 The disastrous humanitarian consequences of this increase, including conflict and instability, 48 generated political motivation for discussing food security, agriculture and trade policy and other aspects of global nutrition, particularly with respect to undernutrition. [49] [50] [51] Fifth, multilateral organisations and academics have been active. Governance was identified as one of the principal weaknesses in global nutrition by WHO's Commission on Social Determinants of Health in 2008 52 ; a Lancet commission cited governance problems as a central obstacle to effective international intervention against undernutrition. 53 Also in 2008 (formalised 2011), the Food and Agriculture Organization, Unicef and World Food Programme (WFP) agreed to launch Renewed Efforts Against Child Hunger and undernutrition (REACH) to strengthen UN actions to fight hunger and malnutrition by coordinating actions within recipient countries. In 2009-2010, WHO and many partners launched the Scaling Up Nutrition (SUN) movement to spur progress against undernutrition. 54 In 2010, WHO's Nutrition Landscape Information System launched with a series of governance indicators, 55 which has made it easier to quantify and demonstrate the large impact of governance on nutrition. 8 Since 2011, REACH has focused on strengthening nutrition management and governance, and supporting multisectoral nutrition actions, such as nutrition-sensitive programming. 39 56 These multilateral efforts have all brought attention to governance, although some have attracted criticism for expanding the influence of the private sector in public health policy. 57 58 This historical analysis reveals why nutrition governance is so crucial. First, it is essential to realise the right to food. Second, it is a tractable place to advance development through encouraging participation and democratisation, and as such is a powerful lever to realise many rights. Third, it is needed to coordinate between the many sectors important to nutrition, and among the many agencies and entities operating domestically and internationally. Fourth, it is required to address the affects of trade on health, particularly in the globalised food industry.\", 'cite_spans': [{'start': 608, 'end': 610, 'text': '20', 'ref_id': 'BIBREF19'}, {'start': 953, 'end': 955, 'text': '21', 'ref_id': 'BIBREF20'}, {'start': 1162, 'end': 1164, 'text': '22', 'ref_id': 'BIBREF21'}, {'start': 1216, 'end': 1218, 'text': '23', 'ref_id': 'BIBREF22'}, {'start': 1343, 'end': 1345, 'text': '24', 'ref_id': 'BIBREF23'}, {'start': 1489, 'end': 1491, 'text': '25', 'ref_id': 'BIBREF24'}, {'start': 1941, 'end': 1943, 'text': '26', 'ref_id': 'BIBREF25'}, {'start': 2100, 'end': 2102, 'text': '27', 'ref_id': 'BIBREF26'}, {'start': 2528, 'end': 2530, 'text': '28', 'ref_id': 'BIBREF27'}, {'start': 2760, 'end': 2765, 'text': '29 30', 'ref_id': None}, {'start': 2918, 'end': 2920, 'text': '31', 'ref_id': 'BIBREF30'}, {'start': 3116, 'end': 3120, 'text': '[32]', 'ref_id': 'BIBREF31'}, {'start': 3121, 'end': 3125, 'text': '[33]', 'ref_id': 'BIBREF32'}, {'start': 3126, 'end': 3130, 'text': '[34]', 'ref_id': 'BIBREF33'}, {'start': 3272, 'end': 3274, 'text': '35', 'ref_id': 'BIBREF34'}, {'start': 3539, 'end': 3541, 'text': '36', 'ref_id': 'BIBREF35'}, {'start': 3713, 'end': 3715, 'text': '20', 'ref_id': 'BIBREF19'}, {'start': 3873, 'end': 3878, 'text': '25 39', 'ref_id': None}, {'start': 4620, 'end': 4622, 'text': '26', 'ref_id': 'BIBREF25'}, {'start': 4952, 'end': 4954, 'text': '40', 'ref_id': 'BIBREF39'}, {'start': 5147, 'end': 5149, 'text': '41', 'ref_id': 'BIBREF40'}, {'start': 5226, 'end': 5228, 'text': '42', 'ref_id': 'BIBREF41'}, {'start': 5375, 'end': 5377, 'text': '35', 'ref_id': 'BIBREF34'}, {'start': 5378, 'end': 5383, 'text': '43 44', 'ref_id': None}, {'start': 5628, 'end': 5633, 'text': '45 46', 'ref_id': None}, {'start': 5699, 'end': 5701, 'text': '47', 'ref_id': None}, {'start': 5974, 'end': 5978, 'text': '[49]', 'ref_id': 'BIBREF48'}, {'start': 5979, 'end': 5983, 'text': '[50]', 'ref_id': 'BIBREF49'}, {'start': 5984, 'end': 5988, 'text': '[51]', 'ref_id': 'BIBREF50'}, {'start': 6334, 'end': 6336, 'text': '53', 'ref_id': 'BIBREF52'}, {'start': 6763, 'end': 6765, 'text': '54', 'ref_id': 'BIBREF53'}, {'start': 6869, 'end': 6871, 'text': '55', 'ref_id': 'BIBREF54'}, {'start': 6970, 'end': 6971, 'text': '8', 'ref_id': 'BIBREF7'}, {'start': 7145, 'end': 7150, 'text': '39 56', 'ref_id': None}, {'start': 7334, 'end': 7339, 'text': '57 58', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The need for governance A review of the literature identified in this search finds that most authors use \\'governance\\' in explanation of their primary findings, but usually do not focus on governance itself. In this usage, one theme could be called \\'the need for governance\\', which investigates problems and BMJ Global Health explains them with reference to weak or missing governance. At the global level, this literature includes calls for better governance as global and national policy environments become more complex 59 and the globalisation of the food industry overwhelms existing governance structures. 60 Governance problems are central to the maldistribution underlying local or regional food insecurity even though global production is adequate. 61 Quality of governance was identified as an important determinant of progress towards the Millennium Development Goals and successful primary healthcare implementation, 62 and as a fundamental component of high performing states: \\'…the most effective, relevant national policies will emerge from a system of governance that firmly connects the needs of the poor to a politically responsive local government that has the technical and institutional capacity to act\\'. 3 A high-profile Lancet article focusing mainly on the global level identified accountability and participation as leading problems: \\'The international community needs to identify and establish a new global governance structure that can provide greater accountability and participation for civil society and the private sector\\'. 53 The WHO Code of Marketing of Breast Milk Substitutes has provisions for punishing violators, but governance problems have rendered the code largely unenforced and ineffective. [63] [64] [65] Donors have attempted to promote accountability and participation mechanisms, but many interventions do not translate into benefits for those not already enfranchised, such as women, 66 and many efforts have been assailed by activists for advancing private sector influence in public health processes. 58 67 68 The importance of nutrition governance is demonstrated by experiences and analyses in many national and local contexts, as well. Some of the largest are collective action problems. 69 In India, which has among the highest burdens related to suboptimal nutrition, governance problems have been deemed more significant than scientific or technical obstacles, 70 and is needed to translate economic growth into progress against undernutrition. 71 Looking at urban areas of the same country, Bhojani et al characterised the main governance problems as weak regulation of quality in the private sector; poor coordination across care providers in the public and private sectors and between clinics, health centres and hospitals; rampant bribery and the absence of systems to respond to formal grievances or provide accountability to citizens. 72 In a policy analysis of maternal and child health in Pakistan, Siddiqi et al argued that good governance is needed to translate policies into results. 73 In a discussion of food security and fisheries, weaknesses in governance were revealed in overfishing, depletion of stocks, minimal enforcement, low oversight and inadequate coordination of policies and actions between national and global authorities. 74 Understanding governance structures is also extremely important for designing strategies to advance food policy on political agendas. 75 The politics of food policy hinges both on government leadership and activism by civil society organisations. 76 Others used \\'governance\\' as an organising category to identify coordination problems, which arise from nutrition\\'s intersectoral nature, as reported in India and Brazil, to name two examples. 77 78 Coordination problems can arise at the intersection of public and private sectors-the Bangladesh Government attempted to advance governance in its policies, but the exercise\\'s impact was attributed to NGO partners. 79 Some analysts have assessed the effect of governance through comparative and synthetic investigations. In a comparison of fragile states, those with higher quality of governance were more likely to join SUN, while the \\'prevalence of malnutrition, health system functioning and level of citizen empowerment had little or no impact\\' on the decision to join. 80 A synthetic review of 58 controlled evaluations argued that \\'nutrition is now recognised to be a governance issue\\', and that better governance was associated with lower prevalence of child undernutrition. 81 A comparison of water quality in Brazil, Ecuador and Malawi found \\'…that access to safe water could be improved if certain water governance challenges were addressed: coordination and data sharing between minis-tries…; monitoring and enforcement of water quality laws; and sufficient technical capacity to improve administrative and technical management of water services…\\'\" 82 \\'Governance\\' has also been used as a general category for describing specific interventions, many of them successful. Extensive community engagement helped address governance problems in Vietnam. 83 Collaboration and coordination problems were resolved with shared governance structures in Colombia. 84 In both Australia and the UK, the clarity and transparency of governance arrangements was important to facilitating cooperation and coordination in obesity reduction efforts. 85 86 In the Philippines, long-term capacity building in both the public and private sectors has facilitated governance by collecting and analysing data to generate evidence for improving policymaking. 87 Systematic data analysis in Haiti has helped to elucidate many factors that promoted good nutrition governance, including \\'effective evidence-based advocacy, partnerships and design, implementation and scale-up of nutrition-specific and sensitive interventions\\'. 88 Another area of scholarship using governance has focused on citizen attitudes and perceptions to explore why technically sound policies are challenging to adopt and implement. Reasons include popular ambivalence towards experts\\' opinion, 12 or the shaping of debate by food industry marketing or sponsored research. 13 14 Contested views of the role of the state versus the private sector were central to the growing obesity epidemic in Australia, where many people did not want the state to counter fast food advertising. 89 Also, politicians were the least trusted group for information on food, according to a telephone survey by the same researchers (farmers were the most trusted). 90 This contest for influence is very difficult for public health advocates. Denmark introduced a saturated fat tax in 2011, supported with BMJ Global Health public health arguments, but it was opposed by the food industry and related actors. Although the tax began to change the national diet as public health advocates had hoped, the tax had no organised supporters and the food industry successfully lobbied for its abolishment the following year. 91 Calls for improved governance were not always matched by clarity about exactly what is needed, suggesting that governance can be challenging to specify and is not always discussed in meaningful detail. Given the complexity and vagueness of both \\'nutrition\\' and \\'governance\\', this finding is hardly surprising. Others have reached this same conclusion. A systematic review of health system barriers to antiretroviral therapy provision found that many authors cited governance problems, but the collective evidence was weak because individual cases included too little context to convey what this meant in detail. 92 In a systematic review of the impact of health systems and policies on behaviour change to promote child survival in LMICs, Velez et al concluded, \\'The evidence directly addressing how to improve the financing and governance of health systems was weak or not available\\'. 93 Another broad review focused on agriculture research, finding that despite vast influence of governance on the agriculture-nutrition impact, only six studies, just 4% of the sample, actually focused on governance. 94 Addressing nutrition governance directly A far smaller portion of the literature reviewed in this study focused directly on nutrition governance, typically regarding undernutrition. In historical perspective, undernutrition, hunger and food insecurity are all wellknown problems that surely predate the written record, whereas obesity has become a public health concern only very recently. In this light, it may not be surprising that a majority of the papers on nutrition governance concerned undernutrition and concentrated on the governance issues related to that problem. The major institutional actors mentioned in the literature review focus the preponderance of activities on undernutrition, including Unicef, SCN, WFP and WHO, and major initiatives such as SUN and REACH, although both Unicef and WHO have smaller portfolios targeting obesity.', 'cite_spans': [{'start': 522, 'end': 524, 'text': '59', 'ref_id': 'BIBREF57'}, {'start': 611, 'end': 613, 'text': '60', 'ref_id': 'BIBREF58'}, {'start': 757, 'end': 759, 'text': '61', 'ref_id': 'BIBREF59'}, {'start': 928, 'end': 930, 'text': '62', 'ref_id': 'BIBREF60'}, {'start': 1225, 'end': 1226, 'text': '3', 'ref_id': 'BIBREF2'}, {'start': 1554, 'end': 1556, 'text': '53', 'ref_id': 'BIBREF52'}, {'start': 1733, 'end': 1737, 'text': '[63]', 'ref_id': 'BIBREF61'}, {'start': 1738, 'end': 1742, 'text': '[64]', 'ref_id': 'BIBREF62'}, {'start': 1743, 'end': 1747, 'text': '[65]', 'ref_id': 'BIBREF63'}, {'start': 1931, 'end': 1933, 'text': '66', 'ref_id': 'BIBREF64'}, {'start': 2050, 'end': 2052, 'text': '58', 'ref_id': 'BIBREF56'}, {'start': 2053, 'end': 2058, 'text': '67 68', 'ref_id': None}, {'start': 2240, 'end': 2242, 'text': '69', 'ref_id': 'BIBREF67'}, {'start': 2416, 'end': 2418, 'text': '70', 'ref_id': 'BIBREF68'}, {'start': 2500, 'end': 2502, 'text': '71', 'ref_id': 'BIBREF69'}, {'start': 2896, 'end': 2898, 'text': '72', 'ref_id': 'BIBREF70'}, {'start': 3050, 'end': 3052, 'text': '73', 'ref_id': 'BIBREF71'}, {'start': 3305, 'end': 3307, 'text': '74', 'ref_id': 'BIBREF72'}, {'start': 3442, 'end': 3444, 'text': '75', 'ref_id': 'BIBREF73'}, {'start': 3555, 'end': 3557, 'text': '76', 'ref_id': 'BIBREF74'}, {'start': 3750, 'end': 3755, 'text': '77 78', 'ref_id': None}, {'start': 3971, 'end': 3973, 'text': '79', 'ref_id': 'BIBREF77'}, {'start': 4330, 'end': 4332, 'text': '80', 'ref_id': 'BIBREF78'}, {'start': 4538, 'end': 4540, 'text': '81', 'ref_id': 'BIBREF79'}, {'start': 4916, 'end': 4918, 'text': '82', 'ref_id': 'BIBREF80'}, {'start': 5115, 'end': 5117, 'text': '83', 'ref_id': 'BIBREF81'}, {'start': 5219, 'end': 5221, 'text': '84', 'ref_id': 'BIBREF82'}, {'start': 5397, 'end': 5402, 'text': '85 86', 'ref_id': None}, {'start': 5599, 'end': 5601, 'text': '87', 'ref_id': 'BIBREF85'}, {'start': 5865, 'end': 5867, 'text': '88', 'ref_id': 'BIBREF86'}, {'start': 6106, 'end': 6108, 'text': '12', 'ref_id': 'BIBREF11'}, {'start': 6184, 'end': 6189, 'text': '13 14', 'ref_id': None}, {'start': 6391, 'end': 6393, 'text': '89', 'ref_id': 'BIBREF88'}, {'start': 6555, 'end': 6557, 'text': '90', 'ref_id': 'BIBREF89'}, {'start': 7006, 'end': 7008, 'text': '91', 'ref_id': 'BIBREF90'}, {'start': 7621, 'end': 7623, 'text': '92', 'ref_id': 'BIBREF91'}, {'start': 7895, 'end': 7897, 'text': '93', 'ref_id': 'BIBREF92'}, {'start': 8112, 'end': 8114, 'text': '94', 'ref_id': 'BIBREF93'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Some authors defined nutrition governance using broad definitions. As illustrated by Solon's articulation, 'governance' may be simply stated: 'Governance is the process of decision-making and implementation'. 87 Pinstrup-Andersen and Watson take a similarly broad approach in writing that 'governance deals with how… conflicting interests are resolved', and may be defined as '…the exercise of authority or management of resources through institutions, policies, traditions, cultures and societal norms'. 95 In these and similar cases, the inclusiveness makes it difficult to understand what would be excluded from 'governance', and it is hard to imagine what specific interventions would follow naturally from the definitions.\", 'cite_spans': [{'start': 209, 'end': 211, 'text': '87', 'ref_id': 'BIBREF85'}, {'start': 505, 'end': 507, 'text': '95', 'ref_id': 'BIBREF94'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Other authors invoked governance to discuss or analyse a limited subset of concepts. For instance, the highly influential Lancet paper by Morris et al focused on governance barriers to international action against undernutrition that could be categorised as coordination, accountability and distributional. 53 These categories are intuitive because they are at the root of food insecurity, and have long been important in undernutrition scholarship and programming. Coordination problems are common because undernutrition often relates to complicated circumstances in which many actors operate without clear lines of authority, responsibility or accountability. Conflict, natural disaster and multiple failures of markets and/or states are all common settings for undernutrition. The UN System Standing Committee on Nutrition (SCN) was founded in 1977 (as SubCommittee on Nutrition) with the express purpose of coordinating UN actions against nutrition problems. 96 A major stated reason for launching SUN in 2010 was to harmonise views, policies and actions across a broader set of stakeholders including countries and donors. 97 98 The proliferation of global health actors has exacerbated this problem further. 99 Accountability problems are commonly referenced because many analysts view governments as guarantors of food security, and insecurity thus represents a government failure, which might be rectified or reduced if governments were more accountable to their citizens. The intersectoral nature of food security also means that many parts of a government may be responsible, but hard to hold accountable. 70 100 Increasing the participation and voice of at-risk groups is a common recommendation. 81 One important pathway is that greater participation and better governance are associated with improved access to safe water, although there are likely many more, as well. 100 101 Adequacy of global food production and its persistent scarcity in particular settings points to distribution, or allocation issues. 100 The same dynamic plays out within countries, where poor distribution systems leave some areas vulnerable even as food is sufficient when measured at the national level. 102 Distributional issues are not strictly limited to food-the distribution of rights and entitlements are also core governance issues with large implications for nutrition. 73 103 104 Among the most prominent nutrition governance frameworks identified in this review was developed at the Institute for Development Studies by Mejía Acosta and Fanzo, and Haddad et al. 105 106 The framework highlights cooperation and coordination-both prominent themes in undernutrition as explained above-and also adds sustainable funding and monitoring and advocacy. The explicit inclusion of funding recognises the central requirement of adequate resources, which the authors characterise as the 'cement' that holds cooperation and coordination together. 105 The monitoring and advocacy category acknowledges the need for governments to collect relevant information and produce analyses to BMJ Global Health understand where there are problems, design and implement solutions and track progress. Advocacy represents the critical role of civil society in detecting problems, raising awareness and facilitating solutions, whether by direct delivery or influencing the government.\", 'cite_spans': [{'start': 307, 'end': 309, 'text': '53', 'ref_id': 'BIBREF52'}, {'start': 1128, 'end': 1130, 'text': '97', 'ref_id': 'BIBREF96'}, {'start': 1131, 'end': 1133, 'text': '98', 'ref_id': 'BIBREF97'}, {'start': 1214, 'end': 1216, 'text': '99', 'ref_id': 'BIBREF98'}, {'start': 1616, 'end': 1618, 'text': '70', 'ref_id': 'BIBREF68'}, {'start': 1619, 'end': 1622, 'text': '100', 'ref_id': 'BIBREF99'}, {'start': 1708, 'end': 1710, 'text': '81', 'ref_id': 'BIBREF79'}, {'start': 1882, 'end': 1889, 'text': '100 101', 'ref_id': None}, {'start': 2022, 'end': 2025, 'text': '100', 'ref_id': 'BIBREF99'}, {'start': 2195, 'end': 2198, 'text': '102', 'ref_id': 'BIBREF101'}, {'start': 2369, 'end': 2371, 'text': '73', 'ref_id': 'BIBREF71'}, {'start': 2372, 'end': 2379, 'text': '103 104', 'ref_id': None}, {'start': 2563, 'end': 2570, 'text': '105 106', 'ref_id': None}, {'start': 2936, 'end': 2939, 'text': '105', 'ref_id': 'BIBREF104'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Very different views on governance came from studies focusing on obesity, where primary themes include the globalisation of food, the products and marketing of multinational corporations (MNCs) and individual lifestyle choices. 40-42 63 107 Globalisation has changed the landscape of food and nutrition by concentrating power in large firms, changing consumer taste through marketing, and limiting the effectiveness of traditional governance mechanisms. Representation, participation, voice, accountability and regulation all are rooted in national structures and are easy to circumvent for MNCs. Where accountability is discussed, it emphasises corporate accountability 108 and tends to focus on global level regulatory issues concerning trade and health. 42 Addressing the Australian context, Sacks et al developed a matrix of sectors and governance levels for thinking about some of these issues, which they used to identify policy options. 109 The sectors ranged from primary production and food processing to distributions, marketing, retail and catering/food service. Governance levels include local, state, national and international. Although the authors do not use the term, this can be considered a nutrition governance framework. Sacks et al identify policy issues and the level of government where they may be addressed. For example, in food processing, safety standards are usually a state government responsibility and product composition standards are usually decided at the national level.', 'cite_spans': [{'start': 228, 'end': 240, 'text': '40-42 63 107', 'ref_id': None}, {'start': 671, 'end': 674, 'text': '108', 'ref_id': 'BIBREF107'}, {'start': 757, 'end': 759, 'text': '42', 'ref_id': 'BIBREF41'}, {'start': 944, 'end': 947, 'text': '109', 'ref_id': 'BIBREF108'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Analysing nutrition governance frameworks These nutrition governance frameworks include elements that are well supported by intuition and research, and draw attention to some critical areas of nutrition governance in both undernutrition and obesity. Their many strengths are evident in the above review: individually, they identify some of the most pressing issues in nutrition governance, and collectively, they provide a place to begin understanding the very difficult landscape of one of humanity's greatest problems.\", 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"However, a synthetic view of scholarship on nutrition governance finds an incomplete picture. There is no shared language or methods common to all the frameworks, and none articulate the philosophical principles on which they are based. Furthermore, they emphasise global-level, technical perspectives, and tend not to consider political issues or variation in state capacity, which can run from strong to absent, as in humanitarian settings. This is limiting, and sometimes becomes problematic. A main limitation is that the frameworks explain only the part of nutrition governance on which they are focused, but do not illuminate the larger landscape. Additionally, the lack of a philosophical basis means that they have difficulty explaining their priorities or defending their boundaries, should the need arise. For instance, the frameworks by Morris et al and Mejía Acosta and Fanzo do not include participation or transparency among their central elements. This choice may reflect that the dominant historical problem in undernutrition is inadequate food, and in this perspective the most basic citizen view can be presumed-the demand for more food. It may also reflect a strong focus on the multilateral architecture of aid, which tends to neglect crucial factors such as domestic political commitment. A full-text search of the Sacks et al framework article does not find a single mention of either 'cooperation' or 'coordination'. It is unlikely that any analyst of governance-including the authors of these fine papers-would say that participation is unimportant, or that transparency is seldom needed, or that coordination is trivial.\", 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Observing the different elements in nutrition governance frameworks raises a dilemma that can be resolved by weighing breadth and depth in either of two directions. In the more inclusive direction, additional elements are added to the framework to increase its explanatory coverage, as with some of the other frameworks covered earlier. In the direction of specificity, the framework must be qualified to particular settings in which the included elements did matter or might matter most. Neither direction is completely satisfying because they trade off universality and specificity without establishing the relationship between the two.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"An obvious division in uses of nutrition governance lies between those concerned with undernutrition and those focused on obesity. The papers reviewed here focused on one or the other, but not both. This division appears to be highly influential on the governance problems that were reported. The authors focusing on undernutrition typically highlighted administrative issues, such as coordination for service delivery, distributional problems and responsiveness or accountability to citizen demand. The authors focusing on obesity typically emphasised political or political economic issues, including the globalisation of the food industry, multinational corporate accountability problems, coordination for regulatory and policy making purposes and the political economy of production and consumption, which includes the contest for public opinion and allows for conflict over food choices. This division suggests that either analysts employ different definitions of governance or refer to 'governance' with reference to specific manifestations rather than underlying principles.\", 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The absence of discussion on these underlying principles creates additional problems, as well. First, these definitions do not prioritise the importance of their elements, meaning it is difficult to know if anything is more important than anything else. Second, the lack of prioritisation disguises the interaction or possible causality between the elements. Third, it is hard to determine what would not qualify as a governance problem, which disguises the difference between issues best approached from this perspective and those that could be addressed BMJ Global Health more easily with another lens. These limitations pose challenges for conceptualising nutrition governance more broadly or attempting to implement solutions.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Although it is not the focus of this paper, I speculate that historical differences between the communities studying undernutrition and obesity account for some of the differences in perspective. The authors writing on undernutrition were more likely to have technical backgrounds in medicine, nutrition sciences, agriculture and related areas. Those focusing on obesity were more likely to have experience with law and the social sciences, and many had previous experience with tobacco control or other areas of globalised trade and health, and tended to draw on scholarship by leading authors in those areas. 15 30 31 110 111 There was little or no overlap in these groups.', 'cite_spans': [{'start': 611, 'end': 613, 'text': '15', 'ref_id': 'BIBREF14'}, {'start': 614, 'end': 627, 'text': '30 31 110 111', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'A unified framework for nutrition governance As the basis for equitably realising the right to food and upholding the right to health, nutrition governance is grounded in universal principles. But as I have discussed above, current articulations of nutrition governance are divided by problem type-undernutrition or obesityand grounded in specific contexts where those problems are found. At one time, undernutrition was the only nutrition problem, and when obesity first emerged as a public health problem it was confined to relatively distinct geographies. This is no longer the case. The nutrition transition 112 and the double burden of undernutrition and obesity mean that single countries are required to deal with both problems. Accordingly, it is for both philosophical and practical considerations that a unified framework for nutrition governance is desirable.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"The starting point for a unified nutrition governance framework is a definition of governance itself. A simple and classic definition of politics was offered by Lasswell in the 1930s as who gets what, when and how, which refers to the underlying definition of politics as a distributive process. 113 I argue that governance can be considered as the structures through which such distributive decisions are made and enforced. This conceptualisation emphasises the structural or formalised elements of the process, which is reflected in common usage of 'governance' in connection with a normative judgement, as in good or strong governance, or bad or weak governance. The conception of something that can be judged this way means there is a standard for doing so, which in this case I define as any of the three dimensions of governance I will propose.\", 'cite_spans': [{'start': 296, 'end': 299, 'text': '113', 'ref_id': 'BIBREF112'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'The basis for my conceptualisation of governance is the social contract that underlies modern nations, as first articulated by Rousseau 114 and Locke 115 in the Enlightenment. This idea holds that citizens cede some powers to the state in exchange for the protection of their remaining rights, and is based on the principle that citizens are the ultimate source of power and the ultimate conveyors of legitimacy. 114 115 I apply the concept of citizens as the source of power and authority to governance and propose that it can be distilled around the primary principles of accountability, participation and responsiveness. Accountability recognises citizens as the source of state power. Participation comes from the recognition that state legitimacy is conditioned on the consent of those governed. Responsiveness refers to the timeliness of the link between what people want, as expressed by participation, and the accountability that may be exercised when needed services are not forthcoming. With particular reference to nutrition, timeliness can be of vital importance, and thus responsiveness is elevated to primary status along with accountability and participation, even though it could be argued that these latter two principles should already reflect responsiveness. Evaluating governance means that each principle should be measured with reference to the authority and legitimacy granted by citizens and their judgements of performance. Stated concisely:', 'cite_spans': [{'start': 127, 'end': 139, 'text': 'Rousseau 114', 'ref_id': None}, {'start': 150, 'end': 153, 'text': '115', 'ref_id': 'BIBREF114'}, {'start': 413, 'end': 420, 'text': '114 115', 'ref_id': None}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Nutrition governance is the ability of institutions and other structures to uphold the principles of participation, responsiveness, and accountability in the realization of the right to food and the achievement of optimal nutrition for all citizens.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'These three primary principles are central to human rights law, appearing prominently in the International Covenant on Economic, Social and Cultural Rights, 116 and beneath them lie many others. As reviewed by Lee et al., for the WHO Commission on Social Determinants of Health, broad conceptions of governance include the three mentioned above and also transparency, a consensus orientation, the rule of law, effectiveness and efficiency and equity and inclusiveness. 15 No doubt there are many more, to be sure. However, I argue that these others are secondary. For instance, I would argue that accountability, participation and responsiveness all require transparency, which for that reason is not a leading independent category. Similarly, I argue that the leading three also depend on equity and the rule of law. A consensus orientation, effectiveness and efficiency and equity and inclusiveness are all factors that citizens would reflect in their participation and their preferences for accountability.', 'cite_spans': [{'start': 157, 'end': 160, 'text': '116', 'ref_id': 'BIBREF115'}, {'start': 469, 'end': 471, 'text': '15', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'With this definition established, it can be used to clarify governance challenges and how they relate to each other. In my view, existing scholarship can be categorised in four areas, as shown below in table 2 as a map of sample nutrition governance problems in undernutrition and obesity at the national and global levels. This exercise reveals how existing frameworks tend to focus on only one square, for example, undernutrition at the global level, as by Morris et al. 53 table 3 further develops this idea by applying the three main pillars of accountability, participation and responsiveness to undernutrition and obesity. Note that this is a characterisation of existing scholarship, and is not inclusive of many important issues that are covered lightly or not at all. Inadequate attention BMJ Global Health has been paid to the interaction of global, national and local levels, or to the differences in capacity and context in strong states, weak stakes, humanitarian disasters or elsewhere, for instance.', 'cite_spans': [{'start': 473, 'end': 475, 'text': '53', 'ref_id': 'BIBREF52'}], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Employing the three categories of accountability, participation and responsiveness facilitates a comparison of undernutrition and obesity problems from a governance perspective. This exercise highlights undernutrition as a problem of dysfunctional structures-mainly people do not get what they want and cannot enforce accountability, although there can be information and education aspects, as well. Aligning services with wants thus addresses the problem, meaning that people who need food then get food. Obesity problems are different-people get too much of what they want, or want unhealthful things (these are also causes of undernutrition-overweight). Because of this, obesity can-and does-occur where governance structures function well. In such cases, a principal challenge lies in the contest for perception and opinion on food and related policies. The formal structural governance problems are subtle because they concern broad political economy issues that are hard to analyse and remain unknown to many people. These include tax policy, agricultural policies, inadequate government authority and regulatory capture and ineffectiveness. Although the beneficiaries of the food industry are engaged, those harmed are not necessarily inclined to think of themselves as harmed or to identify any particular agent as the cause of their problems.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': \"Governance has emerged as an important focus in development programming over the last three decades, and nutrition governance in particular has great potential to improve health. But this analysis finds that although the concept of 'nutrition governance' has become increasingly prominent in scholarship on poor nutritional outcomes, it remains weakly specified and is invoked by different authors to mean different things. An important division of approaches and general meanings exists between those who have focused on undernutrition and those who have concentrated on obesity. Those in the former group have stressed coordination problems and structural issues related to the general functioning of government and the low accountability of international actors. Those in the later group have emphasised international trade policies, regulatory issues and corporate behaviour.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ConClusIon'}, {'text': 'By developing a definition of governance based on the social contract and applying it to nutrition, this paper presents a framework for considering all nutrition problems at the same time. Using the framework to assess undernutrition and obesity finds that its principles apply well in either case, but they indicate different weaknesses. In general, undernutrition problems relate to structural flaws, such as poor or absent accountability, weak or missing participation or inadequate responsiveness. Under the assumption that people do not want to be undernourished, then the problem can be crudely characterised as unmet demand-citizens are not getting a service entitlement they need and want. Some of these issues may also underlie obesity problems, but those scenarios are additionally characterised by more insidious dynamics. Accountability and participation can be strong, but may be corrupted by marketing and other influences on citizen perception. The demands expressed by citizens may be accurately-and harmfully-expressed in unhealthy foods, habits and environments. This shifts the intervention area from governance structures per se to the inputs-the things that citizens want-and can be characterised as a contest for perceptions about good choices in food, food policy and related issues of regulation, tax and trade.', 'cite_spans': [], 'ref_spans': [], 'section': 'ConClusIon'}, {'text': \"The vast prevalence of obesity and undernutrition shows that governments, international agencies and other actors have failed to uphold the right to food and optimal nutrition for most of the world's citizens. This is among the leading embarrassments to all humanity, and is of such widespread consequence that delay in remedial action cannot be justified. The clarification of the three basic governance principles of accountability, participation and responsiveness provides categories for assessing government performance and aid programmes alike. Advancing the state-citizen contract is central to all areas of development, and hence the imperative to assess how aid affects governance applies to every donor-supported project. Projects that bypass or weaken the social contract have been common in the past, but should never be accepted. These ideas may be particularly useful to civil society groups and academic organisations that monitor development assistance efforts and seek to compel governments to uphold the right to food. \", 'cite_spans': [], 'ref_spans': [], 'section': 'ConClusIon'}, {'text': 'For global level institutions, the implications of this analysis lie in two areas. For undernutrition problems, interventions to strengthen the connection between states and their citizens and mechanisms to allow states to hold international actors accountable would help address many major weaknesses. In turn, this would help states and international actors better promote participation and become more responsive. This task is urgent. Undernutrition tends to affect the most vulnerable and is prioritised in the Sustainable Development Goals for that reason. With particular reference to obesity, many of the governance problems identified by this paper have international dimensions that constrain national policy solutions. Globalisation is increasing the importance of this dynamic and points to an urgent need for supranational regulation of the food industry and concerted efforts to contest the perceptions it advances through marketing. No country has yet succeeded in turning the still-rising tide of obesity, regardless of the strength of its governance or the size of its income, further indicating the need for coordinated global action.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}, {'text': 'Acknowledgements I gratefully acknowledge helpful comments from Prerna Banati, Yarlini Balarajan, Carmen Jacqueline Ho, and the anonymous reviewers. All errors remain my own.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Contributors I am the sole author of this work and am responsible for its content.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Funding UNICEF Office of Research-Innocenti.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Competing interests None declared.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Patient consent Not required.', 'cite_spans': [], 'ref_spans': [], 'section': 'Twitter @jessebump'}, {'text': 'Provenance and peer review Not commissioned; externally peer reviewed. open access This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is Table 3 Comparison of governance areas for undernutrition and obesity at global and national levels', 'cite_spans': [], 'ref_spans': [{'start': 391, 'end': 398, 'text': 'Table 3', 'ref_id': None}], 'section': 'Twitter @jessebump'}, {'text': 'Accountability Global: multilaterals, bilaterals, NGOs and others that have a legal or adopted nutrition mandate are not punished or rewarded for their individual or collective performance. Persistent coordination problems result. Also, accountability for food production or crop diversion hard to establish.', 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': 'Global: accountability is very weak for transnational corporate activities and foreign government policies related to food, such as in subsidy, tax and trade. Largely, accountability mechanisms are absent.', 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': 'National: engagement of many sectors creates coordination problems and clouds accountabilities. Government tends to be least accountable to the marginalised people most vulnerable to undernutrition, indicating the need for improved state performance overall.', 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': \"National: accountabilities for unhealthy foods and deceptive marketing are difficult to establish precisely, and citizens' demand for accountability is often influenced in favour of private interests and against health professionals.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Governance area Undernutrition Obesity'}, {'text': 'Global: in theory, national representation in the UN system assures the channel of participation by citizens, but this is highly problematic in many cases, including weak or failed states, or for marginalised or excluded groups, such as migrants, refugees or the vulnerable. Areas of low participation are at greatest risk of undernutrition.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'Global: national representation in global affairs is predominantly in non-health areas and is often linked to corporate interests. This calls for supranational regulatory mechanisms to allow more participation, or the channels for other states and citizens to influence national government positions.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'National: participation by citizens is weak in many cases. People who need nutrition interventions may not be aware, and even if they are, cannot always express their demand effectively. Typically, this need is not visible or meaningful to the state, not reflected in programmes of services, and weak participation means it does not connect to democratic or judicial accountability mechanisms.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'National: participation is often strong-because citizens exercise electoral and economic power in support of corporate interests, and food products and consumption patterns that are unhealthful. The participation problem is not the ability to influence, but the contest for perception about foods, food companies and regulation.', 'cite_spans': [], 'ref_spans': [], 'section': 'Participation'}, {'text': 'Global: multilaterals, bilaterals, NGOs and others operating in nutrition do not respond to the demands and needs of those they ostensibly serve. This is underpinned by low participation and missing or absent accountability mechanisms.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'Global: extremely limited accountability mechanisms mean that there is no easily identified authority to respond specifically to obesity-related issues.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'National: those most likely to suffer undernutrition are typically not able to organise or participate, making it difficult for even well-intentioned states to identify and respond.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'National: government responses may be more immediate to well-organised corporate demands; responsiveness to citizens often concentrated around infrequent elections. Citizens may favour unhealthy policies, as well.', 'cite_spans': [], 'ref_spans': [], 'section': 'Responsiveness'}, {'text': 'properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http:// creativecommons. org/ licenses/ by-nc/ 4. 0/.', 'cite_spans': [], 'ref_spans': [], 'section': 'BMJ Global Health'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'UN Special Rapporteur on the right to food', 'authors': [{'first': 'De', 'middle': [], 'last': 'Schutter', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2014, 'venue': 'Report on agroecology and the right to food', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'General Comment No. 12: The right to adequate food', 'authors': [{'first': '', 'middle': [], 'last': 'Un Cescr', 'suffix': ''}], 'year': 1999, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Population, development and food security: an unresolved challenge for the twenty-first century', 'authors': [{'first': 'M', 'middle': [], 'last': 'Villarreal', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Stloukal', 'suffix': ''}], 'year': 2005, 'venue': 'Genus', 'volume': '61', 'issn': '', 'pages': '215--261', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The right to food: Holding global actors accountable under international law', 'authors': [{'first': 'S', 'middle': [], 'last': 'Narula', 'suffix': ''}], 'year': 2005, 'venue': \"Colum J Transnat'l L\", 'volume': '44', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': \"Assessing countries' commitment to accelerate nutrition action demonstrated in PRSPs, UNDAFs and through nutrition governance. SCN news / United Nations\", 'authors': [{'first': 'K', 'middle': [], 'last': 'Engesveen', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Nishida', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Prudhon', 'suffix': ''}], 'year': 2009, 'venue': 'Administrative Committee on Coordination, Subcommittee on Nutrition', 'volume': '37', 'issn': '', 'pages': '10--16', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study', 'authors': [{'first': 'M', 'middle': [], 'last': 'Ng', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Fleming', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Robinson', 'suffix': ''}], 'year': 2013, 'venue': 'The Lancet', 'volume': '384', 'issn': '', 'pages': '766--81', 'other_ids': {'DOI': ['10.1016/S0140-6736(14)60460-8']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Uneven dietary development: linking the policies and processes of globalization with the nutrition transition, obesity and diet-related chronic diseases', 'authors': [{'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}], 'year': 2006, 'venue': 'Global Health', 'volume': '2', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1744-8603-2-4']}}, 'BIBREF7': {'ref_id': 'b7', 'title': \"Strong nutrition governance is a key to addressing nutrition transition in low and middle-income countries: review of countries' nutrition policies\", 'authors': [{'first': 'B', 'middle': ['F'], 'last': 'Sunguya', 'suffix': ''}, {'first': 'Kic', 'middle': [], 'last': 'Ong', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Dhakal', 'suffix': ''}], 'year': 2014, 'venue': 'Nutr J', 'volume': '13', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1475-2891-13-65']}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Displacement in urban areas: new challenges, new partnerships', 'authors': [{'first': 'J', 'middle': [], 'last': 'Crisp', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Morris', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Refstie', 'suffix': ''}], 'year': 2012, 'venue': 'Disasters', 'volume': '36', 'issn': '', 'pages': '23--42', 'other_ids': {'DOI': ['10.1111/j.1467-7717.2012.01284.x']}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Off the map: the health and social implications of being a non-notified slum in India', 'authors': [{'first': 'R', 'middle': [], 'last': 'Subbaraman', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'O&apos;brien', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Shitole', 'suffix': ''}], 'year': 2012, 'venue': 'Environ Urban', 'volume': '24', 'issn': '', 'pages': '643--63', 'other_ids': {'DOI': ['10.1177/0956247812456356']}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Invisibility and the Welfare State in the Developing World. Hasmath R, ed. Inclusive Growth, Development and Welfare Policy: A Critical Assessment', 'authors': [{'first': 'W', 'middle': ['J'], 'last': 'Poverty', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '211--239', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Public opinion and the politics of obesity in America', 'authors': [{'first': 'J', 'middle': ['E'], 'last': 'Oliver', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 2005, 'venue': 'J Health Polit Policy Law', 'volume': '30', 'issn': '', 'pages': '923--54', 'other_ids': {'DOI': ['10.1215/03616878-30-5-923']}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'The Perils of Ignoring History: Big Tobacco Played Dirty and Millions Died. How Similar Is Big Food?', 'authors': [{'first': 'K', 'middle': ['D'], 'last': 'Brownell', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Warner', 'suffix': ''}], 'year': 2009, 'venue': 'Milbank Quarterly', 'volume': '87', 'issn': '', 'pages': '259--94', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Coca-Cola Funds Scientists Who Shift Blame for Obesity Away From Bad Diets', 'authors': [{'first': 'A', 'middle': [], 'last': 'O&apos;connor', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Globalization, Global Governance and the Social Determinants of Health: A review of the linkages and agenda for action. Ottowa: Globalization and Health Knowledge Network', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Koivusalo', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Ollila', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Food security and nutrition interventions in response to the AIDS epidemic: assessing global action and evidence', 'authors': [{'first': 'N', 'middle': ['L'], 'last': 'Aberman', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Rawat', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Drimie', 'suffix': ''}], 'year': 2014, 'venue': 'AIDS Behav', 'volume': '18', 'issn': '5', 'pages': '554--65', 'other_ids': {'DOI': ['10.1007/s10461-014-0822-z']}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Nutritional contribution of street foods to the diet of people in developing countries: a systematic review', 'authors': [{'first': 'N', 'middle': ['P'], 'last': 'Steyn', 'suffix': ''}, {'first': 'Z', 'middle': [], 'last': 'Mchiza', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Hill', 'suffix': ''}], 'year': 2014, 'venue': 'Public Health Nutr', 'volume': '17', 'issn': '', 'pages': '1363--74', 'other_ids': {'DOI': ['10.1017/S1368980013001158']}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Health and welfare effects of integrating AIDS treatment with food assistance in resource constrained settings: A systematic review of theory and evidence', 'authors': [{'first': 'N', 'middle': [], 'last': 'Tirivayi', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Groot', 'suffix': ''}], 'year': 2011, 'venue': 'Soc Sci Med', 'volume': '73', 'issn': '', 'pages': '685--92', 'other_ids': {'DOI': ['10.1016/j.socscimed.2011.06.056']}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Clinic-Based Food Assistance is Associated with Increased Medication Adherence among HIV-Infected Adults on Long-Term Antiretroviral Therapy in Zambia', 'authors': [{'first': 'N', 'middle': [], 'last': 'Tirivayi', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Koethe', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Groot', 'suffix': ''}], 'year': 2012, 'venue': 'J AIDS Clin Res', 'volume': '03', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.4172/2155-6113.1000171']}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'The right to food in the post-Cold War era', 'authors': [{'first': 'T', 'middle': ['J'], 'last': 'Marchione', 'suffix': ''}], 'year': 1996, 'venue': 'Food Policy', 'volume': '21', 'issn': '', 'pages': '83--102', 'other_ids': {'DOI': ['10.1016/0306-9192(95)00070-4']}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Bilateral health aid: lessons from Europe', 'authors': [{'first': 'P', 'middle': ['S'], 'last': 'Hill', 'suffix': ''}], 'year': 2000, 'venue': 'Aust N Z J Public Health', 'volume': '24', 'issn': '', 'pages': '432--438', 'other_ids': {'DOI': ['10.1111/j.1467-842X.2000.tb01607.x']}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Development and governance: an uneasy relationship', 'authors': [{'first': 'W', 'middle': [], 'last': 'Hout', 'suffix': ''}], 'year': 2009, 'venue': 'Governance and the Depoliticisation of Development. London: Routledge', 'volume': '', 'issn': '', 'pages': '29--43', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Public-Private Partnerships for Combating Micronutrient Malnutrition', 'authors': [{'first': 'M', 'middle': [], 'last': 'Chopra', 'suffix': ''}], 'year': 2001, 'venue': 'Food Nutr Bull', 'volume': '22', 'issn': '', 'pages': '431--436', 'other_ids': {'DOI': ['10.1177/156482650102200416']}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Governing Health Systems', 'authors': [{'first': 'M', 'middle': [], 'last': 'Reich', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Takemi', 'suffix': ''}], 'year': 2013, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Governance for global and national health: a role for framework conventions?', 'authors': [{'first': 'T', 'middle': ['G'], 'last': 'Evans', 'suffix': ''}], 'year': 2013, 'venue': 'Health Hum Rights', 'volume': '15', 'issn': '', 'pages': '5--7', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Interactions with the recipient community in targeted food and nutrition programs', 'authors': [{'first': 'T', 'middle': ['J'], 'last': 'Marchione', 'suffix': ''}], 'year': 2005, 'venue': 'J Nutr', 'volume': '135', 'issn': '', 'pages': '886--895', 'other_ids': {'DOI': ['10.1093/jn/135.4.886']}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Proceedings of the fourth international congress on tropical medicine and malaria', 'authors': [{'first': 'O', 'middle': [], 'last': 'Address', 'suffix': ''}], 'year': 1948, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Spaces for change?: the politics of citizen participation in new democratic arenas: Zed Books', 'authors': [{'first': 'A', 'middle': [], 'last': 'Cornwall', 'suffix': ''}, {'first': 'V', 'middle': ['S'], 'last': 'Coelho', 'suffix': ''}], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Grand challenges in global health governance', 'authors': [{'first': 'L', 'middle': ['O'], 'last': 'Gostin', 'suffix': ''}, {'first': 'E', 'middle': ['A'], 'last': 'Mok', 'suffix': ''}], 'year': 2009, 'venue': 'Br Med Bull', 'volume': '90', 'issn': '', 'pages': '7--18', 'other_ids': {'DOI': ['10.1093/bmb/ldp014']}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'The Pit and the Pendulum: Can globalization take health governance forward?', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 2004, 'venue': 'Development', 'volume': '47', 'issn': '', 'pages': '11--17', 'other_ids': {'DOI': ['10.1057/palgrave.development.1100025']}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Bridging the divide: global governance of trade and health', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Sridhar', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Patel', 'suffix': ''}], 'year': 2009, 'venue': 'Lancet', 'volume': '373', 'issn': '', 'pages': '416--438', 'other_ids': {'DOI': ['10.1016/S0140-6736(08)61776-6']}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'The new International Health Regulations: an historic development for international law and public health', 'authors': [{'first': 'D', 'middle': ['P'], 'last': 'Fidler', 'suffix': ''}, {'first': 'L', 'middle': ['O'], 'last': 'Gostin', 'suffix': ''}], 'year': 2006, 'venue': 'J Law Med Ethics', 'volume': '34', 'issn': '', 'pages': '85--94', 'other_ids': {'DOI': ['10.1111/j.1748-720X.2006.00011.x']}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'The race for Ebola drugs: pharmaceuticals, security and global health governance', 'authors': [{'first': 'A', 'middle': [], 'last': 'Roemer-Mahler', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Elbe', 'suffix': ''}], 'year': 2016, 'venue': 'Third World Q', 'volume': '37', 'issn': '', 'pages': '487--506', 'other_ids': {'DOI': ['10.1080/01436597.2015.1111136']}}, 'BIBREF33': {'ref_id': 'b33', 'title': 'Ebola: a crisis in global health leadership', 'authors': [{'first': 'L', 'middle': ['O'], 'last': 'Gostin', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Friedman', 'suffix': ''}], 'year': 2014, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF34': {'ref_id': 'b34', 'title': 'Non-communicable diseases and global health governance: enhancing global processes to improve health development', 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Magnusson', 'suffix': ''}], 'year': 2007, 'venue': 'Global Health', 'volume': '3', 'issn': '2', 'pages': '', 'other_ids': {'DOI': ['10.1186/1744-8603-3-2']}}, 'BIBREF35': {'ref_id': 'b35', 'title': 'Governance matters VIII: aggregate and individual governance indicators', 'authors': [{'first': 'D', 'middle': [], 'last': 'Kaufmann', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kraay', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Mastruzzi', 'suffix': ''}], 'year': 1996, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF36': {'ref_id': 'b36', 'title': \"Portfolio Review Summary: Summary Review of DFID's Governance Portfolio\", 'authors': [{'first': '', 'middle': [], 'last': 'Dfid', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Governance', 'suffix': ''}], 'year': 2004, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF37': {'ref_id': 'b37', 'title': 'The world health report 2007: A safer future: global public health security in the 21st century', 'authors': [], 'year': 2007, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF38': {'ref_id': 'b38', 'title': 'Joint Evaluation of the REACH Initiative (Renewed Effort Against Child Hunger and Undernutrition', 'authors': [], 'year': 2011, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF39': {'ref_id': 'b39', 'title': 'Diet, health and globalization: five key questions', 'authors': [{'first': 'T', 'middle': [], 'last': 'Lang', 'suffix': ''}], 'year': 1999, 'venue': 'Proc Nutr Soc', 'volume': '58', 'issn': '', 'pages': '335--378', 'other_ids': {'DOI': ['10.1017/S0029665199000452']}}, 'BIBREF40': {'ref_id': 'b40', 'title': 'A global response to a global problem: the epidemic of overnutrition', 'authors': [{'first': 'M', 'middle': [], 'last': 'Chopra', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Galbraith', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Darnton-Hill', 'suffix': ''}], 'year': 2002, 'venue': 'Bull World Health Organ', 'volume': '80', 'issn': '', 'pages': '952--960', 'other_ids': {}}, 'BIBREF41': {'ref_id': 'b41', 'title': 'Trade liberalization and the diet transition: a public health response', 'authors': [{'first': 'G', 'middle': [], 'last': 'Rayner', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Lang', 'suffix': ''}], 'year': 2006, 'venue': 'Health Promot Int', 'volume': '21', 'issn': 'suppl_1', 'pages': '67--74', 'other_ids': {'DOI': ['10.1093/heapro/dal053']}}, 'BIBREF42': {'ref_id': 'b42', 'title': \"Rethinking global health challenges: towards a 'global compact' for reducing the burden of chronic disease\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Magnusson', 'suffix': ''}], 'year': 2009, 'venue': 'Public Health', 'volume': '123', 'issn': '', 'pages': '265--74', 'other_ids': {'DOI': ['10.1016/j.puhe.2008.12.023']}}, 'BIBREF43': {'ref_id': 'b43', 'title': 'The role of business in addressing the long-term implications of the current food crisis', 'authors': [{'first': 'D', 'middle': [], 'last': 'Yach', 'suffix': ''}], 'year': 2008, 'venue': 'Global Health', 'volume': '4', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1744-8603-4-12']}}, 'BIBREF44': {'ref_id': 'b44', 'title': 'Anatomy of a crisis: the causes and consequences of surging food prices', 'authors': [{'first': 'D', 'middle': [], 'last': 'Headey', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Fan', 'suffix': ''}], 'year': 2008, 'venue': 'Agricultural Economics', 'volume': '39', 'issn': '', 'pages': '375--91', 'other_ids': {'DOI': ['10.1111/j.1574-0862.2008.00345.x']}}, 'BIBREF45': {'ref_id': 'b45', 'title': 'Rethinking the global food crisis: The role of trade shocks', 'authors': [{'first': 'D', 'middle': [], 'last': 'Headey', 'suffix': ''}], 'year': 2011, 'venue': 'Food Policy', 'volume': '36', 'issn': '', 'pages': '136--182', 'other_ids': {'DOI': ['10.1016/j.foodpol.2010.10.003']}}, 'BIBREF47': {'ref_id': 'b47', 'title': 'Understanding and responding to the links between conflict and hunger', 'authors': [{'first': 'E', 'middle': [], 'last': 'Messer', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Cohen', 'suffix': ''}], 'year': 2011, 'venue': 'Dev Pract', 'volume': '21', 'issn': '', 'pages': '481--488', 'other_ids': {'DOI': ['10.1080/09614524.2011.562281']}}, 'BIBREF48': {'ref_id': 'b48', 'title': 'Price Volatility in Food and Agricultural Markets: Policy Responses', 'authors': [{'first': 'I', 'middle': [], 'last': 'Fao', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Unctad', 'suffix': ''}], 'year': 2011, 'venue': 'Food and Agricultural Organization', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF49': {'ref_id': 'b49', 'title': 'The 2008 food price crisis: rethinking food security policies: UN', 'authors': [{'first': 'A', 'middle': [], 'last': 'Mittal', 'suffix': ''}], 'year': 2009, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF50': {'ref_id': 'b50', 'title': 'High food prices: the what, who, and how of proposed policy actions', 'authors': [{'first': 'Von', 'middle': [], 'last': 'Braun', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}, {'first': 'Ahmed', 'middle': ['A'], 'last': 'Asenso-Okyere', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF51': {'ref_id': 'b51', 'title': 'Closing the gap in a generation: Health equity through action on the social determinants of health', 'authors': [], 'year': 2008, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF52': {'ref_id': 'b52', 'title': 'Maternal and Child Undernutrition Study Group. Effective international action against undernutrition: why has it proven so difficult and what can be done to accelerate progress?', 'authors': [{'first': 'S', 'middle': ['S'], 'last': 'Morris', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Cogill', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Uauy', 'suffix': ''}], 'year': 2008, 'venue': 'Lancet', 'volume': '371', 'issn': '', 'pages': '608--629', 'other_ids': {'DOI': ['10.1016/S0140-6736(07)61695-X']}}, 'BIBREF53': {'ref_id': 'b53', 'title': 'The history of the SUN Movement: Scaling Up Nutrition', 'authors': [], 'year': 2018, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF54': {'ref_id': 'b54', 'title': 'Nutrition Landscape Information System (NLIS) country profile indicators: interpretation guide. Geneva: WHO, 2012. 56. REACH. REACH Country Facilitator Manual', 'authors': [], 'year': 2013, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF55': {'ref_id': 'b55', 'title': 'Conflicts of interest and global health and nutrition governance: The illusion of robust principles', 'authors': [{'first': 'J', 'middle': [], 'last': 'Richter', 'suffix': ''}], 'year': 2015, 'venue': 'BMJ', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF56': {'ref_id': 'b56', 'title': \"Activists: Don't join SUN, a nutrition drive\", 'authors': [{'first': 'India', 'middle': [], 'last': 'Times Of', 'suffix': ''}], 'year': 2017, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF57': {'ref_id': 'b57', 'title': 'Nutrition and sustainability: an emerging food policy discourse', 'authors': [{'first': 'T', 'middle': [], 'last': 'Lang', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Barling', 'suffix': ''}], 'year': 2013, 'venue': 'Proc Nutr Soc', 'volume': '72', 'issn': '', 'pages': '1--12', 'other_ids': {'DOI': ['10.1017/S002966511200290X']}}, 'BIBREF58': {'ref_id': 'b58', 'title': 'Nutrition: the new world disorder', 'authors': [{'first': 'G', 'middle': [], 'last': 'Cannon', 'suffix': ''}], 'year': 2002, 'venue': 'Asia Pac J Clin Nutr', 'volume': '11', 'issn': 's3', 'pages': '498--509', 'other_ids': {'DOI': ['10.1046/j.1440-6047.11.supp3.5.x']}}, 'BIBREF59': {'ref_id': 'b59', 'title': 'Feeding the world in the coming decades requires improvements in investment, technology and institutions', 'authors': [{'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Martorell', 'suffix': ''}], 'year': 2002, 'venue': 'J Nutr', 'volume': '132', 'issn': '', 'pages': '3435--3441', 'other_ids': {'DOI': ['10.1093/jn/132.11.3435S']}}, 'BIBREF60': {'ref_id': 'b60', 'title': 'Primary health care: making Alma-Ata a reality', 'authors': [{'first': 'J', 'middle': [], 'last': 'Walley', 'suffix': ''}, {'first': 'J', 'middle': ['E'], 'last': 'Lawn', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Tinker', 'suffix': ''}], 'year': 2008, 'venue': 'Lancet', 'volume': '372', 'issn': '', 'pages': '1001--1008', 'other_ids': {'DOI': ['10.1016/S0140-6736(08)61409-9']}}, 'BIBREF61': {'ref_id': 'b61', 'title': 'Ethical consequences for professionals from the globalization of food, nutrition and health', 'authors': [{'first': 'N', 'middle': ['W'], 'last': 'Solomons', 'suffix': ''}], 'year': 2002, 'venue': 'Asia Pac J Clin Nutr', 'volume': '11', 'issn': 's3', 'pages': '653--65', 'other_ids': {'DOI': ['10.1046/j.1440-6047.11.supp3.14.x']}}, 'BIBREF62': {'ref_id': 'b62', 'title': 'Three decades of the WHO code and marketing of infant formulas', 'authors': [{'first': 'S', 'middle': [], 'last': 'Forsyth', 'suffix': ''}], 'year': 2012, 'venue': 'Curr Opin Clin Nutr Metab Care', 'volume': '15', 'issn': '', 'pages': '273--280', 'other_ids': {'DOI': ['10.1097/MCO.0b013e32835204ad']}}, 'BIBREF63': {'ref_id': 'b63', 'title': 'Non-compliance with the International Code of Marketing of Breast Milk Substitutes is not confined to the infant formula industry', 'authors': [{'first': 'S', 'middle': [], 'last': 'Forsyth', 'suffix': ''}], 'year': 2013, 'venue': 'J Public Health', 'volume': '35', 'issn': '', 'pages': '185--90', 'other_ids': {'DOI': ['10.1093/pubmed/fds084']}}, 'BIBREF64': {'ref_id': 'b64', 'title': 'We are forgotten on earth\": international development targets, poverty, and gender in Ethiopia', 'authors': [{'first': 'Von', 'middle': [], 'last': 'Massow', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2000, 'venue': 'Gend Dev', 'volume': '8', 'issn': '', 'pages': '45--54', 'other_ids': {'DOI': ['10.1080/741923410']}}, 'BIBREF65': {'ref_id': 'b65', 'title': 'Nutrition getting the attention it deserves?', 'authors': [{'first': '', 'middle': [], 'last': 'Irin', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF66': {'ref_id': 'b66', 'title': 'GAIN gains NGO status from WHO after it severs big business ties (or does it?): NutraIngredients', 'authors': [{'first': 'S', 'middle': [], 'last': 'Starling', 'suffix': ''}], 'year': 2014, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF67': {'ref_id': 'b67', 'title': 'Role of government in public health: Current scenario in India and future scope', 'authors': [{'first': 'S', 'middle': [], 'last': 'Lakshminarayanan', 'suffix': ''}], 'year': 2011, 'venue': 'J Family Community Med', 'volume': '18', 'issn': '', 'pages': '26--30', 'other_ids': {'DOI': ['10.4103/1319-1683.78635']}}, 'BIBREF68': {'ref_id': 'b68', 'title': 'Flaws in Child Nutrition and Health Governance', 'authors': [{'first': 'A', 'middle': [], 'last': 'Gupta', 'suffix': ''}, {'first': 'N', 'middle': ['S'], 'last': 'Khaira', 'suffix': ''}], 'year': 2008, 'venue': 'Economic and Political Weekly', 'volume': '43', 'issn': '', 'pages': '17--21', 'other_ids': {}}, 'BIBREF69': {'ref_id': 'b69', 'title': 'Why India needs a national nutrition strategy', 'authors': [{'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}], 'year': 2011, 'venue': 'BMJ', 'volume': '343', 'issn': '', 'pages': '6687--6731', 'other_ids': {'DOI': ['10.1136/bmj.d6687']}}, 'BIBREF70': {'ref_id': 'b70', 'title': 'Health system challenges in organizing quality diabetes care for urban poor in South India', 'authors': [{'first': 'U', 'middle': [], 'last': 'Bhojani', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Devedasan', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Mishra', 'suffix': ''}], 'year': 2014, 'venue': 'PLoS One', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.pone.0106522']}}, 'BIBREF71': {'ref_id': 'b71', 'title': \"Pakistan's maternal and child health policy: analysis, lessons and the way forward\", 'authors': [{'first': 'S', 'middle': [], 'last': 'Siddiqi', 'suffix': ''}, {'first': 'I', 'middle': ['U'], 'last': 'Haq', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Ghaffar', 'suffix': ''}], 'year': 2004, 'venue': 'Health Policy', 'volume': '69', 'issn': '', 'pages': '117--147', 'other_ids': {'DOI': ['10.1016/j.healthpol.2003.12.007']}}, 'BIBREF72': {'ref_id': 'b72', 'title': 'Food security and marine capture fisheries: characteristics, trends, drivers and future perspectives', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Garcia', 'suffix': ''}, {'first': 'A', 'middle': ['A'], 'last': 'Rosenberg', 'suffix': ''}], 'year': 2010, 'venue': 'Philos Trans R Soc Lond B Biol Sci', 'volume': '365', 'issn': '', 'pages': '2869--80', 'other_ids': {'DOI': ['10.1098/rstb.2010.0171']}}, 'BIBREF73': {'ref_id': 'b73', 'title': 'Getting food policy on the Mayoral table: a comparison of two election cycles in New York and London', 'authors': [{'first': 'N', 'middle': [], 'last': 'Freudenberg', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Atkinson', 'suffix': ''}], 'year': 2015, 'venue': 'Public Health', 'volume': '129', 'issn': '', 'pages': '295--302', 'other_ids': {'DOI': ['10.1016/j.puhe.2015.02.018']}}, 'BIBREF74': {'ref_id': 'b74', 'title': 'The politics of success in the fight against malnutrition in Peru', 'authors': [{'first': 'Mejía', 'middle': [], 'last': 'Acosta', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2014, 'venue': 'Food Policy', 'volume': '44', 'issn': '', 'pages': '26--35', 'other_ids': {'DOI': ['10.1016/j.foodpol.2013.10.009']}}, 'BIBREF75': {'ref_id': 'b75', 'title': 'Brazilian obesity prevention and control initiatives', 'authors': [{'first': 'P', 'middle': ['C'], 'last': 'Jaime', 'suffix': ''}, {'first': 'Acf', 'middle': [], 'last': 'Da Silva', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Gentil', 'suffix': ''}], 'year': 2013, 'venue': 'Obesity Reviews', 'volume': '14', 'issn': '2', 'pages': '88--95', 'other_ids': {'DOI': ['10.1111/obr.12101']}}, 'BIBREF76': {'ref_id': 'b76', 'title': 'Role of innovative institutional structures in integrated governance. A case study of integrating health and nutrition programs in Chhattisgarh', 'authors': [{'first': 'A', 'middle': [], 'last': 'Kalita', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Mondal', 'suffix': ''}], 'year': 2012, 'venue': 'India. J Health Organ Manag', 'volume': '26', 'issn': '', 'pages': '758--77', 'other_ids': {'DOI': ['10.1108/14777261211277005']}}, 'BIBREF77': {'ref_id': 'b77', 'title': 'Perspectives for integration into the local health system of community-based management of acute malnutrition in children under 5 years: a qualitative study in Bangladesh', 'authors': [{'first': 'C', 'middle': ['E'], 'last': 'Kouam', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Delisle', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Ebbing', 'suffix': ''}], 'year': 2014, 'venue': 'Nutr J', 'volume': '13', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1475-2891-13-22']}}, 'BIBREF78': {'ref_id': 'b78', 'title': 'Scaling up nutrition in fragile and conflict-affected states: The pivotal role of governance', 'authors': [{'first': 'Saj', 'middle': [], 'last': 'Taylor', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Perez-Ferrer', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Griffiths', 'suffix': ''}], 'year': 2015, 'venue': 'Soc Sci Med', 'volume': '126', 'issn': '', 'pages': '119--146', 'other_ids': {'DOI': ['10.1016/j.socscimed.2014.12.016']}}, 'BIBREF79': {'ref_id': 'b79', 'title': 'Tackling the drivers of child undernutrition in developing countries: what works and how should interventions be designed?', 'authors': [{'first': 'P', 'middle': [], 'last': 'Pridmore', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Carr-Hill', 'suffix': ''}], 'year': 2011, 'venue': 'Public Health Nutr', 'volume': '14', 'issn': '', 'pages': '688--93', 'other_ids': {'DOI': ['10.1017/S1368980010001795']}}, 'BIBREF80': {'ref_id': 'b80', 'title': 'Drinking water quality governance: A comparative case study of Brazil, Ecuador, and Malawi', 'authors': [{'first': 'G', 'middle': ['L'], 'last': 'Kayser', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Amjad', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Dalcanale', 'suffix': ''}], 'year': 2015, 'venue': 'Environ Sci Policy', 'volume': '48', 'issn': '', 'pages': '186--95', 'other_ids': {'DOI': ['10.1016/j.envsci.2014.12.019']}}, 'BIBREF81': {'ref_id': 'b81', 'title': 'Utilisation of wartime nutrition survival experiences', 'authors': [{'first': 'T', 'middle': [], 'last': 'Giay', 'suffix': ''}], 'year': 1998, 'venue': 'Asia Pacific journal of clinical nutrition', 'volume': '7', 'issn': '', 'pages': '311--314', 'other_ids': {}}, 'BIBREF82': {'ref_id': 'b82', 'title': 'Lessons from collaborative governance and sociobiology theories for reinforcing sustained cooperation: a government food security case study', 'authors': [{'first': 'L', 'middle': ['A'], 'last': 'Montoya', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Montoya', 'suffix': ''}, {'first': 'Sánchez', 'middle': [], 'last': 'González', 'suffix': ''}, {'first': 'O', 'middle': ['D'], 'last': '', 'suffix': ''}], 'year': 2015, 'venue': 'Public Health', 'volume': '129', 'issn': '', 'pages': '916--947', 'other_ids': {'DOI': ['10.1016/j.puhe.2015.01.030']}}, 'BIBREF83': {'ref_id': 'b83', 'title': \"A stakeholder analysis of the perceived outcomes of developing and implementing England's obesity strategy\", 'authors': [{'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}, {'first': 'A', 'middle': ['L'], 'last': 'Ahern', 'suffix': ''}, {'first': 'S', 'middle': ['A'], 'last': 'Jebb', 'suffix': ''}], 'year': 2008, 'venue': 'BMC Public Health', 'volume': '14', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1471-2458-14-441']}}, 'BIBREF84': {'ref_id': 'b84', 'title': 'Community-based interventions for obesity prevention: lessons learned by Australian policy-makers', 'authors': [{'first': 'M', 'middle': ['M'], 'last': 'Haby', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Doherty', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Welch', 'suffix': ''}], 'year': 2012, 'venue': 'BMC Res Notes', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1756-0500-5-20']}}, 'BIBREF85': {'ref_id': 'b85', 'title': 'Good governance for nutrition in the Philippines: elements, experiences, and lessons learned', 'authors': [{'first': 'F', 'middle': ['S'], 'last': 'Solon', 'suffix': ''}], 'year': 2006, 'venue': 'Food Nutr Bull', 'volume': '27', 'issn': '', 'pages': '343--52', 'other_ids': {'DOI': ['10.1177/156482650602700409']}}, 'BIBREF86': {'ref_id': 'b86', 'title': 'Précis of nutrition of children and women in Haiti: analyses of data from', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Ayoya', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Heidkamp', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Ngnie-Teta', 'suffix': ''}], 'year': 1995, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF88': {'ref_id': 'b88', 'title': 'Governing childhood obesity: framing regulation of fast food advertising in the Australian print media', 'authors': [{'first': 'J', 'middle': [], 'last': 'Henderson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Coveney', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Ward', 'suffix': ''}], 'year': 2009, 'venue': 'Soc Sci Med', 'volume': '69', 'issn': '', 'pages': '1402--1410', 'other_ids': {'DOI': ['10.1016/j.socscimed.2009.08.025']}}, 'BIBREF89': {'ref_id': 'b89', 'title': 'Farmers are the most trusted part of the Australian food chain: results from a national survey of consumers', 'authors': [{'first': 'J', 'middle': [], 'last': 'Henderson', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Coveney', 'suffix': ''}, {'first': 'P', 'middle': ['R'], 'last': 'Ward', 'suffix': ''}], 'year': 2011, 'venue': 'Aust N Z J Public Health', 'volume': '35', 'issn': '', 'pages': '319--343', 'other_ids': {'DOI': ['10.1111/j.1753-6405.2011.00725.x']}}, 'BIBREF90': {'ref_id': 'b90', 'title': 'The Danish tax on saturated fat: why it did not survive', 'authors': [{'first': 'S', 'middle': [], 'last': 'Vallgårda', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Holm', 'suffix': ''}, {'first': 'J', 'middle': ['D'], 'last': 'Jensen', 'suffix': ''}], 'year': 2015, 'venue': 'Eur J Clin Nutr', 'volume': '69', 'issn': '', 'pages': '223--229', 'other_ids': {'DOI': ['10.1038/ejcn.2014.224']}}, 'BIBREF91': {'ref_id': 'b91', 'title': 'A systematic review of health system barriers and enablers for antiretroviral therapy (ART) for HIV-infected pregnant and postpartum women', 'authors': [{'first': 'C', 'middle': ['J'], 'last': 'Colvin', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Konopka', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Chalker', 'suffix': ''}], 'year': 2014, 'venue': 'PLoS One', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.pone.0108150']}}, 'BIBREF92': {'ref_id': 'b92', 'title': 'The role of health systems and policy in producing behavior and social change to enhance child survival and development in low-and middle-income countries: an examination of the evidence', 'authors': [{'first': 'L', 'middle': ['F'], 'last': 'Vélez', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Sanitato', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Barry', 'suffix': ''}], 'year': 2014, 'venue': 'J Health Commun', 'volume': '19', 'issn': '', 'pages': '89--121', 'other_ids': {'DOI': ['10.1080/10810730.2014.939313']}}, 'BIBREF93': {'ref_id': 'b93', 'title': 'Agriculture for improved nutrition: the current research landscape', 'authors': [{'first': 'R', 'middle': [], 'last': 'Turner', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Hawkes', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Jeff', 'suffix': ''}], 'year': 2013, 'venue': 'Food Nutr Bull', 'volume': '34', 'issn': '', 'pages': '369--77', 'other_ids': {'DOI': ['10.1177/156482651303400401']}}, 'BIBREF94': {'ref_id': 'b94', 'title': 'Food Policy for Developing Countries: The Role of Government in Global, National, and Local Food Systems. 1 den', 'authors': [{'first': 'P', 'middle': [], 'last': 'Pinstrup-Andersen', 'suffix': ''}, {'first': 'D', 'middle': ['D'], 'last': 'Watson', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ii', 'suffix': ''}], 'year': 2011, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF95': {'ref_id': 'b95', 'title': 'Standing Committee on Nutrition Mandate', 'authors': [{'first': '', 'middle': [], 'last': 'Unscn', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Un', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF96': {'ref_id': 'b96', 'title': 'Maternal and Child Nutrition Study Group. The politics of reducing malnutrition: building commitment and accelerating progress', 'authors': [{'first': 'S', 'middle': [], 'last': 'Gillespie', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Mannar', 'suffix': ''}], 'year': 2013, 'venue': 'Lancet', 'volume': '382', 'issn': '', 'pages': '552--69', 'other_ids': {'DOI': ['10.1016/S0140-6736(13)60842-9']}}, 'BIBREF97': {'ref_id': 'b97', 'title': 'Global nutrition: What should change?', 'authors': [{'first': 'A', 'middle': [], 'last': 'Müller', 'suffix': ''}, {'first': 'D', 'middle': ['C'], 'last': 'Coitinho', 'suffix': ''}], 'year': 2011, 'venue': 'Food Nutr Bull', 'volume': '32', 'issn': '2', 'pages': '56--64', 'other_ids': {'DOI': ['10.1177/15648265110322S202']}}, 'BIBREF98': {'ref_id': 'b98', 'title': 'Recent Shifts in Global Governance: Implications for the Response to Non-communicable Diseases', 'authors': [{'first': 'D', 'middle': [], 'last': 'Sridhar', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'Brolan', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Durrani', 'suffix': ''}], 'year': 2013, 'venue': 'PLoS Med', 'volume': '10', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1371/journal.pmed.1001487']}}, 'BIBREF99': {'ref_id': 'b99', 'title': 'Reducing Child Undernutrition: Past Drivers and Priorities for the Post-MDG Era', 'authors': [{'first': 'L', 'middle': ['C'], 'last': 'Smith', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}], 'year': 2015, 'venue': 'World Dev', 'volume': '68', 'issn': '', 'pages': '180--204', 'other_ids': {'DOI': ['10.1016/j.worlddev.2014.11.014']}}, 'BIBREF100': {'ref_id': 'b100', 'title': 'Responseoriented measuring inequalities in Tehran: second round of UrbanHealth Equity Assessment and Response Tool (Urban HEART-2), concepts and framework', 'authors': [{'first': 'M', 'middle': [], 'last': 'Asadi-Lari', 'suffix': ''}, {'first': 'M', 'middle': ['R'], 'last': 'Vaez-Mahdavi', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Faghihzadeh', 'suffix': ''}], 'year': 2013, 'venue': 'Med J Islam Repub Iran', 'volume': '27', 'issn': '', 'pages': '236--284', 'other_ids': {}}, 'BIBREF101': {'ref_id': 'b101', 'title': 'Agriculture, health, and wealth convergence: bridging traditional food systems and modern agribusiness solutions', 'authors': [{'first': 'L', 'middle': [], 'last': 'Dube', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Webb', 'suffix': ''}, {'first': 'N', 'middle': ['K'], 'last': 'Arora', 'suffix': ''}], 'year': 2014, 'venue': 'Ann N Y Acad Sci', 'volume': '1331', 'issn': '', 'pages': '1--14', 'other_ids': {'DOI': ['10.1111/nyas.12602']}}, 'BIBREF102': {'ref_id': 'b102', 'title': 'Food security in the Asia-Pacific: Malthus, limits and environmental challenges', 'authors': [{'first': 'C', 'middle': ['D'], 'last': 'Butler', 'suffix': ''}], 'year': 2009, 'venue': 'Asia Pac J Clin Nutr', 'volume': '18', 'issn': '', 'pages': '577--84', 'other_ids': {}}, 'BIBREF103': {'ref_id': 'b103', 'title': 'Can experience-based household food security scales help improve food security governance?', 'authors': [{'first': 'R', 'middle': [], 'last': 'Pérez-Escamilla', 'suffix': ''}], 'year': 2012, 'venue': 'Glob Food Sec', 'volume': '1', 'issn': '', 'pages': '120--125', 'other_ids': {'DOI': ['10.1016/j.gfs.2012.10.006']}}, 'BIBREF104': {'ref_id': 'b104', 'title': 'Fighting maternal and child malnutrition: analysing the political and institutional determinants of delivering a national multisectoral response in six countries', 'authors': [{'first': 'Mejía', 'middle': [], 'last': 'Acosta', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Fanzo', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF105': {'ref_id': 'b105', 'title': 'Accelerating reductions in undernutrition: what can nutrition governance tell us', 'authors': [{'first': 'L', 'middle': [], 'last': 'Haddad', 'suffix': ''}, {'first': 'Mejía', 'middle': [], 'last': 'Acosta', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Fanzo', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2012, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF106': {'ref_id': 'b106', 'title': 'Food and Globalization', 'authors': [{'first': 'L', 'middle': [], 'last': 'Phillips', 'suffix': ''}], 'year': 2006, 'venue': 'Annual Review of Anthropology', 'volume': '35', 'issn': '', 'pages': '37--57', 'other_ids': {'DOI': ['10.1146/annurev.anthro.35.081705.123214']}}, 'BIBREF107': {'ref_id': 'b107', 'title': 'An accountability framework to promote healthy food environments', 'authors': [{'first': 'V', 'middle': ['I'], 'last': 'Kraak', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Swinburn', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Lawrence', 'suffix': ''}], 'year': 2014, 'venue': 'Public Health Nutr', 'volume': '17', 'issn': '', 'pages': '2467--83', 'other_ids': {'DOI': ['10.1017/S1368980014000093']}}, 'BIBREF108': {'ref_id': 'b108', 'title': 'A systematic policy approach to changing the food system and physical activity environments to prevent obesity', 'authors': [{'first': 'G', 'middle': [], 'last': 'Sacks', 'suffix': ''}, {'first': 'B', 'middle': ['A'], 'last': 'Swinburn', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Lawrence', 'suffix': ''}], 'year': 2008, 'venue': 'Aust New Zealand Health Policy', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1743-8462-5-13']}}, 'BIBREF109': {'ref_id': 'b109', 'title': 'Global health promotion: how can we strengthen governance and build effective strategies?', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 2006, 'venue': 'Health Promot Int', 'volume': '21', 'issn': 'suppl_1', 'pages': '42--50', 'other_ids': {'DOI': ['10.1093/heapro/dal050']}}, 'BIBREF110': {'ref_id': 'b110', 'title': 'The multiple meanings of global health governance: a call for conceptual clarity', 'authors': [{'first': 'K', 'middle': [], 'last': 'Lee', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Kamradt-Scott', 'suffix': ''}], 'year': 2014, 'venue': 'Global Health', 'volume': '10', 'issn': '', 'pages': '28--38', 'other_ids': {'DOI': ['10.1186/1744-8603-10-28']}}, 'BIBREF111': {'ref_id': 'b111', 'title': 'The nutrition transition in high-and low-income countries: what are the policy lessons?', 'authors': [{'first': 'B', 'middle': [], 'last': 'Popkin', 'suffix': ''}, {'first': 'S', 'middle': ['W'], 'last': 'Ng', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Sw', 'suffix': ''}], 'year': 2007, 'venue': 'Agricultural Economics', 'volume': '37', 'issn': '', 'pages': '199--211', 'other_ids': {'DOI': ['10.1111/j.1574-0862.2007.00245.x']}}, 'BIBREF112': {'ref_id': 'b112', 'title': 'Politics: Who Gets What, When, How', 'authors': [{'first': 'H', 'middle': ['D'], 'last': 'Lasswell', 'suffix': ''}], 'year': 1936, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF114': {'ref_id': 'b114', 'title': 'Two Treatises of Government. London: Awnsham Churchill, 1690', 'authors': [{'first': 'J', 'middle': [], 'last': 'Locke', 'suffix': ''}], 'year': None, 'venue': 'BMJ Global Health', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF115': {'ref_id': 'b115', 'title': 'International Covenant on Economic, Social and Cultural Rights', 'authors': [], 'year': 1966, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': \"Search conducted 3 May 2015. Search detail: ('nutritional status' (MeSH Terms) OR ('nutritional' (All Fields) AND 'status'(All Fields)) OR 'nutritional status' (All Fields) OR 'nutrition' (All Fields) OR 'nutritional sciences' (MeSH Terms) OR ('nutritional' (All Fields) AND 'sciences' (All Fields)) OR 'nutritional sciences' (All Fields)) AND ('Governance (Oxf)' (Journal) OR 'governance' (All Fields)). ii These included: Mejía Acosta et al 105 ; Gillespie et al 97 ; Haddad et al 106 ;. Sunguya et al.8\", 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'data sharing statement No additional data are available.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Nutrition governance literature search strategy and results by source', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': \"the need for international legal standards iii Data obtained 18 March 2016 from World Bank's 'Projects and Operations' website: http://www.worldbank.org/projects/ search?lang=en&searchTerm=&mjthemecode_exact=2\", 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'Sample nutrition governance problems at national and global levels', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5f4ecb6d129cdde292040692'), 'paper_id': '0a19aacc124c9c42d66d481a9d0c837a76a252e6', 'metadata': {'title': 'VIRUS ON T H E CEREBRAL ACTIVITY OF P L E U R O P N E U M O N I A -L I K E ORGANISMS I N M I C E', 'authors': [{'first': 'John', 'middle': ['B'], 'last': 'Nelson', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [], 'body_text': [{'text': 'Shortly after the isolation of MHV(C) from Balb C mice, in 1955, it was found that Swiss weanlings were equally susceptible and because of their availability they were subsequently used in activity tests (1) . Princeton mice were consistently resistant. Intraperitoneal injection in Swiss mice was generally followed by focal or diffuse necrosis of the liver but was not attended by nervous manifestations. On intracerebral injection the virus produced significant changes in the brain, with some destruction of nerve cells. Lymphocytic infiltration was commonly observed in brain sections but polymorphonuclear leukocytes were absent. Lesions produced in the liver, following carriage of the virus from the brain, were generally focal in character. The death rate was variable. In one series of passages, 12 of 25 mice died between the 3rd and the 5th day after injection. Survival after the 3rd day was irregularly attended by paralysis of the hind legs. The most common sign was a rigid backward extension of one or both limbs. The affected leg was functionless and was dragged by the mouse in moving. This type of paralysis was observed in 9 of the 25 mice. At autopsy on the 5th or 6th day, 5 of them were erect and active while 4 were prone and unable to move. A tendency to roll sideways, if lightly prodded, was observed in one of the latter mice. All of the cranially injected animals showed weight losses of 1 to 3 gin.', 'cite_spans': [{'start': 204, 'end': 207, 'text': '(1)', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': ''}, {'text': 'Unusually acute signs of illness appeared in Swiss mice during the first cranial passage series. By the 3rd transfer, leukocytes were demonstrable in direct films 179 and later in sections from the brain. A cerebral suspension prepared from the mice of the 5th transfer yielded a pure growth of PPLO. The passage series was continued with a Coors filtrate of the contaminated suspension and subsequently maintained in the absence of PPLO. In 1938, Sabin (2) described a nervous disorder of mice that appeared during the cerebral passage of toxoplasma. The characteristic sign was a rolling motion on the long axis of the body. It was also observed after intraabdominal and intrathoracic injection. The incidence was 20 to 40 per cent. Two kinds of brain lesions were found in sections. The first one was indicated by destruction of the periventricular tissue and extensive leukocytic infiltration. It was present in all mice. The second lesion, consisting of almost complete necrosis and lysis of the posterior pole of the cerebellum, occurred only in mice with rolling signs.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Sabin (3) subsequently found that a pleuropneumonia-like organism, later termed type A (5) , was the etiologic factor. The disease was fully reproduced by intracerebral injection of the agent in pure culture. If grown in glucose-serum broth the organism produced a true exotoxin which resulted in the same nervous signs and cerebellar lesion on intravenous injection. Findlay et al. (4) , also in 1938, noted that mice injected intracerebrally, in series, with a neurotropic strain of yellow fever virus developed nervous signs within 2 days, instead of 4 to 5 days. Rolling with a sideways motion was observed in some of the mice. An agent that was not cultivable in ordinary media was separated from the brain but was subsequently lost on passage.', 'cite_spans': [{'start': 6, 'end': 9, 'text': '(3)', 'ref_id': 'BIBREF2'}, {'start': 87, 'end': 90, 'text': '(5)', 'ref_id': 'BIBREF4'}, {'start': 383, 'end': 386, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': ''}, {'text': 'A similar condition was later observed during brain passage of the S strain of lymphocytic choriomeningitis virus. Rolling occurred in about 10 per cent of the injected mice. Seventy-five per cent died in 2 to 7 days. Some of the survivors developed hydrocephalus between the 8th and the 21st day.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Brain sections showed neurolysis and an intense infiltration of leukocytes. The lateral ventricles, meninges, and choroid plexus were invaded. In hydrocephalus the leukocytes were largely replaced by lymphocytes and mononuclears.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'PPLO designated L5 were invariably isolated from the brains of mice with rolling signs. This organism by itself was incapable of reproducing the disease but mixed with a neurotropic virus or agar, or after rapid intracerebral passage, its virulence was raised and the rolling signs resulted. Several other types of PPLO (L,, Ls, and L4) were inactive in the presence of virus.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': \"Cross-protection tests indicated that Sabin's type A organism was closely related to Ls but his was considerably more virulent.\", 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'The first experiments on the behavior of PPLO in the brain were made in normal mice with 2 strains of the catarrhal type, designated S and J. Swiss and Princeton weanlings were injected intracerebrally with pure cultures of the organisms in the absence of any other microbial agent. Subsequent passages were made with brain suspensions.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'The mice used in all of the following experiments were Swiss and Princeton weanlings, 10 to 12 gin. in weight, from colonies maintained at The Rockefeller Institute. They were injected in groups of 4 or 6, using mice of either sex but the same sex in any one group. The intracerebrai injections were made with approximately 0.02 ml. of inoculum, in mice lightly anesthetized with ether. The brain suspensions were prepared in saline from minced tissue, using a TenBroeck grinder, and were about 10 per cent in concentration. Freshly prepared suspensions were generally held for a short period, until sedimentation had occurred, and the supernatant used. In some instances penicillin was added in the amount of 1000 units per ml.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'The PPLO strain designated S was the one originally isolated from the brains of Swiss mice during the cranial passage of MHV(C). The results of nasal and intraperitoneal injection in Princeton weanlings had indicated that it was a catarrhal type. The intracerebral passage in Swiss mice was begun with the 2nd transfer of the organism grown for 48 hours in 20 per cent horse serum--heart infusion bouillon (pH 8).', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': \"Most of the injected mice were killed on the 7th day and their brains removed aseptically. At least one brain from each passage group was placed in Zenker's solution, for histologic study, and sections cut from 3 levels including the cerebellum. They were stained with eosinmethylene blue. A small amount of tissue was aspirated with a capillary pipette from 2 or more of the remaining brains, the pipette being inserted between the hemispheres. Gramstained films of the tissue were prepared for microscopic examination. Cultures were also made on 20 per cent horse serum-nutrient agar plates containing 2500 units of penicillin. Finally, a suspension was prepared from the pooled brains for passaging. In some of the later tests cultures were also made from the suspensions. Several of the mice in this experiment were held under observation for 14 days and killed without a complete examination. Five subsequent passages were made, in each case with a brain suspension from the preceding transfer. Essentially the same methods were used in all of the following tests.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'The PPLO strain designated J was originally isolated during an outbreak of infectious catarrh in a small colony of Japanese mice. It has been maintained for many years in this laboratory by nasal passage or contact in Princeton mice. Intracerebral passage was begun in Princeton weanlings with a freshly isolated 72 hour old culture, the 3rd transfer on isolation from middle ear exudate. Four subsequent cerebral passages were made in Princeton mice and one in Swiss mice.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'Twenty-eight of the 32 Swiss mice used in the 6 cerebral passages of the S strain of PPLO were killed on the 7th day after injection, and 4 on the 14th day. All of the animals gained weight during the observation period and were normal in appearance. At autopsy they showed no consistent pathologic findings. Leukocytes were not observed in either direct films or sections and there was no indication of encephalitis or meningitis. Thirteen of 16 brain cultures gave a pure growth of PPLO and 3 were negative. The amount of growth was regularly scanty, 8 of the plates having 10 colonies or less.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'Similar results were obtained with the cerebral passage of the J strain in Princeton mice. The 25 animals used in the 5 transfers were normal in appearance during the observation period of 7 days. At autopsy, leukocytes were not observed in either brain films or sections. Cultures from the suspensions yielded only a scanty growth of PPLO colonies. In the single experiment with Swiss mice the injected animals were held for 4 weeks. They were likewise normal during life and at autopsy. The terminal culture from the brain suspension yielded 8 PPLO colonies.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Mice with Pleuropneumonia-Like Organisms in Culture'}, {'text': 'The Reaction with Catarrhal Strains of PPLO.--This series was begun with the S strain of PPLO. Eight successive cranial transfers were made in Swiss weanlings, starting with a brain suspension which contained both the organisms and the virus. Prior to use this suspension had been maintained in a frozen state at --20°C. for 21 weeks.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Five mice were used in each of the 8 brain passages. Mter injection they were held under observation until one or more deaths had occurred. At this time, usually the 3rd or 4th day, the survivors were killed with ether and autopsied. Direct brain films and cultures were made from at least one mouse in each passage. Six brains were sectioned for later study.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Twenty of the 40 mice in this series of passages died, 14 on the 3rd day and 6 on the 4th. The 20 survivors were acutely ill when killed for autopsy. They regularly showed a marked loss in weight, up to 4 grn. per mouse. Roughening of the hair was a variable finding. Many of the mice were inactive and some were prone. Convulsive movements were irregularly observed and a tendency to roll was seen in 3. At autopsy the livers commonly showed a normal red color but were regularly spotted with small white loci. These areas were often few in number, 10 or less, and in some instances were visible only on low power magnification. The Gram-stained films regularly showed leukocytes in considerable numbers. In some films extra-and intracellular groupings of PPLO were clearly demonstrable. Areas of inflammation with innumerable leukocytes were observed in the brain sections. A pure growth of PPLO colonies, varying from several thousand to innumerable, was obtained on the plate cultures from 7 of the passages. The growth from the brains of the first passage, which had been made with a previously frozen suspension, was relatively meagre. A culture made from the pooled livers of the 2 survivors in the second passage was bacteriologically sterile.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Supplementary experiments in this group were carried out with 3 additional PPLO strains of the catarrhal type. One strain (J) was recovered from the middle ear exudate of experimentally infected mice and 2 strains (RZ and RH) from naturally infected albino rats. All 3 strains were of recent isolation. Two cerebral passages were made in Swiss weanlings with each of the strains. In preparing the inoculum for the first passage a brain suspension containing only MHV(C) was mixed with an equal volume of a fluid culture of PPLO. The second passage was made with a brain suspension which contained both agents.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'With the RZ strain of PPLO the outward signs of illness were delayed until the 5th day. In other respects the outcome of these tests essentially duplicated the results with the S strain. Signs of acute illness were regularly observed in the injected mice. Thirteen of the 30 animals used in the combined tests died. A tendency to roll was observed in only 2 of the 17 survivors. At autopsy a sparse distribution of small surface foci was observed in all of the livers. Leukocytes were regularly present in brain films and numerous colonies of PPLO were obtained on plate cultures. Brain sections from 2 mice in each group showed extensive leukocytic infiltration.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': \"In the experiment with the J strain of PPLO, cultures were also made from the heart's blood, liver, and spleen. All of these suspensions were bacteriologically sterile. Aside from the liver, the abdominal and thoracic organs of these mice, and indeed of all the mice in the entire series of experiments, were normal in the gross.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'The effect of long continued cultivation on the cerebral activity of PPLO was determined with a culture of the J strain that had been transferred 100 times in serum-bouillon at intervals of 2 to 3 days. In the presence of MHV(C) its pathogenicity was fully as great as that of the recently isolated strains.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'One titration experiment was carried out with brains removed on the 3rd day from Swiss mice injected intracerebrally with MHV(C) and the J strain of PPLO. The highest dilution of the suspension that gave a leukocytic response with positive cultures was 10 -4 . The brains from mice which received the 10 -5 dilution showed no lesions and were bacteriologically sterile.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'The Reaction with Conjunctival Strains of PPLO.--The observations on the activity of MHV(C) and PPLO in the brain were continued with 2 strains of the conjunctival type, designated P and B. These organisms are much less pathogenic for mice than those of the catarrhal type and are commonly inactive on nasal or intraperitoneal injection in susceptible weanlings. Under natural conditions they are associated with a low grade inflammation of the conjunctivae (6).', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'The P strain was obtained from Princeton mice infected by direct contact. A passage series with this strain was begun in 1950 and has been maintained to date. A culture of recent isolation from conjunctival washings (the 3rd subculture) and one that had been recultured after 79 transfers and then stored for 8 months at -20°C. were used. The B strain was obtained from a naturally infected mouse, one of a group sent to us for examination from the Brookhaven National Laboratory. The 2nd culture transfer was employed.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'In the presence of active MHV(C) 2 cerebral passages were made in Swiss weanlings with each of the 2 P strain cultures and 10 passages with the B strain. A single passage was also made with the latter culture in the absence of virus.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'On combination with MHV(C) the activity of the P strain in the brain was essentially the same as that of the catarrhal types. The subculture of the transplant that had been transferred 79 times and then stored in a frozen state was fully as active as the recently isolated one. The first experiments with the B strain showed evidence of an accelerated lethal outcome which was substantiated by subsequent passages. Outward signs of illness were also more con-spicuous with this strain. In other respects its behavior resembled that of the P strain. In the absence of virus the organisms survived in the brain for 2 weeks but produced no demonstrable reaction.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Twelve of the 20 mice used in the 2 experiments with the P strain died on the 3rd to the 5th day after injection. Prior to death they showed external signs of illness. One animal tended to roll. Eight mice were killed and autopsied on the 3rd or 4th day. Their livers were spotted with surface areas of focal necrosis. Leukocytes were regularly present in the brains and numerous colonies of PPLO were obtained on culture.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Deaths in the passage series with the B strain began a day earlier, 15 of the 50 mice dying on the 2nd day after injection. Signs of acute illness were observed in many of the survivors at this time. Fourteen additional deaths occurred between the 3rd and the 5th day. Leukocytes were invariably seen in films or sections from the 21 mice that were killed for autopsy. All of the brain cultures yielded many colonies of PPLO. Two of these mice were hydrocephalic, one showed circling movements, and 5 displayed a tendency to roll.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection in Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Earlier observations on the behavior of MHV(C) in different strains of mice had indicated that the virus alone was commonly inactive on intraperitoneal or intracerebral injection in Princeton weanlings (1) . As an extension of the present findings on the behavior of MHV(C) and PPLO in the brains of Swiss mice a group of experiments was carried out in Princeton mice to determine whether or not either agent was influenced by the presence of the other.', 'cite_spans': [{'start': 202, 'end': 205, 'text': '(1)', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'In a preliminary experiment 5 Princeton weanlings were injected intracerebrally with a brain suspension containing only the virus. These mice showed no outward signs of illness and when killed on the 7th day were strictly normal. Leukocytes were not demonstrable in brain films or sections and cultures were bacteriologically sterile.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'Ten mice were then injected intracerebrally with a mixture of the virus and the S strain of catarrhal PPLO. A similar number received the virus and the J strain of the organisms. The 20 mice, in the 2 groups, were unaffected by the inoculum. When killed on the 7th day the livers were free from focal lesions and the brains showed no indication of leukocytic infiltration. On culture, brain suspensions prepared from each of the 2 groups yielded a sparse growth of PPLO colonies.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton Mice with a Mixture of Pleuropneumonia-Like Organisms and the Balb C Type of Mouse Hepatitis Virus'}, {'text': 'The highly virulent Princeton type of mouse hepatitis virus, MHV(Pr), is pathogenic for Princeton weanlings on intracerebral injection (1). Cerebral multiplication of the virus is not attended, however, by outward signs of nervous disorder and at autopsy there is little evidence of cellular injury in the brain. Carriage of the virus from the brain to the liver commonly occurs and is followed by the customary necrosis. The hepatic reaction is generally fatal.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'Swiss weanlings are naturally resistant to MHV(Pr). The virus fails to multiply in the brain and is usually not recoverable by passage to susceptible Princeton mice. At autopsy the brains and livers are regularly lesion-free.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'Two additional groups of experiments were carried out to determine the cerebral response of Princeton and Swiss weanlings to MHV(Pr) in combination with PPLO.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'Five cerebral passages were made in a total of 25 Princeton mice with a mixture of MHV(Pr) and the J strain of PPLO. Fifteen deaths were recorded as follows: 1 on the 2nd day, 10 on the 3rd, 3 on the 4th, and 1 on the 5th. Ten mice were killed and autopsied, most of them on the 3rd day. Prior to death they appeared acutely ill but were free from outward signs of nervous disorder. The livers of these mice showed focal or semidiffuse necrosis. Leukocytes were observed in brain films and massive areas of leukocytic infiltration in sections. Innumerable colonies of PPLO were obtained on culture.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'Twenty Swiss weanlings were injected intracerebrally with a mixture of MHV(Pr) and PPLO, 10 receiving the J strain and 10 the S strain. There were no deaths. All of the mice gained weight normally and showed no outward signs of illness when killed on the 7th or the 10th day. At autopsy the livers were normal. Leukocytes were not observed in either films or sections from the brains. Eight of 10 brain cultures yielded a few discrete colonies of PPLO and 2 were without growth.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Princeton and Swiss Mice with a Mixture of Pleuropneumonia-Like Organisms and the Pr Type of Mouse Hepatitis Virus'}, {'text': 'A group of experiments was carried out in Princeton and Swiss weaniings to determine the effect of agar on the growth and activity of PPLO in the brain. Findlay et al. (4) had reported that cultures of PPLO which failed to produce rolling signs on intracerebral injection did so in some mice on the addition of agar.', 'cite_spans': [{'start': 168, 'end': 171, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'The J strain of PPLO was used in all of these tests. Heart infusion agar (pH 8) was liquefied, cooled to 40°C., and diluted 1 to 5 with saline, The undiluted medium contained 1.5 per cent agar and was used as routine in the isolation of PPLO. The diluted semisolid agar was mixed with an equal volume of young PPLO cultures in 20 per cent horse serum-bouillon. Twenty-four weanlings of each mouse strain were injected intracerebrally with this inoculum. One series of 3 cerebral passages was made in Princeton mice, starting with a brain suspension from 2 animals injected with the PPLO-agar mixture. Finally, as a control on the activity of the medium, mice of both strains were injected with a sterile mixture of agar and horse serum-bouillon.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'Six of the 48 mice used in the first group of experiments died on the 7th to the 19th day after injection. The survivors were killed and autopsied at in-tervals of 1 and 3 weeks. All of the mice, including those that died, gained weight normally and were free from any outward signs of nervous disorder. Thirteen of the 21 Princeton mice that were killed and 6 of the Swiss showed leukocytes in either films or sections of the brain and a good growth of PPLO on culture. In the absence of an inflammatory reaction the growth was meagre.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'As Findlay et al. (4) had previously noted in their experiments, a significant number of the mice were frankly hydrocephalic. Twelve Princeton weanlings and 10 Swiss showed free fluid in the cranial cavity, accompanied in some instances by a marked elevation of the skull and circumscribed sunken areas in the anterior portion of one or both hemispheres. The brain usually appeared paler than normal.', 'cite_spans': [{'start': 18, 'end': 21, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'All of the 18 mice in the passage series survived and were normal in appearance through the 14th day when they were killed. At autopsy leukocytes were not observed in brain films or sections and only a meagre growth of PPLO was obtained on culture. In the first passage, however, 3 of the mice were hydrocephalic. Their skulls were not elevated but the cranial cavities contained free fluid and areas of collapse were present in one or both hemispheres.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'Two of the 6 Princeton mice injected with the sterile mixture of agar and horse serum-bouillon died. The 10 survivors in both groups showed no outward signs of nervous disorder and were killed on the 21st day. The skulls of 2 Princeton mice were elevated and free fluid was present in the cranial cavities. Four of the Swiss mice were also hydrocephalic, though their skulls were not elevated. Films and sections from the brains of these mice showed no leukocytes and cultures were bacteriologically sterile.', 'cite_spans': [], 'ref_spans': [], 'section': 'Intracerebral Injection of Mice with a Mixture of Pleuropneumonia-Like Organisms and A gar'}, {'text': 'Brain sections from the mice injected with the fluid cultures of PPLO alone were essentially normal. A few lymphocytes were occasionally observed but leukocytes were regularly absent. In some sections the ventricles were somewhat dilated.', 'cite_spans': [], 'ref_spans': [], 'section': 'Histological Examination of the Brains'}, {'text': 'Sections of the cerebrum from the mice injected with a mixture of virus with neurotropic activity and PPLO invariably showed an inflammatory reaction with a preponderance of leukocytes. The most common lesion was a roughly semicircular band composed largely of leukocytes, a few lymphocytes, much necrotic debris, red blood cells, and fibrin (Figs. 1 and 2). It partially enclosed the ventricular spaces and the intermeshing horns of the bilateral ganglia. Large mononuclear cells packed with fat vacuoles (gitter cells) and droplets of free fat were generally observed at its margin. The nerve cells of the adjacent ganglia often showed necrosis with deep blue pyknotic nuclei and pink staining debris. In a few sections the reaction was limited to one or more sharply demarcated abscesses. Dilation of the ventricles sometimes occurred but was not a characteristic finding. Leukocytie involvement of the meninges was observed but was rarely conspicuous. Leukocytes also invaded the cerebellum but much less frequently. A few sections showed degeneration of nerve cells particularly those in the granular layer (Fig. 5) . It was not consistent, however~ in respect to the appearance of rolling signs prior to autopsy.', 'cite_spans': [], 'ref_spans': [{'start': 1112, 'end': 1120, 'text': '(Fig. 5)', 'ref_id': None}], 'section': 'Histological Examination of the Brains'}, {'text': 'Brain sections from the mice injected with the agar-PPLO mixture showed 2 types of cellular response. In the presence of actively growing PPLO there was a marked inflammatory reaction which was commonly circumscribed (Fig. 4) . Leukocytes predominated but lymphocytes and large mononuclear cells, with and without fat droplets, were also present. There was much necrotic debris. In some mice there was definite evidence of encapsulation by connective tissue. Necrosis of nerve cells in the nearby ganglia was generally not observed. Portions of the meninges, particularly in the cerebellum, were distended by an infiltration of leukocytes and lymphocytes. Some of the sections also showed widely dilated ventricles.', 'cite_spans': [], 'ref_spans': [{'start': 217, 'end': 225, 'text': '(Fig. 4)', 'ref_id': None}], 'section': 'Histological Examination of the Brains'}, {'text': 'In the absence of actively growing PPLO there was commonly a lymphocytic infiltration together with hydrocephalus. With no or low magnification the ground substance of the brain was separated symmetrically by unstained open spaces (Fig. 3) . Microscopically the central and lateral ventricles were greatly dilated and often extended beyond the limits of the ependymal cell layer. In some instances this layer had broken away from the margin of the cavity. Rupture of the distended ventricles, possibly at autopsy, with release of the fluid may account for the areas of collapse observed in the intact brain. Lymphocytes and large mononuclear cells were usually present within and around the margin of the ventricles and also in the meninges. Leukocytes were absent. The nerve ceils of the ganglia were intact and appeared normal. Sections from some of the mice injected with the sterile mixture of agar and horse serum-bouillon showed a similar distension of the ventricles but little or no cellular reaction.', 'cite_spans': [], 'ref_spans': [{'start': 231, 'end': 239, 'text': '(Fig. 3)', 'ref_id': None}], 'section': 'Histological Examination of the Brains'}, {'text': 'In naturally infected mice the sites most often frequented by PPLO are the nasal passages and the middle ears. Localization in the lungs, conjunctivae, and joints also occurs but is more sporadic. The present findings together with the earlier ones of Sabin (2, 3) and of Findlay et al. (4) indicate that PPLO may occasionally invade the central nervous system.', 'cite_spans': [{'start': 287, 'end': 290, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'It is not surprising that PPLO have been recovered in a few instances from the brains of supposedly normal mice. The first isolate that we obtained was an organism of the catarrhal type which is widely distributed in nature. This type is enzootic in the Swiss colony, from which our mice were obtained, but is not present in the Princeton colony. In diseased mice the organisms occasionally migrate inwardly from the tympanic cavity to the labyrinth. A small local abscess that impinges on the brain may be produced and provide access to the meninges. Carriage via the circulating blood is also a possibility and would account for the transport of the conjunctival type which ordinarily does not invade the middle ear.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': \"The normal mouse brain evidently fails to provide optimal conditions for the growth of most PPLO. Sabin's type A organism (5) which produces an extotoxin is an outstanding exception. On cranial injection the organisms that we studied survived in the brain for a period of weeks. The level of growth was barely sufficient, however, to maintain them by serial passage and too low to provoke a counter-reaction. Growth was markedly increased by the simultaneous injection of mouse hepatitis virus and was attended by a vigorous leukocytic response. There was no indication of specificity in relation to the type of PPLO, as earlier reported by Findlay et al. (4) . Multiplication of the virus in the brain was a prerequisite but encephalitis was not essential. AI-though direct proof is lacking, it is tempting to attribute the growth enhancement to fatty substances liberated in the brain by the virus. Edward (7) and Smith, Lecce, and Lynn (8) have presented evidence that lipoids, probably lipoproteins, are generally needed for the growth of PPLO in vitro.\", 'cite_spans': [{'start': 656, 'end': 659, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Rolling occurred so infrequently in mice injected with the mixture of MHV and PPLO that it could hardly be called a characteristic sign. It was also observed in an occasional mouse injected with MHV(C) alone. This virus was productive of considerable injury to the brain but rarely affected the nerve cells of the cerebral ganglia. In the absence of the virus or agar PPLO showed little or no evidence of neurotropism. The intracerebral injection of both microbic agents commonly resulted, however, in extensive destruction of the nerve cells in the anterior horns of the cerebrum. This outcome was indicative of an interaction between the 2 agents and suggestive of synergism.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Our findings in regard to the effect of agar on the cerebral behavior of PPLO in mice agreed with the earlier observations of Findlay et al. (4) as to its enhancing properties but differed from theirs in detail. In our experiments none of the mice injected with the agar-PPLO mixture showed any outward signs of nervous disorder. In Swiss mice there was a marked difference between agar and MHV(C) in respect to the number of individuals with an increased growth of PPLO and a leukocytic response at autopsy. The actual rates were about 30 per cent with agar and practically 100 per cent with the virus. Princeton mice were more responsive, the rate with agar being 60 per cent. The present observations suggest that hydrocephalus which frequently appeared in the injected mice was in part a response to the agar as the same condition also followed the injection of a sterile agar inoculum. SUMMARY Pleuropneumonia-like organisms (PPLO) of the catarrhal type were isolated from the brain of a Swiss mouse during the cranial passage of mouse hepatitis virus-MHV(C). Cranial injection of the PPLO alone in Swiss and Princeton weanlings was attended by a meagre growth of the organisms in the brain, with no pathologic change.', 'cite_spans': [{'start': 141, 'end': 144, 'text': '(4)', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'The growth of both catarrhal and conjunctival strains of PPLO in the brains of Swiss mice was greatly enhanced by the simultaneous injection of MHV(C). Rolling was not a characteristic sign prior to autopsy. Brain sections regularly showed a vigorous leukocytic response, commonly accompanied by the destruction of nerve cells in the anterior horns of the cerebrum. Injected in Princeton mice together with the virus, the organisms barely survived and were inactive. MHV(Pr) enhanced the growth and pathogenicity of PPLO in the brains of Princeton mice but failed to do so in Swiss.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'The behavior of PPLO in the brain was likewise affected by the presence of agar, as earlier observed by Findlay et al. In comparison with the effect of MHV, the enhancement was reduced in rate in both strains of mice and was not accompanied by outward signs of nervous disorder. Hydrocephalus which often followed injection of the PPLO-agar mixture was also produced by agarbouillon alone.', 'cite_spans': [], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'All of the following cross-sections of the brain were stained with eosin-rnethyl ene blue. They were photographed by Mr. J. A. Carlile. ', 'cite_spans': [], 'ref_spans': [], 'section': 'BIBLIOGRAPHY EXPLANATION OF PLATE 13'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Acute hepatitis associated with mouse leukemia. V. The neurotropic properties of the causal virus', 'authors': [{'first': 'J', 'middle': ['B'], 'last': 'Nelson', 'suffix': ''}], 'year': 1955, 'venue': 'J. Exp. Med', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Isolation of a filtrable, transmissible agent with \"neurolytic\" properties from toxoplasma-infected tissues', 'authors': [{'first': 'A', 'middle': ['B'], 'last': 'Sabin', 'suffix': ''}], 'year': 1938, 'venue': 'Science', 'volume': '88', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Identification of the filtrable, transmissible neurolytic agent isolated from toxoplasma-infected tissue as a new pleuropneumonia-like microbe', 'authors': [{'first': 'A', 'middle': ['B'], 'last': 'Sabin', 'suffix': ''}], 'year': 1938, 'venue': 'Science', 'volume': '88', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Rolling disease', 'authors': [{'first': 'G', 'middle': ['M'], 'last': 'Findlay', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Klieneberger', 'suffix': ''}, {'first': 'F', 'middle': ['O'], 'last': 'Maccallum', 'suffix': ''}, {'first': 'R', 'middle': ['D'], 'last': 'Mackenzie', 'suffix': ''}], 'year': None, 'venue': 'Lancet', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'The filtrable micro~rganisms of the pleuropneumonia group', 'authors': [{'first': 'A', 'middle': ['B'], 'last': 'Sabin', 'suffix': ''}], 'year': 1941, 'venue': 'Baa. Rev', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Association of a special strain of pleuropneumonia-like organisms with conjunctivitis in a mouse colony', 'authors': [{'first': 'J', 'middle': ['B'], 'last': 'Nelson', 'suffix': ''}], 'year': 1950, 'venue': 'J. Exp. Meal', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Cholesterol in the growth of organisms of the pleuropneumonia group', 'authors': [{'first': 'D', 'middle': ['F'], 'last': 'Edward', 'suffix': ''}, {'first': 'W', 'middle': ['A'], 'last': 'Fitzgerald', 'suffix': ''}], 'year': 1951, 'venue': 'J. Gen. Microbiol', 'volume': '5', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'A lipoprotein as a growth factor for certain pleuropneumonialike organisms', 'authors': [{'first': 'P', 'middle': ['F'], 'last': 'Smith', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Lecce', 'suffix': ''}, {'first': 'R', 'middle': ['J'], 'last': 'Lynn', 'suffix': ''}], 'year': 1954, 'venue': 'J. Bact', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'FIG. |. The cerebral reaction in a mouse injected with MHV(C) and PPLO. The intermeshed horns of the ganglia are partially enclosed by massive areas of leukocytic infiltration, showing as double bands. X 6.3. FIG. 2. A higher magnification of the same section. The outer horn of the ganglion showed marked nerve cell destruction which is not well brought out by the black and white print. There was no ventricular distension. X 20.5. FIG. 3. Hydrocephalic reaction in cerebrum of a mouse injected with PPLO and agar. The ground substance was compressed and displaced by the greatly distended ventricles. Lymphocytes were scattered throughout these spaces but leukocytes were absent. X 6.3. FIG. 4. Inflammatory reaction in cerebrum of a mouse injected with PPLO and agar. The circumscribed area between the bilateral horns contained both lymphocytes and mononuclear cells, as well as leukocytes. There was no destruction of nerve cells in the ganglia. X 20.5. FIG. 5. Cerebellar reaction in a mouse injected with MHV(C) and the B strain of PPLO. This mouse was a \"roller.\" In the central portion there was practically complete destruction of nerve cells. Along the outer margin of this area was a band of migratory cells, chiefly leukocytes. )< 20.5.', 'latex': None, 'type': 'figure'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5f4ecb6f88281d453d146a61'), 'paper_id': '0a296d80d8a8c0408c1ea9559c0f0589fb35cb03', 'metadata': {'title': 'Molecular epidemiology and phylogenetic analysis of diverse bovine astroviruses associated with diarrhea in cattle and water buffalo calves in China', 'authors': [{'first': 'Niyokwishimira', 'middle': [], 'last': 'Alfred', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Huan', 'middle': [], 'last': 'Liu', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Lan', 'middle': [], 'last': 'Li', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Shao', 'middle': ['Feng'], 'last': 'Hong', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Hai', 'middle': ['Bo'], 'last': 'Tang', 'suffix': '', 'affiliation': {'laboratory': 'State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Zhang', 'middle': [], 'last': 'Wei', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Ying', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Kai', 'middle': [], 'last': 'Fa', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': '', 'middle': [], 'last': 'Li', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Yi', 'middle': ['Zhi'], 'last': 'Zhong', 'suffix': '', 'affiliation': {'laboratory': 'State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}, {'first': 'Wei', 'middle': ['Jian'], 'last': 'Huang', 'suffix': '', 'affiliation': {'laboratory': 'Laboratory of Animal Infectious Diseases Prevention and Molecular Immunology', 'institution': 'Guangxi University', 'location': {'addrLine': 'Daxue Road 100', 'postCode': '530004', 'settlement': 'Nanning', 'region': 'Guangxi', 'country': 'China'}}, 'email': ''}]}, 'abstract': [{'text': 'Astroviruses are the principal causative agents of gastroenteritis in humans and have been associated with diarrhea in other mammals as well as birds. However, astroviral infection of animals had been poorly studied. In the present study, 211 rectal swabs collected from cattle and water buffalo calves with mild to severe diarrhea were tested for bovine astrovirus (BAstV) by RT-PCR. Results: 92/211 (43.6%) samples were positive for BAstV, at a rate of 46.10% (71/154) in cattle and 36.84% (21/57) in water buffalo. Phylogenetic analysis based on the partial and full-length of 25 ORF2 amino acid sequences obtained in this study classified the Guangxi BAstVs isolates into five subgroups under the genus of Mamastrovirus, genotype MAstV33, which suggested that the water buffalo was a new host of this genogroup that previously included only cattle and roe deer. Despite the origin of the host, the Guangxi BAstV isolates were closely related to the BAstV Hong Kong isolates (B18/HK and B76-2/HK), but highly divergent from the BAstV NeuroS1 isolate previously associated with neurologic disease in cattle in the U.S.A. Nucleotide sequence-based characterization of the ORF1b/ORF2 junction and corresponding overlapping regions showed distinctive properties, which may be common to BAstVs. Our results suggested that cattle and water buffalo are prone to infection of closely related astroviruses, which probably evolved from the same ancestor. The current study described astroviruses in water buffalo for the first time and is thus far among the largest epidemiological investigations of BAstV infection in cattle conducted in China.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': \"Astroviruses are small and non-enveloped with a single-stranded, positive-sense RNA genome of 6.4 to 7.3 kb in length consisting of three open reading frames (ORFs): ORF1a, which encodes the non-structural polyprotein 1a; ORF1b, which encodes the polyprotein 1ab, including the RNA-dependent RNA polymerase (RdRp) that is expressed by a ribosomal frameshift at the ORF1a/1b junction [1, 15] ; and ORF2, which encodes a viral capsid structural polyprotein. The current International Committee on Taxonomy of Viruses (ICTV) system divides the Astroviridae family into two genera, Mamastrovirus and Avastrovirus, which infect mammals and birds, respectively [5, 21] . Astrovirus was first identified in 1975 as the causative agent of infantile diarrhea in a maternity ward in England [1] . In 2011, astrovirus infection has expanded to 22 animal species or families, including various terrestrial domestic animals, wild animals and aquatic animals, (turkey, chicken, pig, cattle, dogs, cats, deer, ducks, mink, rabbit, sea lion, bats, etc.) [3, 5, 18, 21, 24, 28] . Bovine astrovirus (BAstV) was first described in England in 1978 from acute enteritis of calves [24] and initially considered to be avirulent, as experimental infection of two gnotobiotic calves with astrovirus-like virus did not cause diarrhea [24] . However, in 1984, two bovine astrovirus isolates from the U.S.A., US1 and US2, which were found to be antigenically related to an isolate in England (U.K.), were shown to cause infection and cytopathology of M cells of the dome epithelium covering the Payer's patches of the calf ileum [25] . In addition, astroviruses in co-infection with other enteric pathogens, such as bovine rotavirus (BRV) and bovine torovirus (BToV; Breda virus), were shown to increase the severity of astrovirus infection [26] . In 1985, a serologically based investigation classified bovine astroviruses into two serotypes: BoAstV-1 and BoAstV-2. Meanwhile, a study on the earliest three isolates of bovine astroviruses (UK, US1 and US2) implied that these isolates were different serotypes, suggesting that multiple serotypes of bovine astroviruses may exist in nature [25] . Astroviruses, as well as noroviruses, hepatitis A and E, and rotaviruses, are commonly reported as major causes of foodborne illnesses [2] . Astroviruses are commonly detected alongside other enteric viruses, especially noroviruses in alimentary specimens. A previous study suggested that BAstV may be excreted by up to 60-100% of calves on farms [4] , but a later study showed that only 5 (2.4%) of 209 rectal swabs collected from asymptomatic adult cattle tested positive for BAstV [21] . Unlike other enteric viruses, bovine astrovirus is characterized by asymptomatic viral shedding in stool samples without heavy diarrheal disease [4, 24] .\", 'cite_spans': [{'start': 383, 'end': 386, 'text': '[1,', 'ref_id': None}, {'start': 387, 'end': 390, 'text': '15]', 'ref_id': 'BIBREF16'}, {'start': 655, 'end': 658, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 659, 'end': 662, 'text': '21]', 'ref_id': 'BIBREF22'}, {'start': 781, 'end': 784, 'text': '[1]', 'ref_id': None}, {'start': 1038, 'end': 1041, 'text': '[3,', 'ref_id': 'BIBREF2'}, {'start': 1042, 'end': 1044, 'text': '5,', 'ref_id': 'BIBREF4'}, {'start': 1045, 'end': 1048, 'text': '18,', 'ref_id': 'BIBREF19'}, {'start': 1049, 'end': 1052, 'text': '21,', 'ref_id': 'BIBREF22'}, {'start': 1053, 'end': 1056, 'text': '24,', 'ref_id': 'BIBREF25'}, {'start': 1057, 'end': 1060, 'text': '28]', 'ref_id': 'BIBREF29'}, {'start': 1159, 'end': 1163, 'text': '[24]', 'ref_id': 'BIBREF25'}, {'start': 1308, 'end': 1312, 'text': '[24]', 'ref_id': 'BIBREF25'}, {'start': 1601, 'end': 1605, 'text': '[25]', 'ref_id': 'BIBREF26'}, {'start': 1813, 'end': 1817, 'text': '[26]', 'ref_id': 'BIBREF27'}, {'start': 2162, 'end': 2166, 'text': '[25]', 'ref_id': 'BIBREF26'}, {'start': 2304, 'end': 2307, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 2516, 'end': 2519, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 2653, 'end': 2657, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 2805, 'end': 2808, 'text': '[4,', 'ref_id': 'BIBREF3'}, {'start': 2809, 'end': 2812, 'text': '24]', 'ref_id': 'BIBREF25'}], 'ref_spans': [], 'section': ''}, {'text': 'Even though bovine astrovirus was one of the earliest mammalian astroviruses to be discovered and studied in detail, no further research has been performed on this important enteric pathogen over the past three decades, and its genomic sequence remained uncharacterized until its rediscovery and genomic characterization in 2011 in Hong Kong [21] . The lack of large-scale epidemiological surveillance of bovine astrovirus has continued the divergence of opinions on the morbidity of bovine astrovirus in cattle, especially considering that there is no report of astrovirus infection of water buffalo in the current literature. Furthermore, little molecular information about bovine astrovirus is available, and only limited information is available regarding animal astroviruses in general [9] . Therefore, the diversity, epidemiology and molecular characterization of animal astroviruses remain unclear due to the lack of studies, likely because of the difficulty to grow these viruses in cells and tissue cultures.', 'cite_spans': [{'start': 342, 'end': 346, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 791, 'end': 794, 'text': '[9]', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': ''}, {'text': 'Here, we report our results of a relatively extensive epidemiological survey to elucidate the diversity of bovine astroviruses circulating among cattle and water buffalo in Guangxi province, China, by characterization of subgenomic sequences of the ORF1b/ORF2 overlap region and the 3′-end of ORF2.', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': 'Samples: A total of 211 rectal swabs were collected from calves, aged 0-6 months, with mild to severe diarrhea from five industrial farms (3 dairy and 2 water buffalo) in Guangxi province, China. All samples were collected in sterile tubes containing 10 ml of 1/100 antibiotic 10 mM phosphatebuffered saline and transported on ice to our laboratory within 24 hr. Samples were homogenized by vortexing for 5 min at room temperature and centrifuged at 3,000 × g for 15 min at 4°C, and then, the supernatant was aliquoted and stored at −80°C until assayed.', 'cite_spans': [], 'ref_spans': [], 'section': 'MATERIALS AND METHODS'}, {'text': \"Nucleic acid extraction and cDNA bank synthesis: RNA was extracted from 300 µl of the supernatant obtained from each rectal swab using the RNAiso PLUS kit (Takara Bio, Inc., Dalian, China) following the manufacturer's instructions. Extracted RNA was eluted in 35 µl of RNase-free H 2 O (Takara Bio, Inc.) and used for first strand cDNA bank synthesis with the PrimeScript II 1st strand cDNA Synthesis kit (Takara Bio, Inc.) in accordance with the manufacturer's instructions.\", 'cite_spans': [], 'ref_spans': [], 'section': 'MATERIALS AND METHODS'}, {'text': 'Detection of bovine astrovirus and genome cloning and sequencing: Bovine astrovirus was detected by reverse transcriptase polymerase chain reaction (RT-PCR) analysis using the degenerate primer pair (forward) DPF 5′-GAYTG-GACBCGHTWTGATGG-3′ and (reverse) DPR 5′-KYT-TRACCCACATNCCAA-3′ to target a 418-bp fragment of the RdRp region common to astroviruses, as described previously [21] with some modifications. Some of the RT-PCR-positive samples were sequenced and primarily analyzed by comparison of nucleotide sequences using the online Basic Local Alignment Search Tool (http://blast.ncbi. nlm.nih.gov/Blast.cgi) to confirm the detection of astrovi-ruses. Subsequently, we amplified the 3′-end of ORF2 and the ORF1b/ORF2 regions, which have been confirmed by subgenomic RNA analysis for characterization of astroviruses. Since the direct amplification with gene specific primers (GSPs) failed, the Rapid Amplification of cDNA Ends (RACE) method was implemented to amplify the 3′-end of the ORF1b/ORF2 region. The 3′-end RACE amplification was performed as described previously [16] with the following modifications to the primer pair: QT 5′-CCAGTGAGC AGAGTGACGAGGACTCGAGCTCAAGCT (T) 16 -3′ and QO 5′-CCAGTGAGCAGAGTGACG-3′. The RACE products were reused as templates in a nested PCR performed to amplify desired sequences using GSPs designed in this study based on the B76-2/HK sequence available in the GenBank database (http://www.ncbi.nlm.nih.gov/genbank/) under the accession number HQ916317.1.The GSPs were designed using OLIGO 7 software (Molecular Biology Insights, Inc., Colorado Springs, CO, U.S.A.). The nucleotide sequences of the primer pairs used to amplify the partial 3′-end of ORF2 were as follows: (forward, B1205F and B1350F) 5′-CAG-GTCACCCCAGGCAACAC-3′ and 5′-ATCATACAGGC-GGGCACGAGT-3′, respectively, and (reverse, B1205R) 5′-CCCTTCACCTATGCTAATCAAATC-3′ (expected products length, 1,200 and 1,426 bp, respectively). The two primer pairs used to amplify the ORF1b/ORF2 region were as follows: (1) The PCR cycling conditions consisted of 95°C for 5 min followed by 35 cycles of 94°C for 1 min, 52°C for 1 min, 72°C for 1 min and a final extension step at 72°C for 10 min in an automated thermal cycler (Bio-Rad Laboratories, Inc., Hercules, CA, U.S.A.). 3′-RACE PCR and amplification of the ORF1b/ORF2 region were performed under the same conditions as for the PCR analysis described above with cycling set at 58°C as the annealing temperature for 3′RACE and 56°C as the annealing temperature for amplification of the ORF1b/ORF2 region and an elongation step at 72°C for 1 min for each 1 kb.', 'cite_spans': [{'start': 380, 'end': 384, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 1080, 'end': 1084, 'text': '[16]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'MATERIALS AND METHODS'}, {'text': 'The PCR products of expected sizes were purified and then cloned into pMD18-T plasmid vectors (Takara Bio, Inc.), which were then used to transform competent Escherichia coli Top 10 cells. The recombinant plasmids were submitted in duplicate for DNA sequencing to Invitrogen Biotech (Beijing, China). Editing and assembly of nucleotide sequences were performed using the SeqMan program included in the Lasergene 7 Genomics Suite (DNAstar, Inc., Madison, WI, U.S.A.).', 'cite_spans': [], 'ref_spans': [], 'section': 'MATERIALS AND METHODS'}, {'text': 'The status of a combination of astrovirus with other gastrointestinal viruses was assessed by RT-PCR.', 'cite_spans': [], 'ref_spans': [], 'section': 'Assessment of the co-infection status of BAstV with other bovine gastrointestinal viruses:'}, {'text': 'Phylogenetic and genome analysis: Phylogenetic trees were constructed based on the nucleotide sequences of both partial and full-length ORF2 sequences using the Bootstrap Test Phylogeny algorithm with the neighbor-joining method included in the MEGA 4.1 software package (http://www. megasoftware.net/). Sequences were compared with those of other mammalian astroviruses. Pair distances of nucleotide sequences between bovine and water buffalo astroviruses, as well as the ORF1b/ORF2 junction, were analyzed using DNAstar software (Lasergene 7; MegAlign Program with the ClustalW sequence alignment algorithm).', 'cite_spans': [], 'ref_spans': [], 'section': 'Assessment of the co-infection status of BAstV with other bovine gastrointestinal viruses:'}, {'text': 'Of the 211 rectal swabs tested, 92 (43.6%) were positive for bovine astrovirus (cattle: 46.10%, 71/154; water buffalo: 36.84%, 21/57) ( Table 1 ). These results indicate that astroviruses are widely distributed among cattle and water buffalo populations in Guangxi province, China.', 'cite_spans': [], 'ref_spans': [{'start': 136, 'end': 143, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'Screening and detection of BAstV in cattle and water buffalo:'}, {'text': 'The status of co-infection of BAstV with other bovine gastrointestinal viruses: To assess the status of co-infection with BAstV and other bovine gastrointestinal viruses, 32 samples randomly selected from our study stock were subjected to RT-PCR analysis. Six viruses: bovine astrovirus (BAstV), bovine enterovirus (BEV), bovine viral diarrhea virus (BVDV), bovine coronavirus (BCoV), bovine rotavirus (BRV) and bovine torovirus (BToV) were analyzed in accordance with the results of previous studies [7, 8, 11, 20, 27] . The primer sequences used for detection of gastrointestinal viruses other than astrovirus are shown in Table 2 . As shown in Table 3 , our results clearly demonstrated BAstV co-infections with one or more gastrointestinal viruses in 87.5% (28/32) of cases. Interestingly, 4 (12.5%) of 32 samples were only positive for BAstV and negative for the all other gastrointestinal viruses tested in this study. Thus, the co-infection status was as follows: BEV, 53.1% (17/32); BAstV, 46.9% (15/32); BVDV, 18.7% (6/32); BCoV, 15.6% (5/32); BRV, 6.25% (2/32); and BToV, 0% (0/32).', 'cite_spans': [{'start': 501, 'end': 504, 'text': '[7,', 'ref_id': 'BIBREF6'}, {'start': 505, 'end': 507, 'text': '8,', 'ref_id': None}, {'start': 508, 'end': 511, 'text': '11,', 'ref_id': 'BIBREF12'}, {'start': 512, 'end': 515, 'text': '20,', 'ref_id': 'BIBREF21'}, {'start': 516, 'end': 519, 'text': '27]', 'ref_id': 'BIBREF28'}], 'ref_spans': [{'start': 625, 'end': 632, 'text': 'Table 2', 'ref_id': 'TABREF1'}, {'start': 647, 'end': 654, 'text': 'Table 3', 'ref_id': 'TABREF2'}], 'section': 'Screening and detection of BAstV in cattle and water buffalo:'}, {'text': 'Gene cloning and sequencing: We attempted to amplify the genomes of the 92 BAstV-positive samples. However, sequencing proved difficult due to the limited volume of the clinical samples and to the fact that virus cultivation was unsuccessful. We only successfully amplified and cloned 18 partial nucleotide sequences of approximately 1,200-1,426 bp in length in most 3′-ends of ORF2 (of the18 sequences, 12 were derived from cattle and six from water buffalo). Besides, seven fragments of approximately 3,000 bp in length (five derived from cattle and two from water buffalo) partially covering ORF1b and the full length of ORF2 were successfully amplified. In all, 25 sequences were obtained and submitted to the NCBI GenBank under the accession ', 'cite_spans': [], 'ref_spans': [], 'section': 'Screening and detection of BAstV in cattle and water buffalo:'}, {'text': 'numbers KJ476832-KJ476856. Phylogenetic and genomic analysis: To identify strains of astroviruses circulating among cattle and water buffalo populations in Guangxi province, phylogenetic tree analysis was performed based on both partial and full-length ORF2 sequences (1). Phylogenetic analysis of partial ORF2 sequences showed that three isolates (BAstGX S7-7, BAstGX S12-7 and BAstGX S17-7) from Dairy Farm A clustered together with one isolate (BAstGX J25) from Dairy Farm B forming a subgroup, which had a high similarity with BAstV-B76-2/HK and BAstV-B18/ HK isolated from cattle in Hong Kong. Five of six isolates from water buffalo (Bu-fAstGX M52, BufAstGX M53, BufAstGX M54, BufAstGX M541 and BufAstGX M552) clustered together appeared to form a new independent subgroup. However, one water buffalo isolate (BufAstGX 141) formed a new subgroup and appeared to be very closely related to the CcAstV-1/ DNK/2010 isolate from a roe deer in Europe [17] , suggesting that the Guangxi isolates from water buffalo could be classified into two subgroups. Seven of eight isolates (BAstGX J7, BAstGX J8, BAstGX J22, BAstGX J23, BAstGX J27, BAstGX J251 and BAstGX 252) from Dairy Farm B formed a new subgroup, while one isolate (BAstGX G1) from Dairy Farm C formed a new subgroup on its own from other cattle isolates. Regardless of origin, the isolates from cattle were divided into three subgroups, while those from water buffalo were divided into two subgroups. However, five subgroups of the Guangxi cattle and water buffalo astrovirus isolates belonged to one genogroup previously composed of bovine and roe deer astroviruses (BAstv-B76-2/HK, BAstV-B18/ HK, CcAstV-1/DNK/2010 and CcAstV-2/DNK/2010) in the genus Mamastrovirus, genotype MAstV33 (Fig. 1a) . To confirm this classification, we next constructed another phylogenetic tree based on the seven predicted full-length ORF2 sequences deduced from amino acid sequences (five from cattle and two from water buffalo) obtained in this study together with other full-length ORF2 sequences of other mammalian astroviruses retrieved from the GenBank database. The phylogenetic relationships within the complete ORF2 sequences of different mammalian astroviruses were addressed in reference to the taxonomic proposals for astrovirus classification criteria as described by the Astroviridae Study Group in 2010, and each genotype was represented at least by one prototype strain. The obtained results confirmed the classification under the genus Mamastrovirus, genotype MAstV33, which, thus far, includes only cattle and roe deer astroviruses (Fig. 1b) . Both the partial and full length ORF2 sequences of water buffalo isolates constituted new subgroups in the clade of the genotype MAstV33. The above results classified water buffalo as new host species of the genus Mamastrovirus, genotype MAstV33 ( Fig. 1a and 1b) . Analysis of the ORF1b/ORF2 junction identified a highly conserved 17-nt sequence motif (5′-cgctccttgcctaaaat-3′) upstream of ORF2 within the ORF1b/ORF2 region (Fig.  2a) . The ORF1b/ORF2 overlapping region contained 56 nt that overlapped between the ORF2 start codon and the ORF1b stop codon, with the exception of BAstV NeuroS1 (a divergent bovine astrovirus). The most 3′-end of ORF2 of the bovine-related astroviruses was highly conserved by 42 nt (Fig. 2b) , while this region has been reported as conserved by only 19 nt in human astroviruses [12] .', 'cite_spans': [{'start': 952, 'end': 956, 'text': '[17]', 'ref_id': 'BIBREF18'}, {'start': 3418, 'end': 3422, 'text': '[12]', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 1746, 'end': 1755, 'text': '(Fig. 1a)', 'ref_id': None}, {'start': 2592, 'end': 2601, 'text': '(Fig. 1b)', 'ref_id': None}, {'start': 2852, 'end': 2867, 'text': 'Fig. 1a and 1b)', 'ref_id': None}, {'start': 3029, 'end': 3039, 'text': '(Fig.  2a)', 'ref_id': None}, {'start': 3321, 'end': 3330, 'text': '(Fig. 2b)', 'ref_id': None}], 'section': 'Screening and detection of BAstV in cattle and water buffalo:'}, {'text': 'Here, we detected a high prevalence of bovine astrovirus by RT-PCR from rectal swabs collected from young calves of cattle and water buffalo with diarrhea. However, more studies are needed to determine whether the persistent diarrhea observed in these calves was mainly associated with the high prevalence of astroviruses, as previous studies reported that bovine astroviruses were not directly associated with severe diarrhea in calves under natural conditions [4, 24] . However, other reports [14, 26] indicated that bovine astrovirus may evolve to severe diarrhea in co-infections with other gastrointestinal viruses, as in the case of BAstV co-infection with BRV or BToV (Breda virus) [26] . Nonetheless, the epidemiology of bovine astrovirus remains unclear, especially considering the limited number of studies of cattle and water buffalo. While excretion of BAstV may occur in up to 60-100% of calves on farms [4] , only 5 (2.4%) of 209 rectal swabs collected from asymptomatic adult cattle were positive for BAstV [21] . In the present study, sampling at different time points demonstrated a high prevalence of up to 56.52% among calves with diarrhea. Moreover, in our complementary study, astrovirus was detected alongside other gastrointestinal viruses, including BEV, BCoV, BRV and BVDV, in 87.5% of cases. Surprisingly, 12.5% of these cases were positive for bovine astrovirus, but yet negative for other tested gastrointestinal viruses. In contrast, titers of BRV and BToV, which have been previously reported as principal gastrointestinal co-infecting viruses with bovine astrovirus, were minimal or undetectable in this study. From these results, it is clear that astrovirus may be directly associated with diarrhea or possibly linked to other factors, such as poor hygienic conditions or associated with other non-viral pathogens, such as bacteria or parasites, which are known causative agents of diarrhea in calves. Similar results were reported in Korea, where co-infection of bovine astrovirus with gastrointestinal viruses, other than BRV and BToV, was associated with clinical symptoms of diarrhea in 20-and 14-day-old calves [14] .', 'cite_spans': [{'start': 462, 'end': 465, 'text': '[4,', 'ref_id': 'BIBREF3'}, {'start': 466, 'end': 469, 'text': '24]', 'ref_id': 'BIBREF25'}, {'start': 495, 'end': 499, 'text': '[14,', 'ref_id': 'BIBREF15'}, {'start': 500, 'end': 503, 'text': '26]', 'ref_id': 'BIBREF27'}, {'start': 689, 'end': 693, 'text': '[26]', 'ref_id': 'BIBREF27'}, {'start': 917, 'end': 920, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 1022, 'end': 1026, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 2148, 'end': 2152, 'text': '[14]', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'DISCUSSION'}, {'text': 'Our phylogenetic analysis showed that all isolates in this study were closely related to BAstV-B76-2/HK, BAstV-B18/ HK, CcAstV-1/DNK/2010 and CcAstV-2/DNK/2010, but highly divergent from a BAstV NeuroS1 isolate previously associated with neurologic disease in cattle in the U.S.A. [10] . Nonetheless, our results support that proposal [21] that BAstV and CcAstV may be different strains of the same virus, and water buffalo may be a new host of the BAstV variant of this virus. Moreover, most sequences derived from one farm belonged to one subgroup, although sequence analysis clearly demonstrated origins from different strains. In addition, no significant genetic differences were observed between the bovine and water buffalo astrovirus strains investigated in this study (Table 4 ). These results further support previous evidence that one farm could serve as a reservoir of different bovine astrovirus strains, suggesting possible outbreaks of novel astroviruses due to mutation or recombination events. Notably, considering the history of astroviruses, recombination events have been described in cattle, swine, humans and poultry [19, 21, 22] , and coinfection of two different astroviruses in one head of cattle has been previously reported as well [21] . Consequently, it is important to screen for and control astrovirus infection in order to prevent eventual outbreaks of highly pathogenic astroviruses resulting in mutation or recombination events on farms. Furthermore, the astrovirus isolates from cattle and water buffalo isolated in this study displayed relatively close relationships, indicating that these animals were infected with diverse astroviruses, which probably evolved from the same viral ancestor. Consequently, given these close relationships, evidence exists of possible cross-infection between the two hosts; therefore, control measures against bovine astrovirus should also be taken into consideration when screening of viruses in water buffalo populations.', 'cite_spans': [{'start': 281, 'end': 285, 'text': '[10]', 'ref_id': 'BIBREF11'}, {'start': 335, 'end': 339, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 1138, 'end': 1142, 'text': '[19,', 'ref_id': 'BIBREF20'}, {'start': 1143, 'end': 1146, 'text': '21,', 'ref_id': 'BIBREF22'}, {'start': 1147, 'end': 1150, 'text': '22]', 'ref_id': 'BIBREF23'}, {'start': 1258, 'end': 1262, 'text': '[21]', 'ref_id': 'BIBREF22'}], 'ref_spans': [{'start': 776, 'end': 784, 'text': '(Table 4', 'ref_id': None}], 'section': 'DISCUSSION'}, {'text': 'Appreciation of the genetic diversity and evolution of astroviruses among wild and domestic animal populations is important to fully understand this challenging gastrointestinal virus [21] . However, the organization of the BAstV genome has not yet been fully described. In this study, a sequence motif upstream of ORF2 was predicted to be the signal of the putative promoter for subgenomic RNA (sgRNA) synthesis in bovine astrovirus as well as that for the ORF1b/ORF2 overlap sequence and the most 3′-end of ORF2. It has been suggested that in astroviruses [13, 23] , a conserved sequence acts as a putative promoter for sgRNA synthesis upstream of ORF2. In human astroviruses, the ORF1b/ORF2 overlap is 8 nt in length, while in duck astroviruses, the ORF1b/ORF2 junctions are not overlapped [6, 13, 23] . In contrast, the overlap in the ORF1b/ ORF2 junction of bovine astroviruses may be longer (56 nt) than that of the other known astroviruses. Moreover, compared Fig. 1 . Phylogenetic relationships between the Guangxi bovine astroviruses and other mammalian astroviruses retrieved from the NCBI database. Phylogenetic trees were constructed based on both predicted partial ORF2 (Fig.1a) and full-length ORF2 (Fig.1b) amino acid sequences of the Guangxi bovine astrovirus and documented full-length ORF2 sequences from other mammal astroviruses. The phylogenetic trees were generated using the Bootstrap Test Phylogeny algorithm with the neighbor-joining method included in the MEGA 4.1 software package. Each genotype of the genus Mamastrovirus was represented at least by one or more prototype strains, and genotypes are highlighted. Classification was based on the Taxonomic Proposals submitted to the ICTV by the Astroviridae Study Group in 2010. The Guangxi isolates derived from cattle are marked by (•), and isolates derived from water buffalo are marked by (■). a with a previous report [12] , the 3′-end of ORF2 of bovine astroviruses was highly conserved, although our results suggested further studies and analysis of more sequences from several novel bovine astroviruses to fully characterize ORF2 of bovine astrovirus. In summary, this study is of interest at both the epidemiological and genetic levels. These results will certainly contribute to the understanding of the evolution and pathol-b ogy of bovine astrovirus in cattle and water buffalo, as not only did we provide useful reference material for further studies, but also isolated bovine astrovirus in water buffalo for the first time. The present study is thus far among the largest epidemiological investigations of bovine astrovirus conducted at the farm level in the dairy industry in China.', 'cite_spans': [{'start': 184, 'end': 188, 'text': '[21]', 'ref_id': 'BIBREF22'}, {'start': 558, 'end': 562, 'text': '[13,', 'ref_id': 'BIBREF14'}, {'start': 563, 'end': 566, 'text': '23]', 'ref_id': 'BIBREF24'}, {'start': 793, 'end': 796, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 797, 'end': 800, 'text': '13,', 'ref_id': 'BIBREF14'}, {'start': 801, 'end': 804, 'text': '23]', 'ref_id': 'BIBREF24'}, {'start': 1899, 'end': 1903, 'text': '[12]', 'ref_id': 'BIBREF13'}], 'ref_spans': [{'start': 967, 'end': 973, 'text': 'Fig. 1', 'ref_id': None}, {'start': 1183, 'end': 1191, 'text': '(Fig.1a)', 'ref_id': None}, {'start': 1213, 'end': 1221, 'text': '(Fig.1b)', 'ref_id': None}], 'section': 'DISCUSSION'}, {'text': 'ACKNOWLEDGMENTS. This study was supported by grants from the China Agriculture Research System, Guangxi Piggery Industry Innovation Experts Team Contract (no.: nycytxgxcxtd-03-15-1), National Natural Science Foundation of China (no.: 31460671) and the Swine Principal Epidemic Diseases Prevention and Control Techniques Research Contract (no.: 112333007-3A). Fig. 2 . a: Alignment of the Guangxi cattle and water buffalo astrovirus isolates and NCBI sequences comprising the ORF1b/ORF2 junction identified a highly conserved sequence motif upstream of the ORF2 start codon. Given its site and conservation among strains, this sequence was predicted to be related with the putative promoter for sgRNA synthesis in bovine astroviruses (DNAstar, MegAlign Program: ClustalW Method). b: Alignment of the Guangxi cattle and water buffalo astrovirus isolates and bovine astroviruses fulllength ORF2 sequences retrieved from the NCBI database with a 42-nt, highly conserved sequence in the most 3′-end of ORF2 (DNAstar, MegAlign Program: ClustalW Method).', 'cite_spans': [], 'ref_spans': [{'start': 359, 'end': 365, 'text': 'Fig. 2', 'ref_id': None}], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Letter: Viruses and gastroenteritis in infants', 'authors': [{'first': 'H', 'middle': [], 'last': 'Appleton', 'suffix': ''}, {'first': 'P', 'middle': ['G'], 'last': 'Higgins', 'suffix': ''}], 'year': 1975, 'venue': 'Lancet', 'volume': '1', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1016/S0140-6736(75)92581-7']}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Major foodborne illness causing viruses and current status of vaccines against the diseases', 'authors': [{'first': 'C', 'middle': ['D'], 'last': 'Atreya', 'suffix': ''}], 'year': 2004, 'venue': 'Foodborne Pathog. Dis', 'volume': '1', 'issn': '', 'pages': '89--96', 'other_ids': {'DOI': ['10.1089/153531404323143602']}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Detection of a novel astrovirus in brain tissue of mink suffering from shaking mink syndrome by use of viral metagenomics', 'authors': [{'first': 'A', 'middle': ['L'], 'last': 'Blomström', 'suffix': ''}, {'first': 'F', 'middle': [], 'last': 'Widén', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Hammer', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Belák', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Berg', 'suffix': ''}], 'year': 2010, 'venue': 'J. Clin. Microbiol', 'volume': '48', 'issn': '', 'pages': '4392--4396', 'other_ids': {'DOI': ['10.1128/JCM.01040-10']}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Characterization of a calici-like virus (Newbury agent) found in association with astrovirus in bovine diarrhea', 'authors': [{'first': 'J', 'middle': ['C'], 'last': 'Bridger', 'suffix': ''}, {'first': 'G', 'middle': ['A'], 'last': 'Hall', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Brown', 'suffix': ''}], 'year': 1984, 'venue': 'Infect. Immun', 'volume': '43', 'issn': '', 'pages': '133--138', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Astrovirus infections in humans and animals -molecular biology, genetic diversity, and interspecies transmissions', 'authors': [{'first': 'P', 'middle': [], 'last': 'De Benedictis', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schultz-Cherry', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Burnham', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Cattoli', 'suffix': ''}], 'year': 2011, 'venue': 'Infect. Genet. Evol', 'volume': '11', 'issn': '', 'pages': '1529--1544', 'other_ids': {'DOI': ['10.1016/j.meegid.2011.07.024']}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Complete sequence of a duck astrovirus associated with fatal hepatitis in ducklings', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Fu', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Pan', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Xu', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Xie', 'suffix': ''}, {'first': 'N', 'middle': ['J'], 'last': 'Knowles', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Yang', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Zhang', 'suffix': ''}], 'year': 2009, 'venue': 'J. Gen. Virol', 'volume': '90', 'issn': '', 'pages': '1104--1108', 'other_ids': {'DOI': ['10.1099/vir.0.008599-0']}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Detection of bovine torovirus in neonatal calf diarrhoea in Lower Austria and Styria (Austria)', 'authors': [{'first': 'B', 'middle': [], 'last': 'Haschek', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Klein', 'suffix': ''}, {'first': 'V', 'middle': [], 'last': 'Benetka', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Herrera', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Sommerfeld-Stur', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Vilcek', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Moestl', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Baumgartner', 'suffix': ''}], 'year': 2006, 'venue': 'J. Vet. Med. B Infect. Dis. Vet. Public Health', 'volume': '53', 'issn': '', 'pages': '160--165', 'other_ids': {'DOI': ['10.1111/j.1439-0450.2006.00936.x']}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Survey of bovine enterovirus in biological and environmental samples by a highly sensitive real-time reverse transcription-PCR', 'authors': [{'first': 'J', 'middle': ['C'], 'last': 'Sáiz', 'suffix': ''}], 'year': 2005, 'venue': 'Appl. Environ. Microbiol', 'volume': '71', 'issn': '', 'pages': '3536--3543', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Comparison of capsid sequences from human and animal astroviruses', 'authors': [{'first': 'C', 'middle': ['M'], 'last': 'Jonassen', 'suffix': ''}, {'first': 'T', 'middle': ['O'], 'last': 'Jonassen', 'suffix': ''}, {'first': 'Y', 'middle': ['M'], 'last': 'Saif', 'suffix': ''}, {'first': 'D', 'middle': ['R'], 'last': 'Snodgrass', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Ushijima', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Shimizu', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Grinde', 'suffix': ''}], 'year': 2001, 'venue': 'J. Gen. Virol', 'volume': '82', 'issn': '', 'pages': '1061--1067', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Divergent astrovirus associated with neurologic disease in cattle', 'authors': [{'first': 'L', 'middle': [], 'last': 'Li', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Diab', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Mcgraw', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Barr', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Traslavina', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Higgins', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Talbot', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Blanchard', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Rimoldi', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Fahsbender', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Page', 'suffix': ''}, {'first': 'T', 'middle': ['G'], 'last': 'Phan', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wang', 'suffix': ''}, {'first': 'X', 'middle': [], 'last': 'Deng', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Pesavento', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Delwart', 'suffix': ''}], 'year': 2013, 'venue': 'Emerg. Infect. Dis', 'volume': '19', 'issn': '', 'pages': '1385--1392', 'other_ids': {'DOI': ['10.3201/eid1909.130682']}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Detection of bovine Coronavirus by RT-PCR in a field study', 'authors': [{'first': 'K', 'middle': [], 'last': 'Mohammad', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ahmad', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Hadi', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Farhid', 'suffix': ''}], 'year': 2006, 'venue': 'Vet. Arhiv', 'volume': '76', 'issn': '', 'pages': '296--296', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Molecular characterisation of the 3′-end of the astrovirus genome', 'authors': [{'first': 'C', 'middle': [], 'last': 'Monceyron', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Grinde', 'suffix': ''}, {'first': 'T', 'middle': ['O'], 'last': 'Jonassen', 'suffix': ''}], 'year': 1997, 'venue': 'Arch. Virol', 'volume': '142', 'issn': '', 'pages': '699--706', 'other_ids': {'DOI': ['10.1007/s007050050112']}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Subgenomic RNA sequence of human astrovirus supports classification of Astroviridae as a new family of RNA viruses', 'authors': [{'first': 'S', 'middle': ['S'], 'last': 'Monroe', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Jiang', 'suffix': ''}, {'first': 'S', 'middle': ['E'], 'last': 'Stine', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Koopmans', 'suffix': ''}, {'first': 'R', 'middle': ['I'], 'last': 'Glass', 'suffix': ''}], 'year': 1993, 'venue': 'J. Virol', 'volume': '67', 'issn': '', 'pages': '3611--3614', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Phylogenetic analysis of bovine astrovirus in Korean cattle', 'authors': [{'first': 'J', 'middle': ['K'], 'last': 'Oem', 'suffix': ''}, {'first': 'D', 'middle': ['J'], 'last': 'An', 'suffix': ''}], 'year': 2014, 'venue': 'Virus Genes', 'volume': '48', 'issn': '', 'pages': '372--375', 'other_ids': {'DOI': ['10.1007/s11262-013-1013-0']}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Identification of a novel astrovirus in domestic sheep in Hungary', 'authors': [{'first': 'G', 'middle': [], 'last': 'Reuter', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Pankovics', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Delwart', 'suffix': ''}, {'first': 'Á', 'middle': [], 'last': 'Boros', 'suffix': ''}], 'year': 2012, 'venue': 'Arch. Virol', 'volume': '157', 'issn': '', 'pages': '323--327', 'other_ids': {'DOI': ['10.1007/s00705-011-1151-4']}}, 'BIBREF17': {'ref_id': 'b17', 'title': '3′ end cDNA amplification using classic RACE', 'authors': [{'first': 'E', 'middle': [], 'last': 'Scotto-Lavino', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Du', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Frohman', 'suffix': ''}], 'year': 2006, 'venue': 'Nat. Protoc', 'volume': '1', 'issn': '', 'pages': '2742--2745', 'other_ids': {'DOI': ['10.1038/nprot.2006.481']}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Identification and characterization of deer astroviruses', 'authors': [{'first': 'S', 'middle': ['L'], 'last': 'Smits', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Van Leeuwen', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Kuiken', 'suffix': ''}, {'first': 'A', 'middle': ['S'], 'last': 'Hammer', 'suffix': ''}, {'first': 'J', 'middle': ['H'], 'last': 'Simon', 'suffix': ''}, {'first': 'A', 'middle': ['D'], 'last': 'Osterhaus', 'suffix': ''}], 'year': 2010, 'venue': 'J. Gen. Virol', 'volume': '91', 'issn': '', 'pages': '2719--2722', 'other_ids': {'DOI': ['10.1099/vir.0.024067-0']}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Complete genome sequence of an astrovirus identified in a domestic rabbit (Oryctolagus cuniculus) with gastroenteritis', 'authors': [{'first': 'M', 'middle': ['D'], 'last': 'Stenglein', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Velazquez', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Greenacre', 'suffix': ''}, {'first': 'R', 'middle': ['P'], 'last': 'Wilkes', 'suffix': ''}, {'first': 'J', 'middle': ['G'], 'last': 'Ruby', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Lankton', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Ganem', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Kennedy', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Derisi', 'suffix': ''}], 'year': 2012, 'venue': 'Virol. J', 'volume': '9', 'issn': '', 'pages': '', 'other_ids': {'DOI': ['10.1186/1743-422X-9-216']}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Genomic analysis of closely related astroviruses', 'authors': [{'first': 'E', 'middle': [], 'last': 'Strain', 'suffix': ''}, {'first': 'L', 'middle': ['A'], 'last': 'Kelley', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Schultz-Cherry', 'suffix': ''}, {'first': 'S', 'middle': ['V'], 'last': 'Muse', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': 'Koci', 'suffix': ''}], 'year': 2008, 'venue': 'J. Virol', 'volume': '82', 'issn': '', 'pages': '5099--5103', 'other_ids': {'DOI': ['10.1128/JVI.01993-07']}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Detection of group A Bovine Rotavirus in diarrhoeic calves by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and electropherotyping', 'authors': [{'first': 'T', 'middle': [], 'last': 'Suresh', 'suffix': ''}, {'first': 'R', 'middle': ['B'], 'last': 'Rai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Dhama', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Bhattl', 'suffix': ''}, {'first': 'P', 'middle': ['M'], 'last': 'Sawant', 'suffix': ''}, {'first': 'A', 'middle': ['K'], 'last': 'Sharma', 'suffix': ''}], 'year': 2011, 'venue': 'Vet. Pract', 'volume': '12', 'issn': '', 'pages': '133--137', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Rediscovery and genomic characterization of bovine astroviruses', 'authors': [{'first': 'H', 'middle': [], 'last': 'Tse', 'suffix': ''}, {'first': 'W', 'middle': ['M'], 'last': 'Chan', 'suffix': ''}, {'first': 'H', 'middle': ['W'], 'last': 'Tsoi', 'suffix': ''}, {'first': 'R', 'middle': ['Y'], 'last': 'Fan', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Lau', 'suffix': ''}, {'first': 'S', 'middle': ['K'], 'last': 'Lau', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Woo', 'suffix': ''}, {'first': 'K', 'middle': ['Y'], 'last': 'Yuen', 'suffix': ''}], 'year': 2011, 'venue': 'J. Gen. Virol', 'volume': '92', 'issn': '', 'pages': '1888--1898', 'other_ids': {'DOI': ['10.1099/vir.0.030817-0']}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Genomic analysis of two ORF2 segments of new porcine astrovirus isolates and their close relationship with human astroviruses', 'authors': [{'first': 'J', 'middle': ['C'], 'last': 'Ulloa', 'suffix': ''}, {'first': 'M', 'middle': ['F'], 'last': 'Gutiérrez', 'suffix': ''}], 'year': 2010, 'venue': 'Can. J. Microbiol', 'volume': '56', 'issn': '', 'pages': '569--577', 'other_ids': {'DOI': ['10.1139/W10-042']}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'Identification and sequence determination of the capsid protein gene of human astrovirus serotype 1', 'authors': [{'first': 'M', 'middle': ['M'], 'last': 'Willcocks', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Carter', 'suffix': ''}], 'year': 1993, 'venue': 'FEMS Microbiol. Lett', 'volume': '114', 'issn': '', 'pages': '1--7', 'other_ids': {'DOI': ['10.1111/j.1574-6968.1993.tb06542.x']}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'Isolation of small viruses resembling astroviruses and caliciviruses from acute enteritis of calves', 'authors': [{'first': 'G', 'middle': ['N'], 'last': 'Woode', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Bridger', 'suffix': ''}], 'year': 1978, 'venue': 'J. Med. Microbiol', 'volume': '11', 'issn': '', 'pages': '441--452', 'other_ids': {'DOI': ['10.1099/00222615-11-4-441']}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Serotypes of bovine astrovirus', 'authors': [{'first': 'G', 'middle': ['N'], 'last': 'Woode', 'suffix': ''}, {'first': 'N', 'middle': ['E'], 'last': 'Gourley', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Pohlenz', 'suffix': ''}, {'first': 'E', 'middle': ['M'], 'last': 'Liebler', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Mathews', 'suffix': ''}, {'first': 'M', 'middle': ['P'], 'last': 'Hutchinson', 'suffix': ''}], 'year': 1985, 'venue': 'J. Clin. Microbiol', 'volume': '22', 'issn': '', 'pages': '668--670', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Astrovirus and Breda virus infections of dome cell epithelium of bovine ileum', 'authors': [{'first': 'G', 'middle': ['N'], 'last': 'Woode', 'suffix': ''}, {'first': 'J', 'middle': ['F'], 'last': 'Pohlenz', 'suffix': ''}, {'first': 'N', 'middle': ['E'], 'last': 'Gourley', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Fagerland', 'suffix': ''}], 'year': 1984, 'venue': 'J. Clin. Microbiol', 'volume': '19', 'issn': '', 'pages': '623--630', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Establishment and Application of a RT-PCR Assay for Detection of Bovine Viral Diarrhea Virus', 'authors': [{'first': 'S', 'middle': ['Q'], 'last': 'Zhang', 'suffix': ''}, {'first': 'Li', 'middle': [], 'last': 'Guo', 'suffix': ''}, {'first': 'T', 'middle': ['T'], 'last': 'Zhang', 'suffix': ''}, {'first': 'Y', 'middle': ['W'], 'last': 'Wu', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wu', 'suffix': ''}], 'year': 2011, 'venue': 'China Animal Husbandry Vet. Med', 'volume': '38', 'issn': '', 'pages': '159--162', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Detection of diverse astroviruses from bats in China', 'authors': [{'first': 'H', 'middle': ['C'], 'last': 'Zhu', 'suffix': ''}, {'first': 'D', 'middle': ['K'], 'last': 'Chu', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Liu', 'suffix': ''}, {'first': 'B', 'middle': ['Q'], 'last': 'Dong', 'suffix': ''}, {'first': 'S', 'middle': ['Y'], 'last': 'Zhang', 'suffix': ''}, {'first': 'J', 'middle': ['X'], 'last': 'Zhang', 'suffix': ''}, {'first': 'L', 'middle': ['F'], 'last': 'Li', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Vijaykrishna', 'suffix': ''}, {'first': 'G', 'middle': ['J'], 'last': 'Smith', 'suffix': ''}, {'first': 'H', 'middle': ['L'], 'last': 'Chen', 'suffix': ''}, {'first': 'L', 'middle': ['L'], 'last': 'Poon', 'suffix': ''}, {'first': 'J', 'middle': ['S'], 'last': 'Peiris', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Guan', 'suffix': ''}], 'year': 2009, 'venue': 'J. Gen. Virol', 'volume': '90', 'issn': '', 'pages': '883--887', 'other_ids': {'DOI': ['10.1099/vir.0.007732-0']}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'Pair distances of nucleotide sequences between bovine and water buffalo astrovirus strains', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': '(forward, B-GSP2-2F) 5′-AACAGC ACAGGGAGAGGTATAAGCA-3′ and (reverse, B5130R) 5′-TGGCACGTGTTTCATAGGTCT-3′ (expected product length, 1,850 bp); and (2) (forward, B1350F) 5′-ATCATA CAGGCGGGCACGAGT-3′ and (reverse, B1205R) 5′-CCCTTCACCTATGCTAATCAAATC-3′ (expected product length, 1,426 bp). For PCR, the final reaction volume of 25 µl consisted of 2.5 µl of 10x L.A Taq Polymerase buffer, 4.0 µl of dNTP mixture (2.5 mM each), 0.25 µl of LA Taq Polymerase (Takara Bio, Inc.), 0.5 µl forward (DPF) and reverse (DPF) primers each, 2.5 µl of cDNA template, and 14.75 µl of ddH2O.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Sample collection and RT-PCR detection of BAstV', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Primer sequences used for detection of other bovine gastrointestinal viruses', 'latex': None, 'type': 'table'}, 'TABREF2': {'text': 'The status of co-infection of BAstV with other bovine gastrointestinal viruses', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n",
      "{'_id': ObjectId('5f4ecb70f99e41e2ba784155'), 'paper_id': '0a2ded6cbd632857d491140a57f2773c3610b10b', 'metadata': {'title': 'MRI findings of neuronal ceroid lipofuscinosis in a cat', 'authors': [{'first': 'Crystal', 'middle': [], 'last': 'White', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': 'crwhite@alumni.rvc.ac.uk'}, {'first': 'Jeremy', 'middle': [], 'last': 'Mortier', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}, {'first': 'Ranieri', 'middle': [], 'last': 'Verin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}, {'first': 'Thomas', 'middle': [], 'last': 'Maddox', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}, {'first': 'Rita', 'middle': [], 'last': 'Goncalves', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}, {'first': 'Daniel', 'middle': [], 'last': 'Sanchez-Masian', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Liverpool', 'location': {'settlement': 'Merseyside', 'country': 'UK'}}, 'email': ''}]}, 'abstract': [{'text': 'Case summary A 2-year-old male domestic shorthair cat presented to the University of Liverpool Small Animal Teaching Hospital with a 2 week history of altered mentation, blindness and focal epileptic seizures. MRI examination revealed generalised cerebral and cerebellar atrophy, diffuse T2-weighted hyperintensity of the white matter and meningeal thickening. Neuronal ceroid lipofuscinosis was confirmed on post-mortem examination. Relevance and novel information This is the first report of the MRI findings of neuronal ceroid lipofuscinosis in a cat.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'This paper was handled and processed by the European Editorial Office (ISFM) for publication in JFMS Open Reports', 'cite_spans': [], 'ref_spans': [], 'section': ''}, {'text': \"A 2-year-old, 3.4 kg male neutered domestic shorthair cat presented to the University of Liverpool Small Animal Teaching Hospital with a 2 week history of progressive weight loss, altered mentation, blindness and suspected focal epileptic seizures. Relevant history included a single visit to the referring veterinary surgeon 6 months prior to presentation for nonspecific behavioural changes. On neurological examination, the cat's mentation was obtunded and disorientated. The menace response was markedly reduced bilaterally with intact pupillary light reflexes. Jaw clattering and hypersalivation were demonstrated intermittently, consistent with focal epileptic seizure activity. Stimulus resulted in hyper-reactivity and hypertonicity of all limbs, thus hindering a comprehensive neurological examination, including ophthalmological and visual assessment. Gait analysis was not possible owing to the cat's obtunded status and hyper-reactivity. The remaining general examination was unremarkable. Based on the clinical signs and limited neurological examination, a diffuse forebrain neurolocalisation was suspected. The main differential diagnoses for a 2-year-old cat with diffuse forebrain neurolocalisation included metabolic disease (lysosomal storage disease, thiamine deficiency, hepatic encephalopathy), infectious causes (feline infectious peritonitis, toxoplasmosis, bacterial meningitis), immune-mediated disease (meningoencephalitis of unknown origin), developmental disease (lissencephaly, microencephaly) and degenerative disease (neuroaxonal dystrophy and leukoencephalomyelopathy). Biochemistry, including fasting ammonia and preprandial bile acids, and haematology were within normal limits. Serological testing for feline leukaemia virus, feline immunodeficiency virus, feline coronavirus and toxoplasmosis were negative. Cerebrospinal fluid analysis, including total protein, total nucleated cell count and cytology, was unremarkable.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': 'MRI of the brain was performed using a 1.5 T magnet (Philips Ingenia CX). All slices were 3 mm thick with a 0.3 mm slice gap. Sagittal, dorsal and transverse T2-weighted (T2W) images were acquired. Transverse images for fluid-attenuated inversion recovery (FLAIR), T2*W, T1-weighted before and after intravenous administration of contrast medium (gadobutrol 0.1 mmol/kg bodyweight [Gadovist;', 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': 'Bayer]) and proton-density weighted sequences were obtained.', 'cite_spans': [], 'ref_spans': [], 'section': 'Case description'}, {'text': 'On all sequences there was thinning of the cerebral and cerebellar cortices with widening of the corresponding sulci, demonstrating diffuse cortical atrophy. The corpus callosum was markedly thin and only partially visualised with absence of a visible rostrum, genu and body. Moderate, generalised symmetrical dilation of the ventricular system was present, with complete suppression of contents on FLAIR, indicating that the cerebrospinal fluid was not markedly abnormal. Mild, generalised, symmetrical and homogeneous increased T2W signal intensity of the cerebral white matter was visible, with consequent decrease in the distinction between the white and grey matter ( Figure 1 ). The pachymeninges were mildly and diffusely thickened.', 'cite_spans': [], 'ref_spans': [{'start': 673, 'end': 681, 'text': 'Figure 1', 'ref_id': 'FIGREF0'}], 'section': 'Case description'}, {'text': 'There were no regions of abnormal contrast enhancement. Generalised and marked thickening of the calvarium and osseous tentorium cerebelli was visible (calvarial hyperostosis) with reduction of the fat signal of the diploe ( Figure 2 ). The remaining bones of the skull were normal. Given the MRI findings and the signalment of the cat the presumptive diagnosis was an inherited neurodegenerative disorder, most likely neuronal ceroid lipofuscinosis or other lysosomal storage disease.', 'cite_spans': [], 'ref_spans': [{'start': 225, 'end': 233, 'text': 'Figure 2', 'ref_id': 'FIGREF2'}], 'section': 'Case description'}, {'text': \"Following the presumptive diagnosis of neurodegenerative lysosomal storage disease and worsening of clinical signs the cat was euthanased on humane grounds and underwent a full post-mortem examination. Grossly, the meninges were diffusely moderately thickened and the brain showed moderate diffuse and bilateral cortical atrophy with narrowing of gyri and widening of sulci The cat's left is on the right. Symmetric ventriculomegaly is apparent (*). There is poor white matter/grey matter distinction owing to diffuse hyperintensity of the white matter on T2W sequence. Marked cortical atrophy and widening of the cerebral sulci are visible (black arrow). Generalised, even calvarial hyperostosis is noted (white arrow) ( Figure 3a ). Subjectively, a mild dilation of the ventricular system was observed. Sections of meninges and relevant areas of the brain and cerebellum, including motor, somatosensory, limbic, vestibular and visual system, were sampled for histopathology and transmission electron microscopy (TEM). Samples of the spinal cord at the level of the cervical and lumbosacral intumescences (C5-T1 and L3-L6, respectively) were also obtained for histopathology.\", 'cite_spans': [], 'ref_spans': [{'start': 722, 'end': 731, 'text': 'Figure 3a', 'ref_id': 'FIGREF3'}], 'section': 'Case description'}, {'text': \"Meninges showed diffuse moderate thickening due to deposition of palely eosinophilic mature collagen interpreted as fibrosis and confirmed with Masson's trichrome stain. All cerebral areas examined showed mildto-moderate gliosis and moderate loss of neurons (more severe in cortical areas) with numerous neurons distended and enlarged by botryoid, palely acidophilic to glassy cytoplasmic inclusions (Figure 3b (Figure 3i ), consistent morphologically with previously described intra-neuronal lipofuscins in cats. [1] [2] [3] [4] No further gross and histopathological changes were observed in the main thoracic and abdominal organs, including autonomic ganglia. Furthermore, both eyes were thoroughly examined to rule out the presence of retinal neuronal inclusions and to confirm the suspect of central blindness. Neither eye showed histopathological changes.\", 'cite_spans': [{'start': 514, 'end': 517, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 518, 'end': 521, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 522, 'end': 525, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 526, 'end': 529, 'text': '[4]', 'ref_id': 'BIBREF3'}], 'ref_spans': [{'start': 400, 'end': 410, 'text': '(Figure 3b', 'ref_id': 'FIGREF3'}, {'start': 411, 'end': 421, 'text': '(Figure 3i', 'ref_id': 'FIGREF3'}], 'section': 'Case description'}, {'text': 'To our knowledge this is the first report of MRI findings in a cat with confirmed neuronal ceroid lipofuscinosis. The neuronal ceroid lipofuscinoses represent a heterogeneous group of genetically determined neurodegenerative lysosomal storage diseases. The disease is characterised by abnormal accumulation of autofluorescent lipopigments within the neuronal and extraneural tissue. 5 Neuronal ceroid lipofuscinosis has been described in several domestic species, including dogs, cats, cattle, sheep, goats, monkeys and mice. [6] [7] [8] [9] [10] [11] [12] [13] Clinical signs are similar in all species, including humans, and involve progressive cognitive decline, motor dysfunction, vision deficits and epileptic seizures, ultimately resulting in death or euthanasia. Symptomatic management is generally the mainstay of treatment. 14 Encouraging results have, however, been seen using enzyme-replacement therapy and gene therapy. 15 Carnitine is a breakdown product of subunit c protein, a major component of the storage material that accumulates in a number of neuronal ceroid lipofuscinoses. Delays in cognitive dysfunction have been reported in English Springer Spaniels supplemented long term with carnitine. 15 However, despite these therapeutic advances, neuronal ceroid lipofuscinoses remain an incurable group of diseases.', 'cite_spans': [{'start': 383, 'end': 384, 'text': '5', 'ref_id': 'BIBREF4'}, {'start': 526, 'end': 529, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 530, 'end': 533, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 534, 'end': 537, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 538, 'end': 541, 'text': '[9]', 'ref_id': 'BIBREF8'}, {'start': 542, 'end': 546, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 547, 'end': 551, 'text': '[11]', 'ref_id': 'BIBREF10'}, {'start': 552, 'end': 556, 'text': '[12]', 'ref_id': 'BIBREF11'}, {'start': 557, 'end': 561, 'text': '[13]', 'ref_id': 'BIBREF12'}, {'start': 833, 'end': 835, 'text': '14', 'ref_id': 'BIBREF13'}, {'start': 932, 'end': 934, 'text': '15', 'ref_id': 'BIBREF14'}, {'start': 1215, 'end': 1217, 'text': '15', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The cat in this case demonstrated generalised and symmetrical brain cortical atrophy and secondary dilation of the ventricular system and intracranial subarachnoid space (hydrocephalus ex vacuo). These MRI findings have been consistently described in humans and dogs and are considered cardinal signs for neuronal ceroid lipofuscinosis. 10, [16] [17] [18] [19] The cat in this report also showed moderate meningeal thickening. This finding, not described in the human form of the disease, was also reported in three Chihuahuas and a Dachshund with neuronal ceroid lipofuscinosis. 9,20 An autoimmune cause of meningeal thickening has been alluded to; however, in the case of the Dachshund, a subdural haematoma was also identified and the findings of thickened meninges could represent reactive meningitis. In our case, the moderate meningeal thickening was due to the diffuse moderate hypertrophy and fibrosis, and could be interpreted as an adaptive change due to brain atrophy. Hyperostosis of the osseous tentorium cerebelli and calvarium is visible (black arrow). There is mild widening of the cerebellar sulci (<) due to cerebellar atrophy Diffuse T2W white matter hyperintensity with reduction in the white/grey matter distinction has not been previously described in the veterinary literature. A possible explanation for this could be that animals previously reported were scanned with lower field strength MRI magnets. Better contrast resolution of higher field magnets and newer MRI systems could account for this new finding. In humans, periventricular white matter T2W hyperintensity is a common finding in neuronal ceroid lipofuscinosis, confirmed as gliosis and demyelination on histology. In one study, the authors also described a diffuse increase in T2W signal intensity of the white matter. 21 Our patient showed a thinned and partially visualised corpus callosum, which, in this case, likely resulted from the generalised brain atrophy. Atrophy of the corpus callosum has also been described in dogs and humans with neuronal ceroid lipofuscinosis. 18, 22 The cat in our report had generalised calvarial hyperostosis. No skeletal abnormality has been previously described in the human or animal form of the disease. We believe calvarial hyperostosis developed in response to the chronic ex vacuo negative pressure induced by the brain cortical atrophy. Gross and histopathological findings were consistent with previous cases of neuronal ceroid lipofuscinosis in cats, [1] [2] [3] [4] and confirmed the presence of lysosomal storage neuronal disease with autofluorescent material. TEM showed the presence of characteristic small curvilinear lamellar stacks and electron-dense granular material, consistent morphologically with previously described intra-neuronal lipofuscins in cats, making the diagnosis of neuronal ceroid lipofuscinosis highly likely in this case. Ultrastructural intraneuronal deposits consistent with lipofuscins in cats have been described as granular osmophilic deposits (electron-dense granules), curved lamellar stacks and fingerprint profiles, although this latter, ultrastructural organisation was not observed in our case.', 'cite_spans': [{'start': 337, 'end': 340, 'text': '10,', 'ref_id': 'BIBREF9'}, {'start': 341, 'end': 345, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 346, 'end': 350, 'text': '[17]', 'ref_id': 'BIBREF16'}, {'start': 351, 'end': 355, 'text': '[18]', 'ref_id': 'BIBREF17'}, {'start': 356, 'end': 360, 'text': '[19]', 'ref_id': 'BIBREF18'}, {'start': 1808, 'end': 1810, 'text': '21', 'ref_id': 'BIBREF20'}, {'start': 2066, 'end': 2069, 'text': '18,', 'ref_id': 'BIBREF17'}, {'start': 2070, 'end': 2072, 'text': '22', 'ref_id': 'BIBREF21'}, {'start': 2486, 'end': 2489, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 2490, 'end': 2493, 'text': '[2]', 'ref_id': 'BIBREF1'}, {'start': 2494, 'end': 2497, 'text': '[3]', 'ref_id': 'BIBREF2'}, {'start': 2498, 'end': 2501, 'text': '[4]', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The cat in this case, and those reported in previous studies, 1, 2, 11 presented with neurological features in common with neuronal ceroid lipofuscinosis seen in other species, including humans. Initial manifestations of neuronal ceroid lipofuscinosis in humans occur typically between birth and young adulthood. This is mirrored in dogs and cats, with most reported cases presenting under 2 years of age, as seen in this cat. A case series of feline neuronal ceroid lipofuscinosis in three cats reported disorientation, focal (facial twitching) and generalised epileptic seizures, tactile hyperaesthesia and blindness; signs seen in this cat. 4 Similar signs are seen in humans, with a combination of retinopathy, dementia and epilepsy almost always being present. 23 In this case no lesions were observed bilaterally in the retina and therefore the blindness reported in this cat was likely central in origin.', 'cite_spans': [{'start': 62, 'end': 64, 'text': '1,', 'ref_id': 'BIBREF0'}, {'start': 65, 'end': 67, 'text': '2,', 'ref_id': 'BIBREF1'}, {'start': 68, 'end': 70, 'text': '11', 'ref_id': 'BIBREF10'}, {'start': 644, 'end': 645, 'text': '4', 'ref_id': 'BIBREF3'}, {'start': 766, 'end': 768, 'text': '23', 'ref_id': 'BIBREF22'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'To date, 14 different genes have been implemented in the development of the human form of neuronal ceroid lipofuscinosis (CLN1-CLN14). Traditionally and still commonly encountered in the literature, nomenclature was based on the age of clinical presentation, for example infantile/juvenile/adult. The storage material, along with its ultrastructure, is variable for each neuronal ceroid lipofuscinosis type, and, although similar, the clinical course is slightly altered for each one. Molecular analysis has identified the genetic loci for the neuronal ceroid lipofuscinosis types in humans, with the exception of the CLN9 gene, which remains elusive. 23 The differences in the mutations account for the variable phenotypes between the types. 24 Mutations in nine different genes have been identified in dogs, eight of which are orthologues to the human causative mutations. 23, [25] [26] [27] [28] Sequencing of the exons of CLN1, CLN3, CLN5, CLN8 and CLN10 in a confirmed case of feline neuronal ceroid lipofuscinosis failed to identify the molecular cause in that patient. 4 The genes involved in the development of feline neuronal ceroid lipofuscinosis remain unidentified.', 'cite_spans': [{'start': 652, 'end': 654, 'text': '23', 'ref_id': 'BIBREF22'}, {'start': 743, 'end': 745, 'text': '24', 'ref_id': 'BIBREF23'}, {'start': 875, 'end': 878, 'text': '23,', 'ref_id': 'BIBREF22'}, {'start': 879, 'end': 883, 'text': '[25]', 'ref_id': 'BIBREF24'}, {'start': 884, 'end': 888, 'text': '[26]', 'ref_id': 'BIBREF25'}, {'start': 889, 'end': 893, 'text': '[27]', 'ref_id': 'BIBREF26'}, {'start': 894, 'end': 898, 'text': '[28]', 'ref_id': 'BIBREF27'}, {'start': 1076, 'end': 1077, 'text': '4', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'In humans and dogs, neuronal ceroid lipofuscinosis has been shown to be a recessively inherited disease with the progeny of two carrier parents having a one in four chance of developing the disease. 14 A second cat, from the same litter as the cat in this case, developed similar clinical signs 4 weeks after its littermate and was euthansed owing to severity of clinical signs. Histopathology and TEM confirmed neuronal ceroid lipofuscinosis in this second cat with central nervous system morphological changes similar to the cat described in this case. MRI was not performed in this second case, but pathological findings and the relationship between the two littermates reinforce the hypothesis of an inherited mutation in cats. 3 ', 'cite_spans': [{'start': 732, 'end': 733, 'text': '3', 'ref_id': 'BIBREF2'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Without knowledge of the causative genes involved in feline neuronal ceroid lipofuscinosis, definitive diagnosis is based on necropsy and histopathology results alone. MRI findings, combined with clinical signs, are the mainstay of the ante-mortem presumptive diagnosis. To support the use of this imaging modality in the ante-mortem diagnosis of feline neuronal ceroid lipofuscinosis, recruitment of more feline subjects with confirmed disease into similar descriptive studies is essential in identifying distinct MRI findings within this population. Owing to the similarities in the MRI findings in this cat and those seen in humans and dogs it could be assumed that the imaging features would be the same or similar in other cases of feline neuronal ceroid lipofuscinosis. It would seem prudent, therefore, to consider neuronal ceroid lipofuscinosis within the list of differentials when faced with a cat showing similar neurological signs as our case, with evidence of generalised cerebral and cerebellar atrophy and diffuse T2W hyperintensity of the white matter on MRI.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusions'}, {'text': 'The authors declared no potential conflicts of interest with respect to the research, authorship, and/ or publication of this article.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conflict of interest'}, {'text': 'The authors received no financial support for the research, authorship, and/or publication of this article.', 'cite_spans': [], 'ref_spans': [], 'section': 'Funding'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Neuronal ceroid-lipofuscinosis in a domestic cat: clinical, morphological and immunohistochemical findings', 'authors': [{'first': 'H', 'middle': [], 'last': 'Weissenbeck', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Rossel', 'suffix': ''}], 'year': 1997, 'venue': 'J Comp Pathol', 'volume': '117', 'issn': '', 'pages': '17--24', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Neuronal ceroid-lipofuscinosis in a Japanese domestic shorthair cat', 'authors': [{'first': 'M', 'middle': [], 'last': 'Kuwamura', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nakagawa', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Nabe', 'suffix': ''}], 'year': 2009, 'venue': 'J Vet Med Sci', 'volume': '71', 'issn': '', 'pages': '665--667', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Mutational analysis of the feline CLN3 gene and an ultrastructural evaluation of lysosomal storage material in a cat with neuronal ceroid lipofuscinosis: an investigation into the molecular basis of the disease', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Furusawa', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Mizukami', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yabuki', 'suffix': ''}], 'year': 2012, 'venue': 'Vet J', 'volume': '194', 'issn': '', 'pages': '425--428', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Characterization of neuronal ceroid-lipofuscinosis in 3 cats', 'authors': [{'first': 'M', 'middle': ['D'], 'last': 'Chalkley', 'suffix': ''}, {'first': 'A', 'middle': ['G'], 'last': 'Armien', 'suffix': ''}, {'first': 'D', 'middle': ['H'], 'last': 'Gilliam', 'suffix': ''}], 'year': 2014, 'venue': 'Vet Pathol', 'volume': '51', 'issn': '', 'pages': '796--804', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Towards understanding the neuronal ceroid lipofuscinoses', 'authors': [{'first': 'A', 'middle': [], 'last': 'Kohlschutter', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Schulz', 'suffix': ''}], 'year': 2009, 'venue': 'Brain Dev', 'volume': '31', 'issn': '', 'pages': '499--502', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'A missensce mutation (c. 184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA', 'authors': [{'first': 'I', 'middle': [], 'last': 'Tammen', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Houweling', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Frugier', 'suffix': ''}], 'year': 2006, 'venue': 'Acta Biochim Biophys', 'volume': '1762', 'issn': '', 'pages': '898--905', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Neuronal ceroid-lipofuscinosis in Nubian goats', 'authors': [{'first': 'R', 'middle': ['A'], 'last': 'Fiske', 'suffix': ''}, {'first': 'R', 'middle': ['W'], 'last': 'Storts', 'suffix': ''}], 'year': 1988, 'venue': 'Vet Pathol', 'volume': '25', 'issn': '', 'pages': '173--174', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Neurovisceral ceroid lipofuscinosis in blind Devon cattle', 'authors': [{'first': 'P', 'middle': ['A'], 'last': 'Harper', 'suffix': ''}, {'first': 'K', 'middle': ['H'], 'last': 'Walker', 'suffix': ''}, {'first': 'P', 'middle': ['J'], 'last': 'Healy', 'suffix': ''}], 'year': 1988, 'venue': 'Acta Neuropathol', 'volume': '75', 'issn': '', 'pages': '632--636', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Neuronal ceroidlipofuscinosis in longhaired Chihuahuas: clinical, pathological, and MRI findings', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Nakamoto', 'suffix': ''}, {'first': 'O', 'middle': [], 'last': 'Yamato', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Uchida', 'suffix': ''}], 'year': 2011, 'venue': 'J Am Anim Hosp Assoc', 'volume': '47', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Neuronal ceroid lipofuscinosis in 3 Australian shepherd littermates', 'authors': [{'first': 'D', 'middle': ['P'], 'last': 'O&apos;brien', 'suffix': ''}, {'first': 'M', 'middle': ['L'], 'last': 'Katz', 'suffix': ''}], 'year': 2008, 'venue': 'J Vet Intern Med', 'volume': '22', 'issn': '', 'pages': '472--475', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Neuronal ceroidlipofuscinosis in a cat', 'authors': [{'first': 'R', 'middle': [], 'last': 'Bildfell', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Matwichuk', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Mitchell', 'suffix': ''}], 'year': 1995, 'venue': 'Vet Pathol', 'volume': '32', 'issn': '', 'pages': '485--488', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': \"Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Battens's disease)\", 'authors': [{'first': 'R', 'middle': ['T'], 'last': 'Bronson', 'suffix': ''}, {'first': 'B', 'middle': ['D'], 'last': 'Lake', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Cook', 'suffix': ''}], 'year': 1993, 'venue': 'Ann Neurol', 'volume': '33', 'issn': '', 'pages': '381--385', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'An unsual case of generalized ceroid-lipofuscinosis in a Cynomolgus monkey', 'authors': [{'first': 'V', 'middle': [], 'last': 'Jasty', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Kowalski', 'suffix': ''}, {'first': 'E', 'middle': ['H'], 'last': 'Fonseca', 'suffix': ''}], 'year': 1984, 'venue': 'Vet Pathol', 'volume': '21', 'issn': '', 'pages': '46--50', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'The neuronal ceroidliposfusinoses', 'authors': [{'first': 'M', 'middle': [], 'last': 'Bennett', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Rakheja', 'suffix': ''}], 'year': 2013, 'venue': 'Dev Disabil Res Rev', 'volume': '17', 'issn': '', 'pages': '254--259', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Canine neuronal ceroid lipofusicnosis: a promising model for preclinical testing of therapeutic interventions', 'authors': [{'first': 'M', 'middle': ['L'], 'last': 'Katza', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Rustad', 'suffix': ''}, {'first': 'G', 'middle': ['O'], 'last': 'Robinson', 'suffix': ''}], 'year': 2017, 'venue': 'Neurobiol Dis', 'volume': '108', 'issn': '', 'pages': '277--287', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion)', 'authors': [{'first': 'I', 'middle': [], 'last': 'Jarvela', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Autti', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Lamminranta', 'suffix': ''}], 'year': 1997, 'venue': 'Ann Neurol', 'volume': '42', 'issn': '', 'pages': '799--802', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'MRI in neuronal ceroid lipofuscinosis', 'authors': [{'first': 'L', 'middle': [], 'last': 'D&apos;incerti', 'suffix': ''}], 'year': 2000, 'venue': 'Neurol Sci', 'volume': '21', 'issn': '', 'pages': '71--73', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'MRI of neuronal ceroid lipofuscinosis', 'authors': [{'first': 'T', 'middle': [], 'last': 'Autti', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Ranininko', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Vanhanen', 'suffix': ''}], 'year': 1996, 'venue': 'Neuroradiol', 'volume': '38', 'issn': '', 'pages': '476--482', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Magnetic resonance of neuronal ceroid lipofuscinosis in a Border collie', 'authors': [{'first': 'H', 'middle': [], 'last': 'Koie', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Shibuya', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Sato', 'suffix': ''}], 'year': 2004, 'venue': 'J Vet Med Sci', 'volume': '66', 'issn': '', 'pages': '1453--1456', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Neuronal ceroid lipofuscinosis with a chronic subdural hematoma', 'authors': [{'first': 'M', 'middle': ['G'], 'last': 'Asakawa', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Mackillop', 'suffix': ''}, {'first': 'N', 'middle': ['J'], 'last': 'Olby', 'suffix': ''}], 'year': 2010, 'venue': 'Vet Radiol Ultrasound', 'volume': '51', 'issn': '', 'pages': '155--158', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Neuroimaging of lipid storage disorders', 'authors': [{'first': 'D', 'middle': [], 'last': 'Rieger', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Auerbach', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Robinson', 'suffix': ''}], 'year': 2013, 'venue': 'Dev Disabil Res Rev', 'volume': '17', 'issn': '', 'pages': '269--282', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Magnetic resonance findings of the corpus callosum in canine and feline lysosomal storage diseases', 'authors': [{'first': 'D', 'middle': [], 'last': 'Hasegawa', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Tamura', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Nakamoto', 'suffix': ''}], 'year': 2013, 'venue': 'PLOS One', 'volume': '8', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Neuronal ceroid lipofuscinoses', 'authors': [{'first': 'D', 'middle': ['A'], 'last': 'Nita', 'suffix': ''}, {'first': 'Mole', 'middle': [], 'last': 'Se', 'suffix': ''}, {'first': 'B', 'middle': ['A'], 'last': 'Minassian', 'suffix': ''}], 'year': 2016, 'venue': 'Epileptic Disord', 'volume': '18', 'issn': '2', 'pages': '73--88', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Correlations between genotype, ultrastructural morphology and clinical phenotype in neuronal ceroid lipofuscinoses', 'authors': [{'first': 'S', 'middle': ['E'], 'last': 'Mole', 'suffix': ''}, {'first': 'Williams', 'middle': [], 'last': 'Re', 'suffix': ''}, {'first': 'H', 'middle': ['H'], 'last': 'Goebel', 'suffix': ''}], 'year': 2005, 'venue': 'Neurogenetics', 'volume': '6', 'issn': '', 'pages': '107--126', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'A mutation in canine PPT1 causes early onset neuronal ceroid lipofuscinosis in a Dachshund', 'authors': [{'first': 'D', 'middle': ['N'], 'last': 'Sanders', 'suffix': ''}, {'first': 'F', 'middle': ['H'], 'last': 'Farias', 'suffix': ''}, {'first': 'G', 'middle': ['S'], 'last': 'Johnson', 'suffix': ''}], 'year': 2010, 'venue': 'Mol Genet Metab', 'volume': '100', 'issn': '', 'pages': '349--356', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'A mutation in canine CLN5 causes neuronal ceroid lipofuscinosis in Border collie dogs', 'authors': [{'first': 'S', 'middle': ['A'], 'last': 'Melville', 'suffix': ''}, {'first': 'C', 'middle': ['L'], 'last': 'Wilson', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Chiang', 'suffix': ''}], 'year': 2005, 'venue': 'Genomics', 'volume': '86', 'issn': '', 'pages': '287--294', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid lipofuscinosis', 'authors': [{'first': 'M', 'middle': ['L'], 'last': 'Katz', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Khan', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Awano', 'suffix': ''}], 'year': 2005, 'venue': 'Biochem Biophys Res Commun', 'volume': '327', 'issn': '', 'pages': '541--547', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier', 'authors': [{'first': 'A', 'middle': [], 'last': 'Wohlke', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Philipp', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Bock', 'suffix': ''}], 'year': 2001, 'venue': 'PLoS One', 'volume': '7', 'issn': '', 'pages': '', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': '(a) T2-weighted (T2W), (b) fluid-attenuated inversion recovery, (c) T1-weighted (T1W) and (d) T1W post-contrast transverse images of the brain at the level of the third ventricle.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': \"), with frequent marginalisation of nuclei. Intracytoplasmic vacuoles resulted markedly positive to Luxol fast blue stain (Figure 3c), moderately positive to periodic acid-Schiff (Figure 3d) and stained red with Masson's trichrome (Figure 3e). When observed under a fluorescent microscope (excitation 465-495 nm) the cytoplasmic material showed green autofluorescence (Figure 3f). The cerebellum and the spinal cord were the least affected areas with well-represented neuronal cells showing few (very rare in the spinal cord) intracytoplasmic inclusions. Ultrastructural examination of the intracytoplasmic neuronal deposits in the occipital cortex showed electrondense, membrane-bound material (Figure 3g) composed of small curvilinear lamellar stacks (Figure 3h) and electron-dense, variably sized granular material\", 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'T2-weighted sagittal image of the brain. Moderate dilation of the third and fourth ventricles is apparent.', 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': \"(a) Gross appearance of fresh cross section of the brain at the level of the hippocampus showing moderate atrophy with widening of sulci. (b) Hippocampus, cornu ammonis with pyramidal neurons (arrows) showing intracytoplasmic botryoid deposits of eosinophilic glassy material often associated with marginalisation of nuclei (inset). (c-e) Intracytoplasmic deposits are markedly positive to (c) Luxol fast blue, (d) moderately positive to periodic acid-Schiff stain and (e) red stained with Masson's trichrome stain. (f) Pyramidal neurons show green autofluorescence when observed under the fluorescent microscope (excitation 465-495 nm). (g-i) Transmission electron microscopy of occipital cortical neurons showing (g) membrane-bound material composed of (h) small curvilinear lamellar stacks and (i) electron-dense variably sized granular material morphologically consistent with lipofuscins\", 'latex': None, 'type': 'figure'}}, 'back_matter': []}\n"
     ]
    }
   ],
   "source": [
    "for c in db['noncomm-subset'].find().limit(10):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Comparative Evaluation of Three Homogenization Methods for Isolating Middle East Respiratory Syndrome Coronavirus Nucleic Acids From Sputum Samples for Real-Time Reverse Transcription PCR'}}\n",
      "{'metadata': {'title': 'Chest Computed Tomography Abnormalities and Their Relationship to the Clinical Manifestation of Respiratory Syncytial Virus Infection in a Genetically Confirmed Outbreak'}}\n",
      "{'metadata': {'title': 'Functional analysis of the SRV-1 RNA frameshifting pseudoknot'}}\n",
      "{'metadata': {'title': 'Open Forum Infectious Diseases Open Forum Infectious Diseases ® Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'VIRUS ON T H E CEREBRAL ACTIVITY OF P L E U R O P N E U M O N I A -L I K E ORGANISMS I N M I C E'}}\n",
      "{'metadata': {'title': 'Molecular epidemiology and phylogenetic analysis of diverse bovine astroviruses associated with diarrhea in cattle and water buffalo calves in China'}}\n",
      "{'metadata': {'title': 'MRI findings of neuronal ceroid lipofuscinosis in a cat'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'A rapid, inexpensive yeast-based dual-fluorescence assay of programmed-1 ribosomal frameshifting for high-throughput screening'}}\n",
      "{'metadata': {'title': 'Centers for Disease Control and Prevention, Division of Global Migration and Quarantine San Diego, California, USA Epidemiological surveillance of land borders in North and South America: a case study'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Open Forum Infectious Diseases Infectious Complications After Umbilical Cord Blood Transplantation for Hematological Malignancy'}}\n",
      "{'metadata': {'title': 'The Influenza A Virus Endoribonuclease PA-X Usurps Host mRNA Processing Machinery to Limit Host Gene Expression Article The Influenza A Virus Endoribonuclease PA-X Usurps Host mRNA Processing Machinery to Limit Host Gene Expression'}}\n",
      "{'metadata': {'title': \"Follow-up monitoring in a cat with leishmaniosis and coinfections with Hepatozoon felis and 'Candidatus Mycoplasma haemominutum'\"}}\n",
      "{'metadata': {'title': 'Bone Marrow Dendritic Cells from Mice with an Altered Microbiota Provide Interleukin 17A-Dependent Protection against Entamoeba histolytica Colitis'}}\n",
      "{'metadata': {'title': 'Role of CD25 + CD4 + T cells in acute and persistent coronavirus infection of the central nervous system'}}\n",
      "{'metadata': {'title': 'Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide'}}\n",
      "{'metadata': {'title': 'Macroevolutionary immunology: a role for immunity in the diversification of animal life'}}\n",
      "{'metadata': {'title': 'MOUSE HEPATITIS VIRUS TYPE 4 (JHM STRAIN)- INDUCED FATAL CENTRAL NERVOUS SYSTEM DISEASE I. Genetic Control and the Murine Neuron as the Susceptible Site of Disease*'}}\n",
      "{'metadata': {'title': 'Mark J. Kwakkenbos Stable long-term cultures of self-renewing B cells and their applications'}}\n",
      "{'metadata': {'title': 'Use of noninvasive ventilation at the pulmonary infection control window for acute respiratory failure in AECOPD patients A systematic review and meta-analysis based on GRADE approach Systematic Review and Meta-Analysis Medicine ® OPEN 1'}}\n",
      "{'metadata': {'title': 'Isolation and characterization of a new porcine epidemic diarrhea virus variant that occurred in Korea in 2014'}}\n",
      "{'metadata': {'title': 'Rapid Multiplex Testing for Upper Respiratory Pathogens in the Emergency Department: A Randomized Controlled Trial'}}\n",
      "{'metadata': {'title': 'Send Orders for Reprints to reprints@benthamscience.ae The Role of CXCR3 in Neurological Diseases'}}\n",
      "{'metadata': {'title': 'Advance Access Publication 29'}}\n",
      "{'metadata': {'title': 'Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5 0 -terminal regions of cap0-, cap1-and 5 0 ppp-mRNAs'}}\n",
      "{'metadata': {'title': 'IDBD: Infectious Disease Biomarker Database'}}\n",
      "{'metadata': {'title': 'case report'}}\n",
      "{'metadata': {'title': 'Reply to \"Studies on Influenza Virus Transmission between Ferrets: the Public Health Risks Revisited\"'}}\n",
      "{'metadata': {'title': 'Successive occurrence of recombinant infectious bronchitis virus strains in restricted area of Middle East'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Age-related prevalence of common upper respiratory pathogens, based on the application of the FilmArray Respiratory panel in a tertiary hospital in Greece'}}\n",
      "{'metadata': {'title': 'Adenoviral vector-based strategies against infectious disease and cancer'}}\n",
      "{'metadata': {'title': 'An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov)-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)'}}\n",
      "{'metadata': {'title': 'Nonproliferative and Proliferative Lesions of the Rat and Mouse Special Sense Organs (Ocular [eye and glands], Olfactory and Otic)'}}\n",
      "{'metadata': {'title': 'Unifying evolutionary and thermodynamic information for RNA folding of multiple alignments'}}\n",
      "{'metadata': {'title': 'A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant'}}\n",
      "{'metadata': {'title': 'Chinese research into severe ulcerative colitis has increased in quantity and complexity'}}\n",
      "{'metadata': {'title': 'Perspectives of public health laboratories in emerging infectious diseases'}}\n",
      "{'metadata': {'title': 'Suppression of Drug Resistance in Dengue Virus'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population HHS Public Access'}}\n",
      "{'metadata': {'title': 'Genome Stability of Pandemic Influenza A (H1N1) 2009 Based on Analysis of Hemagglutinin and Neuraminidase Genes'}}\n",
      "{'metadata': {'title': 'RNA methyltransferases involved in 5 0 cap biosynthesis'}}\n",
      "{'metadata': {'title': 'Persistent prion infection disturbs the function of Oct-1, resulting in the down-regulation of murine interferon regulatory factor-3'}}\n",
      "{'metadata': {'title': 'Trends in Incident and Recurrent Rates of First-Ever Ischemic Stroke in Taiwan between 2000 and 2011'}}\n",
      "{'metadata': {'title': 'A fatal case caused by novel H7N9 avian influenza A virus in China'}}\n",
      "{'metadata': {'title': 'The Middle East Respiratory Syndrome-How Worried Should We Be? A NOVEL VIRUS IS IDENTIFIED IN SAUDI ARABIA'}}\n",
      "{'metadata': {'title': 'Magnetic nanoparticle based purification and enzyme-linked immunosorbent assay using monoclonal antibody against enrofloxacin'}}\n",
      "{'metadata': {'title': 'Pilot Evaluation of RT-PCR/Electrospray Ionization Mass Spectrometry (PLEX-ID/Flu assay) on Influenza-Positive Specimens'}}\n",
      "{'metadata': {'title': 'Biosynthesis Ribophorins and Processing of in the Endoplasmic Reticulum'}}\n",
      "{'metadata': {'title': 'Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis'}}\n",
      "{'metadata': {'title': 'A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants'}}\n",
      "{'metadata': {'title': 'Ebola Emergency Preparedness: Simulation Training for Frontline Health Care Professionals'}}\n",
      "{'metadata': {'title': 'ACE/ACE2 Ratio and MMP-9 Activity as Potential Biomarkers in Tuberculous Pleural Effusions'}}\n",
      "{'metadata': {'title': 'Supplement Material and Methods 1 2'}}\n",
      "{'metadata': {'title': 'PEER REVIEW HISTORY'}}\n",
      "{'metadata': {'title': 'Viral adaptation to host: a proteome-based analysis of codon usage and amino acid preferences'}}\n",
      "{'metadata': {'title': ''}}\n",
      "{'metadata': {'title': 'Supporting Information'}}\n",
      "{'metadata': {'title': 'Address for correspondence Insertion/Deletion Polymorphism of Angiotensin Converting Enzyme Gene in Kawasaki Disease'}}\n",
      "{'metadata': {'title': 'Oligomerization of a Membrane Protein Correlates with Its Retention in the Golgi Complex'}}\n",
      "{'metadata': {'title': 'IMG/VR: a database of cultured and uncultured DNA Viruses and retroviruses'}}\n"
     ]
    }
   ],
   "source": [
    "# to print the titles only and suppress the id\n",
    "\n",
    "for c in db['noncomm-subset'].find({},{ 'metadata.title': 1, '_id': 0 }):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5f4ecb5cb752ba3f43f46c36'), 'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24', 'metadata': {'title': '', 'authors': []}, 'abstract': [], 'body_text': [{'text': 'This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.', 'cite_spans': [], 'ref_spans': [], 'section': 'Editorial'}, {'text': \"The Middle East Respiratory Syndrome (MERS) crisis in Korea is coming to an end, but that's not the end of the story. The World Health Organization (WHO) has warned that the MERS crisis was a 'wakeup call. ' Like Severe Acute Respiratory Syndrome (SARS) in 2003 and swine flu in 2009, epidemic outbreaks will continue to happen anywhere. Korea was simply unlucky. In retrospect, it is regrettable to say that we could have done much better. Scholars and colleagues in the medical informatics field should take a moment and think hard about how we can work to fight against another epidemic invasion in the future.\", 'cite_spans': [], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'The Ebola epidemic of 2013 is the largest such outbreak on record, influencing many nations in Africa as well as other countries [1] . The WHO expert panel has pointed out the inadequate emergency care response and has recommended more effective mechanisms for research and development. Others have strongly recommended WHO to innovate because recent Ebola outbreaks have been radically different from previous events, and they have tended to be simultaneous and parallel: \"Highly mobile populations, the spread of Ebola into densely populated cities ... made this epidemic of many outbreaks difficult to control [2] . \"', 'cite_spans': [{'start': 129, 'end': 132, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 613, 'end': 616, 'text': '[2]', 'ref_id': 'BIBREF1'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': \"Other criticisms also include outdated therapeutic protocols, irrelevant information, untimely communication, delays in decision-making due to uncoordinated leadership, unreasonable social behavior, and so on. The recom- tems. The NEDSS can be called a medical informatics leader, which provides a standardized information infrastructure with HL7, LOINC, and SNOMED-CT. Highly useful information is well organized and ready to be used in the US-CDC [6] , so we don't have to reinvent the wheel. All we need is to find a conduit for connection. For example, the task of disease surveillance for MERS is relatively small compared to NEDSS. Using the cell phone data network, we can instantly establish a real-time patient tracking system to monitor 3-tuple data (time, location, temperature) in the country. Cell phone rental can help track down suspicious foreign visitors from arrival to departure. With the support of ISO standards, global healthcare networking is not a hard nut to crack.\", 'cite_spans': [{'start': 449, 'end': 452, 'text': '[6]', 'ref_id': 'BIBREF8'}], 'ref_spans': [], 'section': 'ⓒ 2015 The Korean Society of Medical Informatics'}, {'text': 'When the MERS epidemic outbreak was on the headline news, many attempts were made to compare MERS with tuberculosis. That is, the mortality rate of MERS is far below that of tuberculosis, so it was argued that there was no need to worry about it. The point was clear, but the timing was not right. Have you ever got a thorn stuck under your fingernail? Saying that \"It\\'s OK you\\'re not bleeding\" or \"You won\\'t die from it\" would not comfort anybody at all. I would venture to say that it is surely mistaken to compare the pain at present with a probable outcome yet to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': 'When hospital visitors became MERS patients, a typical example of nosocomial infection was demonstrated. It was a surprise attack, and the whole country was shaken and panicked. The WHO experts reminded us that hospital shopping greatly contributed to the rapid spread of MERS in Korea. We have to understand why patients pursue hospital shopping. The death of professionalism may be an unexpected result of the fashionable social network services (SNS). Patients use SNSs to data-mine their own diagnosis and prescription and then seek medical advice to compare with their own ideas about their personal health. However, such patients suggesting their own diagnoses and treatments can be described as \"Jack of all trades, master of none\". Medical informatics leadership was nowhere to be found. When the MERS epidemic turned fatal, SNS was the only rescue. MERS was unknown to the general public, and the cure was uncertain, so chaos was bound to happen.', 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In Korea medical informatics is on trial. We are standing in front of a river that runs medicine. IT has been trying to cross the river but has never been successful, especially in medical expert systems. The other side of the river is not the land of promise. Because the river of medicine eventu-ally runs into the ocean of the human race, why don't we go with the river instead? There is no doubt that doctors and nurses were the final frontiers in the MERS battle. Despite all the wonderful scientific accomplishments, the MERS crisis reminds us that clinical expertise is the most important value as clearly as ever. Technology can help medicine, not the other way around; that is the way medical informatics should go in between.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"Taoism states that dynamic balance can be obtained from two opposite powers competing with each other, unifying as a complete energy. Similarly, medical informatics should be able to balance between analog medicine and digital technology to create a new value. Medicine is composed of oldfashioned values, such as rapport, which is fading out slowly. Digital technology should help clinicians restore the humanistic flavor of medicine by eliminating managerial overload in healthcare settings. Technology can start from there. Neither Cyclops (the single-eyed monster in Homer's Odyssey) nor Argus (the 100-eyed giant in Greek mythology) is ideal to find the right path. Two-eyed medical informaticians must walk through the path on the mountain ridge, carefully looking at both sides of IT and medicine for balance.\", 'cite_spans': [], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}, {'text': \"In 1347, the first biological warfare took place in the siege of Caffa (now Feodosia in Ukraine) on the Black Sea coast. The Mongol army with bubonic plague catapulted corpse of those who had died from the Black Death over the city walls. Fleeing from central trading ports along the coast, infected inhabitants and rats may have carried the disease throughout Europe [7] (The plague might have killed more than 25 million people). A few regions survived. They simply closed their ports of entry and isolated patients in remote places. The same principle still applies. When in doubt, isolate an infection until it's clear. Time goes by, technology advances, but the basic principle never changes. Medicine should stay analog with a little hint of digital. That's all it takes to fight against any epidemic or pandemic attack in the future.\", 'cite_spans': [{'start': 368, 'end': 371, 'text': '[7]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'What Digital Systems Should Do for Medicine'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Report of the Ebola Interim Assessment Panel', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"What we've learned about fighting Ebola\", 'authors': [{'first': 'R', 'middle': ['S'], 'last': 'Dhillon', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Srikrishna', 'suffix': ''}], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Harvard Business Review; c2015', 'authors': [{'first': '(', 'middle': [], 'last': 'Boston', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Ma)', 'suffix': ''}], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'The next epidemic: lessons from Ebola', 'authors': [{'first': 'B', 'middle': [], 'last': 'Gates', 'suffix': ''}], 'year': 2015, 'venue': 'N Engl J Med', 'volume': '372', 'issn': '15', 'pages': '1381--1385', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'US Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS)', 'authors': [], 'year': None, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Centers for Disease Control and Prevention; c2015', 'authors': [], 'year': 2015, 'venue': '', 'volume': '', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Digital disease detection: harnessing the Web for public health surveillance', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Brownstein', 'suffix': ''}, {'first': 'C', 'middle': ['C'], 'last': 'Freifeld', 'suffix': ''}, {'first': 'L', 'middle': ['C'], 'last': 'Madoff', 'suffix': ''}], 'year': 2009, 'venue': 'N Engl J Med', 'volume': '360', 'issn': '21', 'pages': '2153--2160', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'History of biological warfare and bioterrorism', 'authors': [{'first': 'V', 'middle': [], 'last': 'Barras', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Greub', 'suffix': ''}], 'year': 2014, 'venue': 'Clin Microbiol Infect', 'volume': '20', 'issn': '6', 'pages': '497--502', 'other_ids': {}}}, 'ref_entries': {'TABREF0': {'text': 'Hune Cho http://dx.doi.org/10.4258/hir.2015.21.3.141', 'latex': None, 'type': 'table'}}, 'back_matter': []}\n"
     ]
    }
   ],
   "source": [
    "# find one paper by paper_id\n",
    "\n",
    "for c in db['noncomm-subset'].find({'paper_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24'}):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5f4ecbc6f7c2f0238d4cbc14'), 'paper_id': '1b58422e266ab9339c919119923229d080f27360', 'metadata': {'title': 'ACE/ACE2 Ratio and MMP-9 Activity as Potential Biomarkers in Tuberculous Pleural Effusions', 'authors': [{'first': 'Wen-Yeh', 'middle': [], 'last': 'Hsieh', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Tang-Ching', 'middle': [], 'last': 'Kuan', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Kun-Shan', 'middle': [], 'last': 'Cheng', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Yan-Chiou', 'middle': [], 'last': 'Liao', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Mu-Yuan', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Pei-Heng', 'middle': [], 'last': 'Lin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Yuan-Chang', 'middle': [], 'last': 'Hsu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Chen-Yi', 'middle': [], 'last': 'Huang', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Wei-Hua', 'middle': [], 'last': 'Hsu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mackay Memorial Hospital', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Sheng-Yao', 'middle': [], 'last': 'Yu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mackay Memorial Hospital', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Chih-Sheng', 'middle': [], 'last': 'Lin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}]}, 'abstract': [{'text': 'Objective: Pleural effusion is common problem, but the rapid and reliable diagnosis for specific pathogenic effusions are lacking. This study aimed to identify the diagnosis based on clinical variables to differentiate pleural tuberculous exudates from other pleural effusions. We also investigated the role of renin-angiotensin system (RAS) and matrix metalloproteinase (MMPs) in the pathogenesis of pleural exudates. Experimental design: The major components in RAS and extracellular matrix metabolism, including angiotensin converting enzyme (ACE), ACE2, MMP-2 and MMP-9 activities, were measured and compared in the patients with transudative (n = 45) and exudative (n = 80) effusions. The exudative effusions were come from the patients with tuberculosis (n = 20), pneumonia (n = 32), and adenocarcinoma (n = 28). Results: Increased ACE and equivalent ACE2 activities, resulting in a significantly increased ACE/ACE2 ratio in exudates, were detected compared to these values in transudates. MMP-9 activity in exudates was significantly higher than that in transudates. The significant correlation between ACE and ACE2 activity that was found in transudates was not found in exudates. Advanced analyses showed significantly increased ACE and MMP-9 activities, and decreased ACE2 activity in tuberculous pleural effusions compared with those in pneumonia and adenocarcinoma effusions. The results indicate that increased ACE and MMP-9 activities found in the exudates were mainly contributed from a higher level of both enzyme activities in the tuberculous pleural effusions. Conclusion: Interplay between ACE and ACE2, essential functions in the RAS, and abnormal regulation of MMP-9 probably play a pivotal role in the development of exudative effusions. Moreover, the ACE/ACE2 ratio combined with MMP-9 activity in pleural fluid may be potential biomarkers for diagnosing tuberculous pleurisy.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Pleural effusion is a common medical problem in the chest and involves accumulation of an abnormal amount of pleural fluid in the pleural space. Several diseases such as congestive heart failure, liver cirrhosis, tuberculosis, adenocarcinoma, and pneumonia are common diseases that cause pleural effusions, but there is no rapid and accurate diagnostic method for pleural effusion. Conventional diagnosis of tuberculous pleurisy is based on pleural fluid cytology, culture of pleural effusions, and pleural biopsy tissue culture, but these methods have very low sensitivity and recognised limitations in clinical use, and they usually require weeks for a positive culture report [1] . Therefore, a reliable clinical marker providing simple, rapid, and accurate diagnosis is required for patients with pleural effusion.', 'cite_spans': [{'start': 679, 'end': 682, 'text': '[1]', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'The circulating renin-angiotensin system (RAS) plays a well-described role in maintaining blood pressure homeostasis. Recently, a local tissue-based RAS has also been described and appears to play a key role in injury/repair responses [2, 3] . The expression of RAS components and the elevation of angiotensin converting enzyme (ACE) in a number of lung diseases suggest the existence of a pulmonary RAS and that angiotensin II (Ang II) could mediate, at least in part, the response to lung injury. The central role of ACE is to generate Ang II from Ang I. Ang II is a key effector peptide of RAS that causes vasoconstriction and exerts multiple biological functions. Ang II can also cause the development of interstitial fibrosis via physiological regulation of matrix metalloproteinase (MMP) expression and/or activation [4] .', 'cite_spans': [{'start': 235, 'end': 238, 'text': '[2,', 'ref_id': 'BIBREF1'}, {'start': 239, 'end': 241, 'text': '3]', 'ref_id': 'BIBREF2'}, {'start': 823, 'end': 826, 'text': '[4]', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'ACE2, a close homologue of ACE, functions as a negative regulator of the angiotensin system and was identified as a key receptor for severe acute respiratory syndrome coronavirus infections [5, 6] . ACE2 reduces the generation of Ang II by catalysing the conversion of Ang I to Ang1-9 and facilitating hydrolysis of Ang II to Ang1-7. Ang1-7 has been recognised as a potential endogenous inhibitor of the classical RAS cascade [7] . Hence, the ACE2\\uf02dAng1-7 axis may be an important negative modulator of Ang II bioactivity, counteracting the effects of ACE in determining net tissue Ang II levels. Abnormally elevated ACE combined with decreased ACE2 expression may be involved in fibrotic processes in vitro and in vivo, and the mechanism may involve expression and activation of specific MMPs [8] . Recently, abnormal pleural MMP levels, e.g., MMP-2 and MMP-9, have been reported, and the association between MMPs and development of pleurisy has been investigated [9, 10, 11] .', 'cite_spans': [{'start': 190, 'end': 193, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 194, 'end': 196, 'text': '6]', 'ref_id': 'BIBREF5'}, {'start': 426, 'end': 429, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 793, 'end': 796, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 964, 'end': 967, 'text': '[9,', 'ref_id': 'BIBREF8'}, {'start': 968, 'end': 971, 'text': '10,', 'ref_id': 'BIBREF9'}, {'start': 972, 'end': 975, 'text': '11]', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Here we evaluated the association of two key enzymes in RAS, ACE and ACE2, with MMP-2 and MMP-9 in the pleural fluid of patients with pleural effusion. We also detail discussed whether abnormal RAS, accompanied with high levels of ACE/ACE2, might be a cause of elevated MMP-9 activity in tuberculous pleural effusion. Finally, a high ratio of ACE to ACE2 combined with elevated MMP-9 detected in pleural fluid may be a potential indicator for the diagnosis of tuberculous pleurisy.', 'cite_spans': [], 'ref_spans': [], 'section': 'Introduction'}, {'text': \"Pleural effusions from 125 patients were processed in our laboratory from August 2010 to December 2011. All pleural effusions were designated as transudates or exudates according to Light's criteria [12] . Definitive diagnosis of tuberculous, pneumonia, or adenocarcinoma effusions for the exudate was verified by examining effusion biochemistry, cytology, acid-fast staining, and clinical follow-up. The study was performed with the approval of the Institutional Review Board of Mackay Memorial Hospital. Informed consent was obtained from all patients.\", 'cite_spans': [{'start': 199, 'end': 203, 'text': '[12]', 'ref_id': 'BIBREF11'}], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': \"According to Light's criteria, pleural effusions were divided into 45 transudative pleural effusions and 80 exudative pleural effusions. The exudative pleural effusions were further divided into tuberculous pleural effusions (20 patients), pneumonia pleural effusions (32 patients), and malignant pleural effusions (28 patients). Fresh pleural fluid was collected in sterile tubes without anticoagulant reagents to prevent the release of gelatinases during platelet activation, and the tubes were immediately centrifuged at 3,000 × g for 30 minutes to separate the supernatants and cell pellets. The supernatants were aliquoted and stored with the cell pellets at −80°C until further use.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': 'For each pleural effusion sample, the routine pleural analyses included total protein, lactate dehydrogenase (LDH), glucose, and white blood cell (WBC) count. In addition, the activities of ACE, ACE2, and gelatinases (MMP-2 and MMP-9) in the pleural effusions were measured.', 'cite_spans': [], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': 'Gelatin zymography for detecting MMP-2 and MMP-9 activity was performed with gelatin-containing gels as our previous report [4] . Briefly, 10 \\uf06dl pleural fluid for each subject was loaded to a 10% SDS-PAGE containing 0.1 mg·ml -1 gelatin (Sigma-Aldrich, St. Louis, MO, USA). The gelatinase activities were identified as clear zones against a blue background on the SDS-PAGE and quantified using Scion Image software (NIH, Bethesda, MD, USA), which quantifies the extent of lysis in bands containing gelatinase. Enzyme activity was expressed as ng·ml -1 . [13] . The assay was performed in a micro-quartz cuvette with 20 μl pleural fluid, 50 μM fluorogenic substrate and protease inhibitor cocktail (1:200; Sigma-Aldrich) in a final volume of 100 μl in ACE or ACE2 assay buffer. The reaction was followed kinetically for 1 hour using a fluorescence reader at an excitation wavelength of 330 nm and an emission wavelength of 390 nm. Data were fitted and plotted using Grafit v.4.0 (Sigma-Aldrich), and enzyme activity was expressed as RFU·h -1 ·ml -1 . Parallel samples were incubated with the above-mentioned reaction mixture in the presence of 1 μM captopril (Sigma-Aldrich), a specific ACE inhibitor for determining specific ACE activity, or 1 μM DX600 (AnaSpec), a specific ACE2 inhibitor for determining specific ACE2 activity.', 'cite_spans': [{'start': 124, 'end': 127, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 554, 'end': 558, 'text': '[13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'Gelatin zymography'}, {'text': 'The levels of various markers in the pleural effusion samples are expressed as the mean ± standard deviation (SD) or shown as the median (interquartile range). Group comparisons were made using the nonparametric Kruskal-Wallis test. Differences were considered statistically significant when p < 0.05. Statistical analysis was performed using statistical software (SPSS, Chicago, IL, USA).', 'cite_spans': [], 'ref_spans': [], 'section': 'Statistics'}, {'text': 'The pleural fluid characteristics of 125 patients included in the study are presented in Table 1 . Generally, total protein, LDH, and the number of WBC in exudative effusions (n = 80) were significantly higher than those in transudative effusions (n = 45) (p < 0.001), whereas a lower glucose level was detected in the pleural fluid of exudates compared with that in transudates (p < 0.001).', 'cite_spans': [], 'ref_spans': [{'start': 89, 'end': 96, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'General characteristics of pleural effusions'}, {'text': 'ACE and ACE2 activities in the pleural effusions of all patients were determined. ACE activity in exudative effusions was higher than that in transudative effusions (median, 0.74 (IQR, 0.43-1.47) RFU·h -1 ·ml -1 vs. 0.57 (0.32-0.9) RFU·h -1 ·ml -1 , p < 0.01) ( Figure 1A ). On the contrary, ACE2 activity in exudative effusions was lower than that in transudative effusions (1.58 (1.02-2.54) RFU·h -1 ·ml -1 vs.', 'cite_spans': [], 'ref_spans': [{'start': 262, 'end': 271, 'text': 'Figure 1A', 'ref_id': 'FIGREF1'}], 'section': 'ACE and ACE2 activities in transudates and exudates'}, {'text': '1.98 (1.27-3.12) RFU·h -1 ·ml -1 ) ( Figure 1B ), but this difference was not statistically significant. The ratio of ACE/ACE2 activity in the pleural effusions was significantly higher in exudative effusions than in transudative effusions (0.49 (0.27-0.91) vs. 0.27 (0.19-0.43), p < 0.001) ( Figure  1C ). In transudates, a significant positive correlation was found between ACE and ACE2 activities (r 2 = 0.456, p < 0.001) (Figure 2A) . However, the ACE activity was not correlated with the ACE2 activity in exudative effusions (r 2 = 0.020, p = 0.214) ( Figure 2B ). ', 'cite_spans': [], 'ref_spans': [{'start': 37, 'end': 46, 'text': 'Figure 1B', 'ref_id': 'FIGREF1'}, {'start': 293, 'end': 303, 'text': 'Figure  1C', 'ref_id': 'FIGREF1'}, {'start': 425, 'end': 436, 'text': '(Figure 2A)', 'ref_id': 'FIGREF2'}, {'start': 557, 'end': 566, 'text': 'Figure 2B', 'ref_id': 'FIGREF2'}], 'section': 'ACE and ACE2 activities in transudates and exudates'}, {'text': 'The MMP-2 and MMP-9 activities in the pleural effusions of all patients were determined with gelatin zymography (Figure 3 ). The MMP-2 activity in exudative effusions was comparable with that in transudative effusions (1375 (944-1841) ng·ml -1 vs. 1148 (806-1730) ng·ml -1 ) ( Figure 3A ). However, MMP-9 activity in exudative effusions was significantly higher than that in transudative effusions (30 (19-52) ng·ml -1 vs. 11 (8-23) ng·ml -1 , p < 0.001) ( Figure 3B ).', 'cite_spans': [{'start': 398, 'end': 409, 'text': '(30 (19-52)', 'ref_id': None}], 'ref_spans': [{'start': 112, 'end': 121, 'text': '(Figure 3', 'ref_id': 'FIGREF3'}, {'start': 277, 'end': 286, 'text': 'Figure 3A', 'ref_id': 'FIGREF3'}, {'start': 457, 'end': 466, 'text': 'Figure 3B', 'ref_id': 'FIGREF3'}], 'section': 'MMP-2 and MMP-9 activities in transudates and exudates'}, {'text': 'WBC number, glucose, total protein and LDH concentration in the exudates from of three types, tuberculous, pneumonia and adenocarcinoma effusions, were determined ( Table 2 ). The data show that all of WBC number, glucose and LDH concentration determinations among the three exudative effusions were insignificantly different. ', 'cite_spans': [], 'ref_spans': [{'start': 165, 'end': 172, 'text': 'Table 2', 'ref_id': 'TABREF1'}], 'section': 'WBC and biochemical assay in exudates from patients with different diseases'}, {'text': 'Elevated ACE activity and an elevated ACE/ACE2 ratio were observed in exudative effusions. We then differentiated both ACE and ACE2 activities in the exudates according to different diseases, including tuberculosis, pneumonia, and adenocarcinoma. The ACE activity in the tuberculous pleural effusions was significantly higher than in pneumonia and adenocarcinoma effusions, by 2.89 (p < 0.001) and 2.62 (p < 0.001) fold, respectively ( Figure  4A ). In contrast, ACE2 activity in the tuberculous effusions was significantly lower than in pneumonia and adenocarcinoma effusions, by 0.68 (p < 0.05) and 0.58 (p < 0.05) fold, respectively ( Figure 4B ). According to the changes we detected in ACE and ACE2, a significantly higher difference in the ACE/ACE2 ratio in tuberculous effusions (1.72 (1.09-2.52)) compared with ratios in pneumonia (0.32 (0.20-0.50)) and adenocarcinoma (0.43 (0.26-0.67)) effusions was also observed (p < 0.001) ( Figure 4C ).', 'cite_spans': [], 'ref_spans': [{'start': 436, 'end': 446, 'text': 'Figure  4A', 'ref_id': 'FIGREF4'}, {'start': 638, 'end': 647, 'text': 'Figure 4B', 'ref_id': 'FIGREF4'}, {'start': 938, 'end': 947, 'text': 'Figure 4C', 'ref_id': 'FIGREF4'}], 'section': 'ACE and ACE2 activities in exudates from patients with different diseases'}, {'text': 'The pleural ACE and ACE2 activities among transudates, tuberculosis, pneumonia and adenocar-cinoma were compared. The ACE and ACE2 activities in transudates, tuberculous, pneumonia and adenocarcinoma effusions were 0.67 ± 0.52, 2.16 ± 0.97, 0.74 ± 0.77 and 0.82 ± 0.43 RFU/hour/ml, and 2.19 ± 1.31, 1.38 ± 0.58, 2.05 ± 1.40 and 2.38 ± 1.86 RFU/hour/ml, respectively. It is noted that both of ACE and ACE2 activities in pneumonia and adenocarcinoma effusions were similar to the activities in transudative effusions.', 'cite_spans': [], 'ref_spans': [], 'section': 'ACE and ACE2 activities in exudates from patients with different diseases'}, {'text': 'The MMP-2 and MMP-9 activities in exudative effusions from the patients with different diseases were assayed by gelatin zymography (Figure 5 ). In tuberculous pleural effusions, MMP-2 activity was 1.48 (p < 0.01) and 1.36 fold (p < 0.05) higher than MMP-2 activity in pneumonia and adenocarcinoma effusions, respectively ( Figure 5A ). Similar to MMP-2, MMP-9 activity in tuberculous effusions was significantly higher than MMP-9 activity in pneumonia and adenocarcinoma effusions by 1.62 (p < 0.01) and 1.77 fold (p < 0.01), respectively ( Figure 5B ). ', 'cite_spans': [], 'ref_spans': [{'start': 131, 'end': 140, 'text': '(Figure 5', 'ref_id': 'FIGREF5'}, {'start': 323, 'end': 332, 'text': 'Figure 5A', 'ref_id': 'FIGREF5'}, {'start': 541, 'end': 550, 'text': 'Figure 5B', 'ref_id': 'FIGREF5'}], 'section': 'MMP-2 and MMP-9 activities in exudates from patients with different diseases'}, {'text': 'In the present study, major components of RAS and extracellular matrix (ECM) metabolism, pleural ACE, ACE2, MMP-2, and MMP-9, were measured in patients with pleural effusions. Our main findings are: (1) significantly higher the ACE, MMP-9 activity and ACE/ACE2 ratio in exudative effusions; (2) increased MMP-9 and ACE activities combined with decreased ACE2 activity in tuberculous effusion compared to pneumonia and adenocarcinoma effusions. The increased MMP-9 activity found in tuberculous effusion is in agreement with previous reports [9, 14, 15] . Herein, we first report that the changes of ACE and ACE2 activity are associated with tuberculous pleurisy.', 'cite_spans': [{'start': 541, 'end': 544, 'text': '[9,', 'ref_id': 'BIBREF8'}, {'start': 545, 'end': 548, 'text': '14,', 'ref_id': 'BIBREF13'}, {'start': 549, 'end': 552, 'text': '15]', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Only a few reports have been published on the importance of ACE in pleural fluid. ACE could be detected in pleural fluid, but the ACE level cannot be used to discriminate cancer from non-cancer patients [16, 17] . Söderblom et al. [18] had also measured ACE in pleural effusions and sera of 364 patients and showed that tuberculous effusions contain higher ACE concentrations than any other type of non-rheumatoid effusions. These results indicate that ACE determinations may aid in differentiating rheumatoid and tuberculous pleurisy from other types of pleural disease.', 'cite_spans': [{'start': 203, 'end': 207, 'text': '[16,', 'ref_id': 'BIBREF15'}, {'start': 208, 'end': 211, 'text': '17]', 'ref_id': 'BIBREF16'}, {'start': 231, 'end': 235, 'text': '[18]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'In the present study, we reported the change in ACE2 activity in pleural effusions. Some of the physiological functions of ACE2 are opposite to those of ACE. The significant positive correlation between ACE and ACE2 activities in the transudates suggests that ACE and ACE2 maintain a normal physiological balance. This loss of balance in exudates was detected because of increased ACE. Although the importance of the dysregulation in ACE in exudative effusions has not been explored, a significant role for RAS in the pathophysiological process of exudate development is possible.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'ACE activity was increased (p < 0.001) and ACE2 was decreased (p < 0.05) in tuberculosis specifically, but the ACE and ACE2 activities were no difference between transudate, pneumonia and adenocarcinoma effusions. These results indicated that ACE and ACE2 maybe a biomarker for tuberculosis diagnosis in pleural effusion and it could be emphasized that the increased ACE activity and ratio of ACE/ACE2 in the exudates are mainly contributed from a higher ACE level and lower ACE2 enzyme activities in the tuberculous pleural effusion. In an advanced assay, our data show that the ACE activity of 85% (17/20), 19% (6/32), 18% (5/28) and 18% (8/45) pleural fluids isolated tuberculosis, pneumonia, adenocarcinoma and transudates was > 1 RFU/hour/ml, respectively. It is also indicated that the increased ACE activity found in the exudates are mainly contributed from a higher ACE activity in the tuberculous pleural effusion.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The ACE2 activity in tuberculous, pneumonia and adenocarcinoma effusions were 1.38 ± 0.58, 2.05 ± 1.40 and 2.38 ± 1.86 RFU/hour/ml (mean ± SD), respectively. Although a larger SD was determined in the pneumonia and adenocarcinoma groups, the ACE2 activity in both groups were significantly larger than that in the tuberculosis group (p < 0.05). In advanced assay, the data indicate that there were 75% tuberculosis (15/20) , 56% pneumonia (18/32) and 50% adenocarcinoma (14/28) patients showed the ACE2 activity \\uf0a3 1.80 RFU/hour/ml (75% of interquartile range in tuberculous effusions; IQR, 0.97-1.80). The data also support that the trend of decreased ACE2 activity in the pleural effusions with tuberculosis compared to those with pneumonia or adenocarcinoma. However, more patients should be further included in order to examine the proposition.', 'cite_spans': [{'start': 415, 'end': 422, 'text': '(15/20)', 'ref_id': None}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'It is interesting that significantly increased ACE activity combined with markedly decreased ACE2 activity was measured in tuberculous effusions. This result confirms that abnormal RAS metabolism in pleural spaces may be related to tuberculous pleurisy. It was reported that overexpression of ACE2 may inhibit MMP-9 activity [19] , and ACE2 deficiency leads to increased MMP-9 levels [20] . In inflammatory signalling pathways study, Ang II could stimulate human monocytic U-937 cells to increase MMP-9 expression and activity significantly via activated NF-κB, JNK, and p38 [21] . The ACE inhibitor, captopril, was administrated to isoprenaline-induced left ventricular fibrosis rats and showed that captopril significantly enhanced the isoprenaline-induced myocardial fibrosis and augmented the isoprenaline-induced MMP-9 expression [22] . In addition, ACE2 and Ang 1-7, the regulators in RAS opposed Ang II effect, could affect MMP-9 expression. Overexpression of ACE2 reduces the invasive ability in vitro according to the down-regulation of MMP-2 and MMP-9 [23] . Ang 1-7 revealed the anti-migration and anti-invasion effect mediated through inactivation of the PI3K/Akt, P38 and JNK signal pathways to reduce the expression and activity of MMP-2 and MMP-9 [24] . According to our results, we conclude that reduction in ACE2 along with induction of MMP-9 activity occurred. Our observations of decreased ACE2 and increased MMP-9 activity in tuberculous effusions confirm this conclusion.', 'cite_spans': [{'start': 325, 'end': 329, 'text': '[19]', 'ref_id': 'BIBREF18'}, {'start': 384, 'end': 388, 'text': '[20]', 'ref_id': 'BIBREF19'}, {'start': 575, 'end': 579, 'text': '[21]', 'ref_id': 'BIBREF20'}, {'start': 835, 'end': 839, 'text': '[22]', 'ref_id': 'BIBREF21'}, {'start': 1062, 'end': 1066, 'text': '[23]', 'ref_id': 'BIBREF22'}, {'start': 1262, 'end': 1266, 'text': '[24]', 'ref_id': 'BIBREF23'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'A number of studies have indicated that the ACE-Ang II axis and ACE2-Ang1-7 axis not only regulate the metabolism of ECM proteins, but also modulate MMP expression and activity levels [8] . MMPs have been implicated in the pathogenesis of various lung diseases, including pleural effusions [25, 26] . The activity of MMPs within the pleural space may play a role in the formation of pleural effusions by altering the integrity of the mesothelial and endothelial cell layers and by increasing vascular permeability [10, 27] . Proteolysis by MMPs may be involved in the formation of pleural effusions by increasing vascular permeability, and thus by facilitating fluid influx into the pleural space [28] . Therefore, the presence and enzymatic activities of MMPs have been identified in pleural effusions [15, 25, 29] . Previous studies have shown that the expression of MMPs in the pleural space is altered in a variety of inflammatory and malignant diseases, suggesting that certain members of the MMP family may participate in the formation of pleural effusions [10, 15, 29] . Tissue damage is a characteristic manifestation of Mycobacterium tuberculosis infection. Proteolysis by macrophage-secreted proteases has been implicated in such destructive processes. In this regard, the proteolytic action of MMPs may be involved in the pathogenesis of tuberculosis, like many other diseases associated with tissue destruction. Several studies have reported that macrophages and monocytes release MMP-9 in response to tuberculosis or its cellular components [30, 31] . Studies have evaluated MMPs in tuberculous pleural effusions and found that the MMP activity in pleural fluid are higher in patients with tuberculosis compared with patients with transudative effusions [10, 32] . Our results are in agreement with the above findings, as the MMP-9 activity was highest in tuberculous effusions among the exudates we examined.', 'cite_spans': [{'start': 184, 'end': 187, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 290, 'end': 294, 'text': '[25,', 'ref_id': 'BIBREF24'}, {'start': 295, 'end': 298, 'text': '26]', 'ref_id': 'BIBREF25'}, {'start': 514, 'end': 518, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 519, 'end': 522, 'text': '27]', 'ref_id': 'BIBREF26'}, {'start': 697, 'end': 701, 'text': '[28]', 'ref_id': 'BIBREF27'}, {'start': 803, 'end': 807, 'text': '[15,', 'ref_id': 'BIBREF14'}, {'start': 808, 'end': 811, 'text': '25,', 'ref_id': 'BIBREF24'}, {'start': 812, 'end': 815, 'text': '29]', 'ref_id': 'BIBREF28'}, {'start': 1063, 'end': 1067, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 1068, 'end': 1071, 'text': '15,', 'ref_id': 'BIBREF14'}, {'start': 1072, 'end': 1075, 'text': '29]', 'ref_id': 'BIBREF28'}, {'start': 1554, 'end': 1558, 'text': '[30,', 'ref_id': 'BIBREF29'}, {'start': 1559, 'end': 1562, 'text': '31]', 'ref_id': 'BIBREF30'}, {'start': 1767, 'end': 1771, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 1772, 'end': 1775, 'text': '32]', 'ref_id': 'BIBREF31'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The present study is the first report about the ACE/ACE2 ratio in tuberculosis diagnosis. Although increased ACE and MMP-9 could be specifically determined in the tuberculous effusion. There are still few concerns should be addressed using ACE and MMP-9 as biomarker for tuberculosis diagnosis, because (1) elevated ACE levels may also be seen in several other cardiovascular disorders, and (2) MMP-9 is an inflammation-induced target in several cases [33] . In the RAS, ACE2/Ang-(1-7) axis has been recently highlighted as the counter balancing arm of the RAS to the ACE/Ang II axis. The regulatory mechanisms focused on the alternating ACE and ACE2 regulation are still lack; therefore, the mechanism of reduced ACE2 found in the pleural effusion of patients with tuberculosis remains to be further explored.', 'cite_spans': [{'start': 452, 'end': 456, 'text': '[33]', 'ref_id': 'BIBREF32'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Our data suggest that the interplay between ACE and ACE2, an essential function in RAS, and the change in gelatinase activity may be involved in the development of pleural effusions. Our findings suggest that increased ACE and MMP-9 activities and decreased ACE2 activity in pleural fluid are features of pleural space infection in patients with pleural tuberculosis. Such measurements may be helpful for diagnosing tuberculous pleurisy. However, the findings of the present study require further validation in a large prospective study examining the treatment and outcome of unselected patients with tuberculosis before the above indicators can become part of a clinically meaningful practice.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusion'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy', 'authors': [{'first': 'L', 'middle': [], 'last': 'Valdés', 'suffix': ''}, {'first': 'San', 'middle': [], 'last': 'José', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Alvarez', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 1996, 'venue': 'Eur Respir J', 'volume': '9', 'issn': '', 'pages': '747--51', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'The pulmonary renin-angiotensin system', 'authors': [{'first': 'R', 'middle': ['P'], 'last': 'Marshall', 'suffix': ''}], 'year': 2003, 'venue': 'Curr Pharm Design', 'volume': '9', 'issn': '', 'pages': '715--737', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin', 'authors': [{'first': 'R', 'middle': ['M'], 'last': 'Wösten-Van Asperen', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Lutter', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Haitsma', 'suffix': ''}], 'year': 2008, 'venue': 'Eur Respir J', 'volume': '31', 'issn': '', 'pages': '363--71', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation', 'authors': [{'first': 'C', 'middle': ['L'], 'last': 'Chen', 'suffix': ''}, {'first': 'Sks', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Lin', 'suffix': ''}], 'year': 2008, 'venue': 'J Mol Cell Cardiol', 'volume': '45', 'issn': '', 'pages': '742--53', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kuba', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Imai', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Rao', 'suffix': ''}], 'year': 2005, 'venue': 'Nat Med', 'volume': '11', 'issn': '', 'pages': '875--79', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Imai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kuba', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Ohto-Nakanishi', 'suffix': ''}], 'year': 2010, 'venue': 'Circ J', 'volume': '74', 'issn': '', 'pages': '405--415', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart', 'authors': [{'first': 'C', 'middle': [], 'last': 'Mercure', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yogi', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Callera', 'suffix': ''}], 'year': 2008, 'venue': 'Circ Res', 'volume': '103', 'issn': '', 'pages': '1319--1345', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Interplay of angiotensin II and angiotensin 1-7 in the regulations of matrix metalloproteinases of human cardiocytes', 'authors': [{'first': 'C', 'middle': ['H'], 'last': 'Pan', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Wen', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Lin', 'suffix': ''}], 'year': 2008, 'venue': 'Exp Physiol', 'volume': '93', 'issn': '', 'pages': '599--612', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions', 'authors': [{'first': 'D', 'middle': [], 'last': 'Iglesias', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Alegre', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Alemán', 'suffix': ''}], 'year': 2005, 'venue': 'Eur Respir J', 'volume': '25', 'issn': '', 'pages': '104--113', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration', 'authors': [{'first': 'K', 'middle': ['J'], 'last': 'Park', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Hwang', 'suffix': ''}, {'first': 'S', 'middle': ['S'], 'last': 'Sheen', 'suffix': ''}], 'year': 2005, 'venue': '', 'volume': '72', 'issn': '', 'pages': '166--75', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions. Respiration', 'authors': [{'first': 'S', 'middle': [], 'last': 'Oikonomidi', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kostikas', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Kalomenidis', 'suffix': ''}], 'year': 2010, 'venue': '', 'volume': '80', 'issn': '', 'pages': '285--91', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Pleural effusions: the diagnostic separation of transudates and exudates', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Light', 'suffix': ''}, {'first': 'M', 'middle': ['I'], 'last': 'Macgregor', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Luchsinger', 'suffix': ''}], 'year': 1972, 'venue': 'Ann Intern Med', 'volume': '77', 'issn': '', 'pages': '507--520', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'ACE and ACE2 activity in diabetic mice', 'authors': [{'first': 'J', 'middle': [], 'last': 'Wysocki', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ye', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Soler', 'suffix': ''}], 'year': 2006, 'venue': 'Diabetes', 'volume': '5', 'issn': '', 'pages': '2132--2171', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?', 'authors': [{'first': 'A', 'middle': [], 'last': 'Trajman', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Pai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Dheda', 'suffix': ''}], 'year': 2008, 'venue': 'Eur Respir J', 'volume': '31', 'issn': '', 'pages': '1098--106', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation', 'authors': [{'first': 'P', 'middle': [], 'last': 'Sheen', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'O&apos;kane', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Chaudhary', 'suffix': ''}], 'year': 2009, 'venue': 'Eur Respir J', 'volume': '33', 'issn': '', 'pages': '134--175', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Levels of angiotensin-converting enzyme in pleural effusion', 'authors': [{'first': 'C', 'middle': ['W'], 'last': 'Bedrossian', 'suffix': ''}, {'first': 'D', 'middle': ['A'], 'last': 'Stein', 'suffix': ''}, {'first': 'W', 'middle': ['C'], 'last': 'Miller', 'suffix': ''}], 'year': 1981, 'venue': 'Arch Pathol Lab Med', 'volume': '105', 'issn': '', 'pages': '345--351', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Activity of angiotensin-converting enzyme in pleural fluid and serum in non-sarcoid, non-tuberculous pleural effusion', 'authors': [{'first': 'F', 'middle': ['K'], 'last': 'Rømer', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Geday', 'suffix': ''}], 'year': 1982, 'venue': 'Eur J Respir Dis', 'volume': '63', 'issn': '', 'pages': '102--108', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis', 'authors': [{'first': 'T', 'middle': [], 'last': 'Söderblom', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Nyberg', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pettersson', 'suffix': ''}], 'year': 1996, 'venue': 'Respiration', 'volume': '63', 'issn': '', 'pages': '272--278', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis', 'authors': [{'first': 'B', 'middle': [], 'last': 'Dong', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Feng', 'suffix': ''}], 'year': 2008, 'venue': 'Arterioscler Thromb Vasc Biol', 'volume': '28', 'issn': '', 'pages': '1270--1276', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47 (phox) NADPH oxidase subunit', 'authors': [{'first': 'S', 'middle': [], 'last': 'Bodiga', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Zhong', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Wang', 'suffix': ''}], 'year': 2011, 'venue': 'Cardiovasc Res', 'volume': '91', 'issn': '', 'pages': '151--61', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Angiotensin II induces NF-κB, JNK and p38 MAPK activation in monocytic cells and increases matrix metalloproteinase-9 expression in a PKC-andRho kinase-dependent manner', 'authors': [{'first': 'H', 'middle': [], 'last': 'Yaghooti', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Firoozrai', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Fallah', 'suffix': ''}], 'year': 2011, 'venue': 'Braz J Med Biol Res', 'volume': '44', 'issn': '', 'pages': '193--202', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats', 'authors': [{'first': 'M', 'middle': [], 'last': 'Okada', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Kosaka', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Hoshino', 'suffix': ''}], 'year': 2010, 'venue': 'Biol Pharm Bull', 'volume': '33', 'issn': '', 'pages': '1517--1538', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Feng', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ni', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wan', 'suffix': ''}], 'year': 2011, 'venue': 'Oncol Rep', 'volume': '26', 'issn': '', 'pages': '1157--64', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways', 'authors': [{'first': 'L', 'middle': [], 'last': 'Ni', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Feng', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wan', 'suffix': ''}], 'year': 2012, 'venue': 'Oncol Rep', 'volume': '27', 'issn': '', 'pages': '783--90', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'MMP and TIMP expression pattern in pleural effusions of different origins', 'authors': [{'first': 'O', 'middle': [], 'last': 'Eickelberg', 'suffix': ''}, {'first': 'C', 'middle': ['O'], 'last': 'Sommerfeld', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wyser', 'suffix': ''}], 'year': 1997, 'venue': 'Am J Resp Crit Care', 'volume': '156', 'issn': '', 'pages': '1987--92', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'MMP expression and abnormal lung permeability are important determinants of outcome in IPF', 'authors': [{'first': 'S', 'middle': [], 'last': 'Mckeown', 'suffix': ''}, {'first': 'A', 'middle': ['G'], 'last': 'Richter', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'O&apos;kane', 'suffix': ''}], 'year': 2009, 'venue': 'Eur Respir J', 'volume': '33', 'issn': '', 'pages': '77--84', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Pathophysiology of the pleura', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Jantz', 'suffix': ''}, {'first': 'Antony', 'middle': [], 'last': 'Vb', 'suffix': ''}], 'year': 2008, 'venue': 'Respiration', 'volume': '75', 'issn': '', 'pages': '121--154', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase a activation and cell proliferation', 'authors': [{'first': 'S', 'middle': [], 'last': 'Zucker', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Mirza', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'Conner', 'suffix': ''}], 'year': 1998, 'venue': 'Int J Cancer', 'volume': '75', 'issn': '', 'pages': '780--786', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Human pleural effusions are rich in matrix metalloproteinases', 'authors': [{'first': 'A', 'middle': ['N'], 'last': 'Hurewitz', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Zucker', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Mancuso', 'suffix': ''}], 'year': 1992, 'venue': 'Chest', 'volume': '102', 'issn': '', 'pages': '1808--1822', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Friedland', 'suffix': ''}, {'first': 'T', 'middle': ['C'], 'last': 'Shaw', 'suffix': ''}, {'first': 'N', 'middle': ['M'], 'last': 'Price', 'suffix': ''}], 'year': 2002, 'venue': 'Matrix Biol', 'volume': '21', 'issn': '', 'pages': '103--113', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'tuberculosis induction of matrix metalloproteinase-9: The role of mannose and receptor-mediated mechanisms', 'authors': [{'first': 'C', 'middle': ['A'], 'last': 'Rivera-Marrero', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Schuyler', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Roser', 'suffix': ''}], 'year': 2002, 'venue': 'Am J Physiol Lung Cell Mol Physiol', 'volume': '82', 'issn': '', 'pages': '546--55', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis', 'authors': [{'first': 'G', 'middle': [], 'last': 'Hoheisel', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Sack', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Hui', 'suffix': ''}], 'year': 2001, 'venue': 'Tuberculosis', 'volume': '81', 'issn': '', 'pages': '203--212', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis', 'authors': [{'first': 'M', 'middle': ['E'], 'last': 'Muroski', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': 'Roycik', 'suffix': ''}, {'first': 'R', 'middle': ['G'], 'last': 'Newcomer', 'suffix': ''}], 'year': 2008, 'venue': 'Curr Pharm Biotechnol', 'volume': '9', 'issn': '', 'pages': '34--46', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'ACE and ACE2 activities were assayed with the fluorogenic substrates Mca-YVADAPK and Mca-APK-Dnp (AnaSpec, San Jose, CA, USA), respectively, according to Wysocki et al. with slight modifications', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'Enzymatic activity of ACE and ACE2 in pleural transudative and exudative effusions. The specific activities of ACE (A) and ACE2 (B) in pleural transudative (n = 45) and exudative (n = 80) effusions from 125 patients. The ratio of ACE/ACE2 in the pleural effusions (C). Pleural effusion (20 μl) was assayed for the ability to cleave the fluorescent substrate at 37°C for 1 hour with a specific ACE inhibitor or a specific ACE2 inhibitor. Each symbol represents one individual, and horizontal bars represent median values. ** and *** indicate p < 0.01 and p < 0.001, respectively, compared with transudates.', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': \"Correlations between ACE and ACE2 activities in pleural effusions. ACE and ACE2 activities were measured in each sample of pleural transudative effusions (A; n = 45) and exudative effusions (B; n = 80). For correlation analysis, Pearson's correlation analysis (SPSS statistics package, Chicago, IL) was applied. Statistically significant differences were established at p < 0.05. ACE and ACE2 positively correlate with each other in the group of transudative effusions (F(1,43) = 36.052, r 2 = 0.456, p < 0.001) (A), but not in the group of exudative effusions (F(1,78) = 1.567, r 2 = 0.020, p > 0.05) (B).\", 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'MMP-2 and MMP-9 activities in pleural transudative and exudative effusions. The activities of MMP-2 (A) and MMP-9 (B) in pleural transudative and exudative effusions from 125 patients were determined with zymography. The gelatinase activities detected in this study were based on pro-MMP-2 (72 kDa) and pro-MMP-9 (95 kDa). Each symbol represents one individual, and horizontal bars represent median values. *** indicates p < 0.001 compared with transudates.', 'latex': None, 'type': 'figure'}, 'FIGREF4': {'text': 'ACE and ACE2 activities in exudative effusions from patients with tuberculosis (TB), pneumonia (Pn), and adenocarcinoma (Ad). The activities of ACE (A), ACE2 (B), and the ratio of ACE/ACE2 (C) in TB (n = 20), Pn (n = 32), and Ad (n = 28) effusions. Each symbol represents one individual, and horizontal bars represent median values. * and *** indicate p < 0.05 and p < 0.001, respectively, compared with values measured in Pn and/or Ad effusions.', 'latex': None, 'type': 'figure'}, 'FIGREF5': {'text': 'MMP-2 and MMP-9 activities in exudative effusions from patients with tuberculosis (TB), pneumonia (Pn), and adenocarcinoma (Ad). The activities of MMP-2 (A) and MMP-9 (B) in TB (n = 20), Pn (n = 32), and Ad (n = 28) effusions. The gelatinase activities detected in this study were based on pro-MMP-2 (72 kDa) and pro-MMP-9 (95 kDa). Each symbol represents one individual, and horizontal bars represent median values. * and ** indicate p < 0.05 and p < 0.01, respectively, compared with values measured in Pn and/or Ad effusions.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Pleural fluid characteristics of the study population.Transudates were from patients with heart failure or liver cirrhosis. Exudates were from patients with tuberculous, pneumonia, or adenocarcinoma effusions. Data are the means \\uf0b1 SD. *** indicates p < 0.001 compared with transudates.', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Pleural fluid characteristics of tuberculous, pneumonia and adenocarcinoma effusions.', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We confirm and declare that all authors fulfilled the condition for authorship. There was no commercial support in the process of performing this study and submitting this manuscript.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgements'}, {'text': 'The authors have declared that no competing interest exists.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing Interests'}]}\n"
     ]
    }
   ],
   "source": [
    "# query on nested documents\n",
    "# see: https://docs.mongodb.com/manual/tutorial/query-embedded-documents/\n",
    "\n",
    "for c in db['noncomm-subset'].find({'metadata.title': 'ACE/ACE2 Ratio and MMP-9 Activity as Potential Biomarkers in Tuberculous Pleural Effusions'}):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5f4ecbc6f7c2f0238d4cbc14'), 'paper_id': '1b58422e266ab9339c919119923229d080f27360', 'metadata': {'title': 'ACE/ACE2 Ratio and MMP-9 Activity as Potential Biomarkers in Tuberculous Pleural Effusions', 'authors': [{'first': 'Wen-Yeh', 'middle': [], 'last': 'Hsieh', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Tang-Ching', 'middle': [], 'last': 'Kuan', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Kun-Shan', 'middle': [], 'last': 'Cheng', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Yan-Chiou', 'middle': [], 'last': 'Liao', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Mu-Yuan', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Pei-Heng', 'middle': [], 'last': 'Lin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Yuan-Chang', 'middle': [], 'last': 'Hsu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Chen-Yi', 'middle': [], 'last': 'Huang', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Wei-Hua', 'middle': [], 'last': 'Hsu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mackay Memorial Hospital', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Sheng-Yao', 'middle': [], 'last': 'Yu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mackay Memorial Hospital', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Chih-Sheng', 'middle': [], 'last': 'Lin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}]}, 'abstract': [{'text': 'Objective: Pleural effusion is common problem, but the rapid and reliable diagnosis for specific pathogenic effusions are lacking. This study aimed to identify the diagnosis based on clinical variables to differentiate pleural tuberculous exudates from other pleural effusions. We also investigated the role of renin-angiotensin system (RAS) and matrix metalloproteinase (MMPs) in the pathogenesis of pleural exudates. Experimental design: The major components in RAS and extracellular matrix metabolism, including angiotensin converting enzyme (ACE), ACE2, MMP-2 and MMP-9 activities, were measured and compared in the patients with transudative (n = 45) and exudative (n = 80) effusions. The exudative effusions were come from the patients with tuberculosis (n = 20), pneumonia (n = 32), and adenocarcinoma (n = 28). Results: Increased ACE and equivalent ACE2 activities, resulting in a significantly increased ACE/ACE2 ratio in exudates, were detected compared to these values in transudates. MMP-9 activity in exudates was significantly higher than that in transudates. The significant correlation between ACE and ACE2 activity that was found in transudates was not found in exudates. Advanced analyses showed significantly increased ACE and MMP-9 activities, and decreased ACE2 activity in tuberculous pleural effusions compared with those in pneumonia and adenocarcinoma effusions. The results indicate that increased ACE and MMP-9 activities found in the exudates were mainly contributed from a higher level of both enzyme activities in the tuberculous pleural effusions. Conclusion: Interplay between ACE and ACE2, essential functions in the RAS, and abnormal regulation of MMP-9 probably play a pivotal role in the development of exudative effusions. Moreover, the ACE/ACE2 ratio combined with MMP-9 activity in pleural fluid may be potential biomarkers for diagnosing tuberculous pleurisy.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Pleural effusion is a common medical problem in the chest and involves accumulation of an abnormal amount of pleural fluid in the pleural space. Several diseases such as congestive heart failure, liver cirrhosis, tuberculosis, adenocarcinoma, and pneumonia are common diseases that cause pleural effusions, but there is no rapid and accurate diagnostic method for pleural effusion. Conventional diagnosis of tuberculous pleurisy is based on pleural fluid cytology, culture of pleural effusions, and pleural biopsy tissue culture, but these methods have very low sensitivity and recognised limitations in clinical use, and they usually require weeks for a positive culture report [1] . Therefore, a reliable clinical marker providing simple, rapid, and accurate diagnosis is required for patients with pleural effusion.', 'cite_spans': [{'start': 679, 'end': 682, 'text': '[1]', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'The circulating renin-angiotensin system (RAS) plays a well-described role in maintaining blood pressure homeostasis. Recently, a local tissue-based RAS has also been described and appears to play a key role in injury/repair responses [2, 3] . The expression of RAS components and the elevation of angiotensin converting enzyme (ACE) in a number of lung diseases suggest the existence of a pulmonary RAS and that angiotensin II (Ang II) could mediate, at least in part, the response to lung injury. The central role of ACE is to generate Ang II from Ang I. Ang II is a key effector peptide of RAS that causes vasoconstriction and exerts multiple biological functions. Ang II can also cause the development of interstitial fibrosis via physiological regulation of matrix metalloproteinase (MMP) expression and/or activation [4] .', 'cite_spans': [{'start': 235, 'end': 238, 'text': '[2,', 'ref_id': 'BIBREF1'}, {'start': 239, 'end': 241, 'text': '3]', 'ref_id': 'BIBREF2'}, {'start': 823, 'end': 826, 'text': '[4]', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'ACE2, a close homologue of ACE, functions as a negative regulator of the angiotensin system and was identified as a key receptor for severe acute respiratory syndrome coronavirus infections [5, 6] . ACE2 reduces the generation of Ang II by catalysing the conversion of Ang I to Ang1-9 and facilitating hydrolysis of Ang II to Ang1-7. Ang1-7 has been recognised as a potential endogenous inhibitor of the classical RAS cascade [7] . Hence, the ACE2\\uf02dAng1-7 axis may be an important negative modulator of Ang II bioactivity, counteracting the effects of ACE in determining net tissue Ang II levels. Abnormally elevated ACE combined with decreased ACE2 expression may be involved in fibrotic processes in vitro and in vivo, and the mechanism may involve expression and activation of specific MMPs [8] . Recently, abnormal pleural MMP levels, e.g., MMP-2 and MMP-9, have been reported, and the association between MMPs and development of pleurisy has been investigated [9, 10, 11] .', 'cite_spans': [{'start': 190, 'end': 193, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 194, 'end': 196, 'text': '6]', 'ref_id': 'BIBREF5'}, {'start': 426, 'end': 429, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 793, 'end': 796, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 964, 'end': 967, 'text': '[9,', 'ref_id': 'BIBREF8'}, {'start': 968, 'end': 971, 'text': '10,', 'ref_id': 'BIBREF9'}, {'start': 972, 'end': 975, 'text': '11]', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Here we evaluated the association of two key enzymes in RAS, ACE and ACE2, with MMP-2 and MMP-9 in the pleural fluid of patients with pleural effusion. We also detail discussed whether abnormal RAS, accompanied with high levels of ACE/ACE2, might be a cause of elevated MMP-9 activity in tuberculous pleural effusion. Finally, a high ratio of ACE to ACE2 combined with elevated MMP-9 detected in pleural fluid may be a potential indicator for the diagnosis of tuberculous pleurisy.', 'cite_spans': [], 'ref_spans': [], 'section': 'Introduction'}, {'text': \"Pleural effusions from 125 patients were processed in our laboratory from August 2010 to December 2011. All pleural effusions were designated as transudates or exudates according to Light's criteria [12] . Definitive diagnosis of tuberculous, pneumonia, or adenocarcinoma effusions for the exudate was verified by examining effusion biochemistry, cytology, acid-fast staining, and clinical follow-up. The study was performed with the approval of the Institutional Review Board of Mackay Memorial Hospital. Informed consent was obtained from all patients.\", 'cite_spans': [{'start': 199, 'end': 203, 'text': '[12]', 'ref_id': 'BIBREF11'}], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': \"According to Light's criteria, pleural effusions were divided into 45 transudative pleural effusions and 80 exudative pleural effusions. The exudative pleural effusions were further divided into tuberculous pleural effusions (20 patients), pneumonia pleural effusions (32 patients), and malignant pleural effusions (28 patients). Fresh pleural fluid was collected in sterile tubes without anticoagulant reagents to prevent the release of gelatinases during platelet activation, and the tubes were immediately centrifuged at 3,000 × g for 30 minutes to separate the supernatants and cell pellets. The supernatants were aliquoted and stored with the cell pellets at −80°C until further use.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': 'For each pleural effusion sample, the routine pleural analyses included total protein, lactate dehydrogenase (LDH), glucose, and white blood cell (WBC) count. In addition, the activities of ACE, ACE2, and gelatinases (MMP-2 and MMP-9) in the pleural effusions were measured.', 'cite_spans': [], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': 'Gelatin zymography for detecting MMP-2 and MMP-9 activity was performed with gelatin-containing gels as our previous report [4] . Briefly, 10 \\uf06dl pleural fluid for each subject was loaded to a 10% SDS-PAGE containing 0.1 mg·ml -1 gelatin (Sigma-Aldrich, St. Louis, MO, USA). The gelatinase activities were identified as clear zones against a blue background on the SDS-PAGE and quantified using Scion Image software (NIH, Bethesda, MD, USA), which quantifies the extent of lysis in bands containing gelatinase. Enzyme activity was expressed as ng·ml -1 . [13] . The assay was performed in a micro-quartz cuvette with 20 μl pleural fluid, 50 μM fluorogenic substrate and protease inhibitor cocktail (1:200; Sigma-Aldrich) in a final volume of 100 μl in ACE or ACE2 assay buffer. The reaction was followed kinetically for 1 hour using a fluorescence reader at an excitation wavelength of 330 nm and an emission wavelength of 390 nm. Data were fitted and plotted using Grafit v.4.0 (Sigma-Aldrich), and enzyme activity was expressed as RFU·h -1 ·ml -1 . Parallel samples were incubated with the above-mentioned reaction mixture in the presence of 1 μM captopril (Sigma-Aldrich), a specific ACE inhibitor for determining specific ACE activity, or 1 μM DX600 (AnaSpec), a specific ACE2 inhibitor for determining specific ACE2 activity.', 'cite_spans': [{'start': 124, 'end': 127, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 554, 'end': 558, 'text': '[13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'Gelatin zymography'}, {'text': 'The levels of various markers in the pleural effusion samples are expressed as the mean ± standard deviation (SD) or shown as the median (interquartile range). Group comparisons were made using the nonparametric Kruskal-Wallis test. Differences were considered statistically significant when p < 0.05. Statistical analysis was performed using statistical software (SPSS, Chicago, IL, USA).', 'cite_spans': [], 'ref_spans': [], 'section': 'Statistics'}, {'text': 'The pleural fluid characteristics of 125 patients included in the study are presented in Table 1 . Generally, total protein, LDH, and the number of WBC in exudative effusions (n = 80) were significantly higher than those in transudative effusions (n = 45) (p < 0.001), whereas a lower glucose level was detected in the pleural fluid of exudates compared with that in transudates (p < 0.001).', 'cite_spans': [], 'ref_spans': [{'start': 89, 'end': 96, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'General characteristics of pleural effusions'}, {'text': 'ACE and ACE2 activities in the pleural effusions of all patients were determined. ACE activity in exudative effusions was higher than that in transudative effusions (median, 0.74 (IQR, 0.43-1.47) RFU·h -1 ·ml -1 vs. 0.57 (0.32-0.9) RFU·h -1 ·ml -1 , p < 0.01) ( Figure 1A ). On the contrary, ACE2 activity in exudative effusions was lower than that in transudative effusions (1.58 (1.02-2.54) RFU·h -1 ·ml -1 vs.', 'cite_spans': [], 'ref_spans': [{'start': 262, 'end': 271, 'text': 'Figure 1A', 'ref_id': 'FIGREF1'}], 'section': 'ACE and ACE2 activities in transudates and exudates'}, {'text': '1.98 (1.27-3.12) RFU·h -1 ·ml -1 ) ( Figure 1B ), but this difference was not statistically significant. The ratio of ACE/ACE2 activity in the pleural effusions was significantly higher in exudative effusions than in transudative effusions (0.49 (0.27-0.91) vs. 0.27 (0.19-0.43), p < 0.001) ( Figure  1C ). In transudates, a significant positive correlation was found between ACE and ACE2 activities (r 2 = 0.456, p < 0.001) (Figure 2A) . However, the ACE activity was not correlated with the ACE2 activity in exudative effusions (r 2 = 0.020, p = 0.214) ( Figure 2B ). ', 'cite_spans': [], 'ref_spans': [{'start': 37, 'end': 46, 'text': 'Figure 1B', 'ref_id': 'FIGREF1'}, {'start': 293, 'end': 303, 'text': 'Figure  1C', 'ref_id': 'FIGREF1'}, {'start': 425, 'end': 436, 'text': '(Figure 2A)', 'ref_id': 'FIGREF2'}, {'start': 557, 'end': 566, 'text': 'Figure 2B', 'ref_id': 'FIGREF2'}], 'section': 'ACE and ACE2 activities in transudates and exudates'}, {'text': 'The MMP-2 and MMP-9 activities in the pleural effusions of all patients were determined with gelatin zymography (Figure 3 ). The MMP-2 activity in exudative effusions was comparable with that in transudative effusions (1375 (944-1841) ng·ml -1 vs. 1148 (806-1730) ng·ml -1 ) ( Figure 3A ). However, MMP-9 activity in exudative effusions was significantly higher than that in transudative effusions (30 (19-52) ng·ml -1 vs. 11 (8-23) ng·ml -1 , p < 0.001) ( Figure 3B ).', 'cite_spans': [{'start': 398, 'end': 409, 'text': '(30 (19-52)', 'ref_id': None}], 'ref_spans': [{'start': 112, 'end': 121, 'text': '(Figure 3', 'ref_id': 'FIGREF3'}, {'start': 277, 'end': 286, 'text': 'Figure 3A', 'ref_id': 'FIGREF3'}, {'start': 457, 'end': 466, 'text': 'Figure 3B', 'ref_id': 'FIGREF3'}], 'section': 'MMP-2 and MMP-9 activities in transudates and exudates'}, {'text': 'WBC number, glucose, total protein and LDH concentration in the exudates from of three types, tuberculous, pneumonia and adenocarcinoma effusions, were determined ( Table 2 ). The data show that all of WBC number, glucose and LDH concentration determinations among the three exudative effusions were insignificantly different. ', 'cite_spans': [], 'ref_spans': [{'start': 165, 'end': 172, 'text': 'Table 2', 'ref_id': 'TABREF1'}], 'section': 'WBC and biochemical assay in exudates from patients with different diseases'}, {'text': 'Elevated ACE activity and an elevated ACE/ACE2 ratio were observed in exudative effusions. We then differentiated both ACE and ACE2 activities in the exudates according to different diseases, including tuberculosis, pneumonia, and adenocarcinoma. The ACE activity in the tuberculous pleural effusions was significantly higher than in pneumonia and adenocarcinoma effusions, by 2.89 (p < 0.001) and 2.62 (p < 0.001) fold, respectively ( Figure  4A ). In contrast, ACE2 activity in the tuberculous effusions was significantly lower than in pneumonia and adenocarcinoma effusions, by 0.68 (p < 0.05) and 0.58 (p < 0.05) fold, respectively ( Figure 4B ). According to the changes we detected in ACE and ACE2, a significantly higher difference in the ACE/ACE2 ratio in tuberculous effusions (1.72 (1.09-2.52)) compared with ratios in pneumonia (0.32 (0.20-0.50)) and adenocarcinoma (0.43 (0.26-0.67)) effusions was also observed (p < 0.001) ( Figure 4C ).', 'cite_spans': [], 'ref_spans': [{'start': 436, 'end': 446, 'text': 'Figure  4A', 'ref_id': 'FIGREF4'}, {'start': 638, 'end': 647, 'text': 'Figure 4B', 'ref_id': 'FIGREF4'}, {'start': 938, 'end': 947, 'text': 'Figure 4C', 'ref_id': 'FIGREF4'}], 'section': 'ACE and ACE2 activities in exudates from patients with different diseases'}, {'text': 'The pleural ACE and ACE2 activities among transudates, tuberculosis, pneumonia and adenocar-cinoma were compared. The ACE and ACE2 activities in transudates, tuberculous, pneumonia and adenocarcinoma effusions were 0.67 ± 0.52, 2.16 ± 0.97, 0.74 ± 0.77 and 0.82 ± 0.43 RFU/hour/ml, and 2.19 ± 1.31, 1.38 ± 0.58, 2.05 ± 1.40 and 2.38 ± 1.86 RFU/hour/ml, respectively. It is noted that both of ACE and ACE2 activities in pneumonia and adenocarcinoma effusions were similar to the activities in transudative effusions.', 'cite_spans': [], 'ref_spans': [], 'section': 'ACE and ACE2 activities in exudates from patients with different diseases'}, {'text': 'The MMP-2 and MMP-9 activities in exudative effusions from the patients with different diseases were assayed by gelatin zymography (Figure 5 ). In tuberculous pleural effusions, MMP-2 activity was 1.48 (p < 0.01) and 1.36 fold (p < 0.05) higher than MMP-2 activity in pneumonia and adenocarcinoma effusions, respectively ( Figure 5A ). Similar to MMP-2, MMP-9 activity in tuberculous effusions was significantly higher than MMP-9 activity in pneumonia and adenocarcinoma effusions by 1.62 (p < 0.01) and 1.77 fold (p < 0.01), respectively ( Figure 5B ). ', 'cite_spans': [], 'ref_spans': [{'start': 131, 'end': 140, 'text': '(Figure 5', 'ref_id': 'FIGREF5'}, {'start': 323, 'end': 332, 'text': 'Figure 5A', 'ref_id': 'FIGREF5'}, {'start': 541, 'end': 550, 'text': 'Figure 5B', 'ref_id': 'FIGREF5'}], 'section': 'MMP-2 and MMP-9 activities in exudates from patients with different diseases'}, {'text': 'In the present study, major components of RAS and extracellular matrix (ECM) metabolism, pleural ACE, ACE2, MMP-2, and MMP-9, were measured in patients with pleural effusions. Our main findings are: (1) significantly higher the ACE, MMP-9 activity and ACE/ACE2 ratio in exudative effusions; (2) increased MMP-9 and ACE activities combined with decreased ACE2 activity in tuberculous effusion compared to pneumonia and adenocarcinoma effusions. The increased MMP-9 activity found in tuberculous effusion is in agreement with previous reports [9, 14, 15] . Herein, we first report that the changes of ACE and ACE2 activity are associated with tuberculous pleurisy.', 'cite_spans': [{'start': 541, 'end': 544, 'text': '[9,', 'ref_id': 'BIBREF8'}, {'start': 545, 'end': 548, 'text': '14,', 'ref_id': 'BIBREF13'}, {'start': 549, 'end': 552, 'text': '15]', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Only a few reports have been published on the importance of ACE in pleural fluid. ACE could be detected in pleural fluid, but the ACE level cannot be used to discriminate cancer from non-cancer patients [16, 17] . Söderblom et al. [18] had also measured ACE in pleural effusions and sera of 364 patients and showed that tuberculous effusions contain higher ACE concentrations than any other type of non-rheumatoid effusions. These results indicate that ACE determinations may aid in differentiating rheumatoid and tuberculous pleurisy from other types of pleural disease.', 'cite_spans': [{'start': 203, 'end': 207, 'text': '[16,', 'ref_id': 'BIBREF15'}, {'start': 208, 'end': 211, 'text': '17]', 'ref_id': 'BIBREF16'}, {'start': 231, 'end': 235, 'text': '[18]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'In the present study, we reported the change in ACE2 activity in pleural effusions. Some of the physiological functions of ACE2 are opposite to those of ACE. The significant positive correlation between ACE and ACE2 activities in the transudates suggests that ACE and ACE2 maintain a normal physiological balance. This loss of balance in exudates was detected because of increased ACE. Although the importance of the dysregulation in ACE in exudative effusions has not been explored, a significant role for RAS in the pathophysiological process of exudate development is possible.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'ACE activity was increased (p < 0.001) and ACE2 was decreased (p < 0.05) in tuberculosis specifically, but the ACE and ACE2 activities were no difference between transudate, pneumonia and adenocarcinoma effusions. These results indicated that ACE and ACE2 maybe a biomarker for tuberculosis diagnosis in pleural effusion and it could be emphasized that the increased ACE activity and ratio of ACE/ACE2 in the exudates are mainly contributed from a higher ACE level and lower ACE2 enzyme activities in the tuberculous pleural effusion. In an advanced assay, our data show that the ACE activity of 85% (17/20), 19% (6/32), 18% (5/28) and 18% (8/45) pleural fluids isolated tuberculosis, pneumonia, adenocarcinoma and transudates was > 1 RFU/hour/ml, respectively. It is also indicated that the increased ACE activity found in the exudates are mainly contributed from a higher ACE activity in the tuberculous pleural effusion.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The ACE2 activity in tuberculous, pneumonia and adenocarcinoma effusions were 1.38 ± 0.58, 2.05 ± 1.40 and 2.38 ± 1.86 RFU/hour/ml (mean ± SD), respectively. Although a larger SD was determined in the pneumonia and adenocarcinoma groups, the ACE2 activity in both groups were significantly larger than that in the tuberculosis group (p < 0.05). In advanced assay, the data indicate that there were 75% tuberculosis (15/20) , 56% pneumonia (18/32) and 50% adenocarcinoma (14/28) patients showed the ACE2 activity \\uf0a3 1.80 RFU/hour/ml (75% of interquartile range in tuberculous effusions; IQR, 0.97-1.80). The data also support that the trend of decreased ACE2 activity in the pleural effusions with tuberculosis compared to those with pneumonia or adenocarcinoma. However, more patients should be further included in order to examine the proposition.', 'cite_spans': [{'start': 415, 'end': 422, 'text': '(15/20)', 'ref_id': None}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'It is interesting that significantly increased ACE activity combined with markedly decreased ACE2 activity was measured in tuberculous effusions. This result confirms that abnormal RAS metabolism in pleural spaces may be related to tuberculous pleurisy. It was reported that overexpression of ACE2 may inhibit MMP-9 activity [19] , and ACE2 deficiency leads to increased MMP-9 levels [20] . In inflammatory signalling pathways study, Ang II could stimulate human monocytic U-937 cells to increase MMP-9 expression and activity significantly via activated NF-κB, JNK, and p38 [21] . The ACE inhibitor, captopril, was administrated to isoprenaline-induced left ventricular fibrosis rats and showed that captopril significantly enhanced the isoprenaline-induced myocardial fibrosis and augmented the isoprenaline-induced MMP-9 expression [22] . In addition, ACE2 and Ang 1-7, the regulators in RAS opposed Ang II effect, could affect MMP-9 expression. Overexpression of ACE2 reduces the invasive ability in vitro according to the down-regulation of MMP-2 and MMP-9 [23] . Ang 1-7 revealed the anti-migration and anti-invasion effect mediated through inactivation of the PI3K/Akt, P38 and JNK signal pathways to reduce the expression and activity of MMP-2 and MMP-9 [24] . According to our results, we conclude that reduction in ACE2 along with induction of MMP-9 activity occurred. Our observations of decreased ACE2 and increased MMP-9 activity in tuberculous effusions confirm this conclusion.', 'cite_spans': [{'start': 325, 'end': 329, 'text': '[19]', 'ref_id': 'BIBREF18'}, {'start': 384, 'end': 388, 'text': '[20]', 'ref_id': 'BIBREF19'}, {'start': 575, 'end': 579, 'text': '[21]', 'ref_id': 'BIBREF20'}, {'start': 835, 'end': 839, 'text': '[22]', 'ref_id': 'BIBREF21'}, {'start': 1062, 'end': 1066, 'text': '[23]', 'ref_id': 'BIBREF22'}, {'start': 1262, 'end': 1266, 'text': '[24]', 'ref_id': 'BIBREF23'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'A number of studies have indicated that the ACE-Ang II axis and ACE2-Ang1-7 axis not only regulate the metabolism of ECM proteins, but also modulate MMP expression and activity levels [8] . MMPs have been implicated in the pathogenesis of various lung diseases, including pleural effusions [25, 26] . The activity of MMPs within the pleural space may play a role in the formation of pleural effusions by altering the integrity of the mesothelial and endothelial cell layers and by increasing vascular permeability [10, 27] . Proteolysis by MMPs may be involved in the formation of pleural effusions by increasing vascular permeability, and thus by facilitating fluid influx into the pleural space [28] . Therefore, the presence and enzymatic activities of MMPs have been identified in pleural effusions [15, 25, 29] . Previous studies have shown that the expression of MMPs in the pleural space is altered in a variety of inflammatory and malignant diseases, suggesting that certain members of the MMP family may participate in the formation of pleural effusions [10, 15, 29] . Tissue damage is a characteristic manifestation of Mycobacterium tuberculosis infection. Proteolysis by macrophage-secreted proteases has been implicated in such destructive processes. In this regard, the proteolytic action of MMPs may be involved in the pathogenesis of tuberculosis, like many other diseases associated with tissue destruction. Several studies have reported that macrophages and monocytes release MMP-9 in response to tuberculosis or its cellular components [30, 31] . Studies have evaluated MMPs in tuberculous pleural effusions and found that the MMP activity in pleural fluid are higher in patients with tuberculosis compared with patients with transudative effusions [10, 32] . Our results are in agreement with the above findings, as the MMP-9 activity was highest in tuberculous effusions among the exudates we examined.', 'cite_spans': [{'start': 184, 'end': 187, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 290, 'end': 294, 'text': '[25,', 'ref_id': 'BIBREF24'}, {'start': 295, 'end': 298, 'text': '26]', 'ref_id': 'BIBREF25'}, {'start': 514, 'end': 518, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 519, 'end': 522, 'text': '27]', 'ref_id': 'BIBREF26'}, {'start': 697, 'end': 701, 'text': '[28]', 'ref_id': 'BIBREF27'}, {'start': 803, 'end': 807, 'text': '[15,', 'ref_id': 'BIBREF14'}, {'start': 808, 'end': 811, 'text': '25,', 'ref_id': 'BIBREF24'}, {'start': 812, 'end': 815, 'text': '29]', 'ref_id': 'BIBREF28'}, {'start': 1063, 'end': 1067, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 1068, 'end': 1071, 'text': '15,', 'ref_id': 'BIBREF14'}, {'start': 1072, 'end': 1075, 'text': '29]', 'ref_id': 'BIBREF28'}, {'start': 1554, 'end': 1558, 'text': '[30,', 'ref_id': 'BIBREF29'}, {'start': 1559, 'end': 1562, 'text': '31]', 'ref_id': 'BIBREF30'}, {'start': 1767, 'end': 1771, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 1772, 'end': 1775, 'text': '32]', 'ref_id': 'BIBREF31'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The present study is the first report about the ACE/ACE2 ratio in tuberculosis diagnosis. Although increased ACE and MMP-9 could be specifically determined in the tuberculous effusion. There are still few concerns should be addressed using ACE and MMP-9 as biomarker for tuberculosis diagnosis, because (1) elevated ACE levels may also be seen in several other cardiovascular disorders, and (2) MMP-9 is an inflammation-induced target in several cases [33] . In the RAS, ACE2/Ang-(1-7) axis has been recently highlighted as the counter balancing arm of the RAS to the ACE/Ang II axis. The regulatory mechanisms focused on the alternating ACE and ACE2 regulation are still lack; therefore, the mechanism of reduced ACE2 found in the pleural effusion of patients with tuberculosis remains to be further explored.', 'cite_spans': [{'start': 452, 'end': 456, 'text': '[33]', 'ref_id': 'BIBREF32'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Our data suggest that the interplay between ACE and ACE2, an essential function in RAS, and the change in gelatinase activity may be involved in the development of pleural effusions. Our findings suggest that increased ACE and MMP-9 activities and decreased ACE2 activity in pleural fluid are features of pleural space infection in patients with pleural tuberculosis. Such measurements may be helpful for diagnosing tuberculous pleurisy. However, the findings of the present study require further validation in a large prospective study examining the treatment and outcome of unselected patients with tuberculosis before the above indicators can become part of a clinically meaningful practice.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusion'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy', 'authors': [{'first': 'L', 'middle': [], 'last': 'Valdés', 'suffix': ''}, {'first': 'San', 'middle': [], 'last': 'José', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Alvarez', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 1996, 'venue': 'Eur Respir J', 'volume': '9', 'issn': '', 'pages': '747--51', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'The pulmonary renin-angiotensin system', 'authors': [{'first': 'R', 'middle': ['P'], 'last': 'Marshall', 'suffix': ''}], 'year': 2003, 'venue': 'Curr Pharm Design', 'volume': '9', 'issn': '', 'pages': '715--737', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin', 'authors': [{'first': 'R', 'middle': ['M'], 'last': 'Wösten-Van Asperen', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Lutter', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Haitsma', 'suffix': ''}], 'year': 2008, 'venue': 'Eur Respir J', 'volume': '31', 'issn': '', 'pages': '363--71', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation', 'authors': [{'first': 'C', 'middle': ['L'], 'last': 'Chen', 'suffix': ''}, {'first': 'Sks', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Lin', 'suffix': ''}], 'year': 2008, 'venue': 'J Mol Cell Cardiol', 'volume': '45', 'issn': '', 'pages': '742--53', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kuba', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Imai', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Rao', 'suffix': ''}], 'year': 2005, 'venue': 'Nat Med', 'volume': '11', 'issn': '', 'pages': '875--79', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Imai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kuba', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Ohto-Nakanishi', 'suffix': ''}], 'year': 2010, 'venue': 'Circ J', 'volume': '74', 'issn': '', 'pages': '405--415', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart', 'authors': [{'first': 'C', 'middle': [], 'last': 'Mercure', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yogi', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Callera', 'suffix': ''}], 'year': 2008, 'venue': 'Circ Res', 'volume': '103', 'issn': '', 'pages': '1319--1345', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Interplay of angiotensin II and angiotensin 1-7 in the regulations of matrix metalloproteinases of human cardiocytes', 'authors': [{'first': 'C', 'middle': ['H'], 'last': 'Pan', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Wen', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Lin', 'suffix': ''}], 'year': 2008, 'venue': 'Exp Physiol', 'volume': '93', 'issn': '', 'pages': '599--612', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions', 'authors': [{'first': 'D', 'middle': [], 'last': 'Iglesias', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Alegre', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Alemán', 'suffix': ''}], 'year': 2005, 'venue': 'Eur Respir J', 'volume': '25', 'issn': '', 'pages': '104--113', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration', 'authors': [{'first': 'K', 'middle': ['J'], 'last': 'Park', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Hwang', 'suffix': ''}, {'first': 'S', 'middle': ['S'], 'last': 'Sheen', 'suffix': ''}], 'year': 2005, 'venue': '', 'volume': '72', 'issn': '', 'pages': '166--75', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions. Respiration', 'authors': [{'first': 'S', 'middle': [], 'last': 'Oikonomidi', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kostikas', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Kalomenidis', 'suffix': ''}], 'year': 2010, 'venue': '', 'volume': '80', 'issn': '', 'pages': '285--91', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Pleural effusions: the diagnostic separation of transudates and exudates', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Light', 'suffix': ''}, {'first': 'M', 'middle': ['I'], 'last': 'Macgregor', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Luchsinger', 'suffix': ''}], 'year': 1972, 'venue': 'Ann Intern Med', 'volume': '77', 'issn': '', 'pages': '507--520', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'ACE and ACE2 activity in diabetic mice', 'authors': [{'first': 'J', 'middle': [], 'last': 'Wysocki', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ye', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Soler', 'suffix': ''}], 'year': 2006, 'venue': 'Diabetes', 'volume': '5', 'issn': '', 'pages': '2132--2171', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?', 'authors': [{'first': 'A', 'middle': [], 'last': 'Trajman', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Pai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Dheda', 'suffix': ''}], 'year': 2008, 'venue': 'Eur Respir J', 'volume': '31', 'issn': '', 'pages': '1098--106', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation', 'authors': [{'first': 'P', 'middle': [], 'last': 'Sheen', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'O&apos;kane', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Chaudhary', 'suffix': ''}], 'year': 2009, 'venue': 'Eur Respir J', 'volume': '33', 'issn': '', 'pages': '134--175', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Levels of angiotensin-converting enzyme in pleural effusion', 'authors': [{'first': 'C', 'middle': ['W'], 'last': 'Bedrossian', 'suffix': ''}, {'first': 'D', 'middle': ['A'], 'last': 'Stein', 'suffix': ''}, {'first': 'W', 'middle': ['C'], 'last': 'Miller', 'suffix': ''}], 'year': 1981, 'venue': 'Arch Pathol Lab Med', 'volume': '105', 'issn': '', 'pages': '345--351', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Activity of angiotensin-converting enzyme in pleural fluid and serum in non-sarcoid, non-tuberculous pleural effusion', 'authors': [{'first': 'F', 'middle': ['K'], 'last': 'Rømer', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Geday', 'suffix': ''}], 'year': 1982, 'venue': 'Eur J Respir Dis', 'volume': '63', 'issn': '', 'pages': '102--108', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis', 'authors': [{'first': 'T', 'middle': [], 'last': 'Söderblom', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Nyberg', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pettersson', 'suffix': ''}], 'year': 1996, 'venue': 'Respiration', 'volume': '63', 'issn': '', 'pages': '272--278', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis', 'authors': [{'first': 'B', 'middle': [], 'last': 'Dong', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Feng', 'suffix': ''}], 'year': 2008, 'venue': 'Arterioscler Thromb Vasc Biol', 'volume': '28', 'issn': '', 'pages': '1270--1276', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47 (phox) NADPH oxidase subunit', 'authors': [{'first': 'S', 'middle': [], 'last': 'Bodiga', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Zhong', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Wang', 'suffix': ''}], 'year': 2011, 'venue': 'Cardiovasc Res', 'volume': '91', 'issn': '', 'pages': '151--61', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Angiotensin II induces NF-κB, JNK and p38 MAPK activation in monocytic cells and increases matrix metalloproteinase-9 expression in a PKC-andRho kinase-dependent manner', 'authors': [{'first': 'H', 'middle': [], 'last': 'Yaghooti', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Firoozrai', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Fallah', 'suffix': ''}], 'year': 2011, 'venue': 'Braz J Med Biol Res', 'volume': '44', 'issn': '', 'pages': '193--202', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats', 'authors': [{'first': 'M', 'middle': [], 'last': 'Okada', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Kosaka', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Hoshino', 'suffix': ''}], 'year': 2010, 'venue': 'Biol Pharm Bull', 'volume': '33', 'issn': '', 'pages': '1517--1538', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Feng', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ni', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wan', 'suffix': ''}], 'year': 2011, 'venue': 'Oncol Rep', 'volume': '26', 'issn': '', 'pages': '1157--64', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways', 'authors': [{'first': 'L', 'middle': [], 'last': 'Ni', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Feng', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wan', 'suffix': ''}], 'year': 2012, 'venue': 'Oncol Rep', 'volume': '27', 'issn': '', 'pages': '783--90', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'MMP and TIMP expression pattern in pleural effusions of different origins', 'authors': [{'first': 'O', 'middle': [], 'last': 'Eickelberg', 'suffix': ''}, {'first': 'C', 'middle': ['O'], 'last': 'Sommerfeld', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wyser', 'suffix': ''}], 'year': 1997, 'venue': 'Am J Resp Crit Care', 'volume': '156', 'issn': '', 'pages': '1987--92', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'MMP expression and abnormal lung permeability are important determinants of outcome in IPF', 'authors': [{'first': 'S', 'middle': [], 'last': 'Mckeown', 'suffix': ''}, {'first': 'A', 'middle': ['G'], 'last': 'Richter', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'O&apos;kane', 'suffix': ''}], 'year': 2009, 'venue': 'Eur Respir J', 'volume': '33', 'issn': '', 'pages': '77--84', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Pathophysiology of the pleura', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Jantz', 'suffix': ''}, {'first': 'Antony', 'middle': [], 'last': 'Vb', 'suffix': ''}], 'year': 2008, 'venue': 'Respiration', 'volume': '75', 'issn': '', 'pages': '121--154', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase a activation and cell proliferation', 'authors': [{'first': 'S', 'middle': [], 'last': 'Zucker', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Mirza', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'Conner', 'suffix': ''}], 'year': 1998, 'venue': 'Int J Cancer', 'volume': '75', 'issn': '', 'pages': '780--786', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Human pleural effusions are rich in matrix metalloproteinases', 'authors': [{'first': 'A', 'middle': ['N'], 'last': 'Hurewitz', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Zucker', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Mancuso', 'suffix': ''}], 'year': 1992, 'venue': 'Chest', 'volume': '102', 'issn': '', 'pages': '1808--1822', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Friedland', 'suffix': ''}, {'first': 'T', 'middle': ['C'], 'last': 'Shaw', 'suffix': ''}, {'first': 'N', 'middle': ['M'], 'last': 'Price', 'suffix': ''}], 'year': 2002, 'venue': 'Matrix Biol', 'volume': '21', 'issn': '', 'pages': '103--113', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'tuberculosis induction of matrix metalloproteinase-9: The role of mannose and receptor-mediated mechanisms', 'authors': [{'first': 'C', 'middle': ['A'], 'last': 'Rivera-Marrero', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Schuyler', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Roser', 'suffix': ''}], 'year': 2002, 'venue': 'Am J Physiol Lung Cell Mol Physiol', 'volume': '82', 'issn': '', 'pages': '546--55', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis', 'authors': [{'first': 'G', 'middle': [], 'last': 'Hoheisel', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Sack', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Hui', 'suffix': ''}], 'year': 2001, 'venue': 'Tuberculosis', 'volume': '81', 'issn': '', 'pages': '203--212', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis', 'authors': [{'first': 'M', 'middle': ['E'], 'last': 'Muroski', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': 'Roycik', 'suffix': ''}, {'first': 'R', 'middle': ['G'], 'last': 'Newcomer', 'suffix': ''}], 'year': 2008, 'venue': 'Curr Pharm Biotechnol', 'volume': '9', 'issn': '', 'pages': '34--46', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'ACE and ACE2 activities were assayed with the fluorogenic substrates Mca-YVADAPK and Mca-APK-Dnp (AnaSpec, San Jose, CA, USA), respectively, according to Wysocki et al. with slight modifications', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'Enzymatic activity of ACE and ACE2 in pleural transudative and exudative effusions. The specific activities of ACE (A) and ACE2 (B) in pleural transudative (n = 45) and exudative (n = 80) effusions from 125 patients. The ratio of ACE/ACE2 in the pleural effusions (C). Pleural effusion (20 μl) was assayed for the ability to cleave the fluorescent substrate at 37°C for 1 hour with a specific ACE inhibitor or a specific ACE2 inhibitor. Each symbol represents one individual, and horizontal bars represent median values. ** and *** indicate p < 0.01 and p < 0.001, respectively, compared with transudates.', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': \"Correlations between ACE and ACE2 activities in pleural effusions. ACE and ACE2 activities were measured in each sample of pleural transudative effusions (A; n = 45) and exudative effusions (B; n = 80). For correlation analysis, Pearson's correlation analysis (SPSS statistics package, Chicago, IL) was applied. Statistically significant differences were established at p < 0.05. ACE and ACE2 positively correlate with each other in the group of transudative effusions (F(1,43) = 36.052, r 2 = 0.456, p < 0.001) (A), but not in the group of exudative effusions (F(1,78) = 1.567, r 2 = 0.020, p > 0.05) (B).\", 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'MMP-2 and MMP-9 activities in pleural transudative and exudative effusions. The activities of MMP-2 (A) and MMP-9 (B) in pleural transudative and exudative effusions from 125 patients were determined with zymography. The gelatinase activities detected in this study were based on pro-MMP-2 (72 kDa) and pro-MMP-9 (95 kDa). Each symbol represents one individual, and horizontal bars represent median values. *** indicates p < 0.001 compared with transudates.', 'latex': None, 'type': 'figure'}, 'FIGREF4': {'text': 'ACE and ACE2 activities in exudative effusions from patients with tuberculosis (TB), pneumonia (Pn), and adenocarcinoma (Ad). The activities of ACE (A), ACE2 (B), and the ratio of ACE/ACE2 (C) in TB (n = 20), Pn (n = 32), and Ad (n = 28) effusions. Each symbol represents one individual, and horizontal bars represent median values. * and *** indicate p < 0.05 and p < 0.001, respectively, compared with values measured in Pn and/or Ad effusions.', 'latex': None, 'type': 'figure'}, 'FIGREF5': {'text': 'MMP-2 and MMP-9 activities in exudative effusions from patients with tuberculosis (TB), pneumonia (Pn), and adenocarcinoma (Ad). The activities of MMP-2 (A) and MMP-9 (B) in TB (n = 20), Pn (n = 32), and Ad (n = 28) effusions. The gelatinase activities detected in this study were based on pro-MMP-2 (72 kDa) and pro-MMP-9 (95 kDa). Each symbol represents one individual, and horizontal bars represent median values. * and ** indicate p < 0.05 and p < 0.01, respectively, compared with values measured in Pn and/or Ad effusions.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Pleural fluid characteristics of the study population.Transudates were from patients with heart failure or liver cirrhosis. Exudates were from patients with tuberculous, pneumonia, or adenocarcinoma effusions. Data are the means \\uf0b1 SD. *** indicates p < 0.001 compared with transudates.', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Pleural fluid characteristics of tuberculous, pneumonia and adenocarcinoma effusions.', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We confirm and declare that all authors fulfilled the condition for authorship. There was no commercial support in the process of performing this study and submitting this manuscript.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgements'}, {'text': 'The authors have declared that no competing interest exists.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing Interests'}]}\n"
     ]
    }
   ],
   "source": [
    "# query on an array of embedded documents\n",
    "# see: https://docs.mongodb.com/manual/tutorial/query-array-of-documents/\n",
    "\n",
    "for c in db['noncomm-subset'].find({'metadata.authors.first': 'Wen-Yeh'}):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Query on a text index\n",
    "\n",
    "To query on a search phrase or word, you'll need to build a text index on the fields you want to search. For this tutorial, we'll do this with the MongoDB shell. \n",
    "\n",
    "Note - if the field is nested you'll need to put it in qoutation marks when you build the text index.\n",
    "\n",
    "To build the index:\n",
    "```\n",
    "db.pmc_content.createIndex( { \"body_text.text\": \"text\" } )\n",
    "```\n",
    "\n",
    "To list all the indexes you have on a collection\n",
    "```\n",
    "db.pmc_content.getIndexes()\n",
    "```\n",
    "\n",
    "To remove the index\n",
    "```\n",
    "db.pmc_content.dropIndex(\"body_text.text_text\")\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5f4ecb9678b041422935980e'), 'paper_id': '0cf8f70367fc77ea444519b2d9ed108765edd25f', 'metadata': {'title': 'case report', 'authors': [{'first': 'Ann', 'middle': [], 'last': '', 'suffix': '', 'affiliation': {}, 'email': ''}]}, 'abstract': [], 'body_text': [{'text': \"A cute fibrinous and organizing pneumonia (AFOP) was first described by Beasley et al in 2002 , as a new pattern of lung injury, with histological similarities to organizing pneumonia (OP), diffuse alveolar damage (DAD), and eosinophilic pneumonia (EP). However, it has a distinct overall histological pattern, characterized by intra-alveolar fibrin associated with OP in a patchy distribution. Since Beasley' s initial description, 14 individual case reports of AFOP have been published in English research papers. Although the histopathological features are well described, the clinical manifestations, course, and treatment of AFOP are not characterized. We report a case of a male with bilateral patchy lower lobes consolidation, in which lung biopsy revealed the classical histopathological features seen in AFOP.\", 'cite_spans': [{'start': 72, 'end': 93, 'text': 'Beasley et al in 2002', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': ''}, {'text': 'A 45-year-old man, without significant past medical history, presented with a history of malaise and arthralgia of 8 weeks duration preceded by a flu-like illness. Two weeks prior to his presentation to the emergency room, he complained of left-sided chest pain with dyspnea and nonproductive cough. There was no history of fever, chills, sweats, hemoptysis, or weight loss. Neither a history suggestive of connective tissue diseases was available nor significant occupational or environmental exposure was reported.', 'cite_spans': [], 'ref_spans': [], 'section': 'CASE'}, {'text': 'On examination the patient was alert with temperature of 37.2ºC, pulse rate 100/min, respiratory rate 18/ min, and blood pressure 130/60 mm Hg. He appeared A 45-year-old man presented with malaise, arthralgia, and dyspnea. The chest CT scan showed bilateral patchy consolidation in the lower lobes. A lung biopsy revealed intra-alveolar fibrin \"balls\" deposits and focal features of organizing pneumonia, both of which are typical pathological features of acute fibrinous and organizing pneumonia (AFOP). The patient had a good clinical course after treatment with prednisone. We report this case of idiopathic AFOP and review the published studies on this newly recognized clinicopathological entity that is still underdiagnosed and underreported.', 'cite_spans': [], 'ref_spans': [], 'section': 'CASE'}, {'text': 'lethargic but without obvious signs of respiratory discomfort. Auscultation of the lungs revealed bilateral inspiratory crackles. The rest of his physical examination was unremarkable.', 'cite_spans': [], 'ref_spans': [], 'section': 'CASE'}, {'text': 'Laboratory data revealed a white blood count of 9.8 k/cu mm, white blood count of 9.8×10 9 (4-10×10 9 ) hemoglobin 11.9 g/dL, and platelet count of 546k/mm 3 . The ESR was 34 mm/h. Electrolytes, creatinine, liver function tests, and urine analysis were within normal limits. A sputum gram smear showed scant neutrophils, and a sputum culture detected a growth of normal respiratory flora. Arterial blood gas at room air revealed pH 7.4, PaO 2 63 mm Hg and a PaCO 2 35 mm Hg. Serologic tests for ANA, RF, and C-ANCA and P-ANCA were negative. The pulmonary function test revealed a moderate restrictive ventilatory impairment and a moderate decrease in diffusing capacity. A chest CT scan revealed bilateral patchy peripherally located consolidations, mainly of the lower lobes. Some consolidations appear nodular with thickening of the interlobular septae (Figure 1 ).', 'cite_spans': [], 'ref_spans': [{'start': 855, 'end': 864, 'text': '(Figure 1', 'ref_id': 'FIGREF0'}], 'section': 'CASE'}, {'text': 'An open lung biopsy from the left lower lobe revealed a patchy consolidation of the lung parenchyma with interstitial thickening associated with a mixed inflammatory infiltrate of mononuclear cells and a few neutrophils (Figure 2) . Some alveoli contained fibrin deposits as \"fibrin balls\" admixed with macrophages ( Figure 3) . Focal features of OP were present and characterized by intraalveolar fibroblastic plugs (Figure 4) . Some alveoli were lined by reactive and hyperplastic pneumocytes. The intervening parenchyma between the consolidated areas showed mild interstitial thickening, sparse inflammatory infiltrate, and focal emphysematous changes. Subpleural fibrosis and chronic inflammation were present. No hyaline membranes were seen. The special stains for fungal and mycobacterial organisms were negative. These findings were consistent with AFOP.', 'cite_spans': [], 'ref_spans': [{'start': 220, 'end': 230, 'text': '(Figure 2)', 'ref_id': 'FIGREF1'}, {'start': 317, 'end': 326, 'text': 'Figure 3)', 'ref_id': 'FIGREF2'}, {'start': 417, 'end': 427, 'text': '(Figure 4)', 'ref_id': 'FIGREF3'}], 'section': 'CASE'}, {'text': 'After establishing the diagnosis of AFOP, the patient was started on methylprednisone 60 mg every 6 hours, followed by 50 mg of oral prednisone daily. He showed substantial clinical and radiological improvements after 12 weeks of corticosteroid treatment. The chest scan revealed almost normal findings after 3 months ( Figure 5 ).', 'cite_spans': [], 'ref_spans': [{'start': 320, 'end': 328, 'text': 'Figure 5', 'ref_id': 'FIGREF4'}], 'section': 'CASE'}, {'text': \"From the 17 cases that comprised Beasley' s initial report of AFOP, which were identified by a retrospective review of case material at the Armed Forces Institute of Pathology, 9 cases had fulminating illness and died of the disease, and 8 cases had a subacute disease with recovery. The most common symptoms reported were dyspnea in 11 patients, fever in 6 patients, and cough in 3 patients. Bilateral basilar infiltrates were the most common radiographic pattern. Seven of the 17 patients were treated with corticosteroids. Fourteen individual case reports of AFOP have been published in English, 2-15 after Beasley' s initial description. All patients had symptoms for less than 2 months, with cough and dyspnea as the most common. Radiographic abnormalities included bilateral basilar infiltrates in 11 patients, 2,3,5,7-15 while unilateral complete lung consolidation solitary nodule, 4 miliary nodules, and patchy consolidations 6 were noted in the remaining 3 patients. Identified exposures or associated conditions included medications (abacavir and decitabine), 5,10 connective tissue disease, 8, 11 hematopoietic stem cell transplant, 6 acute lymphoblastic leukemia, 13 HIV, 7 juvenile dermatomyositis, 3 and Whipple disease. 15 No underlying cause or association were identified in 5 cases. 2, 4, 9, 12, 14 Patients were treated with medications including corticosteroids, mycophenolate mofetil, cyclophosphamide, and cyclosporine. Among the 14 case reports, 3 patients required mechanical ventilation, 3, 5, 9 and 2 patients died. 3, 6 In addition to these individual case reports, Hwang et al 16 reported autopsy finding from the lungs of 20 patients who died from severe acute respiratory syndrome. The histological findings of these 20 patients were AFOP pattern in 6 cases, DAD in 8 cases, and both patterns in the remaining cases. In conclusion, AFOP is a newly recognized clinicopathological entity that is still underdiagnosed and underreported. Although the histopathological features are well described, identification of precipitating factors, clinical course, and elements affecting prognosis and treatment need to be fully established.\", 'cite_spans': [{'start': 1103, 'end': 1105, 'text': '8,', 'ref_id': 'BIBREF7'}, {'start': 1106, 'end': 1108, 'text': '11', 'ref_id': 'BIBREF10'}, {'start': 1145, 'end': 1146, 'text': '6', 'ref_id': 'BIBREF5'}, {'start': 1177, 'end': 1179, 'text': '13', 'ref_id': 'BIBREF12'}, {'start': 1213, 'end': 1214, 'text': '3', 'ref_id': 'BIBREF2'}, {'start': 1236, 'end': 1238, 'text': '15', 'ref_id': 'BIBREF14'}, {'start': 1302, 'end': 1304, 'text': '2,', 'ref_id': 'BIBREF1'}, {'start': 1305, 'end': 1307, 'text': '4,', 'ref_id': 'BIBREF3'}, {'start': 1308, 'end': 1310, 'text': '9,', 'ref_id': 'BIBREF8'}, {'start': 1311, 'end': 1314, 'text': '12,', 'ref_id': 'BIBREF11'}, {'start': 1315, 'end': 1317, 'text': '14', 'ref_id': 'BIBREF13'}, {'start': 1514, 'end': 1516, 'text': '3,', 'ref_id': 'BIBREF2'}, {'start': 1517, 'end': 1519, 'text': '5,', 'ref_id': 'BIBREF4'}, {'start': 1520, 'end': 1521, 'text': '9', 'ref_id': 'BIBREF8'}, {'start': 1543, 'end': 1545, 'text': '3,', 'ref_id': 'BIBREF2'}, {'start': 1546, 'end': 1547, 'text': '6', 'ref_id': 'BIBREF5'}, {'start': 1606, 'end': 1608, 'text': '16', 'ref_id': 'BIBREF15'}], 'ref_spans': [], 'section': 'DISCUSSION'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Acute fibrinous and organizing pneumonia: A histological pattern of lung injury and possible variant of diffuse alveolar damage', 'authors': [{'first': 'M', 'middle': ['B'], 'last': 'Beasley', 'suffix': ''}, {'first': 'T', 'middle': ['J'], 'last': 'Franks', 'suffix': ''}, {'first': 'J', 'middle': ['R'], 'last': 'Galvin', 'suffix': ''}, {'first': 'B', 'middle': [], 'last': 'Gochuico', 'suffix': ''}], 'year': 2002, 'venue': 'Arch pathol Lab Med', 'volume': '126', 'issn': '', 'pages': '1064--70', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'Acute fibrinous and organizing pneumonia', 'authors': [{'first': 'C', 'middle': [], 'last': 'Damas', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Morais', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Moura', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Marques', 'suffix': ''}], 'year': 2006, 'venue': 'Rev port pneumol', 'volume': '12', 'issn': '', 'pages': '615--635', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'fetal acute fibrinous and organizing pneumonia in a child with juvenile dermatomyosits', 'authors': [{'first': 'S', 'middle': [], 'last': 'Prahalad', 'suffix': ''}, {'first': 'Bohnsack', 'middle': [], 'last': 'Jf', 'suffix': ''}, {'first': 'C', 'middle': ['G'], 'last': 'Maloney', 'suffix': ''}, {'first': 'Leslie', 'middle': [], 'last': 'Ko', 'suffix': ''}], 'year': 2005, 'venue': 'J pediatr', 'volume': '146', 'issn': '', 'pages': '289--92', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Acute fibrinous and organizing pneumonia: Initial presentation as a solitary nodule', 'authors': [{'first': 'H', 'middle': [], 'last': 'Kobayashi', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Sugimoto', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Kanoh', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Motoyoshi', 'suffix': ''}, {'first': 'Aida', 'middle': ['S'], 'last': '', 'suffix': ''}], 'year': 2005, 'venue': 'J Thorac Imaging', 'volume': '20', 'issn': '', 'pages': '291--294', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction', 'authors': [{'first': 'N', 'middle': [], 'last': 'Yokogawa', 'suffix': ''}, {'first': 'D', 'middle': ['V'], 'last': 'Alcid', 'suffix': ''}], 'year': 2007, 'venue': 'AIDS', 'volume': '21', 'issn': '', 'pages': '2116--2123', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Acute fibrinous and organizing pneumonia following hemaotopoietic stem cell transplantation', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Lee', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Park', 'suffix': ''}, {'first': 'S', 'middle': ['H'], 'last': 'Sung', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Kim', 'suffix': ''}, {'first': 'K', 'middle': ['E'], 'last': 'Lee', 'suffix': ''}, {'first': 'Y', 'middle': ['C'], 'last': 'Mun', 'suffix': ''}], 'year': 2009, 'venue': 'Korean J Intern Med', 'volume': '24', 'issn': '', 'pages': '156--165', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Acute fibrinous and organizing pneumonia in a patient with HIV infection and pneumocysis Jiroveci pneumonia', 'authors': [{'first': 'J', 'middle': ['Y'], 'last': 'Heo', 'suffix': ''}, {'first': 'J', 'middle': ['Y'], 'last': 'Song', 'suffix': ''}, {'first': 'J', 'middle': ['Y'], 'last': 'Noh', 'suffix': ''}, {'first': 'H', 'middle': ['S'], 'last': 'Yong', 'suffix': ''}, {'first': 'H', 'middle': ['J'], 'last': 'Cheong', 'suffix': ''}, {'first': 'W', 'middle': ['J'], 'last': 'Kim', 'suffix': ''}], 'year': 2010, 'venue': 'Respirology', 'volume': '15', 'issn': '', 'pages': '1259--1275', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Acute fibrinous and organizing pneumonia in systemic lupus erythematosus: A case report and review of the literature', 'authors': [{'first': 'Hariri', 'middle': [], 'last': 'Lp', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Unizony', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Stone', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Mino-Kenudson', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Sharma', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Matsubara O', 'suffix': ''}], 'year': 2010, 'venue': 'pathol Int', 'volume': '60', 'issn': '', 'pages': '755--764', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Severe acute fibrinous and organizing pneumonia (Afop) causing ventilator failure: Successful treatment with mycophenolate mofetil and corticosteroids', 'authors': [{'first': 'S', 'middle': [], 'last': 'Bhatti', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Hakeem', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Torrealba', 'suffix': ''}, {'first': 'Mcmahon', 'middle': [], 'last': 'Jp', 'suffix': ''}, {'first': 'K', 'middle': ['C'], 'last': 'Meyer', 'suffix': ''}], 'year': 2009, 'venue': 'Respir Med', 'volume': '103', 'issn': '', 'pages': '1764--71', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'A 64-year -old male with fever and persistent lung infiltrate', 'authors': [{'first': 'T', 'middle': ['S'], 'last': 'Vasu', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Cavallazzi', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Hirani', 'suffix': ''}, {'first': 'Marik', 'middle': [], 'last': 'Pe', 'suffix': ''}], 'year': 2009, 'venue': 'Respir Care', 'volume': '54', 'issn': '', 'pages': '1263--1268', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Acute fibrinous and oraganizing pneumonia in a patient with collagen vascular disease \"stigma', 'authors': [{'first': 'R', 'middle': [], 'last': 'Balduin', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Giacometti', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Saccarola', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': 'Marulli', 'suffix': ''}, {'first': 'Rea', 'middle': ['F'], 'last': 'Bartoli', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2007, 'venue': 'Sarcoidosis Vasc Diffuse Lung Dis', 'volume': '24', 'issn': '', 'pages': '78--80', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Acute fibrinous and organizing pneumonia: a case report and review of the literature', 'authors': [{'first': 'A', 'middle': [], 'last': 'Tzouvelekis', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Koutsopoulos', 'suffix': ''}], 'year': 2009, 'venue': 'J Med Case Reports', 'volume': '3', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Acute lymphoblastic leukemia presenting with an acute fibrinous and organizing pneumonia', 'authors': [{'first': 'C', 'middle': [], 'last': 'Ronald', 'suffix': ''}, {'first': 'Sucaibi', 'middle': [], 'last': 'Sdo', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Ramsey', 'suffix': ''}], 'year': 2007, 'venue': 'J Respir Dis', 'volume': '28', 'issn': '', 'pages': '33--38', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Acute fibrinous and organizing pneumonia presenting as complete lung consolidation', 'authors': [{'first': 'V', 'middle': [], 'last': 'Mittal', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Kulshrestha', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Arya', 'suffix': ''}, {'first': '', 'middle': [], 'last': 'Bajaj', 'suffix': ''}], 'year': 2011, 'venue': 'Singapore Med J', 'volume': '52', 'issn': '', 'pages': '88--90', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Acute fibrinous and organizing pneumonia in Whipple disease', 'authors': [{'first': 'L', 'middle': [], 'last': 'Canessa Pa', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Sivori', 'suffix': ''}, {'first': 'Magistrelli', 'middle': [], 'last': 'Cavazza', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2008, 'venue': 'Monaldi Arch Chest Dis', 'volume': '69', 'issn': '', 'pages': '186--194', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'pulmonary pathology of severe acute respiratory syndrome in Toronto', 'authors': [{'first': 'D', 'middle': ['M'], 'last': 'Hwang', 'suffix': ''}, {'first': 'D', 'middle': ['W'], 'last': 'Chamberlain', 'suffix': ''}, {'first': 'S', 'middle': ['M'], 'last': 'Poutanen', 'suffix': ''}, {'first': 'D', 'middle': ['E'], 'last': 'Low', 'suffix': ''}, {'first': 'S', 'middle': ['L'], 'last': 'Asa', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Butany', 'suffix': ''}], 'year': 2005, 'venue': 'Mod pathol', 'volume': '18', 'issn': '', 'pages': '1--10', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'Chest CT scan revealed bilateral patchy peripherally consolidations locatedmainly in the lower lobes with some appearance of nodular plus thickening of the interlobular septae.', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'Alveolar interstitial thickening with inflammatory infiltrate including neutrophils (H&E stain, ×20).', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': 'Consolidated pulmonary parenchyma with intra-alveolar fibrin deposits \"fibrin balls\" (H&E stain, ×20).', 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'organizing pneumonia with intra-alveolar fibroblastic plugs (H&E stain, ×20).', 'latex': None, 'type': 'figure'}, 'FIGREF4': {'text': 'CT scan after three months of corticosteroid therapy shows significant improvement with almost complete resolution of most of the previously seen findings.', 'latex': None, 'type': 'figure'}}, 'back_matter': [{'text': 'The authors acknowledges the use of Saudi Aramco Medical Services Organization (SAMSO) facilities for the research data utilized in this manuscript. Opinions expressed in this article are those of the authors and not necessarily those of SAMSO.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgments'}]}\n",
      "{'_id': ObjectId('5f4ecb9a16816090440a75eb'), 'paper_id': '0d3de075e16c6d2e02c68e541b4d2654c78bea04', 'metadata': {'title': '', 'authors': [{'first': 'Giorgio', 'middle': [], 'last': 'Castellana', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': 'giorgiocastellana@virgilio.it'}, {'first': 'Vito', 'middle': [], 'last': 'Liotino', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}, {'first': 'Maria', 'middle': ['Rosaria'], 'last': 'Vulpi', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}, {'first': 'Ina', 'middle': [], 'last': 'Ali', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}, {'first': 'Lorenzo', 'middle': [], 'last': 'Marra', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}, {'first': 'Onofrio', 'middle': [], 'last': 'Resta', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}]}, 'abstract': [{'text': 'Breathe | December 2017 | Volume 13 | No 4 317 Cite as: Castellana G, Liotino V, Vulpi MR, et al. Bilateral pulmonary nodules and acute respiratory failure in a 22-year-old man with dyspnoea and fever. Breathe 2017; 13: 317-322.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'Bilateral pulmonary nodules and acute respiratory failure in a 22-year-old man with dyspnoea and fever A 22-year-old white male presented complaining of a 3-week history of fatigue, cough and haemoptysis, accompanied by fever (38°C max), dyspnoea and mucopurulent sputum in the last few days. He denied nausea, vomiting, diarrhoea, dysuria and weight loss. He reported being a smoker (10 pack-years) and a cannabis user, and had a history of allergic rhinitis. He denied occupational exposures.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'Before our evaluation, he received empiric antibiotic therapy for 5 days, which resulted in the abatement of fever. Following the persistence of dyspnoea and haemoptysis, he had chest radiography with multiple nodular opacities associated with pleural effusion on the left (figure 1) and lung ultrasound (US) with a convex probe showing multiple hypoechoic, bilateral foci associated with B-lines and bilateral pleural effusion, mainly on the left.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'On our examination, he had no fever. On auscultation, a widespread reduced vesicular murmur and basilar rales in the left lung were found. On palpation, there was inguinal lymphadenopathy. The remainder of the physical examination was unremarkable.', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 1 Chest radiograph showing bilateral nodular opacities with a lower zone predominance, interstitial thickening and pleural effusion on the left.'}, {'text': 'Oxygen saturation by pulse oximetry was 93% on room air and blood gas analysis showed a mild hypoxaemia, with an arterial oxygen tension (PaO 2 ) of 61 mmHg with respiratory alkalosis (pH 7.46, carbon dioxide tension 32 mmHg and bicarbonate 23.2 mmol⋅L −1 ), and therefore with a standard PaO 2 of 48 mmHg.', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 1 Chest radiograph showing bilateral nodular opacities with a lower zone predominance, interstitial thickening and pleural effusion on the left.'}, {'text': 'Laboratory findings were as follows: white blood cell count of 4140 per μL (54.6% neutrophils, 23.1% lymphocytes and 20.8% monocytes), haemoglobin 13.3 g⋅dL −1 , thrombocytopenia (123 000 per μL), increased serum inflammatory markers (erythrocyte sedimentation rate 17 mm⋅h −1 , C-reactive protein 18.4 mg⋅L −1 , α 2 -globulin 12.8%, γ-globulin 19.8%, procalcitonin 0.49 ng⋅mL −1 and presepsin 275 pg⋅mL −1 ), hypoalbuminaemia (3.1 g⋅dL −1 ), serum iron and ferritin arrangement of chronic disease (serum iron 63 μg⋅dL −1 and ferritin 553 ng⋅dL −1 ), slight increase in alanine aminotransferase (48 U⋅L −1 ), and direct bilirubin (0.23 mg⋅dL −1 ). Renal function and coagulation were in the normal range.', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 1 Chest radiograph showing bilateral nodular opacities with a lower zone predominance, interstitial thickening and pleural effusion on the left.'}, {'text': 'What would be your further investigations for a patient with these features?', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 1'}, {'text': 'Bilateral pulmonary nodules and acute respiratory failure', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 1'}, {'text': 'The patient underwent empirical antibiotic therapy and total-body CT; microbiological tests (of respiratory, blood and urinary samples) were required. Total-body CT showed bilateral pulmonary infiltrate with a pseudonodular aspect, with a tendency toward confluence and surrounded by a ground-glass halo, associated with irregular interlobular interstitial thickening and bilateral pleural effusion. Lymph nodes (LNs) with a colliquative aspect were in the epiaortic, subcarinal, hilar and Barety regions with the maximum diameter of 33 mm (figure 2). LNs with increased volume were also observed also in the laterocervical, axillary, mesenteric, iliac, lumbar and inguinal regions. There were no abnormalities in the other abdominal and pelvic viscera.', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 1'}, {'text': 'What could be the differential diagnoses in the light of the CT report? ', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 2'}, {'text': 'Bronchoscopy was performed and showed a normal endobronchial mucosa. Biopsy was not performed because of hypoxaemia; however, microbiological and cytological examinations of bronchoalveolar lavage fluid were negative.', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 2 Chest CT (axial view) with parenchymal (a, c and d) and mediastinal windows (b). a) Upper lung fields: infiltrate with pseudonodular aspect, surrounded by a ground-glass halo (red arrow) and axillar lymph nodes (green arrows). b) Middle lung fields: mediastinal lymph nodes (green arrow). c and d) Lower lung fields: infiltrates with pseudonodular aspect with a tendency toward confluence (red arrows), interlobular interstitial thickening (orange arrow) and pleural effusion (blue arrows).'}, {'text': 'Other microbiological examinations searching for common bacteria, Mycobacterium tuberculosis, nontuberculous mycobacteria, viruses and fungi were negative, with the exception of: ', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 2 Chest CT (axial view) with parenchymal (a, c and d) and mediastinal windows (b). a) Upper lung fields: infiltrate with pseudonodular aspect, surrounded by a ground-glass halo (red arrow) and axillar lymph nodes (green arrows). b) Middle lung fields: mediastinal lymph nodes (green arrow). c and d) Lower lung fields: infiltrates with pseudonodular aspect with a tendency toward confluence (red arrows), interlobular interstitial thickening (orange arrow) and pleural effusion (blue arrows).'}, {'text': 'Tumour and autoimmune (antinuclear antibody and anti-neutrophil cytoplasmic antibody) markers were required.', 'cite_spans': [], 'ref_spans': [], 'section': 'IgG for Epstein-Barr virus and cytomegalovirus'}, {'text': 'What would be your next step?', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 3'}, {'text': \"Infective disease, lymphoma, metastasis, autoimmune disease or Kaposi's sarcoma (KS) Bilateral pulmonary nodules and acute respiratory failure Consent for an HIV test was acquired and US examination of superficial LNs followed the haematological evaluation. US showed rounded lymphadenopathy with chaotic vascularisation in the right inguinal and left supraclavicular regions with maximum diameter of 21×13 mm and 17×10 mmn respectively. Surgical biopsy of the right inguinal lymph nodes was performed and the histological examination result was reported as a morphological aspect consistent with massive metastasis of KS (figure 3). On immunohistochemistry (IHC), diffuse positivity for HHV8 and CD34 was seen in the tumoural area, and that for factor VIII, actin and smooth muscle actin in the rich vasculature. At the same time, an HIV test was positive (HIV-1 gp120, gp41, p24 and p17 were detected), and a T-lymphocyte count in peripheral blood showed no CD4 + cells, and reduced counts of CD3 + and CD16/56 + CD3 − cells. Tumour markers and autoimmunity examinations were within normal range, except for CA-125 (71.5 U⋅mL −1 ) and α 2 -microglobulin (3.34 mg⋅L −1 ). During the hospitalisation, the patient had fever, which was initially intermittent then continuous, accompanied by deterioration of gas exchange, which prompted an increase in the oxygen therapy. In light of this clinical picture, a diagnosis of KS was made.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Answer 2'}, {'text': 'Definition KS is a slowly growing, multicentric, angioproliferative tumour associated with human herpesvirus (HHV)8 infection [1] . It is the most common tumour associated with HIV-1 infection; indeed, the incidence among patients infected with HIV is one in 20 [2, 3] . Four clinical variants of KS have been described: localisation occurs in 20-75% of cases, particularly in severely immunocompromised patients with low CD4 + counts, with involvement of the lung parenchyma, pleura, LNs and airways [6] [7] [8] [9] . Reports of isolated pulmonary disease have rarely appeared in the literature (0-16% of cases) [6, 7] .', 'cite_spans': [{'start': 126, 'end': 129, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 262, 'end': 265, 'text': '[2,', 'ref_id': 'BIBREF1'}, {'start': 266, 'end': 268, 'text': '3]', 'ref_id': 'BIBREF2'}, {'start': 501, 'end': 504, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 505, 'end': 508, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 509, 'end': 512, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 513, 'end': 516, 'text': '[9]', 'ref_id': 'BIBREF8'}, {'start': 613, 'end': 616, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 617, 'end': 619, 'text': '7]', 'ref_id': 'BIBREF6'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Pulmonary KS is associated with poor outcome, but highly active antiretroviral therapy has been shown to markedly improve the prognosis.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Common symptoms are dry cough and dyspnoea [6] . Fever and haemoptysis can also be found. Typical radiological features are reticular opacities and parenchymal nodules with a bronchovascular distribution, especially in lower lung zones; consolidation; peribronchial cuffing; pleural effusion; and mediastinal lymphadenopathy [6] . However, chest radiography may be normal. A CT scan is more sensible and specific, and can show irregular, poorly defined nodules with speculated borders and peribronchovascular distribution, interstitial thickening and perinodular ground-glass halo signs (due to haemorrhage secondary to fragility of the neovascular tissue). Irregular narrowing of the bronchial lumen, interlobular septal thickening, air-space consolidation and pleural effusion may be associated with the aforementioned findings [6, 8] . Lymphadenopathy can be present in up to 30-35% of patients. The effusion can be transudative or exudative and is often haemorrhagic because of the vascular nature of the disease [10] .', 'cite_spans': [{'start': 43, 'end': 46, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 325, 'end': 328, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 830, 'end': 833, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 834, 'end': 836, 'text': '8]', 'ref_id': 'BIBREF7'}, {'start': 1017, 'end': 1021, 'text': '[10]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Clinical, radiological and bronchoscopic characteristics of pulmonary KS'}, {'text': 'Typical findings on bronchoscopy are red or purple maculopapular lesions that can narrow and obstruct the entire tracheobronchial tree. The identification of these lesions in the presence of classic radiographic involvement is sufficient to make diagnosis of pulmonary KS in the absence of evidence for opportunistic infections [11] .', 'cite_spans': [{'start': 328, 'end': 332, 'text': '[11]', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'Clinical, radiological and bronchoscopic characteristics of pulmonary KS'}, {'text': 'Biopsy may be needed when parenchymal lesions occur in the absence of endobronchial', 'cite_spans': [], 'ref_spans': [], 'section': 'Clinical, radiological and bronchoscopic characteristics of pulmonary KS'}, {'text': 'Haematological evaluation, HIV test and immune system assessment; US of peripheral lymph nodes in order to detect suspicious lymphadenopathies involvement [10] . However, the diagnostic yield of endobronchial biopsies varies between 26% and 60% in different studies, and there is high risk of bleeding, especially for centrally located lesions [12, 13] : the decision to obtain a biopsy must be carefully weighed.', 'cite_spans': [{'start': 155, 'end': 159, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 344, 'end': 348, 'text': '[12,', 'ref_id': 'BIBREF11'}, {'start': 349, 'end': 352, 'text': '13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'Answer 3'}, {'text': 'The histopathology of KS is nearly the same in all variants of disease. Advanced lesions consist of fascicles of spindle cells and vascular structure mixed with chronic infiltrates. On IHC, typical markers are CD31, CD34 and factor VIII-related antigen. Spindle cells express lymphatic markers such as LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1), VEGFR-3 (vascular endothelial growth factor receptor-3) and Prox-1 (Prospero-related homeobox-1). The most important test to distinguish KS from others KS-mimicking diseases is the identification of HHV8 within KS lesion cells by immunostaining for LANA-1 (or LNA-1) [10] .', 'cite_spans': [{'start': 630, 'end': 634, 'text': '[10]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Histopathological features'}, {'text': 'Pulmonary KS is often indistinguishable from other opportunistic lung diseases in patients with AIDS. The differential diagnosis of diffuse pulmonary nodules includes: infective disease (tuberculosis or nontuberculous mycobacterial infection, fungal infection, or septic emboli), neoplastic disease (metastasis, lymphoma or minimally invasive adenocarcinoma), sarcoidosis and other miscellaneous conditions (granulomatosis with polyangiitis, pulmonary alveolar microlithiasis and pulmonary amyloidosis). It is very important to evaluate the size and location of nodules, and the presence of cavities [14] [15] [16] [17] .', 'cite_spans': [{'start': 600, 'end': 604, 'text': '[14]', 'ref_id': 'BIBREF13'}, {'start': 605, 'end': 609, 'text': '[15]', 'ref_id': 'BIBREF14'}, {'start': 610, 'end': 614, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 615, 'end': 619, 'text': '[17]', 'ref_id': 'BIBREF16'}], 'ref_spans': [], 'section': 'Differential diagnosis'}, {'text': 'The halo sign has been described in fungal, mycobacterial and viral infections; inflammatory disease (granulomatosis with polyangiitis) and malignancy. In immunocompromised patients, this radiological finding suggests an infection (e.g. invasive aspergillosis) or, less commonly, pulmonary KS and lymphoproliferative disorders [18] .', 'cite_spans': [{'start': 327, 'end': 331, 'text': '[18]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'Differential diagnosis'}, {'text': 'In patients with HIV infection, subcentimetre pulmonary nodules with centrilobular distribution and cavitation may suggest infective disease, whereas larger nodules can suggest malignancy [19] .', 'cite_spans': [{'start': 188, 'end': 192, 'text': '[19]', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'Differential diagnosis'}, {'text': \"Isolated intrathoracic KS is rarely seen. Moreover, in our case, the diagnosis was made more difficult by the lack of the patient's knowledge of his HIV infection. Clinical suspicion, accurate radiological description and multidisciplinary management were decisive in reaching a correct diagnosis.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusion'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': \"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma\", 'authors': [{'first': 'Y', 'middle': [], 'last': 'Chang', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Cesarman', 'suffix': ''}, {'first': 'M', 'middle': ['S'], 'last': 'Pessin', 'suffix': ''}], 'year': 1994, 'venue': 'Science', 'volume': '266', 'issn': '', 'pages': '1865--1869', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"Kaposi's sarcoma in HIV-positive patients: the state of art in the HAART-era\", 'authors': [{'first': 'La', 'middle': [], 'last': 'Ferla', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Pinzone', 'suffix': ''}, {'first': 'M', 'middle': ['R'], 'last': 'Nunnari', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2013, 'venue': 'Eur Rev Med Pharmacol Sci', 'volume': '17', 'issn': '', 'pages': '2354--2365', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Epidemiology of AIDS related malignancies an international perspective', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Mbulaiteye', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Parkin', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Rabkin', 'suffix': ''}], 'year': 2003, 'venue': 'Hematol Oncol Clin North Am', 'volume': '17', 'issn': '', 'pages': '673--696', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Histological variants of cutaneous Kaposi sarcoma', 'authors': [{'first': 'W', 'middle': [], 'last': 'Grayson', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Pantanowitz', 'suffix': ''}], 'year': 2008, 'venue': 'Diagn Pathol', 'volume': '3', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Imaging manifestations of Kaposi sarcoma', 'authors': [{'first': 'C', 'middle': ['S'], 'last': 'Restrepo', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Martínez', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Lemos', 'suffix': ''}], 'year': 2006, 'venue': 'Radiographics', 'volume': '26', 'issn': '', 'pages': '1169--1185', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': \"The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma\", 'authors': [{'first': 'D', 'middle': ['M'], 'last': 'Aboulafia', 'suffix': ''}], 'year': 2000, 'venue': 'Chest', 'volume': '117', 'issn': '', 'pages': '1128--1145', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': \"Intrathoracic Kaposi's sarcoma: CT findings\", 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Khalil', 'suffix': ''}, {'first': 'M', 'middle': ['F'], 'last': 'Carette', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Cadranel', 'suffix': ''}], 'year': 1995, 'venue': 'Chest', 'volume': '108', 'issn': '', 'pages': '1622--1626', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology', 'authors': [{'first': 'T', 'middle': ['D'], 'last': 'Gasparetto', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Marchiori', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Lourenço', 'suffix': ''}], 'year': 2009, 'venue': 'Orphanet J Rare Dis', 'volume': '4', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Pulmonary malignancies in the immunocompromised patient', 'authors': [{'first': 'J', 'middle': [], 'last': 'Cadranel', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Naccache', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Wislez', 'suffix': ''}], 'year': 1999, 'venue': 'Respiration', 'volume': '66', 'issn': '', 'pages': '289--309', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'A woman in her 30s with a past history of HIV disease presented with recurrent fever, night sweats, and small bilateral pulmonary nodules', 'authors': [{'first': 'H', 'middle': ['R'], 'last': 'Hashmi', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Niazi', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Adrish', 'suffix': ''}], 'year': 2016, 'venue': 'Chest', 'volume': '149', 'issn': '', 'pages': '177--182', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': \"Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory system\", 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Zibrak', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Silvestri', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Costello', 'suffix': ''}], 'year': 1986, 'venue': 'Chest', 'volume': '90', 'issn': '', 'pages': '476--479', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': \"Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome: clinical, radiographic, and pathologic manifestations\", 'authors': [{'first': 'G', 'middle': ['U'], 'last': 'Meduri', 'suffix': ''}, {'first': 'D', 'middle': ['E'], 'last': 'Stover', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 1986, 'venue': 'Am J Med', 'volume': '81', 'issn': '', 'pages': '11--18', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Diagnostic yield of fiberoptic bronchoscopy in evaluating solitary pulmonary nodules', 'authors': [{'first': 'W', 'middle': ['A'], 'last': 'Baaklini', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Reinoso', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Gorin', 'suffix': ''}], 'year': 2000, 'venue': 'Chest', 'volume': '117', 'issn': '', 'pages': '1049--1054', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Diffuse pulmonary nodules', 'authors': [{'first': 'G', 'middle': [], 'last': 'Boitsios', 'suffix': ''}, {'first': 'A', 'middle': ['A'], 'last': 'Bankier', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Eisenberg', 'suffix': ''}], 'year': 2010, 'venue': 'AJR Am J Roentgenol', 'volume': '194', 'issn': '', 'pages': '354--366', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Pictorial essay: multinodular disease: a high-resolution CT scan diagnostic algorithm', 'authors': [{'first': 'S', 'middle': [], 'last': 'Raoof', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Amchentsev', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Vlahos', 'suffix': ''}], 'year': 2006, 'venue': 'Chest', 'volume': '129', 'issn': '', 'pages': '805--815', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Centrilobular opacities in the lung on high-resolution CT: diagnostic considerations and pathologic correlation', 'authors': [{'first': 'J', 'middle': ['F'], 'last': 'Gruden', 'suffix': ''}, {'first': 'W', 'middle': ['R'], 'last': 'Webb', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Warnock', 'suffix': ''}], 'year': 1994, 'venue': 'AJR Am J Roentgenol', 'volume': '162', 'issn': '', 'pages': '569--574', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society', 'authors': [{'first': 'H', 'middle': [], 'last': 'Macmahon', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Naidich', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Goo', 'suffix': ''}], 'year': 2017, 'venue': 'Radiology', 'volume': '284', 'issn': '', 'pages': '228--243', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'A patient with HIV, dyspnea, and multiple pulmonary nodules: pulmonary Kaposi sarcoma', 'authors': [{'first': 'M', 'middle': [], 'last': 'Joshi', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Markelova', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Palacio', 'suffix': ''}], 'year': 2006, 'venue': 'Chest', 'volume': '130', 'issn': '', 'pages': '1924--1928', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Clinical and radiographic predictors of the etiology of computed tomographydiagnosed intrathoracic lymphadenopathy in HIV-infected patients', 'authors': [{'first': 'R', 'middle': ['M'], 'last': 'Jasmer', 'suffix': ''}, {'first': 'M', 'middle': ['B'], 'last': 'Gotway', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Creasman', 'suffix': ''}], 'year': 2002, 'venue': 'J Acquir Immune Defic Syndr', 'volume': '31', 'issn': '', 'pages': '291--298', 'other_ids': {}}}, 'ref_entries': {'FIGREF2': {'text': 'AIDS-related variant affects patient with HIV-infection KS usually presents with cutaneous lesions but it may involve other organs, mostly in the pulmonary and gastrointestinal systems. Intrathoracic', 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'Histological findings from surgical biopsy of the right inguinal lymph nodes: fascicles of monomorphic spindle cells and vascular structure mixed with chronic infiltrates. 100× magnification.', 'latex': None, 'type': 'figure'}}, 'back_matter': [{'text': 'None declared.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conflict of interest'}]}\n",
      "{'_id': ObjectId('5f4ecbc6f7c2f0238d4cbc14'), 'paper_id': '1b58422e266ab9339c919119923229d080f27360', 'metadata': {'title': 'ACE/ACE2 Ratio and MMP-9 Activity as Potential Biomarkers in Tuberculous Pleural Effusions', 'authors': [{'first': 'Wen-Yeh', 'middle': [], 'last': 'Hsieh', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Tang-Ching', 'middle': [], 'last': 'Kuan', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Kun-Shan', 'middle': [], 'last': 'Cheng', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Yan-Chiou', 'middle': [], 'last': 'Liao', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Mu-Yuan', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Pei-Heng', 'middle': [], 'last': 'Lin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Yuan-Chang', 'middle': [], 'last': 'Hsu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Chen-Yi', 'middle': [], 'last': 'Huang', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Wei-Hua', 'middle': [], 'last': 'Hsu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mackay Memorial Hospital', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Sheng-Yao', 'middle': [], 'last': 'Yu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mackay Memorial Hospital', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Chih-Sheng', 'middle': [], 'last': 'Lin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}]}, 'abstract': [{'text': 'Objective: Pleural effusion is common problem, but the rapid and reliable diagnosis for specific pathogenic effusions are lacking. This study aimed to identify the diagnosis based on clinical variables to differentiate pleural tuberculous exudates from other pleural effusions. We also investigated the role of renin-angiotensin system (RAS) and matrix metalloproteinase (MMPs) in the pathogenesis of pleural exudates. Experimental design: The major components in RAS and extracellular matrix metabolism, including angiotensin converting enzyme (ACE), ACE2, MMP-2 and MMP-9 activities, were measured and compared in the patients with transudative (n = 45) and exudative (n = 80) effusions. The exudative effusions were come from the patients with tuberculosis (n = 20), pneumonia (n = 32), and adenocarcinoma (n = 28). Results: Increased ACE and equivalent ACE2 activities, resulting in a significantly increased ACE/ACE2 ratio in exudates, were detected compared to these values in transudates. MMP-9 activity in exudates was significantly higher than that in transudates. The significant correlation between ACE and ACE2 activity that was found in transudates was not found in exudates. Advanced analyses showed significantly increased ACE and MMP-9 activities, and decreased ACE2 activity in tuberculous pleural effusions compared with those in pneumonia and adenocarcinoma effusions. The results indicate that increased ACE and MMP-9 activities found in the exudates were mainly contributed from a higher level of both enzyme activities in the tuberculous pleural effusions. Conclusion: Interplay between ACE and ACE2, essential functions in the RAS, and abnormal regulation of MMP-9 probably play a pivotal role in the development of exudative effusions. Moreover, the ACE/ACE2 ratio combined with MMP-9 activity in pleural fluid may be potential biomarkers for diagnosing tuberculous pleurisy.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Pleural effusion is a common medical problem in the chest and involves accumulation of an abnormal amount of pleural fluid in the pleural space. Several diseases such as congestive heart failure, liver cirrhosis, tuberculosis, adenocarcinoma, and pneumonia are common diseases that cause pleural effusions, but there is no rapid and accurate diagnostic method for pleural effusion. Conventional diagnosis of tuberculous pleurisy is based on pleural fluid cytology, culture of pleural effusions, and pleural biopsy tissue culture, but these methods have very low sensitivity and recognised limitations in clinical use, and they usually require weeks for a positive culture report [1] . Therefore, a reliable clinical marker providing simple, rapid, and accurate diagnosis is required for patients with pleural effusion.', 'cite_spans': [{'start': 679, 'end': 682, 'text': '[1]', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'The circulating renin-angiotensin system (RAS) plays a well-described role in maintaining blood pressure homeostasis. Recently, a local tissue-based RAS has also been described and appears to play a key role in injury/repair responses [2, 3] . The expression of RAS components and the elevation of angiotensin converting enzyme (ACE) in a number of lung diseases suggest the existence of a pulmonary RAS and that angiotensin II (Ang II) could mediate, at least in part, the response to lung injury. The central role of ACE is to generate Ang II from Ang I. Ang II is a key effector peptide of RAS that causes vasoconstriction and exerts multiple biological functions. Ang II can also cause the development of interstitial fibrosis via physiological regulation of matrix metalloproteinase (MMP) expression and/or activation [4] .', 'cite_spans': [{'start': 235, 'end': 238, 'text': '[2,', 'ref_id': 'BIBREF1'}, {'start': 239, 'end': 241, 'text': '3]', 'ref_id': 'BIBREF2'}, {'start': 823, 'end': 826, 'text': '[4]', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'ACE2, a close homologue of ACE, functions as a negative regulator of the angiotensin system and was identified as a key receptor for severe acute respiratory syndrome coronavirus infections [5, 6] . ACE2 reduces the generation of Ang II by catalysing the conversion of Ang I to Ang1-9 and facilitating hydrolysis of Ang II to Ang1-7. Ang1-7 has been recognised as a potential endogenous inhibitor of the classical RAS cascade [7] . Hence, the ACE2\\uf02dAng1-7 axis may be an important negative modulator of Ang II bioactivity, counteracting the effects of ACE in determining net tissue Ang II levels. Abnormally elevated ACE combined with decreased ACE2 expression may be involved in fibrotic processes in vitro and in vivo, and the mechanism may involve expression and activation of specific MMPs [8] . Recently, abnormal pleural MMP levels, e.g., MMP-2 and MMP-9, have been reported, and the association between MMPs and development of pleurisy has been investigated [9, 10, 11] .', 'cite_spans': [{'start': 190, 'end': 193, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 194, 'end': 196, 'text': '6]', 'ref_id': 'BIBREF5'}, {'start': 426, 'end': 429, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 793, 'end': 796, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 964, 'end': 967, 'text': '[9,', 'ref_id': 'BIBREF8'}, {'start': 968, 'end': 971, 'text': '10,', 'ref_id': 'BIBREF9'}, {'start': 972, 'end': 975, 'text': '11]', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Here we evaluated the association of two key enzymes in RAS, ACE and ACE2, with MMP-2 and MMP-9 in the pleural fluid of patients with pleural effusion. We also detail discussed whether abnormal RAS, accompanied with high levels of ACE/ACE2, might be a cause of elevated MMP-9 activity in tuberculous pleural effusion. Finally, a high ratio of ACE to ACE2 combined with elevated MMP-9 detected in pleural fluid may be a potential indicator for the diagnosis of tuberculous pleurisy.', 'cite_spans': [], 'ref_spans': [], 'section': 'Introduction'}, {'text': \"Pleural effusions from 125 patients were processed in our laboratory from August 2010 to December 2011. All pleural effusions were designated as transudates or exudates according to Light's criteria [12] . Definitive diagnosis of tuberculous, pneumonia, or adenocarcinoma effusions for the exudate was verified by examining effusion biochemistry, cytology, acid-fast staining, and clinical follow-up. The study was performed with the approval of the Institutional Review Board of Mackay Memorial Hospital. Informed consent was obtained from all patients.\", 'cite_spans': [{'start': 199, 'end': 203, 'text': '[12]', 'ref_id': 'BIBREF11'}], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': \"According to Light's criteria, pleural effusions were divided into 45 transudative pleural effusions and 80 exudative pleural effusions. The exudative pleural effusions were further divided into tuberculous pleural effusions (20 patients), pneumonia pleural effusions (32 patients), and malignant pleural effusions (28 patients). Fresh pleural fluid was collected in sterile tubes without anticoagulant reagents to prevent the release of gelatinases during platelet activation, and the tubes were immediately centrifuged at 3,000 × g for 30 minutes to separate the supernatants and cell pellets. The supernatants were aliquoted and stored with the cell pellets at −80°C until further use.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': 'For each pleural effusion sample, the routine pleural analyses included total protein, lactate dehydrogenase (LDH), glucose, and white blood cell (WBC) count. In addition, the activities of ACE, ACE2, and gelatinases (MMP-2 and MMP-9) in the pleural effusions were measured.', 'cite_spans': [], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': 'Gelatin zymography for detecting MMP-2 and MMP-9 activity was performed with gelatin-containing gels as our previous report [4] . Briefly, 10 \\uf06dl pleural fluid for each subject was loaded to a 10% SDS-PAGE containing 0.1 mg·ml -1 gelatin (Sigma-Aldrich, St. Louis, MO, USA). The gelatinase activities were identified as clear zones against a blue background on the SDS-PAGE and quantified using Scion Image software (NIH, Bethesda, MD, USA), which quantifies the extent of lysis in bands containing gelatinase. Enzyme activity was expressed as ng·ml -1 . [13] . The assay was performed in a micro-quartz cuvette with 20 μl pleural fluid, 50 μM fluorogenic substrate and protease inhibitor cocktail (1:200; Sigma-Aldrich) in a final volume of 100 μl in ACE or ACE2 assay buffer. The reaction was followed kinetically for 1 hour using a fluorescence reader at an excitation wavelength of 330 nm and an emission wavelength of 390 nm. Data were fitted and plotted using Grafit v.4.0 (Sigma-Aldrich), and enzyme activity was expressed as RFU·h -1 ·ml -1 . Parallel samples were incubated with the above-mentioned reaction mixture in the presence of 1 μM captopril (Sigma-Aldrich), a specific ACE inhibitor for determining specific ACE activity, or 1 μM DX600 (AnaSpec), a specific ACE2 inhibitor for determining specific ACE2 activity.', 'cite_spans': [{'start': 124, 'end': 127, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 554, 'end': 558, 'text': '[13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'Gelatin zymography'}, {'text': 'The levels of various markers in the pleural effusion samples are expressed as the mean ± standard deviation (SD) or shown as the median (interquartile range). Group comparisons were made using the nonparametric Kruskal-Wallis test. Differences were considered statistically significant when p < 0.05. Statistical analysis was performed using statistical software (SPSS, Chicago, IL, USA).', 'cite_spans': [], 'ref_spans': [], 'section': 'Statistics'}, {'text': 'The pleural fluid characteristics of 125 patients included in the study are presented in Table 1 . Generally, total protein, LDH, and the number of WBC in exudative effusions (n = 80) were significantly higher than those in transudative effusions (n = 45) (p < 0.001), whereas a lower glucose level was detected in the pleural fluid of exudates compared with that in transudates (p < 0.001).', 'cite_spans': [], 'ref_spans': [{'start': 89, 'end': 96, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'General characteristics of pleural effusions'}, {'text': 'ACE and ACE2 activities in the pleural effusions of all patients were determined. ACE activity in exudative effusions was higher than that in transudative effusions (median, 0.74 (IQR, 0.43-1.47) RFU·h -1 ·ml -1 vs. 0.57 (0.32-0.9) RFU·h -1 ·ml -1 , p < 0.01) ( Figure 1A ). On the contrary, ACE2 activity in exudative effusions was lower than that in transudative effusions (1.58 (1.02-2.54) RFU·h -1 ·ml -1 vs.', 'cite_spans': [], 'ref_spans': [{'start': 262, 'end': 271, 'text': 'Figure 1A', 'ref_id': 'FIGREF1'}], 'section': 'ACE and ACE2 activities in transudates and exudates'}, {'text': '1.98 (1.27-3.12) RFU·h -1 ·ml -1 ) ( Figure 1B ), but this difference was not statistically significant. The ratio of ACE/ACE2 activity in the pleural effusions was significantly higher in exudative effusions than in transudative effusions (0.49 (0.27-0.91) vs. 0.27 (0.19-0.43), p < 0.001) ( Figure  1C ). In transudates, a significant positive correlation was found between ACE and ACE2 activities (r 2 = 0.456, p < 0.001) (Figure 2A) . However, the ACE activity was not correlated with the ACE2 activity in exudative effusions (r 2 = 0.020, p = 0.214) ( Figure 2B ). ', 'cite_spans': [], 'ref_spans': [{'start': 37, 'end': 46, 'text': 'Figure 1B', 'ref_id': 'FIGREF1'}, {'start': 293, 'end': 303, 'text': 'Figure  1C', 'ref_id': 'FIGREF1'}, {'start': 425, 'end': 436, 'text': '(Figure 2A)', 'ref_id': 'FIGREF2'}, {'start': 557, 'end': 566, 'text': 'Figure 2B', 'ref_id': 'FIGREF2'}], 'section': 'ACE and ACE2 activities in transudates and exudates'}, {'text': 'The MMP-2 and MMP-9 activities in the pleural effusions of all patients were determined with gelatin zymography (Figure 3 ). The MMP-2 activity in exudative effusions was comparable with that in transudative effusions (1375 (944-1841) ng·ml -1 vs. 1148 (806-1730) ng·ml -1 ) ( Figure 3A ). However, MMP-9 activity in exudative effusions was significantly higher than that in transudative effusions (30 (19-52) ng·ml -1 vs. 11 (8-23) ng·ml -1 , p < 0.001) ( Figure 3B ).', 'cite_spans': [{'start': 398, 'end': 409, 'text': '(30 (19-52)', 'ref_id': None}], 'ref_spans': [{'start': 112, 'end': 121, 'text': '(Figure 3', 'ref_id': 'FIGREF3'}, {'start': 277, 'end': 286, 'text': 'Figure 3A', 'ref_id': 'FIGREF3'}, {'start': 457, 'end': 466, 'text': 'Figure 3B', 'ref_id': 'FIGREF3'}], 'section': 'MMP-2 and MMP-9 activities in transudates and exudates'}, {'text': 'WBC number, glucose, total protein and LDH concentration in the exudates from of three types, tuberculous, pneumonia and adenocarcinoma effusions, were determined ( Table 2 ). The data show that all of WBC number, glucose and LDH concentration determinations among the three exudative effusions were insignificantly different. ', 'cite_spans': [], 'ref_spans': [{'start': 165, 'end': 172, 'text': 'Table 2', 'ref_id': 'TABREF1'}], 'section': 'WBC and biochemical assay in exudates from patients with different diseases'}, {'text': 'Elevated ACE activity and an elevated ACE/ACE2 ratio were observed in exudative effusions. We then differentiated both ACE and ACE2 activities in the exudates according to different diseases, including tuberculosis, pneumonia, and adenocarcinoma. The ACE activity in the tuberculous pleural effusions was significantly higher than in pneumonia and adenocarcinoma effusions, by 2.89 (p < 0.001) and 2.62 (p < 0.001) fold, respectively ( Figure  4A ). In contrast, ACE2 activity in the tuberculous effusions was significantly lower than in pneumonia and adenocarcinoma effusions, by 0.68 (p < 0.05) and 0.58 (p < 0.05) fold, respectively ( Figure 4B ). According to the changes we detected in ACE and ACE2, a significantly higher difference in the ACE/ACE2 ratio in tuberculous effusions (1.72 (1.09-2.52)) compared with ratios in pneumonia (0.32 (0.20-0.50)) and adenocarcinoma (0.43 (0.26-0.67)) effusions was also observed (p < 0.001) ( Figure 4C ).', 'cite_spans': [], 'ref_spans': [{'start': 436, 'end': 446, 'text': 'Figure  4A', 'ref_id': 'FIGREF4'}, {'start': 638, 'end': 647, 'text': 'Figure 4B', 'ref_id': 'FIGREF4'}, {'start': 938, 'end': 947, 'text': 'Figure 4C', 'ref_id': 'FIGREF4'}], 'section': 'ACE and ACE2 activities in exudates from patients with different diseases'}, {'text': 'The pleural ACE and ACE2 activities among transudates, tuberculosis, pneumonia and adenocar-cinoma were compared. The ACE and ACE2 activities in transudates, tuberculous, pneumonia and adenocarcinoma effusions were 0.67 ± 0.52, 2.16 ± 0.97, 0.74 ± 0.77 and 0.82 ± 0.43 RFU/hour/ml, and 2.19 ± 1.31, 1.38 ± 0.58, 2.05 ± 1.40 and 2.38 ± 1.86 RFU/hour/ml, respectively. It is noted that both of ACE and ACE2 activities in pneumonia and adenocarcinoma effusions were similar to the activities in transudative effusions.', 'cite_spans': [], 'ref_spans': [], 'section': 'ACE and ACE2 activities in exudates from patients with different diseases'}, {'text': 'The MMP-2 and MMP-9 activities in exudative effusions from the patients with different diseases were assayed by gelatin zymography (Figure 5 ). In tuberculous pleural effusions, MMP-2 activity was 1.48 (p < 0.01) and 1.36 fold (p < 0.05) higher than MMP-2 activity in pneumonia and adenocarcinoma effusions, respectively ( Figure 5A ). Similar to MMP-2, MMP-9 activity in tuberculous effusions was significantly higher than MMP-9 activity in pneumonia and adenocarcinoma effusions by 1.62 (p < 0.01) and 1.77 fold (p < 0.01), respectively ( Figure 5B ). ', 'cite_spans': [], 'ref_spans': [{'start': 131, 'end': 140, 'text': '(Figure 5', 'ref_id': 'FIGREF5'}, {'start': 323, 'end': 332, 'text': 'Figure 5A', 'ref_id': 'FIGREF5'}, {'start': 541, 'end': 550, 'text': 'Figure 5B', 'ref_id': 'FIGREF5'}], 'section': 'MMP-2 and MMP-9 activities in exudates from patients with different diseases'}, {'text': 'In the present study, major components of RAS and extracellular matrix (ECM) metabolism, pleural ACE, ACE2, MMP-2, and MMP-9, were measured in patients with pleural effusions. Our main findings are: (1) significantly higher the ACE, MMP-9 activity and ACE/ACE2 ratio in exudative effusions; (2) increased MMP-9 and ACE activities combined with decreased ACE2 activity in tuberculous effusion compared to pneumonia and adenocarcinoma effusions. The increased MMP-9 activity found in tuberculous effusion is in agreement with previous reports [9, 14, 15] . Herein, we first report that the changes of ACE and ACE2 activity are associated with tuberculous pleurisy.', 'cite_spans': [{'start': 541, 'end': 544, 'text': '[9,', 'ref_id': 'BIBREF8'}, {'start': 545, 'end': 548, 'text': '14,', 'ref_id': 'BIBREF13'}, {'start': 549, 'end': 552, 'text': '15]', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Only a few reports have been published on the importance of ACE in pleural fluid. ACE could be detected in pleural fluid, but the ACE level cannot be used to discriminate cancer from non-cancer patients [16, 17] . Söderblom et al. [18] had also measured ACE in pleural effusions and sera of 364 patients and showed that tuberculous effusions contain higher ACE concentrations than any other type of non-rheumatoid effusions. These results indicate that ACE determinations may aid in differentiating rheumatoid and tuberculous pleurisy from other types of pleural disease.', 'cite_spans': [{'start': 203, 'end': 207, 'text': '[16,', 'ref_id': 'BIBREF15'}, {'start': 208, 'end': 211, 'text': '17]', 'ref_id': 'BIBREF16'}, {'start': 231, 'end': 235, 'text': '[18]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'In the present study, we reported the change in ACE2 activity in pleural effusions. Some of the physiological functions of ACE2 are opposite to those of ACE. The significant positive correlation between ACE and ACE2 activities in the transudates suggests that ACE and ACE2 maintain a normal physiological balance. This loss of balance in exudates was detected because of increased ACE. Although the importance of the dysregulation in ACE in exudative effusions has not been explored, a significant role for RAS in the pathophysiological process of exudate development is possible.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'ACE activity was increased (p < 0.001) and ACE2 was decreased (p < 0.05) in tuberculosis specifically, but the ACE and ACE2 activities were no difference between transudate, pneumonia and adenocarcinoma effusions. These results indicated that ACE and ACE2 maybe a biomarker for tuberculosis diagnosis in pleural effusion and it could be emphasized that the increased ACE activity and ratio of ACE/ACE2 in the exudates are mainly contributed from a higher ACE level and lower ACE2 enzyme activities in the tuberculous pleural effusion. In an advanced assay, our data show that the ACE activity of 85% (17/20), 19% (6/32), 18% (5/28) and 18% (8/45) pleural fluids isolated tuberculosis, pneumonia, adenocarcinoma and transudates was > 1 RFU/hour/ml, respectively. It is also indicated that the increased ACE activity found in the exudates are mainly contributed from a higher ACE activity in the tuberculous pleural effusion.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The ACE2 activity in tuberculous, pneumonia and adenocarcinoma effusions were 1.38 ± 0.58, 2.05 ± 1.40 and 2.38 ± 1.86 RFU/hour/ml (mean ± SD), respectively. Although a larger SD was determined in the pneumonia and adenocarcinoma groups, the ACE2 activity in both groups were significantly larger than that in the tuberculosis group (p < 0.05). In advanced assay, the data indicate that there were 75% tuberculosis (15/20) , 56% pneumonia (18/32) and 50% adenocarcinoma (14/28) patients showed the ACE2 activity \\uf0a3 1.80 RFU/hour/ml (75% of interquartile range in tuberculous effusions; IQR, 0.97-1.80). The data also support that the trend of decreased ACE2 activity in the pleural effusions with tuberculosis compared to those with pneumonia or adenocarcinoma. However, more patients should be further included in order to examine the proposition.', 'cite_spans': [{'start': 415, 'end': 422, 'text': '(15/20)', 'ref_id': None}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'It is interesting that significantly increased ACE activity combined with markedly decreased ACE2 activity was measured in tuberculous effusions. This result confirms that abnormal RAS metabolism in pleural spaces may be related to tuberculous pleurisy. It was reported that overexpression of ACE2 may inhibit MMP-9 activity [19] , and ACE2 deficiency leads to increased MMP-9 levels [20] . In inflammatory signalling pathways study, Ang II could stimulate human monocytic U-937 cells to increase MMP-9 expression and activity significantly via activated NF-κB, JNK, and p38 [21] . The ACE inhibitor, captopril, was administrated to isoprenaline-induced left ventricular fibrosis rats and showed that captopril significantly enhanced the isoprenaline-induced myocardial fibrosis and augmented the isoprenaline-induced MMP-9 expression [22] . In addition, ACE2 and Ang 1-7, the regulators in RAS opposed Ang II effect, could affect MMP-9 expression. Overexpression of ACE2 reduces the invasive ability in vitro according to the down-regulation of MMP-2 and MMP-9 [23] . Ang 1-7 revealed the anti-migration and anti-invasion effect mediated through inactivation of the PI3K/Akt, P38 and JNK signal pathways to reduce the expression and activity of MMP-2 and MMP-9 [24] . According to our results, we conclude that reduction in ACE2 along with induction of MMP-9 activity occurred. Our observations of decreased ACE2 and increased MMP-9 activity in tuberculous effusions confirm this conclusion.', 'cite_spans': [{'start': 325, 'end': 329, 'text': '[19]', 'ref_id': 'BIBREF18'}, {'start': 384, 'end': 388, 'text': '[20]', 'ref_id': 'BIBREF19'}, {'start': 575, 'end': 579, 'text': '[21]', 'ref_id': 'BIBREF20'}, {'start': 835, 'end': 839, 'text': '[22]', 'ref_id': 'BIBREF21'}, {'start': 1062, 'end': 1066, 'text': '[23]', 'ref_id': 'BIBREF22'}, {'start': 1262, 'end': 1266, 'text': '[24]', 'ref_id': 'BIBREF23'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'A number of studies have indicated that the ACE-Ang II axis and ACE2-Ang1-7 axis not only regulate the metabolism of ECM proteins, but also modulate MMP expression and activity levels [8] . MMPs have been implicated in the pathogenesis of various lung diseases, including pleural effusions [25, 26] . The activity of MMPs within the pleural space may play a role in the formation of pleural effusions by altering the integrity of the mesothelial and endothelial cell layers and by increasing vascular permeability [10, 27] . Proteolysis by MMPs may be involved in the formation of pleural effusions by increasing vascular permeability, and thus by facilitating fluid influx into the pleural space [28] . Therefore, the presence and enzymatic activities of MMPs have been identified in pleural effusions [15, 25, 29] . Previous studies have shown that the expression of MMPs in the pleural space is altered in a variety of inflammatory and malignant diseases, suggesting that certain members of the MMP family may participate in the formation of pleural effusions [10, 15, 29] . Tissue damage is a characteristic manifestation of Mycobacterium tuberculosis infection. Proteolysis by macrophage-secreted proteases has been implicated in such destructive processes. In this regard, the proteolytic action of MMPs may be involved in the pathogenesis of tuberculosis, like many other diseases associated with tissue destruction. Several studies have reported that macrophages and monocytes release MMP-9 in response to tuberculosis or its cellular components [30, 31] . Studies have evaluated MMPs in tuberculous pleural effusions and found that the MMP activity in pleural fluid are higher in patients with tuberculosis compared with patients with transudative effusions [10, 32] . Our results are in agreement with the above findings, as the MMP-9 activity was highest in tuberculous effusions among the exudates we examined.', 'cite_spans': [{'start': 184, 'end': 187, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 290, 'end': 294, 'text': '[25,', 'ref_id': 'BIBREF24'}, {'start': 295, 'end': 298, 'text': '26]', 'ref_id': 'BIBREF25'}, {'start': 514, 'end': 518, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 519, 'end': 522, 'text': '27]', 'ref_id': 'BIBREF26'}, {'start': 697, 'end': 701, 'text': '[28]', 'ref_id': 'BIBREF27'}, {'start': 803, 'end': 807, 'text': '[15,', 'ref_id': 'BIBREF14'}, {'start': 808, 'end': 811, 'text': '25,', 'ref_id': 'BIBREF24'}, {'start': 812, 'end': 815, 'text': '29]', 'ref_id': 'BIBREF28'}, {'start': 1063, 'end': 1067, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 1068, 'end': 1071, 'text': '15,', 'ref_id': 'BIBREF14'}, {'start': 1072, 'end': 1075, 'text': '29]', 'ref_id': 'BIBREF28'}, {'start': 1554, 'end': 1558, 'text': '[30,', 'ref_id': 'BIBREF29'}, {'start': 1559, 'end': 1562, 'text': '31]', 'ref_id': 'BIBREF30'}, {'start': 1767, 'end': 1771, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 1772, 'end': 1775, 'text': '32]', 'ref_id': 'BIBREF31'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The present study is the first report about the ACE/ACE2 ratio in tuberculosis diagnosis. Although increased ACE and MMP-9 could be specifically determined in the tuberculous effusion. There are still few concerns should be addressed using ACE and MMP-9 as biomarker for tuberculosis diagnosis, because (1) elevated ACE levels may also be seen in several other cardiovascular disorders, and (2) MMP-9 is an inflammation-induced target in several cases [33] . In the RAS, ACE2/Ang-(1-7) axis has been recently highlighted as the counter balancing arm of the RAS to the ACE/Ang II axis. The regulatory mechanisms focused on the alternating ACE and ACE2 regulation are still lack; therefore, the mechanism of reduced ACE2 found in the pleural effusion of patients with tuberculosis remains to be further explored.', 'cite_spans': [{'start': 452, 'end': 456, 'text': '[33]', 'ref_id': 'BIBREF32'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Our data suggest that the interplay between ACE and ACE2, an essential function in RAS, and the change in gelatinase activity may be involved in the development of pleural effusions. Our findings suggest that increased ACE and MMP-9 activities and decreased ACE2 activity in pleural fluid are features of pleural space infection in patients with pleural tuberculosis. Such measurements may be helpful for diagnosing tuberculous pleurisy. However, the findings of the present study require further validation in a large prospective study examining the treatment and outcome of unselected patients with tuberculosis before the above indicators can become part of a clinically meaningful practice.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusion'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy', 'authors': [{'first': 'L', 'middle': [], 'last': 'Valdés', 'suffix': ''}, {'first': 'San', 'middle': [], 'last': 'José', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Alvarez', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 1996, 'venue': 'Eur Respir J', 'volume': '9', 'issn': '', 'pages': '747--51', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'The pulmonary renin-angiotensin system', 'authors': [{'first': 'R', 'middle': ['P'], 'last': 'Marshall', 'suffix': ''}], 'year': 2003, 'venue': 'Curr Pharm Design', 'volume': '9', 'issn': '', 'pages': '715--737', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin', 'authors': [{'first': 'R', 'middle': ['M'], 'last': 'Wösten-Van Asperen', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Lutter', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Haitsma', 'suffix': ''}], 'year': 2008, 'venue': 'Eur Respir J', 'volume': '31', 'issn': '', 'pages': '363--71', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation', 'authors': [{'first': 'C', 'middle': ['L'], 'last': 'Chen', 'suffix': ''}, {'first': 'Sks', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Lin', 'suffix': ''}], 'year': 2008, 'venue': 'J Mol Cell Cardiol', 'volume': '45', 'issn': '', 'pages': '742--53', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kuba', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Imai', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Rao', 'suffix': ''}], 'year': 2005, 'venue': 'Nat Med', 'volume': '11', 'issn': '', 'pages': '875--79', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Imai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kuba', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Ohto-Nakanishi', 'suffix': ''}], 'year': 2010, 'venue': 'Circ J', 'volume': '74', 'issn': '', 'pages': '405--415', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart', 'authors': [{'first': 'C', 'middle': [], 'last': 'Mercure', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yogi', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Callera', 'suffix': ''}], 'year': 2008, 'venue': 'Circ Res', 'volume': '103', 'issn': '', 'pages': '1319--1345', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Interplay of angiotensin II and angiotensin 1-7 in the regulations of matrix metalloproteinases of human cardiocytes', 'authors': [{'first': 'C', 'middle': ['H'], 'last': 'Pan', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Wen', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Lin', 'suffix': ''}], 'year': 2008, 'venue': 'Exp Physiol', 'volume': '93', 'issn': '', 'pages': '599--612', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions', 'authors': [{'first': 'D', 'middle': [], 'last': 'Iglesias', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Alegre', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Alemán', 'suffix': ''}], 'year': 2005, 'venue': 'Eur Respir J', 'volume': '25', 'issn': '', 'pages': '104--113', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration', 'authors': [{'first': 'K', 'middle': ['J'], 'last': 'Park', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Hwang', 'suffix': ''}, {'first': 'S', 'middle': ['S'], 'last': 'Sheen', 'suffix': ''}], 'year': 2005, 'venue': '', 'volume': '72', 'issn': '', 'pages': '166--75', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions. Respiration', 'authors': [{'first': 'S', 'middle': [], 'last': 'Oikonomidi', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kostikas', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Kalomenidis', 'suffix': ''}], 'year': 2010, 'venue': '', 'volume': '80', 'issn': '', 'pages': '285--91', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Pleural effusions: the diagnostic separation of transudates and exudates', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Light', 'suffix': ''}, {'first': 'M', 'middle': ['I'], 'last': 'Macgregor', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Luchsinger', 'suffix': ''}], 'year': 1972, 'venue': 'Ann Intern Med', 'volume': '77', 'issn': '', 'pages': '507--520', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'ACE and ACE2 activity in diabetic mice', 'authors': [{'first': 'J', 'middle': [], 'last': 'Wysocki', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ye', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Soler', 'suffix': ''}], 'year': 2006, 'venue': 'Diabetes', 'volume': '5', 'issn': '', 'pages': '2132--2171', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?', 'authors': [{'first': 'A', 'middle': [], 'last': 'Trajman', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Pai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Dheda', 'suffix': ''}], 'year': 2008, 'venue': 'Eur Respir J', 'volume': '31', 'issn': '', 'pages': '1098--106', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation', 'authors': [{'first': 'P', 'middle': [], 'last': 'Sheen', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'O&apos;kane', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Chaudhary', 'suffix': ''}], 'year': 2009, 'venue': 'Eur Respir J', 'volume': '33', 'issn': '', 'pages': '134--175', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Levels of angiotensin-converting enzyme in pleural effusion', 'authors': [{'first': 'C', 'middle': ['W'], 'last': 'Bedrossian', 'suffix': ''}, {'first': 'D', 'middle': ['A'], 'last': 'Stein', 'suffix': ''}, {'first': 'W', 'middle': ['C'], 'last': 'Miller', 'suffix': ''}], 'year': 1981, 'venue': 'Arch Pathol Lab Med', 'volume': '105', 'issn': '', 'pages': '345--351', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Activity of angiotensin-converting enzyme in pleural fluid and serum in non-sarcoid, non-tuberculous pleural effusion', 'authors': [{'first': 'F', 'middle': ['K'], 'last': 'Rømer', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Geday', 'suffix': ''}], 'year': 1982, 'venue': 'Eur J Respir Dis', 'volume': '63', 'issn': '', 'pages': '102--108', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis', 'authors': [{'first': 'T', 'middle': [], 'last': 'Söderblom', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Nyberg', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pettersson', 'suffix': ''}], 'year': 1996, 'venue': 'Respiration', 'volume': '63', 'issn': '', 'pages': '272--278', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis', 'authors': [{'first': 'B', 'middle': [], 'last': 'Dong', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Feng', 'suffix': ''}], 'year': 2008, 'venue': 'Arterioscler Thromb Vasc Biol', 'volume': '28', 'issn': '', 'pages': '1270--1276', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47 (phox) NADPH oxidase subunit', 'authors': [{'first': 'S', 'middle': [], 'last': 'Bodiga', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Zhong', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Wang', 'suffix': ''}], 'year': 2011, 'venue': 'Cardiovasc Res', 'volume': '91', 'issn': '', 'pages': '151--61', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Angiotensin II induces NF-κB, JNK and p38 MAPK activation in monocytic cells and increases matrix metalloproteinase-9 expression in a PKC-andRho kinase-dependent manner', 'authors': [{'first': 'H', 'middle': [], 'last': 'Yaghooti', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Firoozrai', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Fallah', 'suffix': ''}], 'year': 2011, 'venue': 'Braz J Med Biol Res', 'volume': '44', 'issn': '', 'pages': '193--202', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats', 'authors': [{'first': 'M', 'middle': [], 'last': 'Okada', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Kosaka', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Hoshino', 'suffix': ''}], 'year': 2010, 'venue': 'Biol Pharm Bull', 'volume': '33', 'issn': '', 'pages': '1517--1538', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Feng', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ni', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wan', 'suffix': ''}], 'year': 2011, 'venue': 'Oncol Rep', 'volume': '26', 'issn': '', 'pages': '1157--64', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways', 'authors': [{'first': 'L', 'middle': [], 'last': 'Ni', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Feng', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wan', 'suffix': ''}], 'year': 2012, 'venue': 'Oncol Rep', 'volume': '27', 'issn': '', 'pages': '783--90', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'MMP and TIMP expression pattern in pleural effusions of different origins', 'authors': [{'first': 'O', 'middle': [], 'last': 'Eickelberg', 'suffix': ''}, {'first': 'C', 'middle': ['O'], 'last': 'Sommerfeld', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wyser', 'suffix': ''}], 'year': 1997, 'venue': 'Am J Resp Crit Care', 'volume': '156', 'issn': '', 'pages': '1987--92', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'MMP expression and abnormal lung permeability are important determinants of outcome in IPF', 'authors': [{'first': 'S', 'middle': [], 'last': 'Mckeown', 'suffix': ''}, {'first': 'A', 'middle': ['G'], 'last': 'Richter', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'O&apos;kane', 'suffix': ''}], 'year': 2009, 'venue': 'Eur Respir J', 'volume': '33', 'issn': '', 'pages': '77--84', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Pathophysiology of the pleura', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Jantz', 'suffix': ''}, {'first': 'Antony', 'middle': [], 'last': 'Vb', 'suffix': ''}], 'year': 2008, 'venue': 'Respiration', 'volume': '75', 'issn': '', 'pages': '121--154', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase a activation and cell proliferation', 'authors': [{'first': 'S', 'middle': [], 'last': 'Zucker', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Mirza', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'Conner', 'suffix': ''}], 'year': 1998, 'venue': 'Int J Cancer', 'volume': '75', 'issn': '', 'pages': '780--786', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Human pleural effusions are rich in matrix metalloproteinases', 'authors': [{'first': 'A', 'middle': ['N'], 'last': 'Hurewitz', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Zucker', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Mancuso', 'suffix': ''}], 'year': 1992, 'venue': 'Chest', 'volume': '102', 'issn': '', 'pages': '1808--1822', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Friedland', 'suffix': ''}, {'first': 'T', 'middle': ['C'], 'last': 'Shaw', 'suffix': ''}, {'first': 'N', 'middle': ['M'], 'last': 'Price', 'suffix': ''}], 'year': 2002, 'venue': 'Matrix Biol', 'volume': '21', 'issn': '', 'pages': '103--113', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'tuberculosis induction of matrix metalloproteinase-9: The role of mannose and receptor-mediated mechanisms', 'authors': [{'first': 'C', 'middle': ['A'], 'last': 'Rivera-Marrero', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Schuyler', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Roser', 'suffix': ''}], 'year': 2002, 'venue': 'Am J Physiol Lung Cell Mol Physiol', 'volume': '82', 'issn': '', 'pages': '546--55', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis', 'authors': [{'first': 'G', 'middle': [], 'last': 'Hoheisel', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Sack', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Hui', 'suffix': ''}], 'year': 2001, 'venue': 'Tuberculosis', 'volume': '81', 'issn': '', 'pages': '203--212', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis', 'authors': [{'first': 'M', 'middle': ['E'], 'last': 'Muroski', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': 'Roycik', 'suffix': ''}, {'first': 'R', 'middle': ['G'], 'last': 'Newcomer', 'suffix': ''}], 'year': 2008, 'venue': 'Curr Pharm Biotechnol', 'volume': '9', 'issn': '', 'pages': '34--46', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'ACE and ACE2 activities were assayed with the fluorogenic substrates Mca-YVADAPK and Mca-APK-Dnp (AnaSpec, San Jose, CA, USA), respectively, according to Wysocki et al. with slight modifications', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'Enzymatic activity of ACE and ACE2 in pleural transudative and exudative effusions. The specific activities of ACE (A) and ACE2 (B) in pleural transudative (n = 45) and exudative (n = 80) effusions from 125 patients. The ratio of ACE/ACE2 in the pleural effusions (C). Pleural effusion (20 μl) was assayed for the ability to cleave the fluorescent substrate at 37°C for 1 hour with a specific ACE inhibitor or a specific ACE2 inhibitor. Each symbol represents one individual, and horizontal bars represent median values. ** and *** indicate p < 0.01 and p < 0.001, respectively, compared with transudates.', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': \"Correlations between ACE and ACE2 activities in pleural effusions. ACE and ACE2 activities were measured in each sample of pleural transudative effusions (A; n = 45) and exudative effusions (B; n = 80). For correlation analysis, Pearson's correlation analysis (SPSS statistics package, Chicago, IL) was applied. Statistically significant differences were established at p < 0.05. ACE and ACE2 positively correlate with each other in the group of transudative effusions (F(1,43) = 36.052, r 2 = 0.456, p < 0.001) (A), but not in the group of exudative effusions (F(1,78) = 1.567, r 2 = 0.020, p > 0.05) (B).\", 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'MMP-2 and MMP-9 activities in pleural transudative and exudative effusions. The activities of MMP-2 (A) and MMP-9 (B) in pleural transudative and exudative effusions from 125 patients were determined with zymography. The gelatinase activities detected in this study were based on pro-MMP-2 (72 kDa) and pro-MMP-9 (95 kDa). Each symbol represents one individual, and horizontal bars represent median values. *** indicates p < 0.001 compared with transudates.', 'latex': None, 'type': 'figure'}, 'FIGREF4': {'text': 'ACE and ACE2 activities in exudative effusions from patients with tuberculosis (TB), pneumonia (Pn), and adenocarcinoma (Ad). The activities of ACE (A), ACE2 (B), and the ratio of ACE/ACE2 (C) in TB (n = 20), Pn (n = 32), and Ad (n = 28) effusions. Each symbol represents one individual, and horizontal bars represent median values. * and *** indicate p < 0.05 and p < 0.001, respectively, compared with values measured in Pn and/or Ad effusions.', 'latex': None, 'type': 'figure'}, 'FIGREF5': {'text': 'MMP-2 and MMP-9 activities in exudative effusions from patients with tuberculosis (TB), pneumonia (Pn), and adenocarcinoma (Ad). The activities of MMP-2 (A) and MMP-9 (B) in TB (n = 20), Pn (n = 32), and Ad (n = 28) effusions. The gelatinase activities detected in this study were based on pro-MMP-2 (72 kDa) and pro-MMP-9 (95 kDa). Each symbol represents one individual, and horizontal bars represent median values. * and ** indicate p < 0.05 and p < 0.01, respectively, compared with values measured in Pn and/or Ad effusions.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Pleural fluid characteristics of the study population.Transudates were from patients with heart failure or liver cirrhosis. Exudates were from patients with tuberculous, pneumonia, or adenocarcinoma effusions. Data are the means \\uf0b1 SD. *** indicates p < 0.001 compared with transudates.', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Pleural fluid characteristics of tuberculous, pneumonia and adenocarcinoma effusions.', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We confirm and declare that all authors fulfilled the condition for authorship. There was no commercial support in the process of performing this study and submitting this manuscript.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgements'}, {'text': 'The authors have declared that no competing interest exists.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing Interests'}]}\n"
     ]
    }
   ],
   "source": [
    "import re\n",
    "regx = re.compile(\"pleural\", re.IGNORECASE)\n",
    "for r in db['noncomm-subset'].find({'body_text.text': { '$regex': regx } }):\n",
    "    print(r)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "# query the text index field created on the body_text field\n",
    "# in the browser use { \"body_text.text\": \"text\" } "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': ObjectId('5f4ecbc6f7c2f0238d4cbc14'), 'paper_id': '1b58422e266ab9339c919119923229d080f27360', 'metadata': {'title': 'ACE/ACE2 Ratio and MMP-9 Activity as Potential Biomarkers in Tuberculous Pleural Effusions', 'authors': [{'first': 'Wen-Yeh', 'middle': [], 'last': 'Hsieh', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Tang-Ching', 'middle': [], 'last': 'Kuan', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Kun-Shan', 'middle': [], 'last': 'Cheng', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Yan-Chiou', 'middle': [], 'last': 'Liao', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Mu-Yuan', 'middle': [], 'last': 'Chen', 'suffix': '', 'affiliation': {}, 'email': ''}, {'first': 'Pei-Heng', 'middle': [], 'last': 'Lin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Yuan-Chang', 'middle': [], 'last': 'Hsu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Chen-Yi', 'middle': [], 'last': 'Huang', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Wei-Hua', 'middle': [], 'last': 'Hsu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mackay Memorial Hospital', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Sheng-Yao', 'middle': [], 'last': 'Yu', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'Mackay Memorial Hospital', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}, {'first': 'Chih-Sheng', 'middle': [], 'last': 'Lin', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'National Chiao Tung University', 'location': {'settlement': 'Hsinchu', 'country': 'Taiwan'}}, 'email': ''}]}, 'abstract': [{'text': 'Objective: Pleural effusion is common problem, but the rapid and reliable diagnosis for specific pathogenic effusions are lacking. This study aimed to identify the diagnosis based on clinical variables to differentiate pleural tuberculous exudates from other pleural effusions. We also investigated the role of renin-angiotensin system (RAS) and matrix metalloproteinase (MMPs) in the pathogenesis of pleural exudates. Experimental design: The major components in RAS and extracellular matrix metabolism, including angiotensin converting enzyme (ACE), ACE2, MMP-2 and MMP-9 activities, were measured and compared in the patients with transudative (n = 45) and exudative (n = 80) effusions. The exudative effusions were come from the patients with tuberculosis (n = 20), pneumonia (n = 32), and adenocarcinoma (n = 28). Results: Increased ACE and equivalent ACE2 activities, resulting in a significantly increased ACE/ACE2 ratio in exudates, were detected compared to these values in transudates. MMP-9 activity in exudates was significantly higher than that in transudates. The significant correlation between ACE and ACE2 activity that was found in transudates was not found in exudates. Advanced analyses showed significantly increased ACE and MMP-9 activities, and decreased ACE2 activity in tuberculous pleural effusions compared with those in pneumonia and adenocarcinoma effusions. The results indicate that increased ACE and MMP-9 activities found in the exudates were mainly contributed from a higher level of both enzyme activities in the tuberculous pleural effusions. Conclusion: Interplay between ACE and ACE2, essential functions in the RAS, and abnormal regulation of MMP-9 probably play a pivotal role in the development of exudative effusions. Moreover, the ACE/ACE2 ratio combined with MMP-9 activity in pleural fluid may be potential biomarkers for diagnosing tuberculous pleurisy.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'Pleural effusion is a common medical problem in the chest and involves accumulation of an abnormal amount of pleural fluid in the pleural space. Several diseases such as congestive heart failure, liver cirrhosis, tuberculosis, adenocarcinoma, and pneumonia are common diseases that cause pleural effusions, but there is no rapid and accurate diagnostic method for pleural effusion. Conventional diagnosis of tuberculous pleurisy is based on pleural fluid cytology, culture of pleural effusions, and pleural biopsy tissue culture, but these methods have very low sensitivity and recognised limitations in clinical use, and they usually require weeks for a positive culture report [1] . Therefore, a reliable clinical marker providing simple, rapid, and accurate diagnosis is required for patients with pleural effusion.', 'cite_spans': [{'start': 679, 'end': 682, 'text': '[1]', 'ref_id': 'BIBREF0'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'The circulating renin-angiotensin system (RAS) plays a well-described role in maintaining blood pressure homeostasis. Recently, a local tissue-based RAS has also been described and appears to play a key role in injury/repair responses [2, 3] . The expression of RAS components and the elevation of angiotensin converting enzyme (ACE) in a number of lung diseases suggest the existence of a pulmonary RAS and that angiotensin II (Ang II) could mediate, at least in part, the response to lung injury. The central role of ACE is to generate Ang II from Ang I. Ang II is a key effector peptide of RAS that causes vasoconstriction and exerts multiple biological functions. Ang II can also cause the development of interstitial fibrosis via physiological regulation of matrix metalloproteinase (MMP) expression and/or activation [4] .', 'cite_spans': [{'start': 235, 'end': 238, 'text': '[2,', 'ref_id': 'BIBREF1'}, {'start': 239, 'end': 241, 'text': '3]', 'ref_id': 'BIBREF2'}, {'start': 823, 'end': 826, 'text': '[4]', 'ref_id': 'BIBREF3'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'ACE2, a close homologue of ACE, functions as a negative regulator of the angiotensin system and was identified as a key receptor for severe acute respiratory syndrome coronavirus infections [5, 6] . ACE2 reduces the generation of Ang II by catalysing the conversion of Ang I to Ang1-9 and facilitating hydrolysis of Ang II to Ang1-7. Ang1-7 has been recognised as a potential endogenous inhibitor of the classical RAS cascade [7] . Hence, the ACE2\\uf02dAng1-7 axis may be an important negative modulator of Ang II bioactivity, counteracting the effects of ACE in determining net tissue Ang II levels. Abnormally elevated ACE combined with decreased ACE2 expression may be involved in fibrotic processes in vitro and in vivo, and the mechanism may involve expression and activation of specific MMPs [8] . Recently, abnormal pleural MMP levels, e.g., MMP-2 and MMP-9, have been reported, and the association between MMPs and development of pleurisy has been investigated [9, 10, 11] .', 'cite_spans': [{'start': 190, 'end': 193, 'text': '[5,', 'ref_id': 'BIBREF4'}, {'start': 194, 'end': 196, 'text': '6]', 'ref_id': 'BIBREF5'}, {'start': 426, 'end': 429, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 793, 'end': 796, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 964, 'end': 967, 'text': '[9,', 'ref_id': 'BIBREF8'}, {'start': 968, 'end': 971, 'text': '10,', 'ref_id': 'BIBREF9'}, {'start': 972, 'end': 975, 'text': '11]', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'Introduction'}, {'text': 'Here we evaluated the association of two key enzymes in RAS, ACE and ACE2, with MMP-2 and MMP-9 in the pleural fluid of patients with pleural effusion. We also detail discussed whether abnormal RAS, accompanied with high levels of ACE/ACE2, might be a cause of elevated MMP-9 activity in tuberculous pleural effusion. Finally, a high ratio of ACE to ACE2 combined with elevated MMP-9 detected in pleural fluid may be a potential indicator for the diagnosis of tuberculous pleurisy.', 'cite_spans': [], 'ref_spans': [], 'section': 'Introduction'}, {'text': \"Pleural effusions from 125 patients were processed in our laboratory from August 2010 to December 2011. All pleural effusions were designated as transudates or exudates according to Light's criteria [12] . Definitive diagnosis of tuberculous, pneumonia, or adenocarcinoma effusions for the exudate was verified by examining effusion biochemistry, cytology, acid-fast staining, and clinical follow-up. The study was performed with the approval of the Institutional Review Board of Mackay Memorial Hospital. Informed consent was obtained from all patients.\", 'cite_spans': [{'start': 199, 'end': 203, 'text': '[12]', 'ref_id': 'BIBREF11'}], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': \"According to Light's criteria, pleural effusions were divided into 45 transudative pleural effusions and 80 exudative pleural effusions. The exudative pleural effusions were further divided into tuberculous pleural effusions (20 patients), pneumonia pleural effusions (32 patients), and malignant pleural effusions (28 patients). Fresh pleural fluid was collected in sterile tubes without anticoagulant reagents to prevent the release of gelatinases during platelet activation, and the tubes were immediately centrifuged at 3,000 × g for 30 minutes to separate the supernatants and cell pellets. The supernatants were aliquoted and stored with the cell pellets at −80°C until further use.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': 'For each pleural effusion sample, the routine pleural analyses included total protein, lactate dehydrogenase (LDH), glucose, and white blood cell (WBC) count. In addition, the activities of ACE, ACE2, and gelatinases (MMP-2 and MMP-9) in the pleural effusions were measured.', 'cite_spans': [], 'ref_spans': [], 'section': 'Pleural effusion samples'}, {'text': 'Gelatin zymography for detecting MMP-2 and MMP-9 activity was performed with gelatin-containing gels as our previous report [4] . Briefly, 10 \\uf06dl pleural fluid for each subject was loaded to a 10% SDS-PAGE containing 0.1 mg·ml -1 gelatin (Sigma-Aldrich, St. Louis, MO, USA). The gelatinase activities were identified as clear zones against a blue background on the SDS-PAGE and quantified using Scion Image software (NIH, Bethesda, MD, USA), which quantifies the extent of lysis in bands containing gelatinase. Enzyme activity was expressed as ng·ml -1 . [13] . The assay was performed in a micro-quartz cuvette with 20 μl pleural fluid, 50 μM fluorogenic substrate and protease inhibitor cocktail (1:200; Sigma-Aldrich) in a final volume of 100 μl in ACE or ACE2 assay buffer. The reaction was followed kinetically for 1 hour using a fluorescence reader at an excitation wavelength of 330 nm and an emission wavelength of 390 nm. Data were fitted and plotted using Grafit v.4.0 (Sigma-Aldrich), and enzyme activity was expressed as RFU·h -1 ·ml -1 . Parallel samples were incubated with the above-mentioned reaction mixture in the presence of 1 μM captopril (Sigma-Aldrich), a specific ACE inhibitor for determining specific ACE activity, or 1 μM DX600 (AnaSpec), a specific ACE2 inhibitor for determining specific ACE2 activity.', 'cite_spans': [{'start': 124, 'end': 127, 'text': '[4]', 'ref_id': 'BIBREF3'}, {'start': 554, 'end': 558, 'text': '[13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'Gelatin zymography'}, {'text': 'The levels of various markers in the pleural effusion samples are expressed as the mean ± standard deviation (SD) or shown as the median (interquartile range). Group comparisons were made using the nonparametric Kruskal-Wallis test. Differences were considered statistically significant when p < 0.05. Statistical analysis was performed using statistical software (SPSS, Chicago, IL, USA).', 'cite_spans': [], 'ref_spans': [], 'section': 'Statistics'}, {'text': 'The pleural fluid characteristics of 125 patients included in the study are presented in Table 1 . Generally, total protein, LDH, and the number of WBC in exudative effusions (n = 80) were significantly higher than those in transudative effusions (n = 45) (p < 0.001), whereas a lower glucose level was detected in the pleural fluid of exudates compared with that in transudates (p < 0.001).', 'cite_spans': [], 'ref_spans': [{'start': 89, 'end': 96, 'text': 'Table 1', 'ref_id': 'TABREF0'}], 'section': 'General characteristics of pleural effusions'}, {'text': 'ACE and ACE2 activities in the pleural effusions of all patients were determined. ACE activity in exudative effusions was higher than that in transudative effusions (median, 0.74 (IQR, 0.43-1.47) RFU·h -1 ·ml -1 vs. 0.57 (0.32-0.9) RFU·h -1 ·ml -1 , p < 0.01) ( Figure 1A ). On the contrary, ACE2 activity in exudative effusions was lower than that in transudative effusions (1.58 (1.02-2.54) RFU·h -1 ·ml -1 vs.', 'cite_spans': [], 'ref_spans': [{'start': 262, 'end': 271, 'text': 'Figure 1A', 'ref_id': 'FIGREF1'}], 'section': 'ACE and ACE2 activities in transudates and exudates'}, {'text': '1.98 (1.27-3.12) RFU·h -1 ·ml -1 ) ( Figure 1B ), but this difference was not statistically significant. The ratio of ACE/ACE2 activity in the pleural effusions was significantly higher in exudative effusions than in transudative effusions (0.49 (0.27-0.91) vs. 0.27 (0.19-0.43), p < 0.001) ( Figure  1C ). In transudates, a significant positive correlation was found between ACE and ACE2 activities (r 2 = 0.456, p < 0.001) (Figure 2A) . However, the ACE activity was not correlated with the ACE2 activity in exudative effusions (r 2 = 0.020, p = 0.214) ( Figure 2B ). ', 'cite_spans': [], 'ref_spans': [{'start': 37, 'end': 46, 'text': 'Figure 1B', 'ref_id': 'FIGREF1'}, {'start': 293, 'end': 303, 'text': 'Figure  1C', 'ref_id': 'FIGREF1'}, {'start': 425, 'end': 436, 'text': '(Figure 2A)', 'ref_id': 'FIGREF2'}, {'start': 557, 'end': 566, 'text': 'Figure 2B', 'ref_id': 'FIGREF2'}], 'section': 'ACE and ACE2 activities in transudates and exudates'}, {'text': 'The MMP-2 and MMP-9 activities in the pleural effusions of all patients were determined with gelatin zymography (Figure 3 ). The MMP-2 activity in exudative effusions was comparable with that in transudative effusions (1375 (944-1841) ng·ml -1 vs. 1148 (806-1730) ng·ml -1 ) ( Figure 3A ). However, MMP-9 activity in exudative effusions was significantly higher than that in transudative effusions (30 (19-52) ng·ml -1 vs. 11 (8-23) ng·ml -1 , p < 0.001) ( Figure 3B ).', 'cite_spans': [{'start': 398, 'end': 409, 'text': '(30 (19-52)', 'ref_id': None}], 'ref_spans': [{'start': 112, 'end': 121, 'text': '(Figure 3', 'ref_id': 'FIGREF3'}, {'start': 277, 'end': 286, 'text': 'Figure 3A', 'ref_id': 'FIGREF3'}, {'start': 457, 'end': 466, 'text': 'Figure 3B', 'ref_id': 'FIGREF3'}], 'section': 'MMP-2 and MMP-9 activities in transudates and exudates'}, {'text': 'WBC number, glucose, total protein and LDH concentration in the exudates from of three types, tuberculous, pneumonia and adenocarcinoma effusions, were determined ( Table 2 ). The data show that all of WBC number, glucose and LDH concentration determinations among the three exudative effusions were insignificantly different. ', 'cite_spans': [], 'ref_spans': [{'start': 165, 'end': 172, 'text': 'Table 2', 'ref_id': 'TABREF1'}], 'section': 'WBC and biochemical assay in exudates from patients with different diseases'}, {'text': 'Elevated ACE activity and an elevated ACE/ACE2 ratio were observed in exudative effusions. We then differentiated both ACE and ACE2 activities in the exudates according to different diseases, including tuberculosis, pneumonia, and adenocarcinoma. The ACE activity in the tuberculous pleural effusions was significantly higher than in pneumonia and adenocarcinoma effusions, by 2.89 (p < 0.001) and 2.62 (p < 0.001) fold, respectively ( Figure  4A ). In contrast, ACE2 activity in the tuberculous effusions was significantly lower than in pneumonia and adenocarcinoma effusions, by 0.68 (p < 0.05) and 0.58 (p < 0.05) fold, respectively ( Figure 4B ). According to the changes we detected in ACE and ACE2, a significantly higher difference in the ACE/ACE2 ratio in tuberculous effusions (1.72 (1.09-2.52)) compared with ratios in pneumonia (0.32 (0.20-0.50)) and adenocarcinoma (0.43 (0.26-0.67)) effusions was also observed (p < 0.001) ( Figure 4C ).', 'cite_spans': [], 'ref_spans': [{'start': 436, 'end': 446, 'text': 'Figure  4A', 'ref_id': 'FIGREF4'}, {'start': 638, 'end': 647, 'text': 'Figure 4B', 'ref_id': 'FIGREF4'}, {'start': 938, 'end': 947, 'text': 'Figure 4C', 'ref_id': 'FIGREF4'}], 'section': 'ACE and ACE2 activities in exudates from patients with different diseases'}, {'text': 'The pleural ACE and ACE2 activities among transudates, tuberculosis, pneumonia and adenocar-cinoma were compared. The ACE and ACE2 activities in transudates, tuberculous, pneumonia and adenocarcinoma effusions were 0.67 ± 0.52, 2.16 ± 0.97, 0.74 ± 0.77 and 0.82 ± 0.43 RFU/hour/ml, and 2.19 ± 1.31, 1.38 ± 0.58, 2.05 ± 1.40 and 2.38 ± 1.86 RFU/hour/ml, respectively. It is noted that both of ACE and ACE2 activities in pneumonia and adenocarcinoma effusions were similar to the activities in transudative effusions.', 'cite_spans': [], 'ref_spans': [], 'section': 'ACE and ACE2 activities in exudates from patients with different diseases'}, {'text': 'The MMP-2 and MMP-9 activities in exudative effusions from the patients with different diseases were assayed by gelatin zymography (Figure 5 ). In tuberculous pleural effusions, MMP-2 activity was 1.48 (p < 0.01) and 1.36 fold (p < 0.05) higher than MMP-2 activity in pneumonia and adenocarcinoma effusions, respectively ( Figure 5A ). Similar to MMP-2, MMP-9 activity in tuberculous effusions was significantly higher than MMP-9 activity in pneumonia and adenocarcinoma effusions by 1.62 (p < 0.01) and 1.77 fold (p < 0.01), respectively ( Figure 5B ). ', 'cite_spans': [], 'ref_spans': [{'start': 131, 'end': 140, 'text': '(Figure 5', 'ref_id': 'FIGREF5'}, {'start': 323, 'end': 332, 'text': 'Figure 5A', 'ref_id': 'FIGREF5'}, {'start': 541, 'end': 550, 'text': 'Figure 5B', 'ref_id': 'FIGREF5'}], 'section': 'MMP-2 and MMP-9 activities in exudates from patients with different diseases'}, {'text': 'In the present study, major components of RAS and extracellular matrix (ECM) metabolism, pleural ACE, ACE2, MMP-2, and MMP-9, were measured in patients with pleural effusions. Our main findings are: (1) significantly higher the ACE, MMP-9 activity and ACE/ACE2 ratio in exudative effusions; (2) increased MMP-9 and ACE activities combined with decreased ACE2 activity in tuberculous effusion compared to pneumonia and adenocarcinoma effusions. The increased MMP-9 activity found in tuberculous effusion is in agreement with previous reports [9, 14, 15] . Herein, we first report that the changes of ACE and ACE2 activity are associated with tuberculous pleurisy.', 'cite_spans': [{'start': 541, 'end': 544, 'text': '[9,', 'ref_id': 'BIBREF8'}, {'start': 545, 'end': 548, 'text': '14,', 'ref_id': 'BIBREF13'}, {'start': 549, 'end': 552, 'text': '15]', 'ref_id': 'BIBREF14'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Only a few reports have been published on the importance of ACE in pleural fluid. ACE could be detected in pleural fluid, but the ACE level cannot be used to discriminate cancer from non-cancer patients [16, 17] . Söderblom et al. [18] had also measured ACE in pleural effusions and sera of 364 patients and showed that tuberculous effusions contain higher ACE concentrations than any other type of non-rheumatoid effusions. These results indicate that ACE determinations may aid in differentiating rheumatoid and tuberculous pleurisy from other types of pleural disease.', 'cite_spans': [{'start': 203, 'end': 207, 'text': '[16,', 'ref_id': 'BIBREF15'}, {'start': 208, 'end': 211, 'text': '17]', 'ref_id': 'BIBREF16'}, {'start': 231, 'end': 235, 'text': '[18]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'In the present study, we reported the change in ACE2 activity in pleural effusions. Some of the physiological functions of ACE2 are opposite to those of ACE. The significant positive correlation between ACE and ACE2 activities in the transudates suggests that ACE and ACE2 maintain a normal physiological balance. This loss of balance in exudates was detected because of increased ACE. Although the importance of the dysregulation in ACE in exudative effusions has not been explored, a significant role for RAS in the pathophysiological process of exudate development is possible.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'ACE activity was increased (p < 0.001) and ACE2 was decreased (p < 0.05) in tuberculosis specifically, but the ACE and ACE2 activities were no difference between transudate, pneumonia and adenocarcinoma effusions. These results indicated that ACE and ACE2 maybe a biomarker for tuberculosis diagnosis in pleural effusion and it could be emphasized that the increased ACE activity and ratio of ACE/ACE2 in the exudates are mainly contributed from a higher ACE level and lower ACE2 enzyme activities in the tuberculous pleural effusion. In an advanced assay, our data show that the ACE activity of 85% (17/20), 19% (6/32), 18% (5/28) and 18% (8/45) pleural fluids isolated tuberculosis, pneumonia, adenocarcinoma and transudates was > 1 RFU/hour/ml, respectively. It is also indicated that the increased ACE activity found in the exudates are mainly contributed from a higher ACE activity in the tuberculous pleural effusion.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The ACE2 activity in tuberculous, pneumonia and adenocarcinoma effusions were 1.38 ± 0.58, 2.05 ± 1.40 and 2.38 ± 1.86 RFU/hour/ml (mean ± SD), respectively. Although a larger SD was determined in the pneumonia and adenocarcinoma groups, the ACE2 activity in both groups were significantly larger than that in the tuberculosis group (p < 0.05). In advanced assay, the data indicate that there were 75% tuberculosis (15/20) , 56% pneumonia (18/32) and 50% adenocarcinoma (14/28) patients showed the ACE2 activity \\uf0a3 1.80 RFU/hour/ml (75% of interquartile range in tuberculous effusions; IQR, 0.97-1.80). The data also support that the trend of decreased ACE2 activity in the pleural effusions with tuberculosis compared to those with pneumonia or adenocarcinoma. However, more patients should be further included in order to examine the proposition.', 'cite_spans': [{'start': 415, 'end': 422, 'text': '(15/20)', 'ref_id': None}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'It is interesting that significantly increased ACE activity combined with markedly decreased ACE2 activity was measured in tuberculous effusions. This result confirms that abnormal RAS metabolism in pleural spaces may be related to tuberculous pleurisy. It was reported that overexpression of ACE2 may inhibit MMP-9 activity [19] , and ACE2 deficiency leads to increased MMP-9 levels [20] . In inflammatory signalling pathways study, Ang II could stimulate human monocytic U-937 cells to increase MMP-9 expression and activity significantly via activated NF-κB, JNK, and p38 [21] . The ACE inhibitor, captopril, was administrated to isoprenaline-induced left ventricular fibrosis rats and showed that captopril significantly enhanced the isoprenaline-induced myocardial fibrosis and augmented the isoprenaline-induced MMP-9 expression [22] . In addition, ACE2 and Ang 1-7, the regulators in RAS opposed Ang II effect, could affect MMP-9 expression. Overexpression of ACE2 reduces the invasive ability in vitro according to the down-regulation of MMP-2 and MMP-9 [23] . Ang 1-7 revealed the anti-migration and anti-invasion effect mediated through inactivation of the PI3K/Akt, P38 and JNK signal pathways to reduce the expression and activity of MMP-2 and MMP-9 [24] . According to our results, we conclude that reduction in ACE2 along with induction of MMP-9 activity occurred. Our observations of decreased ACE2 and increased MMP-9 activity in tuberculous effusions confirm this conclusion.', 'cite_spans': [{'start': 325, 'end': 329, 'text': '[19]', 'ref_id': 'BIBREF18'}, {'start': 384, 'end': 388, 'text': '[20]', 'ref_id': 'BIBREF19'}, {'start': 575, 'end': 579, 'text': '[21]', 'ref_id': 'BIBREF20'}, {'start': 835, 'end': 839, 'text': '[22]', 'ref_id': 'BIBREF21'}, {'start': 1062, 'end': 1066, 'text': '[23]', 'ref_id': 'BIBREF22'}, {'start': 1262, 'end': 1266, 'text': '[24]', 'ref_id': 'BIBREF23'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'A number of studies have indicated that the ACE-Ang II axis and ACE2-Ang1-7 axis not only regulate the metabolism of ECM proteins, but also modulate MMP expression and activity levels [8] . MMPs have been implicated in the pathogenesis of various lung diseases, including pleural effusions [25, 26] . The activity of MMPs within the pleural space may play a role in the formation of pleural effusions by altering the integrity of the mesothelial and endothelial cell layers and by increasing vascular permeability [10, 27] . Proteolysis by MMPs may be involved in the formation of pleural effusions by increasing vascular permeability, and thus by facilitating fluid influx into the pleural space [28] . Therefore, the presence and enzymatic activities of MMPs have been identified in pleural effusions [15, 25, 29] . Previous studies have shown that the expression of MMPs in the pleural space is altered in a variety of inflammatory and malignant diseases, suggesting that certain members of the MMP family may participate in the formation of pleural effusions [10, 15, 29] . Tissue damage is a characteristic manifestation of Mycobacterium tuberculosis infection. Proteolysis by macrophage-secreted proteases has been implicated in such destructive processes. In this regard, the proteolytic action of MMPs may be involved in the pathogenesis of tuberculosis, like many other diseases associated with tissue destruction. Several studies have reported that macrophages and monocytes release MMP-9 in response to tuberculosis or its cellular components [30, 31] . Studies have evaluated MMPs in tuberculous pleural effusions and found that the MMP activity in pleural fluid are higher in patients with tuberculosis compared with patients with transudative effusions [10, 32] . Our results are in agreement with the above findings, as the MMP-9 activity was highest in tuberculous effusions among the exudates we examined.', 'cite_spans': [{'start': 184, 'end': 187, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 290, 'end': 294, 'text': '[25,', 'ref_id': 'BIBREF24'}, {'start': 295, 'end': 298, 'text': '26]', 'ref_id': 'BIBREF25'}, {'start': 514, 'end': 518, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 519, 'end': 522, 'text': '27]', 'ref_id': 'BIBREF26'}, {'start': 697, 'end': 701, 'text': '[28]', 'ref_id': 'BIBREF27'}, {'start': 803, 'end': 807, 'text': '[15,', 'ref_id': 'BIBREF14'}, {'start': 808, 'end': 811, 'text': '25,', 'ref_id': 'BIBREF24'}, {'start': 812, 'end': 815, 'text': '29]', 'ref_id': 'BIBREF28'}, {'start': 1063, 'end': 1067, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 1068, 'end': 1071, 'text': '15,', 'ref_id': 'BIBREF14'}, {'start': 1072, 'end': 1075, 'text': '29]', 'ref_id': 'BIBREF28'}, {'start': 1554, 'end': 1558, 'text': '[30,', 'ref_id': 'BIBREF29'}, {'start': 1559, 'end': 1562, 'text': '31]', 'ref_id': 'BIBREF30'}, {'start': 1767, 'end': 1771, 'text': '[10,', 'ref_id': 'BIBREF9'}, {'start': 1772, 'end': 1775, 'text': '32]', 'ref_id': 'BIBREF31'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'The present study is the first report about the ACE/ACE2 ratio in tuberculosis diagnosis. Although increased ACE and MMP-9 could be specifically determined in the tuberculous effusion. There are still few concerns should be addressed using ACE and MMP-9 as biomarker for tuberculosis diagnosis, because (1) elevated ACE levels may also be seen in several other cardiovascular disorders, and (2) MMP-9 is an inflammation-induced target in several cases [33] . In the RAS, ACE2/Ang-(1-7) axis has been recently highlighted as the counter balancing arm of the RAS to the ACE/Ang II axis. The regulatory mechanisms focused on the alternating ACE and ACE2 regulation are still lack; therefore, the mechanism of reduced ACE2 found in the pleural effusion of patients with tuberculosis remains to be further explored.', 'cite_spans': [{'start': 452, 'end': 456, 'text': '[33]', 'ref_id': 'BIBREF32'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Our data suggest that the interplay between ACE and ACE2, an essential function in RAS, and the change in gelatinase activity may be involved in the development of pleural effusions. Our findings suggest that increased ACE and MMP-9 activities and decreased ACE2 activity in pleural fluid are features of pleural space infection in patients with pleural tuberculosis. Such measurements may be helpful for diagnosing tuberculous pleurisy. However, the findings of the present study require further validation in a large prospective study examining the treatment and outcome of unselected patients with tuberculosis before the above indicators can become part of a clinically meaningful practice.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusion'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': 'Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy', 'authors': [{'first': 'L', 'middle': [], 'last': 'Valdés', 'suffix': ''}, {'first': 'San', 'middle': [], 'last': 'José', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Alvarez', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': '', 'suffix': ''}], 'year': 1996, 'venue': 'Eur Respir J', 'volume': '9', 'issn': '', 'pages': '747--51', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': 'The pulmonary renin-angiotensin system', 'authors': [{'first': 'R', 'middle': ['P'], 'last': 'Marshall', 'suffix': ''}], 'year': 2003, 'venue': 'Curr Pharm Design', 'volume': '9', 'issn': '', 'pages': '715--737', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin', 'authors': [{'first': 'R', 'middle': ['M'], 'last': 'Wösten-Van Asperen', 'suffix': ''}, {'first': 'R', 'middle': [], 'last': 'Lutter', 'suffix': ''}, {'first': 'J', 'middle': ['J'], 'last': 'Haitsma', 'suffix': ''}], 'year': 2008, 'venue': 'Eur Respir J', 'volume': '31', 'issn': '', 'pages': '363--71', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation', 'authors': [{'first': 'C', 'middle': ['L'], 'last': 'Chen', 'suffix': ''}, {'first': 'Sks', 'middle': [], 'last': 'Huang', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Lin', 'suffix': ''}], 'year': 2008, 'venue': 'J Mol Cell Cardiol', 'volume': '45', 'issn': '', 'pages': '742--53', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury', 'authors': [{'first': 'K', 'middle': [], 'last': 'Kuba', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Imai', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Rao', 'suffix': ''}], 'year': 2005, 'venue': 'Nat Med', 'volume': '11', 'issn': '', 'pages': '875--79', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': 'Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Imai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kuba', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Ohto-Nakanishi', 'suffix': ''}], 'year': 2010, 'venue': 'Circ J', 'volume': '74', 'issn': '', 'pages': '405--415', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': 'Angiotensin (1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart', 'authors': [{'first': 'C', 'middle': [], 'last': 'Mercure', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Yogi', 'suffix': ''}, {'first': 'G', 'middle': ['E'], 'last': 'Callera', 'suffix': ''}], 'year': 2008, 'venue': 'Circ Res', 'volume': '103', 'issn': '', 'pages': '1319--1345', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Interplay of angiotensin II and angiotensin 1-7 in the regulations of matrix metalloproteinases of human cardiocytes', 'authors': [{'first': 'C', 'middle': ['H'], 'last': 'Pan', 'suffix': ''}, {'first': 'C', 'middle': ['H'], 'last': 'Wen', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Lin', 'suffix': ''}], 'year': 2008, 'venue': 'Exp Physiol', 'volume': '93', 'issn': '', 'pages': '599--612', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions', 'authors': [{'first': 'D', 'middle': [], 'last': 'Iglesias', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Alegre', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Alemán', 'suffix': ''}], 'year': 2005, 'venue': 'Eur Respir J', 'volume': '25', 'issn': '', 'pages': '104--113', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration', 'authors': [{'first': 'K', 'middle': ['J'], 'last': 'Park', 'suffix': ''}, {'first': 'S', 'middle': ['C'], 'last': 'Hwang', 'suffix': ''}, {'first': 'S', 'middle': ['S'], 'last': 'Sheen', 'suffix': ''}], 'year': 2005, 'venue': '', 'volume': '72', 'issn': '', 'pages': '166--75', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': 'Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions. Respiration', 'authors': [{'first': 'S', 'middle': [], 'last': 'Oikonomidi', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Kostikas', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Kalomenidis', 'suffix': ''}], 'year': 2010, 'venue': '', 'volume': '80', 'issn': '', 'pages': '285--91', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': 'Pleural effusions: the diagnostic separation of transudates and exudates', 'authors': [{'first': 'R', 'middle': ['W'], 'last': 'Light', 'suffix': ''}, {'first': 'M', 'middle': ['I'], 'last': 'Macgregor', 'suffix': ''}, {'first': 'P', 'middle': ['C'], 'last': 'Luchsinger', 'suffix': ''}], 'year': 1972, 'venue': 'Ann Intern Med', 'volume': '77', 'issn': '', 'pages': '507--520', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'ACE and ACE2 activity in diabetic mice', 'authors': [{'first': 'J', 'middle': [], 'last': 'Wysocki', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Ye', 'suffix': ''}, {'first': 'M', 'middle': ['J'], 'last': 'Soler', 'suffix': ''}], 'year': 2006, 'venue': 'Diabetes', 'volume': '5', 'issn': '', 'pages': '2132--2171', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?', 'authors': [{'first': 'A', 'middle': [], 'last': 'Trajman', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Pai', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Dheda', 'suffix': ''}], 'year': 2008, 'venue': 'Eur Respir J', 'volume': '31', 'issn': '', 'pages': '1098--106', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation', 'authors': [{'first': 'P', 'middle': [], 'last': 'Sheen', 'suffix': ''}, {'first': 'C', 'middle': ['M'], 'last': 'O&apos;kane', 'suffix': ''}, {'first': 'K', 'middle': [], 'last': 'Chaudhary', 'suffix': ''}], 'year': 2009, 'venue': 'Eur Respir J', 'volume': '33', 'issn': '', 'pages': '134--175', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Levels of angiotensin-converting enzyme in pleural effusion', 'authors': [{'first': 'C', 'middle': ['W'], 'last': 'Bedrossian', 'suffix': ''}, {'first': 'D', 'middle': ['A'], 'last': 'Stein', 'suffix': ''}, {'first': 'W', 'middle': ['C'], 'last': 'Miller', 'suffix': ''}], 'year': 1981, 'venue': 'Arch Pathol Lab Med', 'volume': '105', 'issn': '', 'pages': '345--351', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Activity of angiotensin-converting enzyme in pleural fluid and serum in non-sarcoid, non-tuberculous pleural effusion', 'authors': [{'first': 'F', 'middle': ['K'], 'last': 'Rømer', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Geday', 'suffix': ''}], 'year': 1982, 'venue': 'Eur J Respir Dis', 'volume': '63', 'issn': '', 'pages': '102--108', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis', 'authors': [{'first': 'T', 'middle': [], 'last': 'Söderblom', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Nyberg', 'suffix': ''}, {'first': 'T', 'middle': [], 'last': 'Pettersson', 'suffix': ''}], 'year': 1996, 'venue': 'Respiration', 'volume': '63', 'issn': '', 'pages': '272--278', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis', 'authors': [{'first': 'B', 'middle': [], 'last': 'Dong', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Zhang', 'suffix': ''}, {'first': 'J', 'middle': ['B'], 'last': 'Feng', 'suffix': ''}], 'year': 2008, 'venue': 'Arterioscler Thromb Vasc Biol', 'volume': '28', 'issn': '', 'pages': '1270--1276', 'other_ids': {}}, 'BIBREF19': {'ref_id': 'b19', 'title': 'Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47 (phox) NADPH oxidase subunit', 'authors': [{'first': 'S', 'middle': [], 'last': 'Bodiga', 'suffix': ''}, {'first': 'J', 'middle': ['C'], 'last': 'Zhong', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Wang', 'suffix': ''}], 'year': 2011, 'venue': 'Cardiovasc Res', 'volume': '91', 'issn': '', 'pages': '151--61', 'other_ids': {}}, 'BIBREF20': {'ref_id': 'b20', 'title': 'Angiotensin II induces NF-κB, JNK and p38 MAPK activation in monocytic cells and increases matrix metalloproteinase-9 expression in a PKC-andRho kinase-dependent manner', 'authors': [{'first': 'H', 'middle': [], 'last': 'Yaghooti', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Firoozrai', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Fallah', 'suffix': ''}], 'year': 2011, 'venue': 'Braz J Med Biol Res', 'volume': '44', 'issn': '', 'pages': '193--202', 'other_ids': {}}, 'BIBREF21': {'ref_id': 'b21', 'title': 'Effects of captopril and telmisartan on matrix metalloproteinase-2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats', 'authors': [{'first': 'M', 'middle': [], 'last': 'Okada', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Kosaka', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Hoshino', 'suffix': ''}], 'year': 2010, 'venue': 'Biol Pharm Bull', 'volume': '33', 'issn': '', 'pages': '1517--1538', 'other_ids': {}}, 'BIBREF22': {'ref_id': 'b22', 'title': 'Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro', 'authors': [{'first': 'Y', 'middle': [], 'last': 'Feng', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Ni', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wan', 'suffix': ''}], 'year': 2011, 'venue': 'Oncol Rep', 'volume': '26', 'issn': '', 'pages': '1157--64', 'other_ids': {}}, 'BIBREF23': {'ref_id': 'b23', 'title': 'Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways', 'authors': [{'first': 'L', 'middle': [], 'last': 'Ni', 'suffix': ''}, {'first': 'Y', 'middle': [], 'last': 'Feng', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Wan', 'suffix': ''}], 'year': 2012, 'venue': 'Oncol Rep', 'volume': '27', 'issn': '', 'pages': '783--90', 'other_ids': {}}, 'BIBREF24': {'ref_id': 'b24', 'title': 'MMP and TIMP expression pattern in pleural effusions of different origins', 'authors': [{'first': 'O', 'middle': [], 'last': 'Eickelberg', 'suffix': ''}, {'first': 'C', 'middle': ['O'], 'last': 'Sommerfeld', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'Wyser', 'suffix': ''}], 'year': 1997, 'venue': 'Am J Resp Crit Care', 'volume': '156', 'issn': '', 'pages': '1987--92', 'other_ids': {}}, 'BIBREF25': {'ref_id': 'b25', 'title': 'MMP expression and abnormal lung permeability are important determinants of outcome in IPF', 'authors': [{'first': 'S', 'middle': [], 'last': 'Mckeown', 'suffix': ''}, {'first': 'A', 'middle': ['G'], 'last': 'Richter', 'suffix': ''}, {'first': 'C', 'middle': [], 'last': 'O&apos;kane', 'suffix': ''}], 'year': 2009, 'venue': 'Eur Respir J', 'volume': '33', 'issn': '', 'pages': '77--84', 'other_ids': {}}, 'BIBREF26': {'ref_id': 'b26', 'title': 'Pathophysiology of the pleura', 'authors': [{'first': 'M', 'middle': ['A'], 'last': 'Jantz', 'suffix': ''}, {'first': 'Antony', 'middle': [], 'last': 'Vb', 'suffix': ''}], 'year': 2008, 'venue': 'Respiration', 'volume': '75', 'issn': '', 'pages': '121--154', 'other_ids': {}}, 'BIBREF27': {'ref_id': 'b27', 'title': 'Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase a activation and cell proliferation', 'authors': [{'first': 'S', 'middle': [], 'last': 'Zucker', 'suffix': ''}, {'first': 'H', 'middle': [], 'last': 'Mirza', 'suffix': ''}, {'first': 'C', 'middle': ['E'], 'last': 'Conner', 'suffix': ''}], 'year': 1998, 'venue': 'Int J Cancer', 'volume': '75', 'issn': '', 'pages': '780--786', 'other_ids': {}}, 'BIBREF28': {'ref_id': 'b28', 'title': 'Human pleural effusions are rich in matrix metalloproteinases', 'authors': [{'first': 'A', 'middle': ['N'], 'last': 'Hurewitz', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Zucker', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Mancuso', 'suffix': ''}], 'year': 1992, 'venue': 'Chest', 'volume': '102', 'issn': '', 'pages': '1808--1822', 'other_ids': {}}, 'BIBREF29': {'ref_id': 'b29', 'title': 'Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis', 'authors': [{'first': 'J', 'middle': ['S'], 'last': 'Friedland', 'suffix': ''}, {'first': 'T', 'middle': ['C'], 'last': 'Shaw', 'suffix': ''}, {'first': 'N', 'middle': ['M'], 'last': 'Price', 'suffix': ''}], 'year': 2002, 'venue': 'Matrix Biol', 'volume': '21', 'issn': '', 'pages': '103--113', 'other_ids': {}}, 'BIBREF30': {'ref_id': 'b30', 'title': 'tuberculosis induction of matrix metalloproteinase-9: The role of mannose and receptor-mediated mechanisms', 'authors': [{'first': 'C', 'middle': ['A'], 'last': 'Rivera-Marrero', 'suffix': ''}, {'first': 'W', 'middle': [], 'last': 'Schuyler', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Roser', 'suffix': ''}], 'year': 2002, 'venue': 'Am J Physiol Lung Cell Mol Physiol', 'volume': '82', 'issn': '', 'pages': '546--55', 'other_ids': {}}, 'BIBREF31': {'ref_id': 'b31', 'title': 'Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis', 'authors': [{'first': 'G', 'middle': [], 'last': 'Hoheisel', 'suffix': ''}, {'first': 'U', 'middle': [], 'last': 'Sack', 'suffix': ''}, {'first': 'D', 'middle': ['S'], 'last': 'Hui', 'suffix': ''}], 'year': 2001, 'venue': 'Tuberculosis', 'volume': '81', 'issn': '', 'pages': '203--212', 'other_ids': {}}, 'BIBREF32': {'ref_id': 'b32', 'title': 'Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis', 'authors': [{'first': 'M', 'middle': ['E'], 'last': 'Muroski', 'suffix': ''}, {'first': 'M', 'middle': ['D'], 'last': 'Roycik', 'suffix': ''}, {'first': 'R', 'middle': ['G'], 'last': 'Newcomer', 'suffix': ''}], 'year': 2008, 'venue': 'Curr Pharm Biotechnol', 'volume': '9', 'issn': '', 'pages': '34--46', 'other_ids': {}}}, 'ref_entries': {'FIGREF0': {'text': 'ACE and ACE2 activities were assayed with the fluorogenic substrates Mca-YVADAPK and Mca-APK-Dnp (AnaSpec, San Jose, CA, USA), respectively, according to Wysocki et al. with slight modifications', 'latex': None, 'type': 'figure'}, 'FIGREF1': {'text': 'Enzymatic activity of ACE and ACE2 in pleural transudative and exudative effusions. The specific activities of ACE (A) and ACE2 (B) in pleural transudative (n = 45) and exudative (n = 80) effusions from 125 patients. The ratio of ACE/ACE2 in the pleural effusions (C). Pleural effusion (20 μl) was assayed for the ability to cleave the fluorescent substrate at 37°C for 1 hour with a specific ACE inhibitor or a specific ACE2 inhibitor. Each symbol represents one individual, and horizontal bars represent median values. ** and *** indicate p < 0.01 and p < 0.001, respectively, compared with transudates.', 'latex': None, 'type': 'figure'}, 'FIGREF2': {'text': \"Correlations between ACE and ACE2 activities in pleural effusions. ACE and ACE2 activities were measured in each sample of pleural transudative effusions (A; n = 45) and exudative effusions (B; n = 80). For correlation analysis, Pearson's correlation analysis (SPSS statistics package, Chicago, IL) was applied. Statistically significant differences were established at p < 0.05. ACE and ACE2 positively correlate with each other in the group of transudative effusions (F(1,43) = 36.052, r 2 = 0.456, p < 0.001) (A), but not in the group of exudative effusions (F(1,78) = 1.567, r 2 = 0.020, p > 0.05) (B).\", 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'MMP-2 and MMP-9 activities in pleural transudative and exudative effusions. The activities of MMP-2 (A) and MMP-9 (B) in pleural transudative and exudative effusions from 125 patients were determined with zymography. The gelatinase activities detected in this study were based on pro-MMP-2 (72 kDa) and pro-MMP-9 (95 kDa). Each symbol represents one individual, and horizontal bars represent median values. *** indicates p < 0.001 compared with transudates.', 'latex': None, 'type': 'figure'}, 'FIGREF4': {'text': 'ACE and ACE2 activities in exudative effusions from patients with tuberculosis (TB), pneumonia (Pn), and adenocarcinoma (Ad). The activities of ACE (A), ACE2 (B), and the ratio of ACE/ACE2 (C) in TB (n = 20), Pn (n = 32), and Ad (n = 28) effusions. Each symbol represents one individual, and horizontal bars represent median values. * and *** indicate p < 0.05 and p < 0.001, respectively, compared with values measured in Pn and/or Ad effusions.', 'latex': None, 'type': 'figure'}, 'FIGREF5': {'text': 'MMP-2 and MMP-9 activities in exudative effusions from patients with tuberculosis (TB), pneumonia (Pn), and adenocarcinoma (Ad). The activities of MMP-2 (A) and MMP-9 (B) in TB (n = 20), Pn (n = 32), and Ad (n = 28) effusions. The gelatinase activities detected in this study were based on pro-MMP-2 (72 kDa) and pro-MMP-9 (95 kDa). Each symbol represents one individual, and horizontal bars represent median values. * and ** indicate p < 0.05 and p < 0.01, respectively, compared with values measured in Pn and/or Ad effusions.', 'latex': None, 'type': 'figure'}, 'TABREF0': {'text': 'Pleural fluid characteristics of the study population.Transudates were from patients with heart failure or liver cirrhosis. Exudates were from patients with tuberculous, pneumonia, or adenocarcinoma effusions. Data are the means \\uf0b1 SD. *** indicates p < 0.001 compared with transudates.', 'latex': None, 'type': 'table'}, 'TABREF1': {'text': 'Pleural fluid characteristics of tuberculous, pneumonia and adenocarcinoma effusions.', 'latex': None, 'type': 'table'}}, 'back_matter': [{'text': 'We confirm and declare that all authors fulfilled the condition for authorship. There was no commercial support in the process of performing this study and submitting this manuscript.', 'cite_spans': [], 'ref_spans': [], 'section': 'Acknowledgements'}, {'text': 'The authors have declared that no competing interest exists.', 'cite_spans': [], 'ref_spans': [], 'section': 'Competing Interests'}]}\n",
      "{'_id': ObjectId('5f4ecb9a16816090440a75eb'), 'paper_id': '0d3de075e16c6d2e02c68e541b4d2654c78bea04', 'metadata': {'title': '', 'authors': [{'first': 'Giorgio', 'middle': [], 'last': 'Castellana', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': 'giorgiocastellana@virgilio.it'}, {'first': 'Vito', 'middle': [], 'last': 'Liotino', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}, {'first': 'Maria', 'middle': ['Rosaria'], 'last': 'Vulpi', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}, {'first': 'Ina', 'middle': [], 'last': 'Ali', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}, {'first': 'Lorenzo', 'middle': [], 'last': 'Marra', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}, {'first': 'Onofrio', 'middle': [], 'last': 'Resta', 'suffix': '', 'affiliation': {'laboratory': '', 'institution': 'University of Medicine \"Aldo Moro\"', 'location': {'settlement': 'Bari', 'country': 'Italy'}}, 'email': ''}]}, 'abstract': [{'text': 'Breathe | December 2017 | Volume 13 | No 4 317 Cite as: Castellana G, Liotino V, Vulpi MR, et al. Bilateral pulmonary nodules and acute respiratory failure in a 22-year-old man with dyspnoea and fever. Breathe 2017; 13: 317-322.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'Bilateral pulmonary nodules and acute respiratory failure in a 22-year-old man with dyspnoea and fever A 22-year-old white male presented complaining of a 3-week history of fatigue, cough and haemoptysis, accompanied by fever (38°C max), dyspnoea and mucopurulent sputum in the last few days. He denied nausea, vomiting, diarrhoea, dysuria and weight loss. He reported being a smoker (10 pack-years) and a cannabis user, and had a history of allergic rhinitis. He denied occupational exposures.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}, {'text': 'Before our evaluation, he received empiric antibiotic therapy for 5 days, which resulted in the abatement of fever. Following the persistence of dyspnoea and haemoptysis, he had chest radiography with multiple nodular opacities associated with pleural effusion on the left (figure 1) and lung ultrasound (US) with a convex probe showing multiple hypoechoic, bilateral foci associated with B-lines and bilateral pleural effusion, mainly on the left.', 'cite_spans': [], 'ref_spans': [], 'section': 'Abstract'}], 'body_text': [{'text': 'On our examination, he had no fever. On auscultation, a widespread reduced vesicular murmur and basilar rales in the left lung were found. On palpation, there was inguinal lymphadenopathy. The remainder of the physical examination was unremarkable.', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 1 Chest radiograph showing bilateral nodular opacities with a lower zone predominance, interstitial thickening and pleural effusion on the left.'}, {'text': 'Oxygen saturation by pulse oximetry was 93% on room air and blood gas analysis showed a mild hypoxaemia, with an arterial oxygen tension (PaO 2 ) of 61 mmHg with respiratory alkalosis (pH 7.46, carbon dioxide tension 32 mmHg and bicarbonate 23.2 mmol⋅L −1 ), and therefore with a standard PaO 2 of 48 mmHg.', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 1 Chest radiograph showing bilateral nodular opacities with a lower zone predominance, interstitial thickening and pleural effusion on the left.'}, {'text': 'Laboratory findings were as follows: white blood cell count of 4140 per μL (54.6% neutrophils, 23.1% lymphocytes and 20.8% monocytes), haemoglobin 13.3 g⋅dL −1 , thrombocytopenia (123 000 per μL), increased serum inflammatory markers (erythrocyte sedimentation rate 17 mm⋅h −1 , C-reactive protein 18.4 mg⋅L −1 , α 2 -globulin 12.8%, γ-globulin 19.8%, procalcitonin 0.49 ng⋅mL −1 and presepsin 275 pg⋅mL −1 ), hypoalbuminaemia (3.1 g⋅dL −1 ), serum iron and ferritin arrangement of chronic disease (serum iron 63 μg⋅dL −1 and ferritin 553 ng⋅dL −1 ), slight increase in alanine aminotransferase (48 U⋅L −1 ), and direct bilirubin (0.23 mg⋅dL −1 ). Renal function and coagulation were in the normal range.', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 1 Chest radiograph showing bilateral nodular opacities with a lower zone predominance, interstitial thickening and pleural effusion on the left.'}, {'text': 'What would be your further investigations for a patient with these features?', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 1'}, {'text': 'Bilateral pulmonary nodules and acute respiratory failure', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 1'}, {'text': 'The patient underwent empirical antibiotic therapy and total-body CT; microbiological tests (of respiratory, blood and urinary samples) were required. Total-body CT showed bilateral pulmonary infiltrate with a pseudonodular aspect, with a tendency toward confluence and surrounded by a ground-glass halo, associated with irregular interlobular interstitial thickening and bilateral pleural effusion. Lymph nodes (LNs) with a colliquative aspect were in the epiaortic, subcarinal, hilar and Barety regions with the maximum diameter of 33 mm (figure 2). LNs with increased volume were also observed also in the laterocervical, axillary, mesenteric, iliac, lumbar and inguinal regions. There were no abnormalities in the other abdominal and pelvic viscera.', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 1'}, {'text': 'What could be the differential diagnoses in the light of the CT report? ', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 2'}, {'text': 'Bronchoscopy was performed and showed a normal endobronchial mucosa. Biopsy was not performed because of hypoxaemia; however, microbiological and cytological examinations of bronchoalveolar lavage fluid were negative.', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 2 Chest CT (axial view) with parenchymal (a, c and d) and mediastinal windows (b). a) Upper lung fields: infiltrate with pseudonodular aspect, surrounded by a ground-glass halo (red arrow) and axillar lymph nodes (green arrows). b) Middle lung fields: mediastinal lymph nodes (green arrow). c and d) Lower lung fields: infiltrates with pseudonodular aspect with a tendency toward confluence (red arrows), interlobular interstitial thickening (orange arrow) and pleural effusion (blue arrows).'}, {'text': 'Other microbiological examinations searching for common bacteria, Mycobacterium tuberculosis, nontuberculous mycobacteria, viruses and fungi were negative, with the exception of: ', 'cite_spans': [], 'ref_spans': [], 'section': 'Figure 2 Chest CT (axial view) with parenchymal (a, c and d) and mediastinal windows (b). a) Upper lung fields: infiltrate with pseudonodular aspect, surrounded by a ground-glass halo (red arrow) and axillar lymph nodes (green arrows). b) Middle lung fields: mediastinal lymph nodes (green arrow). c and d) Lower lung fields: infiltrates with pseudonodular aspect with a tendency toward confluence (red arrows), interlobular interstitial thickening (orange arrow) and pleural effusion (blue arrows).'}, {'text': 'Tumour and autoimmune (antinuclear antibody and anti-neutrophil cytoplasmic antibody) markers were required.', 'cite_spans': [], 'ref_spans': [], 'section': 'IgG for Epstein-Barr virus and cytomegalovirus'}, {'text': 'What would be your next step?', 'cite_spans': [], 'ref_spans': [], 'section': 'Task 3'}, {'text': \"Infective disease, lymphoma, metastasis, autoimmune disease or Kaposi's sarcoma (KS) Bilateral pulmonary nodules and acute respiratory failure Consent for an HIV test was acquired and US examination of superficial LNs followed the haematological evaluation. US showed rounded lymphadenopathy with chaotic vascularisation in the right inguinal and left supraclavicular regions with maximum diameter of 21×13 mm and 17×10 mmn respectively. Surgical biopsy of the right inguinal lymph nodes was performed and the histological examination result was reported as a morphological aspect consistent with massive metastasis of KS (figure 3). On immunohistochemistry (IHC), diffuse positivity for HHV8 and CD34 was seen in the tumoural area, and that for factor VIII, actin and smooth muscle actin in the rich vasculature. At the same time, an HIV test was positive (HIV-1 gp120, gp41, p24 and p17 were detected), and a T-lymphocyte count in peripheral blood showed no CD4 + cells, and reduced counts of CD3 + and CD16/56 + CD3 − cells. Tumour markers and autoimmunity examinations were within normal range, except for CA-125 (71.5 U⋅mL −1 ) and α 2 -microglobulin (3.34 mg⋅L −1 ). During the hospitalisation, the patient had fever, which was initially intermittent then continuous, accompanied by deterioration of gas exchange, which prompted an increase in the oxygen therapy. In light of this clinical picture, a diagnosis of KS was made.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Answer 2'}, {'text': 'Definition KS is a slowly growing, multicentric, angioproliferative tumour associated with human herpesvirus (HHV)8 infection [1] . It is the most common tumour associated with HIV-1 infection; indeed, the incidence among patients infected with HIV is one in 20 [2, 3] . Four clinical variants of KS have been described: localisation occurs in 20-75% of cases, particularly in severely immunocompromised patients with low CD4 + counts, with involvement of the lung parenchyma, pleura, LNs and airways [6] [7] [8] [9] . Reports of isolated pulmonary disease have rarely appeared in the literature (0-16% of cases) [6, 7] .', 'cite_spans': [{'start': 126, 'end': 129, 'text': '[1]', 'ref_id': 'BIBREF0'}, {'start': 262, 'end': 265, 'text': '[2,', 'ref_id': 'BIBREF1'}, {'start': 266, 'end': 268, 'text': '3]', 'ref_id': 'BIBREF2'}, {'start': 501, 'end': 504, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 505, 'end': 508, 'text': '[7]', 'ref_id': 'BIBREF6'}, {'start': 509, 'end': 512, 'text': '[8]', 'ref_id': 'BIBREF7'}, {'start': 513, 'end': 516, 'text': '[9]', 'ref_id': 'BIBREF8'}, {'start': 613, 'end': 616, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 617, 'end': 619, 'text': '7]', 'ref_id': 'BIBREF6'}], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Pulmonary KS is associated with poor outcome, but highly active antiretroviral therapy has been shown to markedly improve the prognosis.', 'cite_spans': [], 'ref_spans': [], 'section': 'Discussion'}, {'text': 'Common symptoms are dry cough and dyspnoea [6] . Fever and haemoptysis can also be found. Typical radiological features are reticular opacities and parenchymal nodules with a bronchovascular distribution, especially in lower lung zones; consolidation; peribronchial cuffing; pleural effusion; and mediastinal lymphadenopathy [6] . However, chest radiography may be normal. A CT scan is more sensible and specific, and can show irregular, poorly defined nodules with speculated borders and peribronchovascular distribution, interstitial thickening and perinodular ground-glass halo signs (due to haemorrhage secondary to fragility of the neovascular tissue). Irregular narrowing of the bronchial lumen, interlobular septal thickening, air-space consolidation and pleural effusion may be associated with the aforementioned findings [6, 8] . Lymphadenopathy can be present in up to 30-35% of patients. The effusion can be transudative or exudative and is often haemorrhagic because of the vascular nature of the disease [10] .', 'cite_spans': [{'start': 43, 'end': 46, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 325, 'end': 328, 'text': '[6]', 'ref_id': 'BIBREF5'}, {'start': 830, 'end': 833, 'text': '[6,', 'ref_id': 'BIBREF5'}, {'start': 834, 'end': 836, 'text': '8]', 'ref_id': 'BIBREF7'}, {'start': 1017, 'end': 1021, 'text': '[10]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Clinical, radiological and bronchoscopic characteristics of pulmonary KS'}, {'text': 'Typical findings on bronchoscopy are red or purple maculopapular lesions that can narrow and obstruct the entire tracheobronchial tree. The identification of these lesions in the presence of classic radiographic involvement is sufficient to make diagnosis of pulmonary KS in the absence of evidence for opportunistic infections [11] .', 'cite_spans': [{'start': 328, 'end': 332, 'text': '[11]', 'ref_id': 'BIBREF10'}], 'ref_spans': [], 'section': 'Clinical, radiological and bronchoscopic characteristics of pulmonary KS'}, {'text': 'Biopsy may be needed when parenchymal lesions occur in the absence of endobronchial', 'cite_spans': [], 'ref_spans': [], 'section': 'Clinical, radiological and bronchoscopic characteristics of pulmonary KS'}, {'text': 'Haematological evaluation, HIV test and immune system assessment; US of peripheral lymph nodes in order to detect suspicious lymphadenopathies involvement [10] . However, the diagnostic yield of endobronchial biopsies varies between 26% and 60% in different studies, and there is high risk of bleeding, especially for centrally located lesions [12, 13] : the decision to obtain a biopsy must be carefully weighed.', 'cite_spans': [{'start': 155, 'end': 159, 'text': '[10]', 'ref_id': 'BIBREF9'}, {'start': 344, 'end': 348, 'text': '[12,', 'ref_id': 'BIBREF11'}, {'start': 349, 'end': 352, 'text': '13]', 'ref_id': 'BIBREF12'}], 'ref_spans': [], 'section': 'Answer 3'}, {'text': 'The histopathology of KS is nearly the same in all variants of disease. Advanced lesions consist of fascicles of spindle cells and vascular structure mixed with chronic infiltrates. On IHC, typical markers are CD31, CD34 and factor VIII-related antigen. Spindle cells express lymphatic markers such as LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1), VEGFR-3 (vascular endothelial growth factor receptor-3) and Prox-1 (Prospero-related homeobox-1). The most important test to distinguish KS from others KS-mimicking diseases is the identification of HHV8 within KS lesion cells by immunostaining for LANA-1 (or LNA-1) [10] .', 'cite_spans': [{'start': 630, 'end': 634, 'text': '[10]', 'ref_id': 'BIBREF9'}], 'ref_spans': [], 'section': 'Histopathological features'}, {'text': 'Pulmonary KS is often indistinguishable from other opportunistic lung diseases in patients with AIDS. The differential diagnosis of diffuse pulmonary nodules includes: infective disease (tuberculosis or nontuberculous mycobacterial infection, fungal infection, or septic emboli), neoplastic disease (metastasis, lymphoma or minimally invasive adenocarcinoma), sarcoidosis and other miscellaneous conditions (granulomatosis with polyangiitis, pulmonary alveolar microlithiasis and pulmonary amyloidosis). It is very important to evaluate the size and location of nodules, and the presence of cavities [14] [15] [16] [17] .', 'cite_spans': [{'start': 600, 'end': 604, 'text': '[14]', 'ref_id': 'BIBREF13'}, {'start': 605, 'end': 609, 'text': '[15]', 'ref_id': 'BIBREF14'}, {'start': 610, 'end': 614, 'text': '[16]', 'ref_id': 'BIBREF15'}, {'start': 615, 'end': 619, 'text': '[17]', 'ref_id': 'BIBREF16'}], 'ref_spans': [], 'section': 'Differential diagnosis'}, {'text': 'The halo sign has been described in fungal, mycobacterial and viral infections; inflammatory disease (granulomatosis with polyangiitis) and malignancy. In immunocompromised patients, this radiological finding suggests an infection (e.g. invasive aspergillosis) or, less commonly, pulmonary KS and lymphoproliferative disorders [18] .', 'cite_spans': [{'start': 327, 'end': 331, 'text': '[18]', 'ref_id': 'BIBREF17'}], 'ref_spans': [], 'section': 'Differential diagnosis'}, {'text': 'In patients with HIV infection, subcentimetre pulmonary nodules with centrilobular distribution and cavitation may suggest infective disease, whereas larger nodules can suggest malignancy [19] .', 'cite_spans': [{'start': 188, 'end': 192, 'text': '[19]', 'ref_id': 'BIBREF18'}], 'ref_spans': [], 'section': 'Differential diagnosis'}, {'text': \"Isolated intrathoracic KS is rarely seen. Moreover, in our case, the diagnosis was made more difficult by the lack of the patient's knowledge of his HIV infection. Clinical suspicion, accurate radiological description and multidisciplinary management were decisive in reaching a correct diagnosis.\", 'cite_spans': [], 'ref_spans': [], 'section': 'Conclusion'}], 'bib_entries': {'BIBREF0': {'ref_id': 'b0', 'title': \"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma\", 'authors': [{'first': 'Y', 'middle': [], 'last': 'Chang', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Cesarman', 'suffix': ''}, {'first': 'M', 'middle': ['S'], 'last': 'Pessin', 'suffix': ''}], 'year': 1994, 'venue': 'Science', 'volume': '266', 'issn': '', 'pages': '1865--1869', 'other_ids': {}}, 'BIBREF1': {'ref_id': 'b1', 'title': \"Kaposi's sarcoma in HIV-positive patients: the state of art in the HAART-era\", 'authors': [{'first': 'La', 'middle': [], 'last': 'Ferla', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Pinzone', 'suffix': ''}, {'first': 'M', 'middle': ['R'], 'last': 'Nunnari', 'suffix': ''}, {'first': 'G', 'middle': [], 'last': '', 'suffix': ''}], 'year': 2013, 'venue': 'Eur Rev Med Pharmacol Sci', 'volume': '17', 'issn': '', 'pages': '2354--2365', 'other_ids': {}}, 'BIBREF2': {'ref_id': 'b2', 'title': 'Epidemiology of AIDS related malignancies an international perspective', 'authors': [{'first': 'S', 'middle': ['M'], 'last': 'Mbulaiteye', 'suffix': ''}, {'first': 'D', 'middle': ['M'], 'last': 'Parkin', 'suffix': ''}, {'first': 'C', 'middle': ['S'], 'last': 'Rabkin', 'suffix': ''}], 'year': 2003, 'venue': 'Hematol Oncol Clin North Am', 'volume': '17', 'issn': '', 'pages': '673--696', 'other_ids': {}}, 'BIBREF3': {'ref_id': 'b3', 'title': 'Histological variants of cutaneous Kaposi sarcoma', 'authors': [{'first': 'W', 'middle': [], 'last': 'Grayson', 'suffix': ''}, {'first': 'L', 'middle': [], 'last': 'Pantanowitz', 'suffix': ''}], 'year': 2008, 'venue': 'Diagn Pathol', 'volume': '3', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF4': {'ref_id': 'b4', 'title': 'Imaging manifestations of Kaposi sarcoma', 'authors': [{'first': 'C', 'middle': ['S'], 'last': 'Restrepo', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Martínez', 'suffix': ''}, {'first': 'J', 'middle': ['A'], 'last': 'Lemos', 'suffix': ''}], 'year': 2006, 'venue': 'Radiographics', 'volume': '26', 'issn': '', 'pages': '1169--1185', 'other_ids': {}}, 'BIBREF5': {'ref_id': 'b5', 'title': \"The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma\", 'authors': [{'first': 'D', 'middle': ['M'], 'last': 'Aboulafia', 'suffix': ''}], 'year': 2000, 'venue': 'Chest', 'volume': '117', 'issn': '', 'pages': '1128--1145', 'other_ids': {}}, 'BIBREF6': {'ref_id': 'b6', 'title': \"Intrathoracic Kaposi's sarcoma: CT findings\", 'authors': [{'first': 'A', 'middle': ['M'], 'last': 'Khalil', 'suffix': ''}, {'first': 'M', 'middle': ['F'], 'last': 'Carette', 'suffix': ''}, {'first': 'J', 'middle': ['L'], 'last': 'Cadranel', 'suffix': ''}], 'year': 1995, 'venue': 'Chest', 'volume': '108', 'issn': '', 'pages': '1622--1626', 'other_ids': {}}, 'BIBREF7': {'ref_id': 'b7', 'title': 'Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology', 'authors': [{'first': 'T', 'middle': ['D'], 'last': 'Gasparetto', 'suffix': ''}, {'first': 'E', 'middle': [], 'last': 'Marchiori', 'suffix': ''}, {'first': 'S', 'middle': [], 'last': 'Lourenço', 'suffix': ''}], 'year': 2009, 'venue': 'Orphanet J Rare Dis', 'volume': '4', 'issn': '', 'pages': '', 'other_ids': {}}, 'BIBREF8': {'ref_id': 'b8', 'title': 'Pulmonary malignancies in the immunocompromised patient', 'authors': [{'first': 'J', 'middle': [], 'last': 'Cadranel', 'suffix': ''}, {'first': 'J', 'middle': [], 'last': 'Naccache', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Wislez', 'suffix': ''}], 'year': 1999, 'venue': 'Respiration', 'volume': '66', 'issn': '', 'pages': '289--309', 'other_ids': {}}, 'BIBREF9': {'ref_id': 'b9', 'title': 'A woman in her 30s with a past history of HIV disease presented with recurrent fever, night sweats, and small bilateral pulmonary nodules', 'authors': [{'first': 'H', 'middle': ['R'], 'last': 'Hashmi', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Niazi', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Adrish', 'suffix': ''}], 'year': 2016, 'venue': 'Chest', 'volume': '149', 'issn': '', 'pages': '177--182', 'other_ids': {}}, 'BIBREF10': {'ref_id': 'b10', 'title': \"Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory system\", 'authors': [{'first': 'J', 'middle': ['D'], 'last': 'Zibrak', 'suffix': ''}, {'first': 'R', 'middle': ['C'], 'last': 'Silvestri', 'suffix': ''}, {'first': 'P', 'middle': [], 'last': 'Costello', 'suffix': ''}], 'year': 1986, 'venue': 'Chest', 'volume': '90', 'issn': '', 'pages': '476--479', 'other_ids': {}}, 'BIBREF11': {'ref_id': 'b11', 'title': \"Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome: clinical, radiographic, and pathologic manifestations\", 'authors': [{'first': 'G', 'middle': ['U'], 'last': 'Meduri', 'suffix': ''}, {'first': 'D', 'middle': ['E'], 'last': 'Stover', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Lee', 'suffix': ''}], 'year': 1986, 'venue': 'Am J Med', 'volume': '81', 'issn': '', 'pages': '11--18', 'other_ids': {}}, 'BIBREF12': {'ref_id': 'b12', 'title': 'Diagnostic yield of fiberoptic bronchoscopy in evaluating solitary pulmonary nodules', 'authors': [{'first': 'W', 'middle': ['A'], 'last': 'Baaklini', 'suffix': ''}, {'first': 'M', 'middle': ['A'], 'last': 'Reinoso', 'suffix': ''}, {'first': 'A', 'middle': ['B'], 'last': 'Gorin', 'suffix': ''}], 'year': 2000, 'venue': 'Chest', 'volume': '117', 'issn': '', 'pages': '1049--1054', 'other_ids': {}}, 'BIBREF13': {'ref_id': 'b13', 'title': 'Diffuse pulmonary nodules', 'authors': [{'first': 'G', 'middle': [], 'last': 'Boitsios', 'suffix': ''}, {'first': 'A', 'middle': ['A'], 'last': 'Bankier', 'suffix': ''}, {'first': 'R', 'middle': ['L'], 'last': 'Eisenberg', 'suffix': ''}], 'year': 2010, 'venue': 'AJR Am J Roentgenol', 'volume': '194', 'issn': '', 'pages': '354--366', 'other_ids': {}}, 'BIBREF14': {'ref_id': 'b14', 'title': 'Pictorial essay: multinodular disease: a high-resolution CT scan diagnostic algorithm', 'authors': [{'first': 'S', 'middle': [], 'last': 'Raoof', 'suffix': ''}, {'first': 'A', 'middle': [], 'last': 'Amchentsev', 'suffix': ''}, {'first': 'I', 'middle': [], 'last': 'Vlahos', 'suffix': ''}], 'year': 2006, 'venue': 'Chest', 'volume': '129', 'issn': '', 'pages': '805--815', 'other_ids': {}}, 'BIBREF15': {'ref_id': 'b15', 'title': 'Centrilobular opacities in the lung on high-resolution CT: diagnostic considerations and pathologic correlation', 'authors': [{'first': 'J', 'middle': ['F'], 'last': 'Gruden', 'suffix': ''}, {'first': 'W', 'middle': ['R'], 'last': 'Webb', 'suffix': ''}, {'first': 'M', 'middle': [], 'last': 'Warnock', 'suffix': ''}], 'year': 1994, 'venue': 'AJR Am J Roentgenol', 'volume': '162', 'issn': '', 'pages': '569--574', 'other_ids': {}}, 'BIBREF16': {'ref_id': 'b16', 'title': 'Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society', 'authors': [{'first': 'H', 'middle': [], 'last': 'Macmahon', 'suffix': ''}, {'first': 'D', 'middle': ['P'], 'last': 'Naidich', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Goo', 'suffix': ''}], 'year': 2017, 'venue': 'Radiology', 'volume': '284', 'issn': '', 'pages': '228--243', 'other_ids': {}}, 'BIBREF17': {'ref_id': 'b17', 'title': 'A patient with HIV, dyspnea, and multiple pulmonary nodules: pulmonary Kaposi sarcoma', 'authors': [{'first': 'M', 'middle': [], 'last': 'Joshi', 'suffix': ''}, {'first': 'N', 'middle': [], 'last': 'Markelova', 'suffix': ''}, {'first': 'D', 'middle': [], 'last': 'Palacio', 'suffix': ''}], 'year': 2006, 'venue': 'Chest', 'volume': '130', 'issn': '', 'pages': '1924--1928', 'other_ids': {}}, 'BIBREF18': {'ref_id': 'b18', 'title': 'Clinical and radiographic predictors of the etiology of computed tomographydiagnosed intrathoracic lymphadenopathy in HIV-infected patients', 'authors': [{'first': 'R', 'middle': ['M'], 'last': 'Jasmer', 'suffix': ''}, {'first': 'M', 'middle': ['B'], 'last': 'Gotway', 'suffix': ''}, {'first': 'J', 'middle': ['M'], 'last': 'Creasman', 'suffix': ''}], 'year': 2002, 'venue': 'J Acquir Immune Defic Syndr', 'volume': '31', 'issn': '', 'pages': '291--298', 'other_ids': {}}}, 'ref_entries': {'FIGREF2': {'text': 'AIDS-related variant affects patient with HIV-infection KS usually presents with cutaneous lesions but it may involve other organs, mostly in the pulmonary and gastrointestinal systems. Intrathoracic', 'latex': None, 'type': 'figure'}, 'FIGREF3': {'text': 'Histological findings from surgical biopsy of the right inguinal lymph nodes: fascicles of monomorphic spindle cells and vascular structure mixed with chronic infiltrates. 100× magnification.', 'latex': None, 'type': 'figure'}}, 'back_matter': [{'text': 'None declared.', 'cite_spans': [], 'ref_spans': [], 'section': 'Conflict of interest'}]}\n"
     ]
    }
   ],
   "source": [
    "for c in db['noncomm-subset'].find({'$text':{'$search':'Pleural'}}):\n",
    "    print(c)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': 'United States', 'count': 1}\n",
      "{'_id': \"People's Republic of China\", 'count': 1}\n",
      "{'_id': 'UK', 'count': 2}\n",
      "{'_id': 'Brazil, Brazil, Brazil (', 'count': 1}\n",
      "{'_id': 'P.R. China, P.R. China', 'count': 1}\n",
      "{'_id': 'Italy', 'count': 1}\n",
      "{'_id': 'Hungary', 'count': 1}\n",
      "{'_id': 'USA', 'count': 14}\n",
      "{'_id': 'Denmark', 'count': 1}\n",
      "{'_id': 'Switzerland', 'count': 1}\n",
      "{'_id': 'Japan', 'count': 1}\n",
      "{'_id': None, 'count': 27}\n",
      "{'_id': 'The Netherlands', 'count': 2}\n",
      "{'_id': 'Paraguay', 'count': 1}\n",
      "{'_id': 'Korea', 'count': 4}\n",
      "{'_id': 'France', 'count': 1}\n",
      "{'_id': 'China', 'count': 6}\n",
      "{'_id': 'Israel', 'count': 1}\n",
      "{'_id': 'Ann Arbor', 'count': 1}\n",
      "{'_id': 'Taiwan', 'count': 3}\n"
     ]
    }
   ],
   "source": [
    "for a in db['noncomm-subset'].aggregate([{'$group':{'_id':{'$arrayElemAt': ['$metadata.authors.affiliation.location.country', 0]},\n",
    "                                                    'count':{'$sum': 1}}}]):\n",
    "    print(a)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': \"People's Republic of China\", 'count': 1}\n",
      "{'_id': 'United States', 'count': 1}\n",
      "{'_id': 'Brazil, Brazil, Brazil (', 'count': 1}\n",
      "{'_id': 'Taiwan', 'count': 3}\n",
      "{'_id': 'Italy', 'count': 1}\n",
      "{'_id': 'P.R. China, P.R. China', 'count': 1}\n",
      "{'_id': 'Hungary', 'count': 1}\n",
      "{'_id': 'USA', 'count': 14}\n",
      "{'_id': 'Denmark', 'count': 1}\n",
      "{'_id': 'Switzerland', 'count': 1}\n",
      "{'_id': None, 'count': 27}\n",
      "{'_id': 'Japan', 'count': 1}\n",
      "{'_id': 'The Netherlands', 'count': 2}\n",
      "{'_id': 'Paraguay', 'count': 1}\n",
      "{'_id': 'Korea', 'count': 4}\n",
      "{'_id': 'France', 'count': 1}\n",
      "{'_id': 'China', 'count': 6}\n",
      "{'_id': 'Israel', 'count': 1}\n",
      "{'_id': 'Ann Arbor', 'count': 1}\n",
      "{'_id': 'UK', 'count': 2}\n"
     ]
    }
   ],
   "source": [
    "for a in db['noncomm-subset'].aggregate([{'$group':{'_id':{'$arrayElemAt': ['$metadata.authors.affiliation.location.country', 0]},\n",
    "                                                    'count':{'$sum': 1}}}]):\n",
    "    print(a)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'_id': '0dc475f4419836c2dc352073498f56ae982170a0', 'count': 1}\n",
      "{'_id': '0adc0c7498f0ebbb3c8f1c662da34605d5f91fe2', 'count': 1}\n",
      "{'_id': '01af2562df4acf3113843d039c3b82bb801b1427', 'count': 1}\n",
      "{'_id': '0e63d19fa3d2ebfcc7cdb06f85225ae0489acf8e', 'count': 1}\n",
      "{'_id': '0f90aed025cdf162b89014244740266ce67a3f47', 'count': 1}\n",
      "{'_id': '1a2900a53677a6c68ff37167c31ca33ad219acdb', 'count': 1}\n",
      "{'_id': '0c3068b22cb2cb50114316f9fed2738a943d2435', 'count': 1}\n",
      "{'_id': '0dc8d11784da63b899dbb2b404be4efd330e4ac3', 'count': 1}\n",
      "{'_id': '0f0bb7346d45679cc1bb2435c66d5ad3ef52c108', 'count': 1}\n",
      "{'_id': '01bc7fe59fc7feb0e3d23c716aa23a694a4362a2', 'count': 1}\n",
      "{'_id': '1b7520912fbd483ef60014fe0e7f0d0c2df1d07e', 'count': 1}\n",
      "{'_id': '0b90f302993b075229dbe5f9bc03a180b2e2632f', 'count': 1}\n",
      "{'_id': '0a098b3876e799d9b21608e26e80d05aa9ec6475', 'count': 1}\n",
      "{'_id': '0c92f5b237572a3461ae2205a62ba7622c07a6ab', 'count': 1}\n",
      "{'_id': '0ad29b032fe87db2641893f4cc880c22f2107712', 'count': 1}\n",
      "{'_id': '0a19aacc124c9c42d66d481a9d0c837a76a252e6', 'count': 1}\n",
      "{'_id': '1b58422e266ab9339c919119923229d080f27360', 'count': 1}\n",
      "{'_id': '00e5a723d44eb9f2698c38b518eff85c00f9753b', 'count': 1}\n",
      "{'_id': '0aa3eda0fb09bf9f55864fc2b9157b9317f62323', 'count': 1}\n",
      "{'_id': '0f9341750af1f556fdfee5d61d707278005663ca', 'count': 1}\n",
      "{'_id': '0a296d80d8a8c0408c1ea9559c0f0589fb35cb03', 'count': 1}\n",
      "{'_id': '0df0d5270a9399cf4e23c0cdd877a80616a9725e', 'count': 1}\n",
      "{'_id': '0f2e41a966ec7d622762dc64ba63009e00a69bd5', 'count': 1}\n",
      "{'_id': '01b3d789dbd69fff374842fbe2d7f4150fb3d8f5', 'count': 1}\n",
      "{'_id': '0bcc4d843bd37ae1c8623e45dab6fff11263f798', 'count': 1}\n",
      "{'_id': '1bed4f8a5412cfa315b0936705a647059ceaec62', 'count': 1}\n",
      "{'_id': '1a39379895d1e136f64c7b79ef2204de094dfa75', 'count': 1}\n",
      "{'_id': '0cf8f70367fc77ea444519b2d9ed108765edd25f', 'count': 1}\n",
      "{'_id': '0a2ded6cbd632857d491140a57f2773c3610b10b', 'count': 1}\n",
      "{'_id': '0adc2dfd5f26656ce3527dbb5dec379d44d0601e', 'count': 1}\n",
      "{'_id': '0f8f7f09b42b4b45e128591191176aa358f29b1b', 'count': 1}\n",
      "{'_id': '01aa247284f0baf43293d8ea335b70781365a985', 'count': 1}\n",
      "{'_id': '1bfdb418d0771a30669663e4fa7bc18f5745d780', 'count': 1}\n",
      "{'_id': '1bfeba839c9c98eb6e49ceb13cfcdba28620a61d', 'count': 1}\n",
      "{'_id': '0e78935692851b0466f5a9234adb024e7735c8a3', 'count': 1}\n",
      "{'_id': '1a6e69772e4e79d9106015988c0d6ed48dc25ceb', 'count': 1}\n",
      "{'_id': '1a7676018fd73150a122c2afb1362324dbab4918', 'count': 1}\n",
      "{'_id': '0ace222a6c33986dfe57d3f24779fe5f674724c7', 'count': 1}\n",
      "{'_id': '00a00d0edc750db4a0c299dd1ec0c6871f5a4f24', 'count': 1}\n",
      "{'_id': '0e7c4297d1710cac2a64886cb9a748777b0cd03d', 'count': 1}\n",
      "{'_id': '0f6091029a2cc8ddd6a5c6ee18de7478b73daab2', 'count': 1}\n",
      "{'_id': '0b064096b51c4cada7b64af37eae826b7e7c9649', 'count': 1}\n",
      "{'_id': '0e1c055e39c45d7cef611b6bd17fb67c249ed742', 'count': 1}\n",
      "{'_id': '0f34670b6327305bb3d66de79d1aa96a5d8de2b2', 'count': 1}\n",
      "{'_id': '0a64b2c55fc2091358da4f83ac6fdc7701ddb46e', 'count': 1}\n",
      "{'_id': '0eed9647904ba87a841a177c12a0238faf5c2bd0', 'count': 1}\n",
      "{'_id': '0cea2b0d9b7187e2c5a596ed433be46208186d32', 'count': 1}\n",
      "{'_id': '0f506a74e190c45a399f382c153919612fa1ef5b', 'count': 1}\n",
      "{'_id': '1aaa45043de59cda6c14acd355518c688f37b374', 'count': 1}\n",
      "{'_id': '1be90a46380a03cc53bacd389834702db88ac79b', 'count': 1}\n",
      "{'_id': '0b2c383c48f644edcb7c4dcf40046bd58dd5e0f8', 'count': 1}\n",
      "{'_id': '0fc5801b4cdc21c018c93aa3cbc9b601491fdeb4', 'count': 1}\n",
      "{'_id': '0e2c97d34c8c6042f26cc11e83e1a2fbac521203', 'count': 1}\n",
      "{'_id': '0afa3ea846396533c7ca515968abcfea3f895082', 'count': 1}\n",
      "{'_id': '0e18097a83b2801c4865c72065b7933fa24face3', 'count': 1}\n",
      "{'_id': '0c88aef176b70c6b11a51028124680237a6e5abd', 'count': 1}\n",
      "{'_id': '0c83fb7b5413cd36d8ca958f15e7640636c8e730', 'count': 1}\n",
      "{'_id': '0d0af538cf60b6330d1eb7f5da52bef9ea30fd9c', 'count': 1}\n",
      "{'_id': '0d0ca66887cfd2b3a09f5205cdcbaa4479f17337', 'count': 1}\n",
      "{'_id': '0ae1cad5b20badf8dcea32e8c80209b8948d1e49', 'count': 1}\n",
      "{'_id': '0b627ea5840e5e48709565840313984dc900af8d', 'count': 1}\n",
      "{'_id': '0ae7bedff3dfbfc1ccaeb5b662bbace00ae16b33', 'count': 1}\n",
      "{'_id': '0ce1f213337247a67628f95cf699bdabddc94d9c', 'count': 1}\n",
      "{'_id': '0d3de075e16c6d2e02c68e541b4d2654c78bea04', 'count': 1}\n",
      "{'_id': '0f67baef306ea56d7b574059fb72ff68affb0246', 'count': 1}\n",
      "{'_id': '1badb9da3cd92175be22f42538742c07f58eb5f8', 'count': 1}\n",
      "{'_id': '0a449e173239afb38816257e1a53811b47bf13f4', 'count': 1}\n",
      "{'_id': '1a3ac4ed56c42714b04e97e0e5e11a93c5a91508', 'count': 1}\n",
      "{'_id': '1bf18631b9c161ea2834b3d7c8ea42875319d18c', 'count': 1}\n",
      "{'_id': '0caa109e0faf5c5fefe81a8108e1199058cb3a27', 'count': 1}\n",
      "{'_id': '1c3abd60f3deefb350c36d0f51ba2ae27eff56b5', 'count': 1}\n"
     ]
    }
   ],
   "source": [
    "for a in db['noncomm-subset'].aggregate([{'$group':{'_id':'$paper_id','count':{'$sum': 1}}}]):\n",
    "    print(a)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
